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Chronic pain is a disease of the central nervous system. Neuropsychological symptoms present in 
some conditions suggest changes in brain function similar to those typically seen in people with 
brain lesions. One striking example is Complex Regional Pain Syndrome (CRPS), which presents 
as sensory, motor, and autonomic dysfunctions in the affected body part. People with CRPS can 
also show distortions in body representation, spatial cognition, and other cognitive functions. 
These neuropsychological symptoms appear to contribute to the clinical manifestations of CRPS. 
The role of spatial attention biases was initially suggested by the apparent efficacy of a 
neurocognitive treatment that targets changes in spatial cognition, called prism adaptation. 
However, its effects on clinical symptoms of CRPS were only tested in small, uncontrolled 
studies, and the direct evidence of spatial biases in CRPS is often inconsistent. Thus, our current 
understanding of the nature and clinical relevance of the neuropsychological symptoms is limited, 
as is the evidence of the effectiveness of neurocognitive treatments for CRPS. This thesis 
investigates (1) how neuropsychological functions are altered in CRPS, (2) whether 
neuropsychological symptoms contribute to the clinical manifestations of CPRS, and (3) whether 
prism adaptation treatment can reduce pain and other symptoms of CRPS. First, I present a critical 
literature review, concluding that people with CRPS can present with distorted representation of 
the affected limb, lateralised biases in spatial cognition, and non-spatially-lateralised cognitive 
deficits. I further discuss the potential mechanisms of such neuropsychological changes. The 
experimental studies I present in the following chapters primarily concern the spatial biases. They 
call into question some of the previous findings about neuropsychological changes in CRPS and 
their clinical relevance by showing that (a) when a significant spatial bias is observed at individual 
level, it is not necessarily stable over time, even when pain and body representation are, and (b) 
when I conducted robust assessments on a large sample, there was no evidence of spatial biases 
at group level, or of their relationship with clinical symptoms. Finally, I present a randomised 
controlled trial of prism adaptation treatment for CRPS, which showed no therapeutic effects on 
pain or CRPS severity beyond those of a control treatment, while overall CRPS severity decreased 
over time. These results suggest that the previously reported apparent benefits of prism adaptation 
could be attributed to movement of the affected limb or placebo effect. Overall, this thesis 
highlights the heterogeneity of neuropsychological symptoms in CRPS, and that previously 
reported changes in spatial cognition and their clinical relevance might have been overstated. 
Instead, my findings support the conclusion that motor function and body representation might 
be associated with clinical manifestation of CRPS and its progression over time. The major 
contribution of this thesis is providing a detailed and systematic evaluation of neuropsychological 
changes - especially spatial biases - in CRPS, and a robust test of prism adaptation treatment. The 
conclusions offer a balanced perspective on the role of neuropsychological functions in the 
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In this general introduction, I will describe the concept of pain, considering its primary adaptive 
functions as well as its pathological manifestation as chronic pain. I will further introduce 
Complex Regional Pain Syndrome (CRPS), which is the subject of this thesis, and summarise its 
clinical presentation and proposed mechanisms. Focusing on changes in brain function, I will 
refer to cortical reorganisation and higher cognitive functions that are altered in chronic pain. I 
will then summarise generally established relationships between pain and cognition, primarily 
focusing on attention, and demonstrate how these functions might be affected differently in CRPS. 
I will provide an overview of cognitive changes found in CRPS, centring on biases in lateralised 
spatial cognition that resemble hemispatial neglect syndrome. These spatial biases will be the 
main focus of this thesis. Next, I will summarise currently available treatments for CRPS and 
their efficacy, and introduce a recently suggested neurocognitive treatment, called prism 
adaptation, which targets the changes in spatial cognition. This will be followed by a 
consideration of the proposed mechanisms through which prism adaptation can affect pain and 
other clinical symptoms of CRPS. Finally, I will provide an outline of the following chapters. 
Pain is a common and natural experience, which we regularly encounter in our daily lives in 
different forms and under varying circumstances. For example, we feel instantaneous pain when 
we stub our toe on a coffee table, and we can get a headache when working too much on a 
computer. The International Association for the Study of Pain defines pain as an “unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage” (Merskey & Bogduk, 1994, p. 209). However, despite its negative 
connotation, pain serves a crucial and adaptive function to protect our body from harm. In fact, 
immediate pain typically acts as a warning mechanism, signalling potential injury and facilitating 
action to minimise impending damage, such as taking our hand off a hot stove. Intense, acute pain 
can persist with severe injury. However, injury-induced pain also facilitates resting behaviour, for 
instance, after a surgery, which reduces the chance of worsening the injury and increases the 
chance of healing. Pain is also a symptom of other diseases (Treede et al., 2019), including mild 
infections, tissue inflammation, stroke, and cancer. It is therefore not surprising that pain is one 
of the leading reasons to seek medical advice (Finley et al., 2018; Mäntyselkä et al., 2001). Taken 
together, pain serves the purpose of signalling that there might be something wrong with our body 
and that we should alter our behaviour. 
In many cases, pain acts as a symptom of some associated tissue damage. Some examples are a 
needle piercing skin and muscles during injection, a fracture damaging the bones and surrounding 
soft tissues, or a surgeon cutting through organs during an operation. However, while all these 
physiological factors can inflict pain, the intensity of perceived pain cannot be considered 
identical to the severity of tissue damage. This is because pain is a subjective experience and 
depends on a multitude of physiological and psychological factors. These include our emotional 
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state, cognitive factors such as attention or expectations, and the sensitivity of our central nervous 
system (Melzack & Casey, 1968). In fact, pain intensity can be disproportionate to the extent of 
any injury. One trivial example, which might be familiar to many people, is stepping on a Lego 
brick. Other examples can be found in the clinical context, for instance, in patients with allodynia, 
who experience pain evoked by light touch. Furthermore, there are several cases in which we 
cannot identify any observable physical cause of pain, like in migraine, when pain is experienced 
in the absence of identifiable damage to tissue or ligaments, or when it is felt even long after an 
initial injury has healed. In such cases, where pain does not act as a symptom of physical damage, 
its ongoing manifestation can seem paradoxical. In other words, despite its primarily adaptive 
function, pain can become pathological in situations when it is not strictly associated with physical 
injury to the body or persists beyond any adaptive purpose.  
Pain that persists beyond the time of normal healing, or for a given length of time based on 
common medical experience, is defined as chronic. Three months is conventionally used as the 
point of division between acute and non-malignant chronic pain, however, this definition is 
arbitrary and the division can vary depending on the type of injury (Merskey & Bogduk, 1994). 
Chronic pain is an independently acknowledged disease affecting one in five people worldwide 
(Gureje et al., 1998), although recent estimates in the UK suggest even higher levels of prevalence 
(Fayaz et al., 2016). In many chronic pain conditions, such as fibromyalgia or non-specific low 
back pain, pain severity cannot be accounted for by any apparent physical damage or peripheral 
changes, but rather depends on mechanisms within the central nervous system (hereafter termed 
“central mechanisms”). Thus, chronic pain has been considered a disorder of the central nervous 
system, involving plasticity at both the spinal and supraspinal level (for reviews, see Henry, 
Chiodo, & Yang, 2011; Kuner & Flor, 2017; Lee, Nassikas, & Clauw, 2011; Seifert & Maihöfner, 
2008). One such example, which is the central focus of this thesis, is Complex Regional Pain 
Syndrome (CRPS), and will be described in further detail below.  
CRPS is a primarily unilateral chronic pain syndrome that can develop after an injury to a limb. 
It is associated with spontaneous and evoked pain of a magnitude and duration that is 
disproportionate to any inciting trauma (Merskey & Bogduk, 1994). The incidence of CRPS is 
between 6 and 26 in 100 000 people per year (de Mos et al., 2007; Sandroni et al., 2003). A higher 
incidence was found amongst people who have suffered an injury to a limb, most commonly a 
fracture, sprain, or surgery (de Mos et al., 2007), although CRPS symptoms can also develop 
spontaneously (Rooij et al., 2010). Regardless of the type of inciting event, people with CRPS 
present with disproportionate continuous pain and other sensory, autonomic, and motor 
symptoms, some of which are illustrated in Figure 1. They can experience innocuous touch as 
painful, and present with hypersensitivity to pain or loss of sensation in the affected limb. They 
can show temperature, colour, and sweating asymmetries between the limbs, as well as swelling 
and changes in the skin, nails, and hair growth in the affected extremity. Motor abnormalities can 
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involve decreased range of movement, tremor, muscle spasms, dystonia, or weakness (Harden et 
al., 2010; see Chapter 1 for full diagnostic criteria). 
 
Figure 1. Clinical presentation of CRPS. All photographs illustrate upper limbs of individuals 
diagnosed with CRPS in their right hand and / or wrist. Examples of apparent CRPS symptoms 
include: (A) dystrophic changes in the skin, skin colour asymmetry, and muscle weakness (visible 
atrophy); (B) sweating asymmetry and oedema; (C) oedema, shiny skin, and limited range of 
movement (inability to open the hand); and (D) dystonia (fingers fixed in unusual posture). 
Although CRPS is regional, and thus primarily affects one extremity, its symptomology cannot 
be explained by peripheral mechanisms alone. There are two types of CRPS that are distinguished 
based on the presence (type II) or absence (type I) of major peripheral nerve damage, although 
the clinical symptomatology and diagnostic criteria are the same for both types. While nerve 
injury is one of the possible causes of CRPS, there is a range of other mechanisms through which 
CRPS develops. Existing literature indicates that its complex, yet elusive, pathophysiology 
depends on abnormal interactions between peripheral and central mechanisms. Peripheral 
processes include inflammation and vasomotor dysfunction, whereas central processes involve 
neuroplasticity, such as central sensitization (increased responsiveness of spinal neurons, which 
send nociceptive signals to the cortex even in absence of such input) and cortical reorganisation 
(for reviews, see Maihofner, Seifert, & Markovic, 2010; Marinus et al., 2011; Reinersmann, 
Maier, Schwenkreis, & Lenz, 2013). Peripheral inflammatory mechanisms are thought to 
dominate in the earlier stages of CRPS (up to 6 months after onset), whereas central 
neuroplasticity is considered the leading pathophysiological mechanism in more chronic stages 
(Birklein & Schlereth, 2015).  
There is evidence that functional reorganisation in the brain, specifically in the primary 
somatosensory and motor cortices, plays a role in the development and maintenance of similar 
chronic pain conditions. For instance, in people with phantom limb pain (pain perceived in a limb 
that has been amputated), the extent of cortical reorganisation was found to strongly correlate 
with pain intensity (Flor et al., 1995; Karl et al., 2001). Similar relationships were found in 
individuals with CRPS (Maihofner, Handwerker, Neundorfer, & Birklein, 2003; Pleger et al., 
2006) or fibromyalgia, which is a widespread chronic pain condition (Kim et al., 2015). 
Furthermore, the extent of reorganisation of somatosensory cortical maps was found to increase 
with disease duration in people with chronic back pain (Flor et al., 1997). However, it should be 
noted that the relationship between pain and cortical plasticity is still being debated – for instance, 
high-resolution neuroimaging studies revealed that reorganisation of sensory representations of 
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the missing hand in amputees with phantom limb pain, and of the affected hand in people with 
CRPS, might not be as robust as previously reported, and its extent is not necessarily related to 
pain severity (Makin et al., 2015; Mancini et al., 2019).  
Notwithstanding the mixed evidence for cortical reorganisation, CRPS is a particularly vivid 
example of chronic pain that cannot be explained solely by peripheral pathology. In fact, central 
neuroplasticity might account for some of the puzzling clinical symptoms of this disorder, such 
as increased sensitivity to pain that is not limited to the primarily affected part of the body and is 
present in the areas that do not overlap with the skin areas mainly supplied by single spinal nerves 
(Rommel et al., 1999). Intriguingly, neuroplasticity also appears to manifest through changes in 
higher cognitive functions in CRPS and other chronic pain conditions. While cortical 
representations are based on the neural maps of the areas of the brain dedicated to processing 
sensory or motor functions, cognitive representations refer to internal mental models of our body 
and external environment. Altered cognitive representations of the body and external space have 
been reported in chronic back pain, fibromyalgia, neuropathic pain, phantom limb pain, and other 
types of pain affecting one limb (Förderreuther et al., 2004; Galer & Jensen, 1999; Kolb et al., 
2012; Reinersmann et al., 2010; Bufacchi et al., 2017; Makin et al., 2010; Tsay et al., 2015; 
Martínez et al., 2018). The assumption that plastic changes in the brain contribute to pain 
(although the mechanisms for this relationship are unclear) builds the basis for several behavioural 
treatments that aim to normalise cortical and / or cognitive representations. For example, training 
of sensory and motor function reversed cortical reorganisation and reduced pain in phantom limb 
pain and CRPS (Flor et al., 1997; Pleger et al., 2005). Furthermore, neurocognitive rehabilitation 
methods that target cognitive representations of the painful part of the body, such as mirror visual 
feedback or graded motor imagery, reduced pain in both phantom limb pain and CRPS (Moseley, 
2006; Ramachandran & Altschuler, 2009). Therefore, treatments that target changes in brain 
function have the potential to reduce clinical manifestations of chronic pain, including CRPS. 
Cognitive functions are integral to pain processing, however, their relationship in CRPS appears 
to be somewhat different than in the context of acute pain and chronic pain more generally. 
Overall, selective attention, spatial perception, and action selection play a crucial role in 
protecting the body from potential harm (Legrain & Torta, 2015). The function of these processes 
is to prioritise the meaningful information that could act as a warning (e.g. pain) and integrate this 
information with the representations of the body and surrounding space to guide defensive 
behaviours. The role of selective attention is to prioritise the most significant information. Spatial 
perception allows locating the painful site or threatening object in space. Action selection prepares 
the most appropriate motor response to the threat / pain. Locating the potentially threatening 
information is necessary for identifying the part of the body that could be affected, and to guide 
a defensive reaction. Thus, coordinating the representations between body and external space is 
important for pain processing. The relevant regions of space perception can be divided into body 
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space, based on anatomical coordinates, near space within one’s reach and far space beyond one’s 
reach, based on external spatial coordinates (Kerkhoff, 2001; Legrain & Torta, 2015). The spatial 
location of potentially threatening information is coded based on both anatomical and external 
coordinates. An example of evidence for this is that crossing the hands over the body midline, 
which induces incongruence between anatomical and external coordinates, decreases accuracy in 
the localisation of nociceptive stimuli applied to the hands relative to when the hands are 
uncrossed (Sambo et al., 2013). Likewise, nociceptive stimulation of one side of the body 
increases our attention to non-painful information in the corresponding side of near space 
(Filbrich, Alamia, Blandiaux, et al., 2017). Another example of how pain can affect our spatial 
attention and representations comes from patients with trigeminal neuralgia: chronic pain 
affecting one side of the face, in which even a light touch can trigger excruciating pain. The 
representation of the “painful” side of near space in these patients was found to extend further 
from their body than the representation of the “non-painful” side, which could reflect increased 
vigilance to any approaching stimulus that could trigger pain (Bufacchi et al., 2017). Therefore, 
coordinating body and external representations allows us to locate a potential threat and facilitate 
action to minimise the damage or avoid exacerbation of pain, for instance, when warding off a 
wasp, or guarding the painful body part from touch. Examining the relationships between CRPS 
and these cognitive representations is the central goal of this thesis. 
The effects of pain on cognition go beyond the adaptive function to protect the body and can also 
be detrimental. Up to 20% of patients with chronic pain show clinically significant impairments 
in working memory, verbal learning and memory, psychomotor speed, and attentional capacity 
(Hart et al., 2000; Landrø et al., 2013). While all these cognitive functions are, to some extent, 
considered in this thesis, the main focus lies on attention. Chronic pain has constant interruptive 
effects on attention that result in an impaired ability to disengage attention from pain (Eccleston 
& Crombez, 1999). These effects can also manifest as attention bias towards pain-related 
information which can further exacerbate and maintain pain (although its prevalence in chronic 
pain has been debated; see Crombez, Van Ryckeghem, Eccleston, & Van Damme, 2013). Thus, 
deflecting attention away from pain is thought to decrease its perceived intensity (McCaul & 
Malott, 1984). However, Eccleston (1994) suggested that processing severe pain requires 
conscious attentional control, and that diverting attention away from pain and towards other tasks 
might only be possible in the case of low pain intensity.  
Taken together, the relationship between pain and cognition appears to be mutual and involve 
representations of our body, external space, and attentional processes. Pain is attention-grabbing 
and can bias our processing of bodily and external information, usually towards the pain. 
However, while these effects have been largely shown in acute pain and chronic pain more 
generally (i.e., regardless of diagnosis), individuals with CRPS seem to show rather opposite 
effects of pain-attention interaction. I will discuss these in more detail below. 
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Higher cognitive changes found in CRPS can affect the perception, representation of, and 
attention to the CRPS-affected limb and the corresponding side of external space (Galer & Jensen, 
1999; Lewis et al., 2007; Moseley et al., 2009; Schwoebel et al., 2001). Throughout the thesis, I 
will refer to these cognitive changes as neuropsychological symptoms, and their full breadth will 
be discussed in Chapter 1. In brief, previous research has focused on two main areas of 
dysfunction: body representation and lateralised spatial cognition. Distortions of body 
representation include, for example, overestimation of the perceived size of the CRPS-affected 
limb, altered perception of its shape and weight, poor awareness of its position, reduced sense of 
ownership of the limb, and difficulties in recognising the laterality of images of limbs 
corresponding to the affected body part (Lewis et al., 2007, 2010; Moseley, 2005a; Schwoebel et 
al., 2001). Biases in lateralised spatial cognition are comprised of a deviation of egocentric 
reference frame (coding of external spatial information in relation to one’s own body) towards 
the CRPS-affected side, reduced attention to the affected relative to the unaffected side, and 
requiring direct attention to move the affected limb. These biases appear to be linked to the 
affected limb and / or the side of space in which the affected limb usually resides (Bultitude et al., 
2017; Galer et al., 1995; Moseley et al., 2009; Reid et al., 2016, 2018; Sumitani, Shibata, et al., 
2007). The evidence for changes in spatial cognition in CRPS remains ambiguous and is one topic 
of this thesis, however, in general, spatial attention bias is directed away from the affected side 
and resembles the neurological syndrome called hemispatial neglect.  
Hemispatial neglect can follow a brain injury (e.g. a stroke), after which patients show reduced 
attention to the contralesional, relative to the ipsilesional side of their body and / or space. These 
attention deficits can affect processing of sensory information, movements, and / or cognitive 
representations, and they cannot be explained by sensory or motor loss (Kerkhoff, 2001). Biases 
in spatial cognition found in CRPS are often described through an analogy to hemispatial neglect 
(Galer et al., 1995; Legrain et al., 2012). While patients with brain lesions neglect the side 
contralateral to their injured hemisphere, people with CRPS appear to neglect their affected side. 
Throughout this thesis I will use the term “neglect-like” to describe reduced attention to the 
affected relative to the unaffected side of the body and space for the purpose of readability and 
conciseness. However, it is worth noting that there are mechanistic differences between 
hemispatial neglect and biases in spatial cognition in CRPS. For instance, while cases have been 
reported where CRPS developed after a stroke (Harrison & Field, 2015), it is typically not 
associated with brain injury. Furthermore, in contrast to neglect after brain injury, people with 
CRPS are often aware of some aspects of their attentional deficits, and are able to verbalise them 
(Frettlöh et al., 2006; Galer & Jensen, 1999). Despite these differences, an extensive body of 
research on hemispatial neglect provides a robust theoretical and methodological framework to 
study spatial cognition in CRPS, which, in contrast, has not been extensively studied. This 
framework substantially informs the hypotheses I put forward and the methods I use in this thesis, 
including the potential utility of a novel neurocognitive treatment for CRPS.  
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Current guidelines for CRPS management (Goebel et al., 2018) emphasise an integrated, 
interdisciplinary approach to reduce pain, restore function, facilitate self-management of the 
condition, and ultimately improve quality of life. These objectives should be achieved through 
pain relief medication and procedures, physical and occupational therapy, patient education, and 
psychological interventions. Pharmacotherapy, in addition to pain relief, also targets 
inflammation, motor impairment, and loss of bone density. Invasive treatments such as 
sympathetic nerve blockade or spinal cord stimulation are less common but can provide pain relief 
for some patients. Physical rehabilitation and behavioural interventions used in clinical practice 
focus on restoring function and normal perception of the affected limb through exposure 
therapies, desensitisation, mirror therapy, and graded motor imagery. Self-management education 
includes advice to direct attention to the affected limb, recognising that patients might “neglect” 
it. Finally, psychological interventions most often follow principles of cognitive-behavioural 
therapy (Birklein & Schlereth, 2015; Goebel et al., 2018). A systematic review of randomised 
controlled trials of treatments for CRPS (Cossins et al., 2013) revealed that there is strong 
evidence supporting physiotherapy (including graded motor imagery), bisphosphonates 
(preventing loss of bone density early after CRPS onset), and repetitive transcranial magnetic 
stimulation. The review further reported moderate evidence for ketamine infusions, and limited 
evidence for spinal cord stimulation. Nevertheless, for most of the methods used in clinical 
practice, a lack of robust, randomised controlled trials prevents providing conclusive therapeutic 
guidelines. Despite the available treatments, the prognosis of recovery from CRPS is relatively 
poor. Population-based studies revealed that, in usual care, the greatest reduction in symptom 
severity occurred within the first six months after onset. However, only 5.4% of cases resolved 
completely within the first 12 months (Bean et al., 2016). Two or more years after onset, 64% of 
patients still fulfilled the CRPS diagnostic criteria, one third was unable to work, and 16% 
reported that their symptoms were still worsening (de Mos et al., 2009). Although CRPS primarily 
affects a distal extremity, such as a hand or a foot, the symptoms might also expand to other limbs 
over time (Rijn et al., 2011). Moreover, people with a history of CRPS have increased risk of 
developing CRPS in a second, previously unaffected extremity, when it is subjected to an injury 
or a surgery (Satteson et al., 2017). Although it is rare, CRPS has a disproportionately high 
individual and societal cost in terms of quality of life, withdrawal from work and social life, and 
high burden on the healthcare systems (de Mos et al., 2009; Elsamadicy et al., 2018; van Velzen 
et al., 2014). Therefore, developing novel treatments holds promise for improving management 
and outcomes of this debilitating condition. Considering the evidence of cortical reorganisation 
and neuropsychological symptoms in CRPS, neurocognitive treatments that, in lay terms, aim to 
“retrain the brain”, have potential to reduce pain and improve function through normalising 
cortical and / or cognitive representations of the body, movement, and the environment. 
Prism adaptation is a form of sensory-motor training that has been used to study temporary 
plasticity in the healthy brain (Redding & Wallace, 1993; von Helmholtz, 1909) and to normalise 
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spatial attention deficits in hemispatial neglect after brain injury (Rossetti et al., 1998). Typical 
prism adaptation procedures use prismatic lenses, which refract the light so that the position of an 
object viewed through such lenses appears shifted to one side of its true location (Figure 2). When 
we try to quickly reach for that object while wearing prismatic lenses, at first, we miss in the 
direction of the visual shift. Thus, the actual consequences of our movement do not match the 
expected consequences. However, this discrepancy diminishes with repeated movement 
experiences, and after several trials we can accurately reach for the object viewed through 
prismatic lenses. One process involved in the adjustment of our movements is a strategic online 
correction of movement trajectory, that is, deliberately mis-pointing further to the side of the 
perceived object location. Another process involved in the adaptation of our movements to lateral 
visual shift is a slower but sustained spatial realignment of visual, proprioceptive, and motor 
reference frames. This spatial realignment is thought to be automatic and not accessible to 
conscious awareness. The outcomes of this “true” adaptation can be observed as after-effects: 
once prismatic lenses are removed, and we try to reach for the object again, we miss in the 
direction opposite to the visual shift (Redding & Wallace, 1993).  
 
Figure 2. A pair of prism goggles and a left hand viewed through a prismatic lens. The left side 
of the scene has been photographed through a leftward-shifting prismatic lens, thus the objects 
appear shifted to the left of their true location. The right side of the image represents the scene 
without any visual distortion. 
Research in healthy individuals and people with hemispatial neglect after brain injury shows that 
the effects of prism adaptation are not limited to lower-level realignment of sensory-motor 
reference frames (Redding & Wallace, 2006), but also generalise to higher-level cognitive 
functions, such as spatial attention, mental representations of space, and spatially-defined motor 
function (Frassinetti et al., 2002; Jacquin-Courtois et al., 2013; Michel, 2016; Striemer & Borza, 
2017). In fact, there is robust evidence that two weeks of once- or twice-daily prism adaptation 
treatment can ameliorate spatial attention deficits after a stroke (Làdavas et al., 2011; Mizuno et 
al., 2011), and effects can last up to 3 months (Frassinetti et al., 2002; Serino et al., 2007, 2009; 
Vangkilde & Habekost, 2010). This evidence includes direct comparisons of prism adaptation to 
sham treatments in randomized controlled trials.  
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Considering that people with CRPS can present with spatial attention biases resembling 
hemispatial neglect, and that prism adaptation can effectively reduce attention deficits, this 
method has been used to treat CRPS, with promising preliminary results (Figure 3). Prism 
adaptation performed with the affected limb and using lenses that induced visual shifts away from 
the affected side (thus producing after-effects towards the affected side) significantly reduced 
pain and other CRPS symptoms in a total of 13 patients with upper-limb CRPS across three 
independent studies (Bultitude & Rafal, 2010; Christophe, Chabanat, et al., 2016; Sumitani, 
Rossetti, et al., 2007). Pain reduction was maintained for up to two weeks after treatment cessation 
(Bultitude & Rafal, 2010; Christophe, Chabanat, et al., 2016). The evidence of the effectiveness 
of prism adaptation treatment for CRPS, however, is limited, as the abovementioned studies only 
tested small samples of patients and included neither control treatments nor blinding. Hence, a 
robust evaluation of the effects of this treatment is required before it can be incorporated into 
CRPS management. 
 
Figure 3. Pain reduction following prism adaptation treatment. The effects of prism adaptation 
(PA) on pain intensity reported in three previous studies of this treatment in CRPS are 
summarised. Pain intensity is expressed on an 11-point Numerical Rating Scale: 0 = “no pain at 
all”, 10 = “the worst pain imaginable” used by Sumitani, Rossetti, et al. (2007) and Bultitude and 
Rafal (2010); average ratings from a 0-100 Visual Analogue Scale with the same anchors used by 
Christophe, Chabanat, et al. (2016) were scaled for the purpose of comparison with the two former 
studies. 
Another potential limitation to recommending prism adaptation as a standard therapeutic 
intervention for CRPS is that the mechanisms through which it can reduce pain remain unknown 
(Torta et al., 2016). The primary mechanism of action is thought to involve normalisation of the 
spatial attention bias, which is consistent with the initial clinical application of prism adaptation 
to reduce neglect symptoms after brain injury. This mechanism is supported by the evidence that 
the effects of prism adaptation generalise across different domains of spatial cognition and motor 
function in people with and without brain injury (Jacquin-Courtois et al., 2013; Michel, 2016). 
However, it is unclear how spatial cognition relates to pain. Sumitani, Shibata, et al. (2007) 






















Sumitani et al., 2007;
N=5; 2 weeks, once daily
Bultitude & Rafal, 2010;
N=1; 3 weeks, once daily
Christophe et al., 2016;
N=7; 4 days, twice daily
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reversed when they transiently decreased their participants’ pain using a nerve blockade in the 
affected limb. This finding suggests that persistent pain can induce a bias in spatial cognition. 
Although empirical evidence that CRPS pain causes “neglect-like” biases is lacking, one 
possibility is that habitually directing attention away from pain might serve the purpose of 
decreasing its perceived intensity (McCaul & Malott, 1984). However, this strategy seems to be 
maladaptive in the long-term, as the extent of “neglect-like” biases in CRPS has been related to 
greater severity of pain and other clinical symptoms (Frettlöh et al., 2006; Kolb et al., 2012; 
Moseley et al., 2009; Moseley, Gallace, & Iannetti, 2012; Reid et al., 2016, 2018; Wittayer et al., 
2018). Therefore, increasing attention to the affected side might have therapeutic benefits. Spatial 
representations were also found to modulate CRPS symptoms. Specifically, Moseley and his 
colleagues found that limb temperature asymmetry normalised if people with CRPS physically 
rested the affected limb in the unaffected side of space (Moseley, Gallace, & Iannetti, 2012), or 
simply viewed it in this location by means of an illusory prismatic shift (Moseley et al., 2013). 
However, our recent study could not replicate this effect (Vittersø et al., 2020). Direction-specific 
effects of prism adaptation further support the attentional mechanism of its effects on pain. That 
is, while prism adaptation inducing after-effects towards the CRPS-affected side (hence 
increasing attention to that side) was found to reduce pain intensity, inducing after-effects away 
from the affected side increased pain in one CRPS patient (Sumitani, Rossetti, et al., 2007). Thus, 
restoring the balance of spatial attention seems to be a key component of the mechanism leading 
to pain reduction, and this will be the leading hypothesis for this thesis. Nonetheless, there is some 
evidence speaking against the attentional mechanism. In Christophe, Chabanat, et al.'s (2016) 
study, prism adaptation significantly reduced pain, without any effect on patients’ spatial 
cognition or motor function. Also, no “neglect-like” symptoms were found in these patients at 
baseline. Indeed, relationships between “neglect-like” biases and pain intensity in CRPS were not 
consistently found in several other studies (Bultitude et al., 2017; Filbrich, Alamia, Verfaille, et 
al., 2017; Michal et al., 2016; Reinersmann et al., 2012).  
A potential second mechanism through which prism adaptation could reduce pain is normalisation 
of sensory-motor integration. It has been suggested that distorted body representation contributes 
to discrepancies between motor intention and sensory feedback during movement, which can 
cause pathological pain, similar to how incongruence between visual and vestibular information 
can induce motion sickness (Bultitude & Rafal, 2010; Harris, 1999; McCabe & Blake, 2008). 
Although experimental studies in healthy volunteers generally failed to induce painful sensations 
using sensory-motor conflicts (McCabe et al., 2005; Moseley, 2005c; Moseley & Gandevia, 
2005), such manipulations exacerbated pain in people with chronic pain, including CRPS (Brun 
et al., 2019). Both central and peripheral mechanisms could contribute to persistent discrepancies 
between motor intention, proprioception, and vision in CRPS. Centrally, they could be driven by 
cortical reorganisation, distorted body perception, and visuospatial deficits (Bultitude et al., 2017; 
Di Pietro et al., 2013b, 2013a; Filbrich, Alamia, Verfaille, et al., 2017; Lewis et al., 2007; 
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Schwoebel et al., 2001; Sumitani, Shibata, et al., 2007). Peripherally, these discrepancies could 
arise from primary sensory and motor symptoms, and impaired proprioception (Harden et al., 
2010; Lewis et al., 2010). The hypothesis that these sensory-motor discrepancies cause (McCabe 
& Blake, 2008), or rather exacerbate and maintain pain in CRPS, implies that re-establishing 
sensory-motor congruence could reduce pain. This could relate to the efficacy of prism adaptation 
because the initial sensory-motor discrepancy during the early phase of prism adaptation could 
provide a potent error signal that triggers normalisation of body representation and recalibration 
of distorted sensory and motor representations in people with CRPS. Consistent with this potential 
sensory-motor mechanism of action, sensory feedback from the affected limb during prism 
adaptation seems necessary for the therapeutic effects to occur, because performing the treatment 
with the unaffected limb did not reduce pain in a study of one CRPS patient (Bultitude & Rafal, 
2010). Nonetheless, this mechanism does not account for the direction-specific effects of prim 
adaptation in CRPS, and empirical evidence supporting the sensory-motor model of pain in CRPS 
is scarce.  
The two proposed mechanisms through which prism adaptation could reduce pain, that is 
normalising spatial attention and sensory-motor integration, are not mutually exclusive. In this 
thesis, I will examine the evidence for these mechanisms by exploring whether any spatial biases 
and / or body representation distortions are related to clinical CRPS symptoms, and to any 
reduction in pain and other symptoms following prism adaptation. Although I will consider both 
changes in spatial cognition and body representation, my investigations will primarily focus on 
testing spatial biases, because most inconsistencies in the current CRPS literature occur within 
this area. Mixed evidence for spatial attention bias in CPRS could be partly due to methodological 
limitations of the previous studies. In this thesis, I will address these limitations by drawing on 
the hemispatial neglect literature to create a more appropriate and better-controlled set of tests to 
measure spatial cognition in CRPS. 
In summary, central mechanisms of CRPS involve cortical neuroplasticity that can manifest in 
neuropsychological symptoms. Some of these symptoms resemble hemispatial neglect after brain 
injury, although the evidence of the direction and magnitude of biases in spatial cognition in 
CRPS is not consistent and requires more systematic, robust investigation. Preliminary studies 
suggested that targeting spatial biases through prism adaptation treatment could provide 
therapeutic benefits. However, so far there are no sufficiently powered and controlled studies 
supporting the effectiveness of prism adaptation for CRPS. Furthermore, the working 
mechanisms of the effects of prism adaptation on pain are poorly understood, and so is the 
relevance of neuropsychological symptoms for the severity of clinical symptoms of the disorder.  
In this thesis, I will focus on the role of neuropsychological changes in the clinical manifestation 
of CRPS-I, and how understanding them can inform developing more effective treatments for 
individuals living with this condition. My three overall aims are to investigate (1) how 
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neuropsychological functions are altered in CRPS, (2) whether neuropsychological symptoms 
contribute to the clinical manifestations of CPRS, and (3) whether prism adaptation treatment can 
reduce pain and other symptoms of CRPS. 
Chapter 1 provides a conceptual background to the thesis in the form of a comprehensive 
overview of the current state of research on higher cognitive functions in CRPS. Here I present a 
review of behavioural evidence of neuropsychological changes in CRPS and discuss the 
hypothesised mechanisms through which such changes could arise. To this end, I bring together 
the evidence regarding multiple domains of body representation, lateralised spatial cognition 
(including “neglect-like” symptoms), and non-spatially lateralised cognitive functions such as 
object recognition and constructional abilities, numerical processing, working memory, executive 
functions, and language processing. I further discuss the relevance of neuropsychological changes 
for clinical signs of CRPS and outline existing treatment approaches that target 
neuropsychological functions. Integration of the existing evidence of neuropsychological 
symptoms and their clinical relevance contributes to a better understanding of CRPS as a disorder 
of the central nervous system. Although the core of this thesis is set around biases in spatial 
cognition and their relevance for treatment, Chapter 1 contextualises this topic within the full 
breadth of neuropsychological changes in CRPS and their implications. Through further 
comparison of cognitive changes in CRPS and other chronic pain syndromes, this chapter 
demonstrates the potential benefits of studying CRPS as an exemplary condition that can inform 
us about neuropsychological aspects of other similar syndromes or chronic pain more generally.  
Chapter 2 is the first experimental study and investigates under what circumstances spatial biases 
in CRPS might arise through a longitudinal case study. This allows me to test some of the 
hypothesised mechanisms proposed in the first chapter. This study follows a woman with CRPS 
who has previously presented to our laboratory with neglect-like symptoms and body 
representation disturbance of a severity that is normally only seen in brain-lesioned patients. I 
assessed her neuropsychological functions over two further sessions with the aim of dissociating 
the regions of space and sensory modalities in which these biases can manifest. This study 
provides a proof of concept that 1) people with CRPS can have spatial biases that are apparent on 
experimental measures of attention such as those that have been developed to test hemispatial 
neglect after stroke, 2) such biases can change in direction over time (specifically, from a bias 
away from to a bias towards the affected side), and 3) the biases can be independent of pain or 
body representation. So far, no other study has assessed the consistency of neuropsychological 
symptoms in people with CRPS over long periods of time. Changes in the direction of the spatial 
bias have potential implications for designing interventions that target neuropsychological 
symptoms for the treatment of CRPS. 
Chapters 3, 4, and 5 describe a double-blind, randomised, controlled trial of a neurocognitive 
treatment that was first tested on CRPS due to the apparent “neglect-like” component to the 
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disorder. The purpose of this trial is twofold. First, it aims to robustly test the effects of prism 
adaptation on clinical symptoms and neuropsychological functions in people with CRPS (Chapter 
5). This trial substantially improves upon the methods of the previous studies that provided initial 
evidence for the effectiveness of prism adaptation treatment by including a large sample of people 
with CRPS, a control treatment, randomisation, and double-blinding. The secondary aim is to 
investigate the relationships between the extent of any neuropsychological deviations in people 
with CRPS (compared to healthy controls) and the severity of clinical symptoms of CRPS 
(Chapter 4). Understanding which cognitive functions are affected in CRPS could help optimise 
neurocognitive treatments, for example by identifying how to better tailor the treatments or select 
individuals for rehabilitation, thus the secondary aim is integral to the study. Another significant 
contribution of this trial is that it explores two potential working mechanism of prism adaptation, 
that is, whether it reduces pain through normalising spatial biases and / or body representation in 
CRPS. 
Chapter 3 presents the protocol of the trial, including the rationale, detailed methodology and 
analysis plan upon which the following two experimental chapters are built. 
Chapter 4 reports on the baseline (i.e. pre-treatment) neuropsychological functioning of 
individuals with CRPS who were recruited into the trial. It comprises a series of experiments 
assessing a range of neuropsychological functions, including visual spatial attention, mental 
representation of space, and spatially-defined motor function. In contrast to Chapter 2, which aims 
to show how spatial cognition can be disrupted in CRPS, the purpose of this chapter is to 
demonstrate what is typical of CRPS and reconcile some of the discrepancies in previous literature 
that are summarised in Chapter 1 by comprehensively testing a large cohort of people with this 
condition. Drawing from the neglect literature, I composed a battery of computer-based and 
psychophysical measures of spatial cognition and spatially-defined motor function, which is more 
comprehensive, sensitive, and better-controlled than in previous research. I examined whether 
people with CRPS present with systematic spatial biases on these measures compared to healthy 
control participants. Furthermore, I explored potential relationships between neuropsychological 
functioning of people with CRPS and the severity of their pain and other CRPS symptoms. 
Understanding spatial biases and their relevance to clinical symptoms could provide valuable 
insights into disrupted cognitive functions in CRPS and potential treatment strategies. 
Chapter 5 presents the outcomes of the randomised controlled trial of prism adaptation treatment 
for CRPS. The primary aim of this study is to provide a robust test of the effects of prism 
adaptation, compared to a control treatment, on pain intensity and CRPS symptoms severity 
(primary outcomes). To elucidate the mechanisms of any therapeutic benefits, I also examined 
the effects of prism adaptation on several secondary outcomes. These comprised other clinical 
signs of the disorder, patients’ self-reported CRPS-related and psychological functioning, and 
neuropsychological functions (including spatial cognition, spatially-defined motor function, and 
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body representation). Furthermore, to examine how long any benefits of treatment are sustained 
for, I investigated the time course of any changes on the primary and secondary outcomes in each 
group, assessed four to six times over the period of 2.5 to 7.5 months. Finally, I explored the 
potential clinical, self-reported, and neuropsychological predictors of changes in pain and CRPS 
severity within that time frame, regardless of treatment, to identify possible markers of CRPS 
progression over time.  
Finally, in the general discussion I will summarise the main findings presented in the thesis. I will 
discuss how these contribute to our understanding of the central mechanisms of CRPS, especially 
the role of neuropsychological functions in the manifestation and treatment of its clinical 
symptoms, and what implications can be drawn for other chronic pain conditions.
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Chapter 1: Neuropsychological changes in Complex Regional 
Pain Syndrome (CRPS)  
Chapter 1 – Introduction 
This chapter presents the current state of knowledge regarding higher cognitive functions in 
CRPS. Previous findings suggest that people with CRPS can show cognitive deficits resembling 
hemispatial neglect that is typically caused by brain injury (“neglect-like” symptoms). Through 
an exhaustive literature review, I provide a comprehensive, critical summary of changes in higher 
cognitive functions observed in CPRS, demonstrating that they are not limited to “neglect-like” 
deficits in spatial cognition. The full breadth of neuropsychological symptoms has not been 
covered in any previous reviews. Yet, integration of the existing evidence is pertinent to 
understanding the higher-order cognitive processes that might be relevant for the development, 
maintenance, and treatment of CRPS. 
First, this chapter summarises the clinical symptomatology and proposed pathophysiology of 
CRPS, introducing neuropsychological changes as one aspect of the central mechanisms of the 
condition. The core of this chapter comprises a review of behavioural evidence of alterations in 
three cognitive domains: body representation, lateralised spatial cognition, and non-spatially-
lateralised cognitive functions. Throughout these three main sections, the findings are integrated 
within and between each cognitive domain, in an attempt to reconcile any arising inconsistencies 
by considering potential mechanisms of the neuropsychological changes. This chapter further 
discusses the clinical relevance of altered cognitive functions and outlines current neurocognitive 
treatments for CRPS. Although both the theoretical and experimental aspects of this thesis are 
centred on CRPS, studying this exemplary condition can have implications for understanding 
other pathological pain syndromes that share similar changes in the central nervous system. 
Therefore, I briefly refer to neuropsychological changes found in other related disorders. This 
chapter closes with several concluding remarks and outstanding questions, as well as suggestions 
of how future research in this field can be improved to further advance our understanding of 
neuropsychological aspects of CRPS and chronic pain more generally.  
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Complex Regional Pain Syndrome (CRPS) is a poorly understood chronic pain condition of 
multifactorial origin. CRPS involves sensory, motor, and autonomic symptoms primarily 
affecting one extremity. Patients can also present with neuropsychological changes such as 
reduced attention to the CRPS-affected extremity, reminiscent of hemispatial neglect, yet in the 
absence of any brain lesions. However, this “neglect-like” framework is not sufficient to 
characterise the range of higher cognitive functions that can be altered in CRPS. This 
comprehensive literature review synthesises evidence of neuropsychological changes in CRPS in 
the context of potential central mechanisms of the disorder. The affected neuropsychological 
functions constitute three distinct, but not independent groups: distorted body representation, 
deficits in lateralised spatial cognition, and impairment of non-spatially-lateralised higher 
cognitive functions. We suggest that many of these symptoms appear to be consistent with a 
broader disruption to parietal function beyond merely what could be considered “neglect-like”. 
Moreover, the extent of neuropsychological symptoms might be related to the clinical signs of 
CRPS, and rehabilitation methods that target the neuropsychological changes can improve clinical 
outcomes in CRPS and other chronic pain conditions. Based on the limitations and gaps in the 
reviewed literature, we provide several suggestions to improve further research on 




Complex Regional Pain Syndrome (CRPS) is a chronic pain condition of poorly understood origin 
that predominately affects distal parts of one extremity, although in some cases it can spread to 
other limbs over time [1]. It is characterised by a combination of sensory, motor, and autonomic 
abnormalities. There is growing body of evidence suggesting that despite the absence of any brain 
lesions, people with CRPS can present with neuropsychological symptoms. Previous reviews 
have attempted to address the topic of “neglect-like” symptoms (e.g. spatial attention bias away 
from the CRPS-affected side [2–4]). Going beyond the analogy to hemispatial neglect and 
integrating the current knowledge about the full breadth of cognitive changes found in CRPS is 
important for elucidating the cortical and cognitive mechanisms that could be involved in the 
development, maintenance, and treatment of its clinical symptoms. This might have implications 
for other chronic pain conditions that share similar neuropsychological components. Therefore, 
this article provides a comprehensive, critical review of the evidence for altered 
neuropsychological functions in CRPS.  
We conducted a literature search using the PubMed database for articles including keywords 
regarding Complex Regional Pain Syndrome published in English between 1995 and 2019. To 
identify relevant articles, we screened the titles and abstracts for keywords regarding cognitive 
function. We also manually searched and cross-referenced the reference lists of relevant articles 
to identify additional studies that were not detected through the initial literature search. Because 
the clinical presentation and recovery rates of paediatric CRPS differ from CRPS in the adult 
population [5–7], we limited the scope of this review to adults. However, it is noteworthy that we 
did not identify any studies investigating neuropsychological changes in children with CRPS in 
the literature search. 
Integrating the existing evidence for neuropsychological changes in CRPS, in the current review 
we: 
• Summarise the clinical presentation of CRPS and proposed pathophysiological mechanisms, 
including peripheral and central processes, with the aim to situate the neuropsychological 
symptoms in the clinical picture of the syndrome; 
• Review the evidence of neuropsychological changes in CRPS, distinguishing three major 
categories: body representation disturbances, lateralised spatial cognition deficits, and non-
spatially-lateralised higher cognitive deficits. Where applicable, we relate these symptoms to 
evidence of similar cognitive deficits in people who suffered brain lesions or other chronic 
pain conditions; 
• Discuss the specificity of neuropsychological symptoms to CRPS and their clinical relevance 
with regard to the development, maintenance, and treatment of CRPS.  
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We conclude that the currently used “neglect-like” framework is insufficient for characterising 
the variety of neuropsychological changes shown by people with CRPS, and advocate the role of 
parietal cortical networks in the emergence of these symptoms.  
2. Clinical features and pathophysiology of CRPS 
CRPS most commonly develops following a fracture, sprain, or surgery, although there are known 
instances of spontaneous onset [8–10]. Persistent, continuing pain disproportionate to any 
preceding injury is the primary complaint, but CRPS also affects a range of other physical and 
cognitive functions. Below we summarise the clinical manifestations of CRPS and their proposed 
pathophysiological mechanisms, to provide context for understanding the changes in higher 
cognitive functions in these patients.  
2.1. Sensory, autonomic, and motor symptoms 
The diagnosis of CRPS requires both self-reported symptoms and signs that are evident during 
clinical examination [11] (see diagnostic criteria in Table 1). Sensory changes include perceiving 
non-noxious stimulation as painful (allodynia) and / or experiencing severe or prolonged pain in 
response to mildly noxious stimulation (hyperalgesia). Autonomic dysfunction can manifest as 
temperature, skin colour, and sweating asymmetry between the affected and unaffected limbs, 
oedema, and changes in skin appearance and hair and nail growth on the affected extremity. Motor 
abnormalities include tremor, decreased range of movement, muscle weakness, and / or having 
the affected limb set in a sustained, fixed posture (dystonia). The breadth of clinical 
manifestations and their possible combinations means that CRPS is a multifaceted and 
heterogeneous disease.  
Table 1 Budapest diagnostic criteria for CRPS [11,12] 
I. Continuous pain disproportionate to any inciting event 
II. Reporting at least one symptom in at least three (clinical diagnostic criteria) or four (research 
diagnostic criteria) categories 
III. Displaying at least one sign at the time of assessment in at least two categories 
IV. Lacking other diagnosis that could better explain the symptoms and signs 
Category Symptoms / signs 
Sensory • Hyperesthesia / hyperalgesia 
• Allodynia 
Vasomotor • Temperature asymmetry 
• Skin colour changes / asymmetry 
Sudomotor / Oedema • Sweating changes / asymmetry 
• Oedema 
Motor / Trophic • Decreased range of motion 
• Motor dysfunction (weakness, tremor, dystonia) 




2.2. Peripheral and central mechanisms of CRPS 
The pathophysiology of CRPS is not well understood and evidence points towards a multifactorial 
origin of this disorder. The most strongly implicated mechanisms can be classified into peripheral 
and central processes (for reviews see [13–16]). In brief, an aberrant inflammatory response to 
tissue trauma can lead to sensitisation of peripheral and spinal nociceptive fibres, 
neuroinflammation, and dysfunction of peripheral blood circulation [17–20]. Peripheral 
mechanisms cannot fully account for the fact that CRPS symptoms persist long after the 
inflammatory response should have resolved. However, patients also show maladaptive plastic 
changes in the central nervous system [16,21,22]. Changes on the spinal and supraspinal level 
directly linked to clinical signs of CRPS involve central sensitisation, whereby spinal nociceptive 
neurons become hyper-responsive to peripheral input and increase nociceptive signalling to the 
cortex even in absence of such input [23–26]. A shift from inhibition towards facilitation of 
nociceptive input was also found in the endogenous pain modulation system in CRPS [27]. 
Peripheral and central mechanisms are not contradictory and they can interact to produce clinical 
signs of CRPS. Central changes also occur at a higher, cortical level [16,28]. The evidence 
regarding structural reorganization is scarce [29,30], but extensive evidence of functional cortical 
reorganization of sensory and motor representations of the limbs in CRPS has been reviewed 
elsewhere [31,32]. This review concerns behavioural and clinical evidence for altered higher 
cognitive functions (i.e. neuropsychological symptoms), which thus far have not been 
comprehensively summarised.  
3. Altered neuropsychological functions in CRPS 
In the following section, we review higher cognitive processes that are affected in CRPS and that 
suggest cortical reorganization. The known physiological underpinnings of CRPS alone cannot 
account for some cognitive phenomena observed in this condition, though neuropsychology 
provides a useful framework for explaining them. The neuropsychological changes include body 
representation distortions (section 3.1.), lateralised spatial cognition deficits (section 3.2.), and 
other neuropsychological symptoms that implicate disruption of broad cortical networks, 
especially parietal functioning (section 3.3.). We summarise and discuss the study details and 
behavioural findings from research investigating these neuropsychological changes in CRPS (see 




Table 2 Summary of neuropsychological functions investigated in people with CRPS in research 
studies published between July 1995 and June 2019 
Neuropsychological 
function / symptom 






Interview Distorted representation of the 
affected limb (altered 
perceptions of size, shape, and 
weight, desire to amputate, 
mismatch between sensations 
and appearance of the limb, 
erasure of its anatomical parts, 
poor awareness of its position, 
asomatognosia) 
Galer et al. [33], N=11; 





Asomatognosia (feelings of 
foreignness and lack of 
ownership of the affected 
limb) (17-90%) 
Förderreuther et al. [37], 
N=40; Frettlöh et al. 
[35], N=123, PC; Galer 
and Jensen [36], N=224; 
Kolb et al. [38], N=20, 
HC, PC†; Michal et al. 
[39], N=50, PC; 
Reinersmann et al. [40], 
N=24, PC†, [41], N=24, 
PC; Wittayer et al. [42], 
N=53 




Distorted representation of the 
affected limb (see above) 
Brun et al. [44], N=13; 
Bultitude et al. [45], 
N=24; Kotiuk et al. [46], 
N=50; Lewis and 
Schweinhardt [47], 
N=22, HC; Tajadura-
Jiménez et al. [48], 
N=12 
Objective limb size Estimation of 
actual limb size 
based on enlarged 
or shrunk images 
Overestimation of size of the 
affected limb 
Moseley [49], N=50, 
PC, AL; Peltz et al. [50], 
N=30, HC, AL 
 Tactile distance 
judgements 
following tool-use 
Perceived lengthening of the 
unaffected arm and shortening 
of the affected arm  
Vitterso et al. [51], N = 
36, HC, BL 
Limb position sense Limb position 
matching  
Reduced accuracy in both 
limbs 
Brun et al. [44], N=13, 
HC, BL; Lewis et al. 




Bias towards the affected side 
of space  
Christophe et al. [53], 
N=1, NC, BL; Jacquin-
Courtois et al. [54], 
N=1, NC, HC, AL 
  Normal Christophe et al. [55], 
N=7, NC, BL; Kolb et 





function / symptom 





Estimation of the 
extent of actual 
movement relative 
to altered visual 
feedback  
Reduced accuracy and 
precision in the affected limb 
Brun et al. [44], N=13, 
HC, AL 






Reduced accuracy for the 
affected vs unaffected limb 
images 
Johnson et al. [56], 
N=29 
  Longer reaction times for the 
affected vs unaffected limb 
images 
Johnson et al. [56], 
N=29; Moseley [57], 
N=18, HC; Reid et al. 
[58], N=130; Schwoebel 
et al. [59], N=13, HC, 
[60], N=12 
  Longer reaction times for 
images of both limbs in the 
affected vs unaffected side of 
space 
Reid et al. [58], N=130 
  Longer reaction times for 
images of both limbs 
Bultitude et al. [45], 
N=24, HC; Kohler et al. 
[61], N=15, HC; 
Reinersmann et al. [62], 
N=12, HC, PC†; 
Wittayer et al. [42], 
N=53, HC 
  Normal Breimhorst et al. [63], 
N=20, HC; 
Reinersmann et al. [40], 
N=24, HC, PC 
Multisensory 




Normal Reinersmann et al. [41], 






Reduced illusion strength for 
vision-proprioception only 
(abnormal bimanual 
representation); normal with 
tactile input 
Wang et al. [64]; N=20, 
HC, BL 
Lateralised spatial cognition 
Self-reported motor 
neglect 
Interview / clinical 
observation 
Motor neglect for the affected 
limb (slower initiation, 
execution, and decreased 
amplitude and spatial extent 
of movements, required 
directed attention to move the 
affected limb, and occurrence 
of involuntary movements) 




function / symptom 







Motor neglect for the affected 
limb (see above) (17-90%) 
Frettlöh et al. [35], 
N=123, PC; Galer and 
Jensen [36], N=224; 
Kolb et al. [38], N=20, 
HC, PC†; Michal et al. 
[39], N=50, PC; 
Reinersmann et al. [40], 
N=24, PC†, [41], N=42, 




Line bisection Bias towards the affected 
relative to unaffected side of 
space 
Christophe et al. [53], 
N=1, NC, BL; Jacquin-
Courtois et al. [54], 
N=1, HC, NC, AL; 
Förderreuther et al. [37], 
N=29, HC, BL  
  Bias away from the affected 
relative to unaffected side of 
space 
Robinson et al. [65], 
N=1, NC 
  Normal Christophe et al. [55], 
N=7, NC, BL; 
Förderreuther et al. [37], 
N=29, HC, BL; Kolb et 
al. [38], N=20, HC, PC; 
Reid et al. [58], N=13, 
NC, BL; Reinersmann et 
al. [40], N=24, HC, PC 
 Robot-assisted 
line bisection 
Bias towards the left relative 
to right side of space 
Verfaille et al. [66], 
N=15, HC, UL 
 Line bisection on 
the limbs 
Bias away from the affected 
relative to unaffected side of 
space (on the affected limb 
and on both limbs on the 
affected side of space) 
Reid et al. [58], N=13, 
NC, BL 
 Clock drawing test Normal Kolb et al. [38], N=20, 
HC, PC 
Egocentric frame of 
reference 
Visual subjective 
body midline  
Bias towards the affected 
relative to unaffected side of 
space (only in the dark) 
Christophe et al. [53], 
N=1, NC; Jacquin-
Courtois et al. [54], 
N=1, HC, NC; Sumitani 
et al. [67], N=27, HC 
[68], N=36, HC, [69], 
N=5, NC; Uematsu et al. 
[70], N=22, PC 
  Bias towards the left relative 
to right side of space (in the 
dark) 
Reinersmann et al. [40], 
N=24, HC, PC 
  Normal (in the dark) Christophe et al. [55], 
N=7, NC; Wittayer et al. 




function / symptom 










Omissions of stimuli on the 
affected side of the body 
(extinction; 14%) 
Cohen et al. [71], N=22, 
BL 
 Temporal Order 
Judgements 
Bias away from the affected 
relative to unaffected limb 
(when tactile stimuli delivered 
to uncrossed hands) 
Reid et al. [58], N=13, 
NC 
 Temporal Order 
Judgements 
Bias away from the affected 
limb (when tactile stimuli 
delivered to uncrossed hands) 
and from the affected side of 
space (when tactile stimuli 
delivered to hands crossed 
over body midline), relative to 
the unaffected limb and side 
of space  
Moseley et al. [72], 
N=10, [73], N=10, HC 
  Normal (crossed and 
uncrossed hands) 












Bias away from the affected 
relative to unaffected side of 
space and limb (when visual 
stimuli presented in near 
space without hands, or on the 
surface of uncrossed hands, 
but not when hands were 
crossed over body midline) 
Bultitude et al. [45], 
N=24, HC 
  Bias away from the affected 
relative to unaffected side of 
space (when visual stimuli 
presented near uncrossed 
hands, but not far from the 
hands) 
Filbrich et al. [74], 
N=14, NC 
 Orienting 
saccades to cued 
and non-cued 
stimuli in the left 
and right visual 
fields 
Normal Filippopulos et al. [75], 
N=8, HC 
 Speeded detection 
task 
Longer reaction times in the 
right side of space 







Deviation away from the 
affected relative to unaffected 
side of space 





function / symptom 
Measure / task Performance of participants 
with CRPSa,b 
Study detailsc 
  Deviation towards the 
affected relative to unaffected 
side of space 
Christophe et al. [53], 
N=1, NC; Jacquin-
Courtois et al. [54], 





Normal / no hands asymmetry 
(with one and both hands, in 
uncrossed and crossed 
posture, with and without 
visual feedback) 
Christophe et al. [55], 
N=7, HC, BL  
  Normal / no hands asymmetry 
(with one and both hands, 
hands close together or further 
apart, without visual 
feedback) 
Christophe et al. [53], 
N=1, BL 
 Speeded button 
pressing 
Slower and more variable 
movements (with the affected 
vs unaffected hand in both 
sides of space, and with both 
hands in the affected vs 
unaffected side of space) 
Reid et al. [76], N=13, 
BL 
 Circle drawing 
task 
Reduced accuracy (with the 
affected vs unaffected hand in 
both sides of space, and with 
both hands in the affected vs 
unaffected side of space) 
Reid et al. [76], N=13, 
BL 
  Normal / no hands asymmetry Christophe et al. [55], 
N=7, HC, BL 
Non-spatially-lateralised cognition 
Object recognition Tactile 
recognition of 
objects 
Astereognosia for the affected 
hand (64%)  
Cohen et al. [71], N=22, 
HC, BL 
 Visual recognition 
of objects 
Normal  Robinson et al. [65], 
N=1, NC 
Face recognition Benton Test of 
Face Perception 
Prosopagnosia Robinson et al. [65], 
N=1, NC 
Finger identification Identification of 
indicated fingers 
(verbally, by 
touch, pointing, or 
movement) 
Finger agnosia on the affected 
limb (48-59%); longer 
reaction times, reduced 
accuracy, and increased 
variability of finger 
discrimination (on both hands, 
but worse on the affected 
hand) 
Cohen et al. [71], N=22, 
HC, BL; Förderreuther 
et al. [37], N=73, BL; 
Kuttikat et al. [77], 
N=13, HC, BL 
  Normal  Robinson et al. [65], 
N=1, NC, UL 
Tactile recognition 





onto one’s palm 
Dysgraphaesthesia on the 
affected hand (36%) 





function / symptom 











Constructional apraxia for the 
affected hand (32%) 
Cohen et al. [71], N=22, 
HC, BL 










letters / words, 
spelling 
Dyscalculia (27%); 
dysgraphia for the affected 
hand (27%) 
Cohen et al. [71], N=22, 
HC, BL 





Conductional dysphasia (4%) Cohen et al. [71], N=22, 
HC 





















Agnosia for object orientation Robinson et al. [65], 
N=1, NC 
Knowledge about 
order and orientation 
of numbers and 




Mirror-reversal in writing and 
reading; horizontal inversion 
of letters and words, and 
letters and numbers ordering 
in writing (cases for the 
affected hand, both hands, and 
unaffected hand)  
Cohen et al. [71], N=22, 
HC, BL; Robinson et al. 
[65], N=1, UL 
 Letter orientation 
recognition 
Normal (for standard vs 
reflected letters, and left vs 
right side of space) 





parts (verbally, by 
touch, or pointing) 
Left-right disorientation (9%) Cohen et al. [71], N=22, 
HC, BL 
  Normal Robinson et al. [65], 




function / symptom 








Ideomotor apraxia (5%) Cohen et al. [71], N=22, 
HC, BL 
Temporal acuity Temporal Order 
Judgements 
Reduced temporal acuity Bultitude et al. [45], 
N=24, HC 
Alertness Test of Attentional 
Performance 
Normal response readiness Reinersmann et al. [62], 
N=12; HC, PC 
Working memory Digit span Impaired working memory 
span 
Libon et al. [78], 
N=137, NC 
 Test of Attentional 
Performance 
Normal continuous updating Reinersmann et al. [62], 





Normal Kolb et al. [38], N=20, 





Learning test II 
Impaired encoding, recall, and 
recognition 












Global processing impairment 
(particularly impaired naming, 
declarative memory, 
executive function; 23%) or 
mild dysexecutive syndrome 
(particularly impaired 
working memory and verbal 
fluency; 42%) 
Libon et al. [78], 
N=137, NC 
aPercentages represent the proportion of individuals with CRPS out of the total CRPS sample who presented 
with abnormal performance. We reported percentages where available; in other cases, we presented group 
effects. 
bNormal performance indicates that there were no differences between participants with CRPS and control 
participants, and / or between the affected and unaffected side among participants with CRPS. 
cN represents CRPS sample size. Where applicable, we specified which control group was included (HC = 
healthy / pain-free controls; PC = pain controls; NC = normative data or comparison against zero; † = no 
significant difference between CRPS and control group), and which limb(s) were tested (AL = affected 
limb; UL = unaffected limb; BL = both limbs).  
3.1. Body representation 
Altered body representation is among the earliest and best characterised neuropsychological 
changes in CRPS. Cognitive representations of one’s body are derived from proprioceptive, 
vestibular, somatosensory, and visual information that interact with the motor system to guide 
actions [79]. This dynamic online representation of body posture is often called “body schema” 
[80]. However, in this review we use a broader term “body representation” that also incorporates 
the structural definition of the body (i.e., perception of its size, shape, and boundaries) as well as 
the body image (defined as the semantic representation of the names and function of distinct body 
parts) [80]. Distortions of body representation manifest in CRPS as self-reported disturbed 
perceptions, ownership of and feelings towards the affected limb; difficulties with mentally 
rotating and recognising the laterality of pictures of the limbs; and erroneous estimation of the 
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size, position, and movement of the limbs from single sensory modalities (while multisensory 
integration appears intact). Below we discuss evidence for each of these manifestations in turn. 
3.1.1. Self-reported body perception disturbances 
Initial clinical reports [33] and questionnaire studies [36,37] showed that up to 60% of patients 
reported loss of ownership, recognition, or awareness of their CRPS-affected limb. This research 
aimed to measure so-called “neglect-like” symptoms in CRPS. Neglect is an attention deficit 
affecting the hemispace contralateral to a brain lesion [81], discussed in more detail in section 
3.2. (see also Table 3). Early research in CRPS considered reports of the affected limb not being 
part of the patient’s body and feeling dead as “cognitive neglect” symptoms [35,36], yet we would 
argue that they are better characterised as a disturbance of the mental representation of the body. 
Specifically, these symptoms closely resemble asomatognosia (lost sense of ownership of one’s 
limb), which can follow temporo-parietal lesions. Asomatognosia often co-occurs with 
hemispatial neglect, yet it is not a diagnostic feature of the neglect syndrome [82,83]. Interviews 
of people with CRPS about their perceptions of their body [34] revealed a range of disturbances 
consistent with distorted body representation (see also [52]). These included perceptions of the 
affected limb as being larger or smaller, misshapen, or heavier relative to its true size, shape, and 
weight; negative feelings towards the affected limb such as disgust or hatred (reminiscent of 
misoplegia [84]); the desire to amputate it; a mismatch between sensation of the affected limb and 
its appearance; lacking parts of the limb from their mental representation; and poor awareness of 
the affected limb’s position. Although more prevalent in chronic CRPS [37], such experiences 
can manifest within days of disease onset [34]. The severity of self-reported body perception 
disturbance correlated with impaired tactile acuity [47], which was linked to reorganization of the 
primary and secondary cortical maps of the CRPS-affected limb [85,86]. This suggests that 
subjective body representation distortion could be accompanied by changes in the brain pertaining 
to the central mechanisms of CRPS. 
3.1.2. Limb laterality recognition 
Several studies have used variations of the limb laterality recognition task, also sometimes 
referred to as mental hand / foot rotation, to measure body schema in CRPS (e.g. [45,57–59,61–
63]). In a typical procedure, the task requires speeded identification of left or right limbs from 
pictures of hands or feet in different postures and / or at different angles of rotation from the 
upright (canonical) position. In pain-free controls, response times increase with the angle of 
rotation (i.e., they get longer consistent with the spatial disparity between the pictures of limbs 
and the canonical posture, and also according to the biomechanical constraints that make some 
hand rotations physically easier than others [87]). Therefore, it is thought that the limb laterality 
recognition task involves mentally rotating the pictured limb to match it to the current position of 
one’s own limb (or vice versa) in a manner that complies with biomechanical constraints 
[59,88,89]. This is thought to require the participants to use the cognitive representations of the 
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limb that corresponds to the one depicted in the picture [90,91]. Consistent with the involvement 
of motor imagery [87], neuroimaging studies show increased activation of premotor and parietal 
regions during hand laterality recognition [92,93].  
People with CRPS were less accurate and slower in determining the laterality of images 
corresponding to their painful limb than of images corresponding to their unaffected limb [56–
60], indicative of the cognitive representation of the affected limb being distorted. Moreover, Reid 
et al. [58] found that in addition to taking longer to recognise pictures of limbs corresponding to 
their affected side of the body, people with CRPS took longer to recognise pictures of limbs 
presented in their affected side of space. The latter effect occurred for both the images of hands 
and feet regardless of whether participants had CRPS in upper or lower limbs, however, it was 
specific to images of body parts, and not to other stimuli (e.g. letters). Although there appears to 
be strong evidence for lateralised body representation distortions in CRPS, some authors have 
reported equally slowed limb laterality judgements for pictures representing both the affected and 
unaffected limbs, compared to healthy controls [42,45,61,62]. This could be due to 
methodological differences, or it could indicate more generalised changes in body representation, 
or reduced psychomotor speed due to the effects of pain medication [94] or chronic pain in general 
(rather than CRPS specifically) [95]. This would be consistent with the finding of comparable 
slowing in laterality recognition of both limbs in phantom limb pain and CRPS [45,62]. Finally, 
there are also contradictory findings suggesting that both people with CRPS and healthy controls 
are faster in recognising the images of limbs corresponding to their dominant hand, regardless of 
which side of the body is affected [40], or do not differ in limb laterality recognition [63]. 
3.1.3. Estimation of limb size, position, and movement from unisensory cues 
Distorted perceptions of the body are evident in several modalities, including its visual and 
proprioceptive representations. Patients with CRPS were presented with compressed and 
expanded schematic drawings of hands [50] and real pictures of their own hands manipulated in 
the same manner [49]. When asked to indicate the pictures that most accurately represented the 
size of their affected hands, they tended to choose enlarged images, overestimating the size of 
their painful extremities.  
Distorted estimates of limb position and limb movement have also been reported for people with 
CRPS. “Manual” or “proprioceptive straight-ahead” [96] requires participants to point straight 
ahead of their perceived body midline, without vision of the limb or external space (e.g. with the 
eyes closed), and thus relies on integrating proprioceptive information about position of an arm 
with perceived body midline. A shift of manual straight-ahead towards the affected side of space 
relative to objective midline has been found in a case of CRPS [53,54] when the patient used the 
affected hand, and also when she used the unaffected one. Nevertheless, two group studies found 
no significant deviations from the true body midline, nor from the subjective midline of healthy 
and pain controls, on the same manual task performed with either or both arms [38,55]. Manual 
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straight-ahead estimations of individuals with CRPS were not more variable than among the 
controls [38]. However, people with CRPS presented with impaired limb position sense in two 
studies that used matching tasks. In Lewis et al.’s [52] study, participants were required to match 
the position of their affected and unaffected arm to specified targets that were external to their to 
their body (i.e. point their arms as though they were the hour hand on a clock showing a particular 
time). In Brun et al.’s [44] study, they were required to match the position of the affected or 
unaffected arm to the mirror-reverse position of their other arm, which had been passively moved 
by a robot. In both of these studies, people with CRPS made more errors and were less precise 
than healthy controls when positioning both arms when they did not have vision of their limbs. 
This suggests that proprioceptive deficits are bilateral and thus cannot be attributed solely to 
sensory deficits in the CRPS-affected limb. 
In a third task, people with CRPS also presented with reduced accuracy and precision in the sense 
of limb movement. Participants observed movement of a virtual limb anchored to the movement 
of their unseen affected limb and judged whether it was smaller or greater than their actual 
movement. People with CRPS both under- and overestimated the extent of their movements 
relative to healthy controls [44]. Both this impaired sense of movement of the affected limb, and 
the previous findings of more variable positioning performance for the affected and unaffected 
limbs, provide evidence of impaired proprioception, since participants could not see their limbs 
and thus were forced to rely on proprioception for these tasks [44,52–54]. However, these deficits 
are not consistently found [38,55]. 
3.1.4. Multisensory contributions to body representation in CRPS 
Research also investigated how information from multiple sensory modalities is combined to 
contribute to body representation in CRPS. An additional observation from the study by Lewis et 
al. [52] is that when people with CRPS kept their eyes open while they placed their affected arm 
at particular clock face locations, their limb position deficits were smaller than when they 
performed the task with their eyes closed. Positioning of the unaffected arm did not significantly 
improve with vision. This demonstrates that people with CRPS rely on visual cues in addition to 
proprioceptive ones when estimating the position of the affected limb. Furthermore, Tajadura-
Jiménez et al. [48] found that the self-reported inability to visualize the affected limb or 
overestimation of its size could be altered by auditory feedback during movement. In this study, 
people with upper or lower limb CRPS heard manipulated sounds linked to their footsteps, with 
higher frequencies inducing an impression of lighter body weight and smaller body dimensions, 
and lower frequencies inducing an impression of heavier weight and larger body dimensions. 
Similar to the performance of healthy participants in another study [97] the gait of people with 
CRPS was altered in that the time of foot contact with the floor increased with lower-frequency 
sounds, consistent with having heavier body. For some participants, the sound feedback also 
helped to restore the representations of previously missing parts of their body. The studies of 
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Lewis et al. [52] and Tajadura-Jiménez et al. [48] suggest that people with CRPS can integrate 
visual and auditory feedback with proprioceptive information from their body into the body 
representation.  
However, the process of updating body representation might differ for the affected and the 
unaffected side. In a recent study, Vittersø et al. [51] demonstrated altered updating of body 
representation following tool use for people with CRPS compared to controls. Participants 
estimated the felt distance between two points touching the arm before and after tool use. Tool 
use typically leads to a shortening of the felt distance between the two points, which is interpreted 
as a perceived lengthening of the arms as the body representation is updated to incorporate the 
tools. Relative to pain-free controls, people with upper limb CRPS had a more pronounced 
updating of body representation for their unaffected arm following tool use (i.e. a larger perceived 
lengthening than the controls), and showed the opposite pattern for their affected arm (i.e. a 
perceived shortening). These findings suggest that the representation of the body is more 
malleable for people with CRPS, and that multisensory information can have different effects for 
the affected and unaffected limb.  
Susceptibility to body-related multisensory illusions can provide insights into which mechanisms 
governing body representation might be disrupted or preserved in CRPS. The rubber hand illusion 
is a phenomenon thought to indicate that body ownership arises from integrating congruent visual 
and tactile input with the existing mental representation of one’s body [98]. Thus, preserved 
multisensory integration should be necessary for illusory ownership of the rubber hand to occur. 
During the rubber hand illusion, a participant views a real-size rubber arm placed where their real 
arm would normally reside, while their real arm is placed out of sight nearby and in an analogous 
orientation [98]. The experimenter applies tactile stimulation (e.g. strokes from paintbrushes) to 
the rubber and real hand synchronously. There are three classic measures of successful induction 
of the rubber hand illusion - subjective ownership of the rubber hand; skin conductance responses 
to viewing the rubber hand being harmed; and a proprioceptive drift of the felt position of the real 
hand towards the position of the rubber hand. In a study that used the first two of these measures, 
Reinersmann et al. [41] demonstrated that people with CRPS were able to experience this illusion 
normally both when the affected and unaffected limbs were stimulated. Specifically, their 
subjective ownership of the rubber hand and skin conductance responses were not significantly 
different from those of people with other types of upper limb pain and pain-free controls [41]. We 
can draw two main conclusions from these findings: that people with CRPS can experience an 
illusory ownership of an artificial limb, and that they have intact multisensory integration. 
Successful induction of rubber hand illusion [41] showed that people with CRPS have the normal 
ability to perceive an illusory ownership of an artificial body part, despite their decreased sense 
of ownership of their own affected limb reported in other studies [36,37]. In Reinersmann et al.’s 
[41] study, the strength of the illusion was not significantly related to the subjective distortion of 
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body representation as measured by the “neglect-like” symptoms questionnaire [35], which also 
includes questions about perceived ownership of the painful limb (although see their analysis of 
a subgroup of right-CRPS participants who reported more distorted perception of their affected 
limb, and weaker ownership of a rubber hand, than left-CRPS participants [41]). This is consistent 
with the findings that the perceived ownership of a rubber hand does not necessitate a 
disownership of one’s real hand [99]. Because these two phenomena appear to be independent, 
people with CRPS could have normal susceptibility to rubber hand illusion [41], and still 
experience a decreased sense of ownership of their own affected limb, as reported in other studies 
[36,37]. 
The second conclusion that can be drawn from Reinersmann et al.’s [41] study is that people with 
CRPS have an intact ability to integrate visual and tactile information (because they have normal 
susceptibility to the rubber hand illusion). Consistent with this finding, the aforementioned tool 
use study by Vittersø et al. [51], showing more pronounced updating of bodily representations, 
also demonstrated intact visuo-tactile integration in participants with CRPS. These two studies 
suggest that the multisensory mechanisms that contribute to body representation are intact. Thus, 
a deficit in multisensory integration per se does not seem to be a plausible explanation for 
distorted body representation in CRPS. Alternatively, a specific impairment in integration of 
proprioceptive information with other sensory inputs could drive these distortions. People can 
experience subjective ownership of a rubber hand without feeling a proprioceptive drift of their 
real hand towards the artificial limb [100]. Although the proprioceptive effect of the rubber hand 
illusion was not measured in Reinersmann et al.’s [41] study, this sensory modality has been 
investigated in the context of an artificial finger illusion discussed below. 
Reinersmann et al.’s [41] study suggests intact visuo-tactile integration in people with CRPS by 
virtue of a normal rubber hand illusion. On the other hand, a study by Wang et al. [64] suggests 
that despite impaired proprioception, they can integrate tactile and proprioceptive information 
and normally experience a multisensory illusion. In their study, people with CRPS were less 
susceptible to an artificial finger illusion, compared to healthy controls, when only proprioceptive 
information was available [64]. In the illusion, the hands are positioned one above the other, 
aligned vertically but some distance apart, and obscured from the participant’s view. The index 
finger of the bottom hand is placed snugly in a pipe, and the index finger of the top hand is placed 
adjacent to (proprioceptive only condition) or grasping (proprioceptive and tactile condition) an 
artificial finger. Typically, both of these conditions create an illusion that the hands are closer 
together in vertical distance than they are in reality [64]. Regardless of which hand (affected or 
unaffected) was positioned on the top or bottom, this effect was not found in people with CRPS 
when they were not grasping the artificial finger. Interestingly, people with CRPS did experience 
the illusion to a similar extent as healthy controls when they received tactile input (i.e. while 
grasping the artificial finger). This study suggests that although proprioception itself might be 
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altered in CRPS, it can still be integrated with any available tactile information and result in 
normal performance on a multisensory bodily illusion [64]. The findings of Wang et al. [64] 
complement those of Reinersmann et al. [41] from the rubber hand illusion with explicit 
involvement of proprioceptive information, and further support the conclusion that people with 
CRPS have intact multisensory integration. 
3.1.5. Summary of changes in body representation 
Across the current literature, people with CRPS consistently report symptoms pertaining to 
altered body representation include asomatognosia, distorted perception of the affected parts of 
the body, and negative feelings about the affected limb. These findings arise not only from self-
report measures, but are in agreement with experimental tests of body representation such as limb 
laterality recognition [56–60], as well as limb size matching and limb position matching 
[44,49,50,52–54]. However, manual estimates of body midline were not consistently impaired in 
people with CRPS [38,55]. Body representation relies on the dynamic integration of visual, tactile, 
and proprioceptive information. Broadly speaking, multisensory integration seems to be intact in 
people with CRPS and thus cannot account for their distorted body representations. The 
availability of visual cues can improve (but not fully normalize) position sense for the affected 
limb [52], suggesting that visuo-proprioceptive integration is possible. The effects of tool use, the 
rubber hand illusion, and the artificial finger illusion suggest intact visuo-tactile [41,51] and 
tactile-proprioceptive [64] integration. When whole body movement is concerned [48], auditory-
proprioceptive integration can modify subjective perception of the body. Thus it appears that 
people with CRPS are able to experience certain body-related multisensory illusions [41,48,64] 
and their performance on proprioceptive tasks improves when congruent input from additional 
senses is available [52]. Furthermore, people with CRPS are able to update the representation of 
their body [48], but this process might differ between the affected and non-affected side [51]. 
Greater updating of bodily representations in people with CRPS compared to pain-free individuals 
suggests that these representations might be less stable in CRPS [51].  
Deficits in systematically measured aspects of body representation mostly appear to arise when 
people with CRPS have to rely on proprioception, and additional sensory cues are either missing 
(e.g. when positioning the affected limb with eyes closed [52]) or are incongruent with other 
senses or motor commands (e.g. when visual feedback about the movement is altered [44]). One 
possible explanation is that proprioceptive information from the affected limb is not reliable. 
Sometimes proprioception is impaired in the analogous unaffected limb, too [44,52], which 
potentially occurs through central mechanisms since in this case the core symptoms of CRPS are 
not present. There is evidence that we integrate different sensory cues by adaptively making a 
weighted linear average based on the reliability of each sensory modality [101,102]. Therefore 
disrupted reliability of proprioception in people with CRPS could mean that the weighting of 
other senses (e.g. vision) is stronger to compensate [102,103]. Overall, there is consistent 
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evidence that multisensory integration in CRPS is intact. This mechanism is known to contribute 
to building and updating multimodal body representations [79,104], and both are governed by 
similar parietal networks [104–107]. However, neither multisensory nor unisensory 
representations were directly linked to self-reported body perception disturbance in CRPS [44,52] 
(for exceptions, see [41,48]). Because multisensory integration is intact, it cannot explain the 
distorted body representation in this population. Therefore, other, potentially higher-level 
mechanisms might contribute to these distortions. 
3.2. Lateralised spatial cognition 
In addition to the distortions in body representation discussed in the previous section, many people 
with CRPS report symptoms resembling the hemispatial neglect syndrome (“neglect”) that can 
follow a brain lesion. Neglect is an attentional deficit in sensation, movements and / or 
representations of the contralesional (usually left) side of body and / or space that cannot be 
completely attributed to a sensory or motor loss [81]. It most often occurs following lesions to the 
right inferior parietal lobe and temporo-parietal junction [108–111], but can also stem from 
lesions to other cortical and subcortical areas, such as the mid superior-temporal gyrus, angular 
gyrus, basal ganglia, and thalamus [112]. Neglect has served as an analogy to describe some of 
the neuropsychological symptoms found in CRPS. Thus, it is important to consider which aspects 
of higher cognition are affected in post-stroke patients to systematically characterise related 
deficits in chronic pain patients. Table 3 summarises examples of deficits shown by people with 
neglect following brain lesions in different perceptual, motor, and representational modalities; 
egocentric and allocentric reference frames; and personal, peripersonal, and extrapersonal regions 
of space1 (for a comprehensive review, see [81]).  
Although CRPS is generally not associated with any brain lesions, the unilateral nature of CRPS 
means that we could expect any cognitive deficits to be predominantly associated with the activity 
of the hemisphere contralateral to the painful side. However, thus far the evidence for such 
lateralised manifestations of neuropsychological symptoms in CRPS is not straightforward. In the 
following sections, we review research regarding spatially lateralised cognitive functions in 
CRPS, with the primary focus on spatial attention. We aim to discern the discrepancies in the 
direction of lateralised spatial deficits in CRPS, and the particular conditions under which they 
manifest. Finally, we attempt to integrate the changes in spatial cognition with the evidence of 
distorted body representation. 
 
1 In addition to our use of “reference frames” when distinguishing between egocentric and allocentric 
encoding of space, “reference frames” can also be used to refer to the distinction between the ways that 
information in personal, peripersonal, and extrapersonal space is encoded and represented. However, to 
enable a clear discussion of the overlapping and distinct spatial effects in egocentric / allocentric 
representations versus personal / peripersonal / extrapersonal representations, in this paper we reserve the 
term “reference frames” for the former distinction and “regions of space” for the latter distinction. 
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Table 3 Post-stroke hemispatial neglect symptoms 
Domains Categories Deficits 
Modality Perceptual neglect Difficulty with allocating attention to visual, tactile, or auditory 
stimuli appearing on the contralesional side of space 
 Motor neglect Reduced or slowed movements using the contralesional limb that 
cannot be attributed to primary motor deficit; reduced or slowed 
movements in / towards the contralesional side of space 
 Representational 
neglect 




Egocentric Underrepresentation of contralesional side of space in relation to 
one’s own body / body parts (e.g. subjective estimate of one’s 
body midline or straight-ahead shifted towards the ipsilesional 
side) 
 Allocentric Underrepresentation of contralesional side of spatial relationships 
between external objects separated in space (e.g. bisections of 




Personal Reduced attention to contralesional side of the body 
 Peripersonal Reduced attention to contralesional side of the space within one’s 
reach 
 Extrapersonal Reduced attention to contralesional side of the space beyond one’s 
reach 
3.2.1. Self-report and clinically assessed “neglect-like” symptoms  
The first published evidence for systematic spatial biases in CRPS come from clinical reports [33] 
and self-administered surveys [36] reporting motor and cognitive changes consistent with neglect 
of the affected limb. Galer et al. [33] observed “motor neglect” in CRPS, specifically slower 
movement initiation (hypokinesia), slower movement execution (bradykinesia), decreased 
movement amplitude (hypometria), and decreased spatial extent of movements performed with 
the CRPS-affected hand compared to the unaffected one. Further signs of motor neglect in CRPS 
are patients’ reported need for directed attention to move the affected limb, and the occurrence of 
involuntary movements. There are also anecdotal reports of patients who failed to move the 
CRPS-affected limbs when they were concealed from view despite being convinced that they 
were performing bilateral arm movements [113]. This phenomenon might be characterised as 
motor extinction (a deficit of motor production that either worsens or only becomes apparent 
during bilateral movements [114]), although the authors did not report if performance with the 
affected limb was better when making unilateral movements under the same conditions. 
“Cognitive neglect” as defined by Galer and Jensen [36] involves feelings of foreignness and lack 
of ownership over the affected limb. However, the authors never intended for the term “neglect” 
to be taken literally in the context of CRPS, and we argue that these symptoms more closely 
resemble body representation distortion than hemispatial neglect (see section 3.1.1.). Between 
17% and 90% of patients with CRPS report motor and / or cognitive “neglect-like” symptoms as 
defined above [33,35–40,42,62]. Also, the frequency [39] and severity of these self-reported 
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symptoms appears to be greater in CRPS than other pain conditions [35]. Thus, based on this 
clinical and self-report evidence, it could be argued that people with CRPS present with 
neuropsychological deficits that resemble hemispatial neglect and related syndromes of body 
awareness, such as asomatognosia (loss of ownership) [82] and misoplegia (dislike or hatred of 
the affected limb) [84]. 
3.2.2. Standard neuropsychological tests of neglect 
Following the self-reports of neuropsychological symptoms resembling neglect, some researchers 
pursued a more objective assessment of these deficits in CRPS by administering classic 
neurological assessments and pen-and-paper tests that are typically used with brain-injured 
patients. During confrontation testing, a standard neurological assessment of neglect, patients 
with post-stroke hemispatial neglect typically fail to report seeing or feeling targets presented on 
the contralesional side, indicating extinction (when the failure is only during bilateral stimulation) 
or neglect (when the failure is also during unilateral stimulation). Confrontation testing performed 
by Cohen et al. [71] revealed that only three out of the 22 tested people with CRPS presented with 
tactile extinction, while Förderreuther et al. [37] did not observe either neglect or extinction in 
individuals with CRPS. Five of Cohen et al.’s [71] participants, however, showed tactile allochiria 
(i.e. perceiving unilateral touch only in the analogous contralateral location), which has been 
reported in several modalities in hemispatial neglect patients [115–118].   
One of the classic bedside tests of hemispatial neglect involves dividing a straight horizontal line 
in half [119]. For example, a patient who has reduced attention to the left side, relative to the 
right, would ignore the left end of the line and place the bisection mark further to its right side. A 
deviation from the centre is thus indicative of spatial attention bias. In CRPS, there are only single 
case studies reporting deviations in classic line bisection performance: one away from the affected 
(right) side of space [65] and one towards the affected (left) side of space [53,54]. Interestingly, 
Christophe et al. [53] describe that the patient in their study showed a bias towards the affected 
side when line bisection was performed with either the healthy or affected hand and the line was 
positioned at body midline. However, the bias was abolished when was positioning the to-be-
bisected line in the affected side of space abolished the bias. These single case reports point 
towards impaired perception of spatial relationships between external objects (allocentric frame 
of reference) located within reaching distance (i.e. in peripersonal space) [81]. Although the 
direction of the bias relative to the affected side is inconsistent between the two cases [53,54,65], 
both patients presented with a leftward bias. This appears to be consistent with a third type of 
abnormal bisection performance that has been reported for people with CRPS, which was found 
in robot-assisted line bisections performed with the healthy limb [66]. In this group study, 
independent of the CRPS-affected side of the body, participants’ bisections consistently deviated 
towards the left relative to those of the pain-free controls. These findings resemble an 
exaggeration of “pseudoneglect”. That is, healthy controls show the consistent leftward deviation 
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of bisection judgements on some spatial tasks, which is interpreted as an effect of right-
hemisphere dominance in spatial perception [120–122]. Finally, several group studies of people 
with CRPS have reported no signs of line bisection bias relative to healthy controls 
[37,38,40,55,58] when the task was performed with either the affected or unaffected hand. No 
lateralised impairment was found on other classic bedside tests of neglect, for example, clock-
drawing, clock-reading, rod orientation, Kohs blocks, or block tapping [38]. 
Overall, the performance of people with CRPS on confrontation testing and standard 
neuropsychological tests does not provide sufficient support for the hypothesis that CRPS 
involves neglect of the affected limb or side of space. Some findings even suggest the opposite 
direction of spatial bias or exaggerated "pseudoneglect”. The inconsistence between the normal 
performance of people with CRPS on classic bedside tests of neglect in most studies, despite the 
high percentage of self-reported “neglect-like” symptoms in large sample studies (e.g. 
[35,36,39,42]), might stem from the differences between what these two types of measures entail. 
That is, the questionnaire about “neglect-like” symptoms measures asomatognosia and motor 
aspect of neglect, whereas classic bedside tests of neglect primarily measure its perceptual aspect 
(although they usually require motor responses, too). Another possibility is that classic neglect 
tests are not sufficiently sensitive to reveal the subtle neuropsychological changes in CRPS, given 
that classic pen-and-paper tests of neglect were developed to test people who suffered brain 
lesions, and neuropsychological changes in CRPS are likely to develop because of less overt 
structural and / or functional changes. 
3.2.3. Sensitive measures of lateralised cognitive functions 
Inconsistent findings regarding the spatial bias in people with CRPS led some researchers to 
measure lateralised spatial cognition using methods that are more sensitive. Substantial research 
on lateralised spatial deficits in brain-lesioned patients and healthy controls has revealed that 
better precision and sensitivity of assessment can be achieved through experimental manipulation 
of the properties of the stimuli used to measure attention, spatial representations, and motor 
control; and by altering the conditions under which these tasks are performed. Below we present 
the evidence available from several sensitive measures of lateralised changes: the subjective body 
midline task, temporal order judgements, mental number line bisection, and tests of spatially 
defined motor control. Through these tasks, researchers have found evidence for biases in people 
with CRPS on the following domains of spatial cognition: the egocentric frame of reference, 
tactile spatial attention in personal space, visual spatial attention in personal and peripersonal 
space, the internal representation of space, and spatially defined motor control.  
3.2.3.1. Subjective body midline 
In the visual subjective body midline judgement task (or “visual straight-ahead”), participants 
verbally indicate when a light moving horizontally from one side of extrapersonal space to the 
Chapter 1 
39 
other crosses the point that is directly in front of the middle of their body. When performed in the 
dark, with no other visual cues available, the task is thought to measure any lateral shift of the 
egocentric frame of reference, defined as the coding of the location of external objects in relation 
to one’s own body midline  [68,123,124]. Multiple studies reported a deviation of subjective body 
midline towards the affected side of space in people with CRPS compared to healthy and pain 
controls when judged in a darkened room (median deviation from objective midline ranging from 
0.59° to 5.13° [53,54,67–69]). The people with CRPS showed no bias in body midline under 
illuminated conditions when it is possible to make use of the allocentric frame of reference 
(external cues). This suggests that if people with CRPS have a distorted subjective body midline, 
it affects only the representation of external space in relation to their own body. Christophe et al. 
[53] also demonstrated a distance-based dissociation in one patient who showed a significant 
deviation towards the affected side when stimuli were presented at two meters distance from the 
trunk (similar to other studies cited in this section), but not at one meter. The spatial bias of 
egocentric frame of reference towards the affected side is consistent with an over-representation 
of the affected relative to unaffected side of space. In contrast to the above findings, Reinersmann 
et al. [40] found that their participants with CRPS made subjective body midline judgements that 
were biased further towards the left than healthy and pain controls (0.7° vs. 0.1° and 0.09°), 
irrespective of which side of the body was affected. This pattern can be interpreted as exaggerated 
“pseudoneglect”, consistent with the previously discussed findings from the robotic line bisection 
study by Verfaille et al. [66], and could be due to disruption of right-hemisphere cortical networks 
involved in spatial processing. Visual straight-ahead biases, both towards the affected side and 
towards the left side, suggest that people with CRPS can have problems with combining external 
visual information with their subjective body midline. Yet other authors demonstrated that people 
with CRPS showed no bias when judging their body midline using the visual straight-ahead task 
[42,55]. Thus, it appears that any shifts of egocentric frame of reference are subject to high 
individual variability because these effects do not always replicate. 
3.2.3.2. Temporal order judgement 
According to the law of prior entry, attended stimuli are perceived before unattended ones 
[125,126]. This principle forms the basis of Temporal Order Judgement (TOJ) tasks. In TOJ 
procedures, the participant is presented with pairs of identical stimuli, one on each side of space, 
with different onsets. They report the temporal order of the two stimuli, that is, which occurred 
first / second. The pattern of left-right responses across different stimulus onsets indicates whether 
participant’s attention is shifted towards one side of space relative to the other. The TOJ task is a 
sensitive measure of lateralised spatial attention, that is, the distribution of covert attention in one 
side of space relative to the other.   
On tactile TOJ tasks, people with CRPS exhibited reduced attention to tactile stimulation applied 
to the affected limb (i.e., touch on the affected limb had to occur ~17-27ms before touch on the 
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unaffected limb for the two stimuli to be perceived as simultaneous [58,72,73]; however, Filbrich 
et al. [74] failed to replicate this effect). When the limbs were crossed, their performance indicated 
inattention to the unaffected hand, now located in the affected side of space (touch had to occur 
~18ms earlier than on the affected hand in the unaffected side of space [73]). CRPS participants 
exhibited the same pattern of attention bias both with and without visual feedback about the limbs’ 
position [72]. Tactile stimulation inherently involves body-relevant information, thus it would 
seem that the tactile TOJs should rely on a personal frame of reference. However, it appears that 
those judgements at the same time rely on the current location of the body parts in peripersonal 
space.  
The tactile attention bias away from the affected side also extends to TOJs about visual stimuli 
presented near [74] or on the surface of the patients’ hands and on a blank board in near space 
[45] (with magnitude of ~14-25ms). In accord with Moseley et al. [73], the authors concluded 
that visual attention bias in CRPS is space-based, because it was observed regardless of the 
involvement of the body. However, Bultitude et al. [45] also found no lateral shift of visual 
attention when the limbs were crossed such that the affected limb was located in the unaffected 
side of space. This suggests that people with CRPS had a deviation in attention both away from 
the affected side and from the affected limb (regardless of where it was located), which cancelled 
each other out when the limbs onto which the visual stimuli were presented were crossed. 
Despite evidence for spatial attention bias from TOJs, these deficits do not seem to affect all 
aspects of visual spatial attention in CRPS. Filippopulos et al. [75] argued that attention deficits 
in CRPS do not involve allocation of visual attention, as they failed to find any delay of orienting 
saccades to cued and non-cued visual targets presented in either hemifield. Similarly, no spatial 
bias away from the affected side of space was found on a computerised task measuring simple 
reaction times to visual stimuli [38]. The contrasting results on the TOJ tasks and these other 
computerised tasks might be because of the different regions of space involved, since computer 
monitors are invariably placed within the participant’s extrapersonal space (e.g. at a distance of 
60 cm) rather than personal or peripersonal space. 
In summary, the results on sensitive tests of spatial cognition in people with CRPS tend to indicate 
that judgements of their subjective body midline are biased towards the affected side, that is, in 
the direction opposite to what would be expected based on their self-reported “neglect” of the 
affected limb. Yet, TOJs of tactile and visual stimuli tend to be systematically biased away from 
the affected side of space, and problems with attention allocation [67] cannot explain this bias. 
Given that both visual and tactile TOJs were affected [45,58,72,73], attention biases in CRPS 
might be supramodal. On the other hand, when the same individuals were tested on TOJs in 
multiple modalities, one study found they only presented with visual, but not tactile biases [74]; 
and another study found they only presented with tactile, but not auditory biases [58]. Similar 
dissociations between sensory modalities can also be found in neglect after brain injury [127].  
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3.2.3.3. Mental number line bisection 
Analogous to the conventional line bisection task that involves the allocentric frame of reference, 
the mental number line bisection task is thought to involve the “bisection” of the internal 
representation of space. It is considered to be an implicit measure of mental spatial representations 
[128], and is independent of motor abilities. In mental number line bisection, participants verbally 
indicate, without calculating, the number that is halfway between a given pair of numbers. 
Because the number line is internally represented from left to right [129–131], a bias towards the 
higher numbers would be equivalent to a rightward spatial bias, as has been demonstrated in 
hemispatial neglect [128,132–134]. Midpoint number judgements in CRPS were found to deviate 
away from the affected side compared to healthy controls [67]. The opposite direction of such a 
bias was observed in a single case of CRPS of the left limb [53,54], who also presented with a 
consistent leftward bias on a range of other spatial tasks. Despite this exception, the group study 
suggests that inattention to the affected side of personal and peripersonal space exhibited by 
people with CRPS also affects the internal representation of space. In contrast to personal and 
peripersonal space, mental number line bisection does not rely on bodily information about the 
affected limb and its position in external space, or the visual representation of the affected side of 
space. Therefore, biased mental number bisection suggests a generalized distortion of spatial 
representations in CRPS, which could potentially occur via shared higher-order mechanisms. 
3.2.3.4. Spatially defined motor control  
Following the early clinical and self-reports of motor “neglect-like” symptoms [33,36], several 
studies also tested for spatially lateralised deficits in movements using sensitive experimental 
measures. Contrary to the motor neglect hypothesis, people with CRPS did not show any signs of 
neglect or extinction on behavioural motor tasks such as finger tapping when performed with one 
or both hands; in normal posture or with the hands crossed such that the affected limb was located 
in the unaffected side of space, and vice versa; or with or without visual feedback [53,55]. 
Similarly, there was no asymmetry (i.e. extinction) in hand movement patterns while performing 
a bimanual circle drawing task measuring motor accuracy [55]. The performance of people with 
CRPS on both the tapping and circle drawing tasks did not differ from healthy controls. Another 
study with a larger sample size (13 vs 7) and a slightly different measure of finger tapping found 
worse motor accuracy and coordination on circle drawing and button pressing tasks when using 
the affected limb compared to the unaffected limb, regardless of the side of space in which patients 
performed the tasks. Importantly, the people with CRPS also showed similar deficits when the 
tasks were performed on the affected compared to unaffected side of space with the unaffected 
hand [76]. Thus, there appear to be spatially defined motor deficits in CRPS (that is, deficits 
modulated by where the movements are performed relative to body midline). It is not possible to 
ascertain whether the asymmetries between the affected and unaffected limbs and sides of space 
reported in people with CRPS were greater than normal, because there was no control sample 
[76]. Nonetheless, the findings of this study are consistent with self-reported “neglect-like” 
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symptoms, which primarily entail movement difficulties [33,36]. However, another perspective 
that we will now outline is that motor deficits in CRPS arise from decreased use of the affected 
limb rather than attention bias [3]. 
Punt et al. [3] proposed a learning-based account for motor deficits in CRPS framed as non-use 
of the affected limb. Learned non-use manifests as motor difficulties greater than expected based 
on actual physical constraints, or as a difference between what the patients do spontaneously and 
what they are able to do in clinical examination. This could explain why motor “neglect-like” 
symptoms are reported by the people with CRPS, but not necessarily apparent upon experimental 
testing [55]. After a stroke, learned non-use develops through operant conditioning and can affect 
the entire contralesional side of the body. Punt et al. [3] argued that in CRPS learned non-use is 
normally limb-specific rather than involving the entirety of one hemibody and could manifest in 
protective behaviours (e.g. guarding and holding an affected hand close to the chest). However, 
despite these differences in the manifestation of learned non-use in CRPS compared to stroke, its 
progression is thought to follow a similar pathway [3]. Limb trauma is followed by enforced 
immobility, leading to poor coordination and dexterity, which result in less frequent attempts to 
move. Movement is additionally suppressed by pain and fear avoidance behaviours [135]. At the 
same time, compensatory movements of the unaffected limb are developed and reinforced. These 
changes can alter cognitive and cortical representation of the CRPS-affected limb [3]. For 
instance, primary somatosensory and motor cortical representations of the affected hand were 
found to be smaller (compared to the unaffected hand and to representations of healthy controls) 
[85,86,136–141], consistent with underutilization, while the sensory map of the unaffected hand 
was found to be enlarged [142], consistent with compensatory use (although these findings have 
recently been disputed [143]). 
In contrast to the framework of motor neglect that attributes spatially-defined motor impairments 
to attentional deficits, the proposal of Punt et al. [3] explains motor control deficits using a 
learning-based theoretical account. In an attempt to dissociate these two possible explanations of 
visuo-motor deficits in CRPS, Verfaille et al. [66] analysed goal-directed movements of the 
unaffected limb to bisect horizontal lines in both sides of space. Contrary to the neglect 
framework, the bisections of participants with CRPS did not show a bias in relation to the affected 
side, nor depending on in which side of space the bisections occurred. Nonetheless, they showed 
a significant leftward bias, consistent with exaggerated “pseudoneglect”. This finding opposes 
the learned non-use account, because the participants performed the bisections with the unaffected 
limbs. To disentangle the account of motor neglect, future research could investigate if there are 
any signs of directional hypokinesia or bradykinesia in CRPS. If people with CRPS show 
performance asymmetries analogous to that of patients with hemispatial neglect after brain injury, 
they should have slower initiation or execution of movements directed towards the affected side 
of space compared to movements directed towards the unaffected side of space, even when the 
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unaffected hand is used. All movements in Verfaille et al.’s [66] study were directed towards the 
CRPS-affected side of space, and thus it was not possible for their study to discern directional 
“neglect-like” motor changes. Nonetheless, even based on the evidence available thus far, 
attention-based and learning-based explanations are not mutually exclusive, and some changes in 
motor control in CRPS could arise from a combination of both. 
Although Punt et al. [3] sought to separate perceptual and motor aspects of neglect, we propose 
that their learned non-use hypothesis can also provide a basis for explaining how perceptual 
spatial biases could arise in CRPS. Previous studies involving amputees and healthy participants 
with limb immobilization provide evidence in favour of action-driven spatial representations (see 
also [144]). Specifically, upper limb amputees were found to “neglect” the side of near (but not 
far) space corresponding to their missing arm [145], and in healthy participants experimental cast 
immobilization of one arm led to shrinkage of its peripersonal space [146]. These findings suggest 
that lack of limb action can change the representation of space surrounding that limb. Because of 
decreased mobility of the affected limb, people with CRPS perform fewer movements in the 
affected side of near space. We hypothesise that this could give rise to changes in the cognitive 
representation of space. Underrepresentation of the CRPS-affected side of space could potentially 
hinder the ability to perform motor tasks on that side, in line with spatially-defined deficits in 
motor accuracy and coordination found in people with CRPS [76]. It could also contribute to 
reduced attention to that side of space demonstrated in TOJ studies [45,58,72–74].  
3.2.4. Summary of changes in lateralised spatial cognition and potential mechanisms  
Overall, research suggests people with CRPS might present with neuropsychological deficits 
resembling hemispatial neglect that can follow a stroke. However, the evidence is not consistent. 
Researchers have rarely found lateralised spatial biases using standard bedside measures of 
neglect, or using sensitive measures such as saccades and reaction times to visual targets, auditory 
TOJs, and some experimental measures of motor performance. Other sensitive tests of perceptual 
(visual or tactile TOJs) and representational (mental representation of space) changes have 
revealed lateralised deficits in spatial cognition consistent with a bias away from the CRPS-
affected side of the body and / or space. Yet other findings from visual subjective midline 
judgements point to a shift of egocentric frame of reference toward the affected side in CRPS, 
thus in the direction opposite to what would be expected for neglect of the affected side. The 
opposing biases away from the affected side of space in TOJ tasks and towards the affected side 
in visual subjective body midline cannot be explained by the different modalities that are tested 
in these tasks, because TOJs were biased in the visual domain. We consider two possible 
explanations for these opposing biases: the dissociation between near and far regions of space, 
and the distinct functional aspects of peripersonal space (defensive and goal-directed). 
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3.2.4.1. Near space versus far space 
The different regions of space in which participants perform the TOJs and subjective body midline 
judgements could potentially account for the inconsistent biases shown by people with CRPS on 
these tasks. The studies using visual subjective body midline judgements in CRPS presented 
stimuli in far / extrapersonal space (generally two meters away from the trunk). The studies using 
TOJs, on the other hand, presented stimuli in either personal space (e.g. tactile TOJ, visual TOJ 
when stimuli are presented on body surface) or near / peripersonal space (e.g. visual TOJ when 
stimuli are presented on a blank board within arms’ reach, or immediately next to the hands). Like 
perceptual TOJs, the internal representation of space (as measured through mental number line 
bisections) is also biased away from the affected side. Dissociations between distinct regions of 
space have been found in some post-stroke hemispatial neglect patients, where attention deficits 
manifested either exclusively in their personal space [147], near / peripersonal space [148], far / 
extrapersonal space [149,150], or internal representation of space [132,151]. Although rare, there 
are reports of individual patients with post-stroke neglect [152–155] who show opposite 
directions of bias on different tasks, as also reported in Sumitani et al.’s [67] CRPS study 
(opposing biases in subjective body midline and mental number line bisection).  
3.2.4.2. Defensive versus goal-directed space 
Above we have suggested a possible explanation for the inconsistent biases shown by people with 
CRPS on TOJ and visual straight-ahead tasks based on known cortical dissociations between the 
representation of near and far space identified through research on brain-lesioned patients. 
However, given that people with CRPS typically do not have any history of brain damage, it could 
be more meaningful to consider potential cognitive mechanisms that might better account for the 
different results on this task. Peripersonal space is thought to dissociate into two representations 
according to distinct functions: for preparing defensive responses (defensive peripersonal space), 
and for preparing actions (goal-directed peripersonal space) [156]. Furthermore, Bufacchi and 
Iannetti [157] argue that peripersonal space cannot be defined in terms of fixed boundaries around 
the body (or body part), but its extent is rather graded and dynamically changing according to the 
action being performed and the proximity or valence of external information. Thus, we speculate 
that different dynamic changes to goal-directed and defensive peripersonal space specific to the 
affected extremity [158] might explain the contrasting biases that have been reported in people 
with CRPS at different distances from the body. Reduced activity of the affected limb [3], 
resulting in fewer interactions with the affected side of goal-directed peripersonal space, could 
reduce visuospatial processing near the body in the affected compared to unaffected side. For 
example, Makin et al. [145] found that visuospatial processing of amputees favoured their intact 
side when stimuli were presented at a distance of 50cm. The biased TOJs in people with CRPS 
were observed within the same distance (see also [158] for a review of how peripersonal space is 
shaped by action and integration of multisensory information from the body and the environment). 
In contrast, it has been shown in healthy participants that approaching, threatening stimuli can 
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extend peripersonal space in such a way that is sensitive to the trajectory of the threat [159,160]. 
No studies have measured the dimensions of the affected side of defensive peripersonal space in 
CRPS. However, we suggest that it could be enlarged due to heightened hypervigilance to threat, 
as has been reported for the representation corresponding to the affected area in trigeminal 
neuralgia [161]. This could explain why people with CRPS showed greater tool-use dependent 
updating of peripersonal space than controls [51], which could indicate that their spatial 
representations are less stable. It is conceivable that such a heighted defensive awareness to 
stimuli that are potentially threatening to the CRPS-affected limb (due to allodynia and 
hyperalgesia) could drive a bias towards the affected side in extrapersonal space. This might 
particularly be the case for dynamically moving stimuli such as those used in the visual subjective 
midline task. This speculation should, however, consider that the visual subjective body midline 
in CRPS has typically been assessed at two meter distance from the trunk, which is beyond the 
extent of peripersonal space normally reported in healthy participants (80-90cm [162]). Body 
midline judgements made at one meter were not biased in a case of CRPS [53], similar to a group 
study that reported no bias on visual TOJs for stimuli presented 90 cm from the trunk [74]. 
However, thus far, no studies have mapped the extent of defensive peripersonal space in people 
with CPRS in the context of threatening and / or dynamically approaching stimuli (note that the 
TOJ stimuli appeared in a fixed distance from the participant’s body). Spatial representations can 
be dynamically changing depending on the conditions and the meaning of the testing stimuli. 
Therefore, an enlarged defensive yet diminished goal-directed peripersonal space representation 
of the affected side could still account for the seemingly contradictory findings of attention bias 
in CRPS.  
On balance, the discussed findings suggest that CRPS is associated with contrasting alterations in 
spatial attention, representations of space, and spatially defined motor control. The 
neuropsychological changes in these domains are observed in different modalities (visual and 
tactile), and different regions of space (personal, peripersonal, extrapersonal, and 
representational). The existing evidence cannot fully account for the conflicting directions of the 
spatial biases that have been reported (towards or away from the CRPS-affected side). Yet 
hypothetically, some of the contrasting patterns of performance in the spatial tasks could be 
explained by hypervigilance to approaching stimuli within the affected side of extrapersonal or 
defensive peripersonal space, simultaneous to “neglect” of the affected side of personal and goal-
directed peripersonal space stemming from learned non-use. 
3.2.5. Overlap of body perception distortion and “neglect-like” symptoms  
Thus far, we separately reviewed evidence for body perception disturbances and deficits in 
lateralised spatial cognition in CRPS. However, these two cognitive functions are inherently 
linked (e.g. spatial representations are anchored in the represented location of the body [158,163]), 
and neuropsychological changes in them often present simultaneously [45,58]. Somatosensory, 
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motor, and body representation distortions are largely confined to the CRPS-affected limb 
(although bilateral and hemisensory deficits have also been reported, e.g. [23,26,52,164]), thus 
they can be considered primarily lateralised. This is comparable to the changes in spatial cognition 
discussed so far, which most often take the CRPS-affected side as a point of reference. Whether 
problems with body representation and attentional orienting are truly dissociable in CRPS remains 
uncertain. For instance, Reid et al. [58] suggested that interactions between spatial attention and 
processing of body-relevant information (e.g. seeing the limbs) might exacerbate usually subtle 
lateralised spatial changes by evoking distorted body representation.  
3.2.5.1. The “Somatospatial inattention” hypothesis 
Some spatial biases might only manifest when the body is directly involved in the task at hand, 
demonstrating an overlap of the cognitive changes in body representation and spatial attention. 
When directly investigating these interactions, Reid et al. [58] found a deviation away from the 
affected side in people with CRPS when line bisections were performed on the surface of their 
hands, but not when performed on paper. This perceptual bias was space-dependent because it 
was present not only on the affected limb, but also on the healthy limb when placed in the affected 
side of space. Participants with CRPS exhibited a similar deviation away from the affected side 
when they bisected the length of their affected hand and forearm [58]. Interaction between spatial 
bias and body representation was also demonstrated by difficulties with recognising the laterality 
of body parts specifically when they were presented in the affected hemifield [58]. Based on this 
evidence, and the previously found attention bias away from the affected side on tactile TOJs, 
Reid et al. [58] proposed that the disruption of spatial processing in CRPS specifically involves 
problems with integrating spatial information with body representation, a phenomenon they called 
“somatospatial inattention”. This hypothesis was partially supported by Filbrich et al. [74], who 
found a significant attention bias in visual TOJs only when patients’ hands were positioned close 
to the visual stimuli in near space, but not when the hands were out of sight, close to the trunk. 
Deviated visual subjective body midline in CRPS [67–70] is also somewhat in agreement with 
this hypothesis since this measure requires integrating body midline with the external visuospatial 
reference frame. However, in this case the performance of people with CRPS is consistent with 
over-representation of the affected side rather than inattention. Furthermore, the proposed 
“somatospatial inattention” does not fully account for all spatial attention biases found in CRPS, 
because significant deviation away from the affected side was also observed in visual TOJs for 
stimuli that did not involve and were not near to any body parts [45].  
3.2.5.2. Proposed mechanisms of interactions between bodily and spatial representations 
We suggest there are two hypothetical mechanisms through which body representation 
disturbances might drive attentional biases even when body parts are not directly involved in the 
spatial tasks: reduced ownership and increased perceived size of the CRPS-affected limb. More 
generally, body representation forms the basis for spatial cognition [158,165]. In CRPS, reduced 
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awareness and ownership of the painful limb could contribute to inattention to the affected side. 
For example, the severity of body perception disturbance was found to predict the magnitude of 
spatial attention bias away from the affected side in people with CRPS [45]. Furthermore, a 
perceived increased size of the affected extremity [49] could conversely drive hyperattention to 
that side.  
Peripheral CRPS symptoms in the affected limb might offer an additional explanation of how 
body-related disturbances could drive attentional biases. First, it has been suggested that the bias 
in visual subjective body midline judgements towards the CRPS-affected side is due to an 
exaggerated somatosensory input from the painful limb [68,166]. Second, CRPS signs can 
manifest as a combination of sensory gain (e.g. pain, hyperalgesia) and sensory loss (e.g. 
hypoesthesia) [167]. Thus, suppression of some types of somatosensory input could potentially 
explain tactile inattention to the affected limb (e.g. on TOJ tasks when the hands are uncrossed). 
Third, mechanical constraints related to motor symptoms of CRPS can trigger underutilization of 
the affected limb [3]. As we argued in in section 3.2.3.4., such underutilization could lead to 
space-based inattention, because fewer movements performed in the affected side of space would 
drive asymmetries in spatial representations. Although these peripheral somatosensory and motor 
abnormalities are not equivalent to distorted body representation, this representation is generated 
and continuously updated based on multimodal sensory input and motor feedback during action 
[79,80,158,165]. Therefore, the peripheral (somatosensory and motor) and central (body 
representation) mechanisms could serve as complementary explanations of how body-related 
information could exacerbate spatial biases, even when that information is not directly relevant 
to the task. Nonetheless, direct empirical evidence for how body representation, somatosensory, 
and motor disturbances might shape spatial processing in CRPS is limited and it remains unclear 
why the attention bias is sometimes found to be shifted away and sometimes towards the CRPS-
affected side. 
In conclusion, people with CRPS show several changes to lateralised spatial cognition. These 
share many similarities with hemispatial neglect, yet there are also several differences. Although 
the abovementioned aspects of body representation disturbance might relate to lateralised 
attention deficits, they should not be treated synonymously (i.e. as “neglect-like” symptoms). A 
distinction between the two concepts can help to avoid theoretical, terminological, and 
mechanistic confusion in research. 
3.3. Non-spatially-lateralised cognition  
In addition to changes in body representation and lateralised spatial cognition reviewed thus far, 
people with CRPS can also present with cognitive deficits that are not lateralised with respect to 
the affected side of the body or space. In this section, we discuss non-lateralised cognitive 
processes that comprise aspects of both spatial and non-spatial cognition. Examples of potentially 
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affected aspects of non-spatially-lateralised spatial cognition include spatial orientation; memory 
for spatial locations; visuospatial exploration and coordination; constructional abilities; and 
knowledge about the orientation and order of objects, letters, or numbers. Examples of potentially 
affected aspects of non-spatially-lateralised non-spatial cognition include numerical and language 
processing, recognition of objects and faces, imitating complex movements, generalised attention, 
working memory, and executive function. Broadly speaking, these can be broken into cognitive 
functions that have been associated with the parietal lobe; and executive functions, memory, and 
language. 
3.3.1. Parietal functions 
Comprehensive standard neuropsychological assessments of people with CRPS revealed no 
systematic abnormalities in spatial orientation, visual exploration, constructional abilities, spatial 
memory, or visuospatial coordination on a group level, compared to healthy and pain controls 
[38]. However, Cohen et al. [71] assembled a custom battery of standard neuropsychological tests 
to assess functions specifically associated with the parietal lobe. They found that 68% of their 
tested participants with CRPS showed one or more deficit in the ability to: recognise objects by 
touch (astereognosia), identify the fingers of the hand (finger agnosia; see also [37,77]), identify 
numbers outlined on the surface of the hand (dysgraphaesthesia), draw objects (constructional 
apraxia), comprehend arithmetic (dyscalculia), write (dysgraphia), repeat speech (conductional 
dysphasia), differentiate between the left and the right side of the body, and / or imitate gestures 
or tool use (ideomotor apraxia). Deficits like these all typically occur after parietal lobe lesions 
[168]. However, the assessed individuals with CRPS had never sustained brain injury that could 
account for these deficits (confirmed by normal MRI scans in 12 out of 22 patients), and had not 
had any cognitive difficulties prior to the onset of CRPS symptoms (corroborated by their 
families). None of the healthy control participants tested on a shortened version of the same 
battery presented with any neuropsychological deficits, suggesting that these symptoms could be 
due to CRPS-related functional cortical reorganization of the parietal networks. Although tested 
on both upper limbs, the abnormalities on the manual and tactile / haptic tests were only present 
on the affected side of the body of participants with CRPS. This means that some of the observed 
deficits could be attributed to peripheral sensory loss or motor impairment. However, 27% of 
patients with lower-limb CRPS also presented with behavioural deficits despite being tested on 
their unaffected upper limbs [71]. Therefore, it is likely that at least some of the reported changes 
are due to cortical reorganization that driven by parietal changes. 
There are also reports from this and other studies of individual people with CRPS who presented 
with more unusual and severe non-spatially-lateralised deficits. Cohen et al. [71] reported cases 
of horizontal inversion of individual letters and words, and inverted ordering of letters or numbers, 
in spontaneous writing (resembling a form of dysgraphia [169]), although people with CRPS did 
not show any impairment of letter orientation recognition in a different study [58]. These deficits 
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were apparent when patients used their affected limb, and, in one patient - bilaterally. Robinson 
et al. [65] also presented a case of a right upper-limb CRPS patient with no history of brain injury 
who exhibited mirror reversal in writing single words with his unaffected hand and in reading 
single letters. Mirror writing is rare but can follow various focal lesions to the left hemisphere 
[170,171]: the hemisphere contralateral to this patient’s CRPS-affected hand. The same patient 
also presented with severely impaired face perception (i.e. prosopagnosia, a neuropsychological 
symptom that can occur following a lesion to fusiform gyrus on the ventral surface of the temporal 
lobe [172]) that had not been present prior to the development of CRPS. Despite being able to 
visually recognise and name objects, the patient failed to recognise if objects were in the upright 
orientation and he copied objects into inverted orientations. Orientation agnosia is most 
commonly found in patients with lesions to the posterior parietal cortex [173–175].  
The studies directly assessing parietal lobe function in CRPS thus far have had relatively small 
sample sizes and usually lack pain or age-matched control groups (although an unspecified control 
samples was tested on most of the tasks in Cohen et al.’s study [71]). Therefore, it is difficult to 
estimate the real prevalence of the symptoms discussed above in CRPS. An exception is a study 
by Kolb et al. [38], who tested for several neuropsychological symptoms linked to parietal 
function. In this study, people with CRPS on average did not present with any abnormalities that 
would be consistent with parietal dysfunction. However, the authors did not report individual 
cases, and for some measures did not specify which hand was tested (for instance, Cohen et al.’s 
[71] patients were not impaired when using their unaffected hand). We cannot argue that the 
neuropsychological changes discussed in this section are common in CRPS population, because 
they were observed only in a proportion of patients or in single cases (see Table 2). Nevertheless, 
reports of deficits in CRPS that are typical of patients with temporal and parietal lesions suggest 
a disruption of visuospatial functions that could be due to functional cortical reorganization in 
these areas. 
3.3.2. Executive functions, memory, and language 
Although there is evidence for biased spatial attention in people with CRPS, not all aspects of 
attention appear to be affected in this population. Specifically, no differences between people with 
CRPS, healthy controls, and pain controls were found on measures of alertness (response 
readiness) and working memory [62]. People with CRPS did, however, have poor temporal acuity 
when making spatial judgements: in a visual TOJ task they needed larger intervals between the 
two stimuli to reliably indicate their order of presentation [45]. In another, large sample study (N 
= 137), 42% of people with CRPS presented with mild dysexecutive syndrome (relative to age- 
and education-matched normative data), including impaired performance on working memory 
and verbal fluency tests [78]. Twenty-three percent of people with CRPS showed global cognitive 
processing impairments. Besides executive deficits, they also demonstrated impaired naming and 
declarative memory [78]. Executive, naming, and memory deficits are consistent with pathology 
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of the frontal lobes. Together with the deficits in general (non-lateralised) spatial cognition, 
problems with language processing also suggest changes to parietal function in CRPS.  
3.3.3. Summary of non-spatially-lateralised cognitive changes 
In summary, people with CRPS can present with non-spatially-lateralised deficits in higher 
cognition that resemble impairments found in neurological conditions other than hemispatial 
neglect. Findings from standard neuropsychological test batteries are still mixed, however, some 
individuals with CRPS present with neuropsychological symptoms like those shown by patients 
with lesions to the parietal lobe (e.g. astereognosia, finger agnosia, or constructional apraxia) and 
/ or temporal lobe (e.g. mirror reversal of writing, object orientation agnosia, or prosopagnosia). 
These unusual symptoms appear to affect only a subset of people with CRPS, yet they 
demonstrate that changes in visuospatial functions are not limited to lateralised spatial processing 
biases. Furthermore, people with CRPS can also present with features of dysexecutive syndrome 
and some language processing difficulties that are typical of frontal and parietal lobe pathology. 
Hemispatial neglect most often occurs after a lesion to temporo-parietal regions of the right 
hemisphere [108], which would be expected to disrupt other neuropsychological functions that 
depend on these networks. Thus, non-spatially-lateralised deficits can also co-occur with neglect. 
Such changes include impaired sustained attention, impaired selective attention, a tendency to 
favour local features over global configurations, and deficits in spatial working memory [112] 
(for reviews, see [176,177]). Yet these symptoms are not diagnostic features of neglect. This 
combined evidence suggests that the neglect framework is useful but not sufficient for 
characterising the breadth of neuropsychological changes in CRPS. Instead, disruption of parietal 
function and / or cortical networks involving the parietal lobe appears to be a better candidate.  
Although there is no direct neuroimaging evidence linking parietal cortex to cognitive deficits in 
CRPS, several studies on sensory and motor function reported altered patterns of activation in 
parietal regions. For instance, tactile stimulation of the fingers of both hands resulted in weaker 
superior [77] and inferior parietal lobe [140] evoked responses in people with CRPS compared to 
healthy controls. Furthermore, relative to healthy people, individuals with CRPS showed greater 
activation of the inferior parietal lobe during movement (relative to rest) of the affected compared 
to unaffected hand [178], and when they were observing hand movements (relative static hands) 
[179]. Finally, another study reported reduced grey matter volume in the inferior parietal lobe in 
early-stage (less than 10 months) CRPS, compared to healthy controls [30]. These parietal regions 
have been linked to the perception of space and limb location in other studies [180,181], which 
supports the conclusion that functional and / or structural reorganization of parietal networks 
might be associated with neuropsychological symptoms in CRPS. However, further studies are 




4. Clinical relevance of neuropsychological changes in CRPS 
In the following sections, we will discuss the clinical significance of aberrant changes in higher 
cognitive functions in CRPS. Their interactions and relationships with clinical signs of the 
disorder reflect the role of the neuropsychological changes in the manifestation of CRPS. They 
can also inform the treatment approaches targeting these higher cognitive changes to improve the 
clinical outcomes.  
4.1. Supraspinal modulation of sensory, motor, and autonomic function 
Although this review primarily focuses on higher-level cognition, here we provide examples of 
cortical modulation of low-level sensory, autonomic, and motor functions in CRPS (Table 4), 
relevant to understanding the higher-order central mechanisms of clinical signs of this condition. 
Previous research suggests that resting or seeing the affected limb in the unaffected side of space 
can normalize the temperature of that limb [72,182] (although this effect is not always found 
[51]). Furthermore, manipulating the perceived size of CRPS-affected hands can modulate 
movement-related pain intensity and swelling [183]. Sensory conflicts, such as viewing 
ambiguous visual stimuli, can increase pain and induce other sensory disturbances, dystonic 
reactions, and asymmetric autonomic response [184,185]. Sensory disturbances associated with 
increased pain can also be triggered by sensory-motor conflicts [186]. Heightened susceptibility 
to such conflicts suggests that CRPS-related sensory impairments might extend beyond the 
cortical networks related to sensory-motor processing of the affected body parts. Specifically, 
they can arise from processing visual objects [184,185] or sound [187] unrelated to the body, or 
during movements of the unaffected arm [186]. People with CRPS also presented with abnormal 
sensations in the CRPS-affected limb evoked without actual somatosensory stimulation, solely 
by creating a visual illusion of the affected limb being touched [188]. Overall, the many examples 
of relief or worsening of symptoms by spatial or multisensory manipulations support the notion 
that sensory and autonomic abnormalities in CRPS cannot be fully accounted for by peripheral 
mechanisms and suggest an involvement of supraspinal cortical mechanisms in generating or 
aggravating physical symptoms of CRPS. 
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Table 4 Evidence of modulation of low-level sensory and autonomic functions in CRPS by spatial 
or multisensory manipulations 
Function Manipulation Affected low-level sensory / 
autonomic / motor function 




Viewing ambiguous / 
conflicting visual 
stimuli 
Increased pain (61-73%), 
sensory disturbances (73%), 
dystonia (33%) in the affected 
limb, and asymmetric 
vasomotor response (34%) 
Cohen et al. [184], 
N=30, HC, BL; Hall 






Painful sensations to sound 
(hyperacusis; 38%) 





visual feedback during 
active movements 
Increased pain and sensory 
disturbances 
Brun et al. [186], 
N=38, HC, PC, BL 
Tactile 
perception 
Mirror visual feedback of 
stimulated unaffected 
limb 
Pain and paraesthesia 
experienced in the 
corresponding location on the 
non-stimulated affected limb 
(allochiria); cold perceived 
concurrently on the stimulated 
and non-stimulated limb 
(dysynchiria) 
Acerra and Moseley 




Physically resting or 
viewing the affected 
limb as positioned in 
the unaffected side of 
space through prism 
glasses 
Normalization of temperature 
asymmetry between the limbs 
Moseley et al. [182], 
N=10, HC, BL, [72], 
N=23, HC, BL 
Visual 
perception 
Viewing enlarged image 
of the affected limb 
through magnifying 
lenses or in virtual 
environment, or shrunk 
images of affected limb 
through minifying 
lenses. 
Pain and swelling (evoked by 
movement) increased when 
viewing enlarged image, 
reduced when viewing 
shrunken image 
Matamala-Gomez et 
al. [189], N=9, PC, 
AL; Moseley et al. 
[183], N=10, AL 
aPercentages represent the proportion of individuals with CRPS out of the total CRPS sample who presented 
with abnormal performance. We reported percentages where available; in other cases, we presented group 
effects. 
bN represents CRPS sample size. Where applicable, we specified what control group was included (HC = 
healthy / pain-free controls; PC = pain controls), and which limb(s) were tested (AL = affected limb; BL = 
both limbs). 
4.2. Neuropsychological symptoms related to pain intensity 
Interrelationships between the changes in higher cognitive functions and clinical signs of CRPS 
further demonstrate the involvement of central mechanisms in the manifestation of the syndrome. 
For example, higher pain intensity was associated with greater body perception disturbance, 
longer time taken to recognise the laterality of images of the affected limb, and more impaired 
sense of limb movement [44,47,57,60]. People with CRPS also reported increased pain intensity 
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while completing the limb laterality recognition task, which was greater in higher cognitive load 
conditions (i.e. when limbs were presented for shorter time) [63]. Finally, the severity of spatially-
modulated motor deficits [76], self-reported “neglect-like” symptoms [42], and magnitude of 
spatial attention bias [58,72,73] were related to more intense pain, although several studies 
reported finding no such relationships [39,40,45,74]. Nevertheless, self-reported “neglect-like” 
symptoms might have important prognostic value and contribute to the maintenance of CRPS, 
because they predict pain outcomes six months later in chronic CRPS [42]. The existing 
behavioural evidence cannot ascertain whether neuropsychological symptoms are primary or 
secondary to clinical signs of CRPS. However, the reported relationships between these outcomes 
suggest that cognitive and behavioural interventions targeting changes in processing conflicting 
information, body representation, and lateralized spatial function, have a potential to improve 
clinical outcomes in CRPS and other pain conditions.  
4.3. Are neuropsychological symptoms specific to CRPS? 
One outstanding question is to what extent the neuropsychological symptoms that we have 
reported here are unique to CRPS. Of those neuropsychological changes we have discussed, 
space- and body-related neurocognitive phenomena often relate to clinical symptoms of CRPS 
and might be specific to this pain syndrome. The lateral shift of subjective body midline [40,70], 
overestimation of the size of the affected limbs [49], referred somatosensation from the healthy 
to the affected limb under mirror visual feedback [188], and sensory disturbances and increased 
pain due to viewing conflicting visual stimuli [185] seem to be unique to CRPS. This is because 
they were not found in control patients with other pain disorders who participated in the same 
studies.  
However, changes in body representation [190], spatial representations [161], auditory perception 
[191], tactile acuity [192], and proprioception [190] can also be present in other chronic pain 
conditions. For instance, despite being slower than healthy participants in recognising hand 
laterality, when the performance of participants with CRPS was directly compared to those with 
phantom limb pain [62] or other non-CRPS upper limb pain [40], there were no differences 
compared to these groups. Self-reported “neglect-like” symptoms were also found in other 
chronic pain conditions, particularly upper limb pain [37,33,36,38,62,40] (although see [35]). 
Thus, some deficits in body representation and lateralised spatial cognition appear to be present 
in lateralised chronic pain conditions other that CRPS. Altered body representation was also 
observed in widespread pain (fibromyalgia) and chronic back pain (for a review, see [190]). 
People with fibromyalgia also reported similar experiences during sensory-motor conflict as 
individuals with CRPS [186]. It is thus possible that the above changes in body representation are 
common features of a group of related chronic pain conditions.  
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Certain cognitive changes might be associated with chronic pain more generally, regardless of its 
site and origin. For instance, deficits in working memory, verbal learning and memory, and non-
lateralised attention have been found in people with chronic pain other than CRPS [95,193]. A 
comprehensive literature review by Hart et al. [193] concluded that attentional capacity, 
processing speed, and psychomotor speed are commonly affected in people with chronic pain 
(without a history of brain injury) compared to healthy controls. The severity of their cognitive 
deficits has often been associated with reported pain intensity, and most studies ruled out the 
effect of medication on the participants’ performance. Even when the severity of depressive 
symptoms is controlled for, approximately 20% of people with non-malignant chronic pain 
present with cognitive impairment relative to normative cut-offs [95]. Conversely, a meta-
analysis revealed no attention bias towards pain-related information in patients with chronic pain 
other than CRPS [194].  
Although an exhaustive review of neuropsychological changes in chronic pain is beyond the scope 
of the current article, it is clear that many of the neuropsychological changes reported in CRPS 
are not unique to this condition. Nonetheless, the therapeutic benefit of treating such changes in 
CRPS suggests that they are important for understanding its pathology. Furthermore, 
understanding these cognitive symptoms could potentially result in expanding the neurocognitive 
treatments that are effective in CRPS to other pain populations. 
4.4. Targeting neuropsychological changes for treatment of CRPS 
The supraspinal mechanisms of CRPS are thought to involve functional cortical reorganization. 
For instance, the severity of pain and other CRPS signs (mechanical hyperalgesia, tactile 
discrimination impairment, decreased grip strength, and impaired reach to grasp movements) 
were related to the extent of functional reorganization of primary sensory and motor cortices 
[85,86,136,137,139,178,195]. Functional reorganization of the cortical representation of the 
CRPS-affected limb can be reversed in the course of CRPS treatment [85,196], and such a reversal 
is associated with improvement of CRPS symptoms. In one study, the patients who initially 
showed shrinkage of the cortical representation of the affected limb (relative to unaffected limb 
and representations of healthy controls) [139] were followed-up at least a year later, after 
successful drug therapy accompanied by physical therapy. Reorganization of the primary 
somatosensory representations of their CRPS-affected hands was reversed, and this correlated 
with the extent of the improvement in their CRPS symptoms [196]. Reversal of cortical 
reorganization of primary and secondary sensory maps was also associated with pain reduction 
and improved tactile discrimination following drug therapy accompanied by graded 
desensitization and motor tasks (sensory-motor returning treatment) [85]. The extent of re-
reorganization associated with the reduction in CRPS pain suggests that pain is related to the 
extent of neuroplasticity. Although these findings of cortical reorganization and then 
normalisation following treatment are only correlational, there is some evidence that targeting the 
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cortical reorganization itself might reduce pain and other symptoms of CRPS. Cortical changes 
have been targeted directly by anodal transcranial Direct Current Stimulation over primary 
sensory and motor cortex [197,198] or repetitive TMS over the motor cortex [199–201]. Both of 
these interventions resulted in promising analgesic effects in chronic pain, including CRPS in 
preliminary studies, although the abovementioned studies have not tested whether they actually 
reverse cortical reorganization.  
Compared to direct efforts to induce cortical reorganization, the research on behavioural methods 
addressing neuropsychological deficits in CRPS has been more extensive. Several therapies, such 
as mirror therapy, graded motor imagery, and prism adaptation, appear to have beneficial effects 
on both the neuropsychological and clinical symptoms of CRPS. Mirror visual feedback therapy 
[202] relies on correcting the mismatch between motor commands and sensory feedback. This 
method reduced pain and other symptoms, and improved motor function of the affected limb, in 
people with CRPS with [203–205] and without [46,206] neurological injury. In Graded Motor 
Imagery, hand laterality recognition training and imagined hand movements are thought to 
sequentially activate cortical motor networks without requiring real movements, and thus reduce 
movement-related pain that might be associated with mirror therapy [207–209]. This treatment 
decreased pain and oedema, and reduced the speed of limb laterality recognition in CRPS 
(although one study failed to replicate the effect of pain reduction [56]). Mirror visual feedback 
and Graded Motor Imagery can also reduce pain and improve motor function in other chronic 
pain conditions, particularly phantom limb pain [207,210,211]. Prism adaptation [212,213], 
adapted from rehabilitation of post-stroke neglect, is hypothesised to normalise attention bias and 
/ or the sensory-motor integration system in CRPS. In small uncontrolled studies it has been 
shown to reduce subjective body midline bias, body representation distortions, and pain; and 
improve autonomic symptoms and motor function in CRPS [55,69,214] (see [215], Chapter 3, for 
a protocol for a randomised controlled trial). Neurorehabilitation has certain advantages over 
analgesic medications and brain stimulation. For example, it is easily accessible, inexpensive, is 
not associated with severe side effects, and can be self-administered. However, the 
neurorehabilitation techniques discussed above are not alternatives to other rehabilitation 
methods. Instead, they could be used as adjunct therapies to drug treatment, physical / functional 
therapy, and brain stimulation. Reducing clinical signs such as pain and motor impairment, and 
cognitive symptoms such as body representation distortion, can help overcome pragmatic barriers 
in engaging with traditional rehabilitation.   
4.5. Summary of clinical relevance of neuropsychological changes 
To summarise, supraspinal mechanisms appear to contribute to CRPS symptomatology on the 
level of cognitive functions. This is demonstrated by spatial and multisensory modulation of 
sensory, motor, and autonomic function; and evidence that the extent of neuropsychological 
changes is related to pain severity. There is emerging support for targeting neuropsychological 
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deficits to relieve physical symptoms of CRPS. Neuroimaging studies indicate that cortical 
reorganization in CRPS can be reversed, although thus far, no study has investigated if this 
reversal is accompanied by any cognitive changes. Conversely, it remains unclear whether 
neurocognitive treatments reduce the clinical symptoms of CRPS through reversing cortical 
reorganization, or through changes on a behavioural level (or both). In particular, there is currently 
no neuroimaging research on whether any functional reorganization in parietal networks (implied 
by neuropsychological changes) relates to clinical manifestations of CRPS. Despite the promising 
effects of emerging neurorehabilitation strategies, their working mechanisms are yet to be fully 
understood, and the quality of evidence supporting their implementation in standard clinical 
practice is still insufficient. One potential avenue towards developing new treatments could 
involve taking advantage of intact cognitive functions. For example, the rubber hand illusion [41] 
could be used to work towards tolerating touch on the affected limb while observing touch on the 
artificial limb, and altered auditory feedback [48] could be used during auditory-motor adaptation 
to improve movement of the affected limb. 
5. Conclusions and outstanding questions 
Overwhelming evidence of neuropsychological alterations warrants their consideration in the 
management of CRPS along with the sensory, motor, and autonomic symptoms. Although 
posttraumatic aberrant inflammatory response can explain several symptoms of CRPS, changes 
in the central nervous system might better account for these once the peripheral processes subside. 
The role of cortical mechanisms in CRPS is evident in the neuropsychological symptoms, 
modulation of low-level sensory and autonomic symptoms by higher cognitive functions (see 
Table 4), and functional cortical reorganization. Neuropsychological changes found in CRPS 
include distorted body representation, deficits in lateralised spatial cognition, and impairment of 
other non-spatially-lateralised cognitive functions (see Table 2). They appear to pertain to 
manifestation of this syndrome and relate to its clinical outcomes, such as pain. Here we provide 
several concluding remarks and lay out suggestions for further research to investigate the 
cognitive aspects of CRPS and other chronic pain syndromes. 
1) The “neglect-like” framework does not fully capture the neuropsychological changes found 
in CRPS. Instead, disruption to the parietal cortical network might provide a better framework 
for characterising these symptoms. This would incorporate “neglect-like” symptoms that are 
often reported in CRPS (which in hemispatial neglect are often associated with temporo-
parietal right hemisphere lesions [109–111]). But the parietal framework would also include 
other changes in spatial cognition that are not consistent with reduced attention to the affected 
relative to unaffected side (e.g. the shift of the egocentric reference frame towards the affected 
side [68,70], or a leftward spatial bias regardless of which side is affected by CRPS [40,66]). 
The posterior parietal cortex has been implicated as a crucial area for constructing spatial 
representations of the body and external space, as well as body ownership [104,216–219]. 
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Other cognitive changes reminiscent of parietal deficits that have been seen in people with 
CRPS include impaired non-spatially-lateralised constructional and gnostic abilities 
[65,71,220], although some parietal functions such as multisensory integration might be intact 
[41,104]. Overall, combined evidence of abnormal lateralised spatial cognition, body 
representation, and non-spatially-lateralised cognitive functions in CRPS suggests that 
functional reorganization of the parietal cortex could underlie the manifestation of 
neuropsychological symptoms in CRPS. Further neuroimaging studies could test whether 
functional alterations in parietal cortex indeed correlate with observed neuropsychological 
symptoms to complement the behavioural findings. 
2) Neuropsychological symptoms might not all be specific to CRPS, but instead could have 
ramifications for understanding the cognitive aspects of other chronic pain conditions and 
applying neurocognitive treatments that are beneficial for CRPS to these disorders. Chronic 
pain in general can impair cognitive functions such as memory, attention, or executive 
function, and these impairments have been linked to pain intensity [95,193]. There are some 
cognitive changes that distinguish CRPS from other unilateral limb pain syndromes (such as 
arthritis or neuropathic pain [35,70,186]). Nonetheless, some neuropsychological symptoms 
are seen across these different pain disorders as well as in people with non-lateralised and 
widespread pain (such as chronic back pain or fibromyalgia) [190]. There are groups of 
chronic pain syndromes that are associated with plastic changes in the central nervous system, 
including phantom limb pain, fibromyalgia, and CRPS [221]. People with these conditions 
can present with similar distortions of body representation and spatial cognition (e.g. 
[62,145,190,222,223]), which inspired therapeutic approaches targeting these symptoms to 
reduce pain [224].  
3) Striking findings that cortical reorganization in CRPS can be reversed after recovery [85,196] 
suggest that the central mechanisms of chronic pain can be targeted for treatment. 
Recognising similarities between mechanisms and symptomatology of different pain 
syndromes can facilitate broader applications of treatments that are beneficial in some 
disorders. Several neurocognitive rehabilitation strategies developed for CRPS, or adapted 
from other neurological or pain conditions, have provided some relief from pain and other 
symptoms [69,206,208]. However, there is a need for studies involving larger patient groups 
and more rigorous controls to better evaluate the benefits of many of these treatments. 
Another issue is that studies of treatments that target neuropsychological symptoms or 
cortical networks rarely evaluate the changes in these factors. Identifying the mechanisms of 
action of neurocognitive treatments, and understanding which neuropsychological symptoms 
should be targeted for rehabilitation, would help to maximise its therapeutic effects. For 
instance, not all individuals with CRPS present with the same neuropsychological changes, 
thus stratified management might be most efficient. 
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4) Recognising the limitations of the research reviewed in this article and gaps in our 
understanding of the neuropsychological aspects of CRPS, we would like to put forward some 
recommendations that could improve further studies on this topic. Even though there is a body 
of evidence suggesting systematic neuropsychological changes in CRPS that are apparent on 
a group level, it would be an overstatement to suggest that all people with CRPS present with 
such symptoms. High variability in the clinical presentation of CRPS [15] also applies to 
neuropsychological changes, which do not always replicate across different studies. Some 
studies (including single cases) might have specifically targeted patients with pronounced 
impairments (e.g. [53,54,65,71]), or have a high proportion of such patients through a 
combination of random chance and small sample size. This could lead to overestimating 
certain neuropsychological symptoms in CRPS. Fortunately, there is an increasing tendency 
to publish null findings, which should allow a more balanced appraisal of the emerging 
evidence. Although sample sizes in CRPS research are often limited by the availability of 
people with this rare condition, large-sample, unbiased studies are needed to establish the 
prevalence of certain neuropsychological changes, and potentially identify the characteristics 
of subgroups of patients in whom these symptoms are more prominent. This could be 
achieved by combining research efforts across multiple sites and countries. Longitudinal 
research tracking cognitive changes throughout the course of CRPS and its recovery could 
enhance the understanding of how they can contribute to the development and maintenance 
of the disorder, and how stable they are over time. Future research could focus on whether 
there are any cognitive changes in paediatric CRPS and how they correspond to those found 
in adults. Neuropsychological symptoms in CRPS typically do not arise from any brain injury 
(in contrast to, for example, hemispatial neglect), thus they might be more subtle compared 
to those seen in neurological disorders. To detect and precisely quantify these symptoms in 
CRPS, researchers should use sensitive measures (e.g. TOJs). In contrast to some 
neurological conditions, people with CRPS often have insight into their cognitive problems, 
especially in body representation. Therefore, self-report measures appear to be useful in 
capturing these symptoms [35,43]. However, inconsistencies between self-reported 
disturbances and the same symptoms measured experimentally suggest that we might lack 
appropriate methods to quantify these changes in a reliable and objective manner. Some 
studies fail to verify whether observed neuropsychological symptoms are indeed abnormal 
(see Table 2). Directly comparing the performance of participants with CRPS and matched 
healthy controls on the same tests allows appropriate quantification of any deviation from 
what would be considered a normal performance. This is particularly relevant to studying 
lateralised spatial attention, as a mild leftward bias (“pseudoneglect” [122]) is often found in 
neurologically healthy participants. Furthermore, routinely including pain control groups 
would provide insights into which neuropsychological symptoms are unique to CRPS and 
which are present in other pain conditions as well. This in turn might facilitate our 
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understanding of any central mechanisms specific to CRPS and the development of more 
targeted treatments.  
In summary, CRPS appears to be associated with complex neuropsychological changes that 
include distortions in body representation, deficits in lateralised spatial cognition, and non-
spatially-lateralised higher cognitive functions. Some of these cognitive changes are reminiscent 
of other neuropsychological syndromes that can follow brain lesions, and some might be 
associated with chronic pain. We argue that the hemispatial neglect framework is not sufficient 
to characterise the higher cognitive functions affected in people with CRPS. Emerging findings 
suggest that disruption of parietal cortical networks can play a role in the manifestation of these 
neuropsychological symptoms. Importantly, cognitive changes in CRPS (and potentially other 
chronic pain conditions) can be targeted for treatment. Further research taken beyond the analogy 
to hemispatial neglect could provide a better understanding of the neuropsychological 
components of CRPS and elucidate how cortical changes contribute to clinical symptoms of this 
debilitating condition. 
 
Conflicts of Interest 
The authors declare that there is no conflict of interest regarding the publication of this paper. 
Funding Statement 
This research did not receive any specific grant from funding agencies in the public, commercial, 




1.  Rijn MA van, Marinus J, Putter H, Bosselaar SRJ, Moseley GL, Hilten JJ van. Spreading 
of complex regional pain syndrome: not a random process. Journal of Neural 
Transmission. 2011;118: 1301–1309. doi:10.1007/s00702-011-0601-1 
2.  Legrain V, Bultitude JH, De Paepe AL, Rossetti Y. Pain, body, and space: What do 
patients with complex regional pain syndrome really neglect?: Pain. 2012;153: 948–951. 
doi:10.1016/j.pain.2011.12.010 
3.  Punt DT, Cooper L, Hey M, Johnson MI. Neglect-like symptoms in complex regional 
pain syndrome: Learned nonuse by another name?: Pain. 2013;154: 200–203. 
doi:10.1016/j.pain.2012.11.006 
4.  Torta DM, Legrain V, Rossetti Y, Mouraux A. Prisms for pain. Can visuo-motor 
rehabilitation strategies alleviate chronic pain? European Journal of Pain. 2016;20: 64–
69. doi:10.1002/ejp.723 
5.  Tan EC, Zijlstra B, Essink ML, Goris RJA, Severijnen RS. Complex regional pain 
syndrome type I in children. Acta Paediatrica. 2008;97: 875–879. doi:10.1111/j.1651-
2227.2008.00744.x 
6.  Stanton-Hicks M. Plasticity of Complex Regional Pain Syndrome (CRPS) in children. 
Pain Med. 2010;11: 1216–1223. doi:10.1111/j.1526-4637.2010.00910.x 
7.  Becerra L, Sava S, Simons LE, Drosos AM, Sethna N, Berde C, et al. Intrinsic brain 
networks normalize with treatment in pediatric complex regional pain syndrome. 
NeuroImage: Clinical. 2014;6: 347–369. doi:10.1016/j.nicl.2014.07.012 
8.  de Mos M, de Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker ChBH, Sturkenboom 
MCJM. The incidence of complex regional pain syndrome: A population-based study: 
Pain. 2007;129: 12–20. doi:10.1016/j.pain.2006.09.008 
9.  Ott S, Maihöfner C. Signs and symptoms in 1,043 patients with Complex Regional Pain 
Syndrome. The Journal of Pain. 2018;19: 599–611. doi:10.1016/j.jpain.2018.01.004 
10.  Rooij AM, Perez RSGM, Huygen FJ, Eijs F, Kleef M, Bauer MCR, et al. Spontaneous 
onset of Complex Regional Pain Syndrome. European Journal of Pain. 2010;14: 510–
513. doi:10.1016/j.ejpain.2009.08.007 
11.  Harden RN, Bruehl S, Perez RSGM, Birklein F, Marinus J, Maihofner C, et al. Validation 
of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain 
Syndrome: Pain. 2010;150: 268–274. doi:10.1016/j.pain.2010.04.030 
12.  Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for 
complex regional pain syndrome. Pain Medicine. 2007;8: 326–331.  
13.  Birklein F, Schlereth T. Complex regional pain syndrome—significant progress in 
understanding: PAIN. 2015;156: S94–S103. doi:10.1097/01.j.pain.0000460344.54470.20 
14.  Maihofner C, Seifert F, Markovic K. Complex regional pain syndromes: new 
pathophysiological concepts and therapies. European Journal of Neurology. 2010;17: 
649–660.  
15.  Marinus J, Moseley GL, Birklein F, Baron R, Maihöfner C, Kingery WS, et al. Clinical 
features and pathophysiology of complex regional pain syndrome. The Lancet Neurology. 
2011;10: 637–648. doi:10.1016/S1474-4422(11)70106-5 
16.  Reinersmann A, Maier C, Schwenkreis P, Lenz M. Complex regional pain syndrome: 
more than a peripheral disease. Pain Management. 2013;3: 495–502. 
doi:10.2217/pmt.13.53 
17.  Bruehl S, Maihöfner C, Stanton-Hicks M, Perez RSGM, Vatine J-J, Brunner F, et al. 
Complex regional pain syndrome: evidence for warm and cold subtypes in a large 
Chapter 1 
61 
prospective clinical sample. PAIN. 2016;157: 1674–1681. 
doi:10.1097/j.pain.0000000000000569 
18.  Littlejohn G. Neurogenic neuroinflammation in fibromyalgia and complex regional pain 
syndrome. Nature Reviews Rheumatology. 2015;11: 639–648. 
doi:10.1038/nrrheum.2015.100 
19.  Veldman PH, Reynen HM, Arntz IE, Goris RJA. Signs and symptoms of reflex 
sympathetic dystrophy: prospective study of 829 patients. The Lancet. 1993;342: 1012–
1016.  
20.  Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex 
sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with 
recovery. Archives of Neurology. 1999;56: 613–620.  
21.  Jänig W, Baron R. Complex regional pain syndrome is a disease of the central nervous 
system. Clinical Autonomic Research. 2002;12: 150–164. doi:10.1007/s10286-002-0022-
1 
22.  van Rijn MA, Marinus J, Putter H, van Hilten JJ. Onset and progression of dystonia in 
Complex Regional Pain Syndrome. PAIN. 2007;130: 287–293. 
doi:10.1016/j.pain.2007.03.027 
23.  Drummond PD, Finch PM, Birklein F, Stanton-Hicks M, Knudsen LF. Hemi-sensory 
disturbances in patients with complex regional pain syndrome: PAIN. 2018; 1. 
doi:10.1097/j.pain.0000000000001280 
24.  Kuner R. Central mechanisms of pathological pain. Nature Medicine. 2010;16: 1258–
1266. doi:10.1038/nm.2231 
25.  Merskey H, Bogduk N. Classification of chronic pain, IASP Task Force on Taxonomy. 
Seattle, WA: International Association for the Study of Pain Press (Also available online 
at www iasp-painorg). 1994.  
26.  Rommel O, Gehling M, Dertwinkel R, Witscher K, Zenz M, Malin J-P, et al. 
Hemisensory impairment in patients with complex regional pain syndrome. Pain. 
1999;80: 95–101. doi:10.1016/S0304-3959(98)00202-4 
27.  Seifert F, Kiefer G, DeCol R, Schmelz M, Maihöfner C. Differential endogenous pain 
modulation in complex-regional pain syndrome. Brain. 2009;132: 788–800.  
28.  Kuttikat A, Noreika V, Shenker N, Chennu S, Bekinschtein T, Brown CA. 
Neurocognitive and neuroplastic mechanisms of novel clinical signs in CRPS. Frontiers 
in Human Neuroscience. 2016;10. doi:10.3389/fnhum.2016.00016 
29.  van Velzen GAJ, Rombouts SARB, van Buchem MA, Marinus J, van Hilten JJ. Is the 
brain of complex regional pain syndrome patients truly different? European Journal of 
Pain. 2016;20: 1622–1633. doi:10.1002/ejp.882 
30.  Shokouhi M, Clarke C, Morley-Forster P, Moulin DE, Davis KD, St. Lawrence K. 
Structural and functional brain changes at early and late stages of Complex Regional Pain 
Syndrome. The Journal of Pain. 2018;19: 146–157. doi:10.1016/j.jpain.2017.09.007 
31.  Di Pietro F, McAuley JH, Parkitny L, Lotze M, Wand BM, Moseley GL, et al. Primary 
motor cortex function in complex regional pain syndrome: a systematic review and meta-
analysis. The Journal of Pain. 2013;14: 1270–1288. doi:10.1016/j.jpain.2013.07.004 
32.  Di Pietro F, McAuley JH, Parkitny L, Lotze M, Wand BM, Moseley GL, et al. Primary 
somatosensory cortex function in complex regional pain syndrome: a systematic review 
and meta-analysis. The Journal of Pain. 2013;14: 1001–1018.  
33.  Galer BS, Butler S, Jensen MP. Case reports and hypothesis: A neglect-like syndrome 
may be responsible for the motor disturbance in reflex sympathetic dystrophy (complex 




34.  Lewis J, Kersten P, McCabe CS, McPherson KM, Blake DR. Body perception 
disturbance: A contribution to pain in complex regional pain syndrome (CRPS): Pain. 
2007;133: 111–119. doi:10.1016/j.pain.2007.03.013 
35.  Frettlöh J, Hüppe M, Maier C. Severity and specificity of neglect-like symptoms in 
patients with complex regional pain syndrome (CRPS) compared to chronic limb pain of 
other origins: Pain. 2006;124: 184–189. doi:10.1016/j.pain.2006.04.010 
36.  Galer BS, Jensen M. Neglect-like symptoms in complex regional pain syndrome: results 
of a self-administered survey. Journal of Pain and Symptom Management. 1999;18: 213–
217.  
37.  Förderreuther S, Sailer U, Straube A. Impaired self-perception of the hand in complex 
regional pain syndrome (CRPS): Pain. 2004;110: 756–761. 
doi:10.1016/j.pain.2004.05.019 
38.  Kolb L, Lang C, Seifert F, Maihöfner C. Cognitive correlates of “neglect-like syndrome” 
in patients with complex regional pain syndrome: Pain. 2012;153: 1063–1073. 
doi:10.1016/j.pain.2012.02.014 
39.  Michal M, Adler J, Reiner I, Wermke A, Ackermann T, Schlereth T, et al. Association of 
neglect-like symptoms with anxiety, somatization, and depersonalization in Complex 
Regional Pain Syndrome. Pain Medicine. 2016; pnw214. doi:10.1093/pm/pnw214 
40.  Reinersmann A, Landwehrt J, Krumova EK, Ocklenburg S, Güntürkün O, Maier C. 
Impaired spatial body representation in complex regional pain syndrome type 1 (CRPS I): 
Pain. 2012;153: 2174–2181. doi:10.1016/j.pain.2012.05.025 
41.  Reinersmann A, Landwehrt J, Krumova EK, Peterburs J, Ocklenburg S, Güntürkün O, et 
al. The rubber hand illusion in complex regional pain syndrome: Preserved ability to 
integrate a rubber hand indicates intact multisensory integration☆: Pain. 2013;154: 1519–
1527. doi:10.1016/j.pain.2013.03.039 
42.  Wittayer M, Dimova V, Birklein F, Schlereth T. Correlates and importance of neglect-
like symptoms in complex regional pain syndrome: PAIN. 2018;159: 978–986. 
doi:10.1097/j.pain.0000000000001173 
43.  Lewis J, McCabe CS. Body perception disturbance (BPD) in CRPS. Practical Pain 
Management. 2010;10: 60–66.  
44.  Brun C, Giorgi N, Pinard A-M, Gagné M, McCabe CS, Mercier C. Exploring the 
relationships between altered body perception, limb position sense, and limb movement 
sense in Complex Regional Pain Syndrome. The Journal of Pain. 2019;20: 17–27. 
doi:10.1016/j.jpain.2018.07.008 
45.  Bultitude JH, Walker I, Spence C. Space-based bias of covert visual attention in complex 
regional pain syndrome. Brain. 2017;140: 2306–2321. doi:10.1093/brain/awx152 
46.  Kotiuk V, Burianov O, Kostrub O, Khimion L, Zasadnyuk I. The impact of mirror 
therapy on body schema perception in patients with complex regional pain syndrome 
after distal radius fractures. British Journal of Pain. 2019;13: 35–42. 
doi:10.1177/2049463718782544 
47.  Lewis J, Schweinhardt P. Perceptions of the painful body: The relationship between body 
perception disturbance, pain and tactile discrimination in complex regional pain 
syndrome: Perceptions of the painful body in complex regional pain syndrome. European 
Journal of Pain. 2012;16: 1320–1330. doi:10.1002/j.1532-2149.2012.00120.x 
48.  Tajadura-Jiménez A, Cohen H, Bianchi-Berthouze N. Bodily sensory inputs and 
anomalous bodily experiences in complex regional pain syndrome: Evaluation of the 
potential effects of sound feedback. Frontiers in Human Neuroscience. 2017;11. 
doi:10.3389/fnhum.2017.00379 
49.  Moseley GL. Distorted body image in complex regional pain syndrome. Neurology. 
2005;65: 773–773. doi:10.1212/01.wnl.0000174515.07205.11 
Chapter 1 
63 
50.  Peltz E, Seifert F, Lanz S, Müller R, Maihöfner C. Impaired hand size estimation in 
CRPS. The Journal of Pain. 2011;12: 1095–1101. doi:10.1016/j.jpain.2011.05.001 
51.  Vittersø AD, Buckingham G, Halicka M, Proulx MJ, Bultitude JH. Altered updating of 
bodily and spatial representations following tool-use in Complex Regional Pain 
Syndrome. bioRxiv. 2019; 841205. doi:10.1101/841205 
52.  Lewis J, Kersten P, McPherson KM, Taylor GJ, Harris N, McCabe CS, et al. Wherever is 
my arm? Impaired upper limb position accuracy in Complex Regional Pain Syndrome: 
Pain. 2010;149: 463–469. doi:10.1016/j.pain.2010.02.007 
53.  Christophe L, Delporte L, Revol P, DePaepe A, Rode G, Jacquin-Courtois S, et al. 
Complex regional pain syndrome associated with hyperattention rather than neglect for 
the healthy side: A comprehensive case study. Annals of Physical and Rehabilitation 
Medicine. 2016;59: 294–301. doi:10.1016/j.rehab.2016.10.001 
54.  Jacquin-Courtois S, Christophe L, Chabanat E, Reilly KT, Rossetti Y. Unilateral chronic 
pain may neglect the healthy side. Cortex. 2017;90: 163–165. 
doi:10.1016/j.cortex.2016.12.004 
55.  Christophe L, Chabanat E, Delporte L, Revol P, Volckmann P, Jacquin-Courtois S, et al. 
Prisms to shift pain away: Pathophysiological and therapeutic exploration of CRPS with 
prism adaptation. Neural Plasticity. 2016;2016: 1–21. doi:10.1155/2016/1694256 
56.  Johnson S, Hall J, Barnett S, Draper M, Derbyshire G, Haynes L, et al. Using graded 
motor imagery for complex regional pain syndrome in clinical practice: Failure to 
improve pain: GMI in CRPS. European Journal of Pain. 2012;16: 550–561. 
doi:10.1002/j.1532-2149.2011.00064.x 
57.  Moseley GL. Why do people with complex regional pain syndrome take longer to 
recognize their affected hand? Neurology. 2004;62: 2182–2186.  
58.  Reid E, Wallwork SB, Harvie D, Chalmers KJ, Gallace A, Spence C, et al. A new kind of 
spatial inattention associated with chronic limb pain?: Somatospatial inattention in pain. 
Annals of Neurology. 2016;79: 701–704. doi:10.1002/ana.24616 
59.  Schwoebel J, Friedman R, Duda N, Coslett HB. Pain and the body schema. Brain. 
2001;124: 2098–2104. doi:10.1093/brain/124.10.2098 
60.  Schwoebel J, Coslett HB, Bradt J, Friedman R, Dileo C. Pain and the body schema: 
Effects of pain severity on mental representations of movement. Neurology. 2002;59: 
775–777. doi:10.1212/WNL.59.5.775 
61.  Kohler M, Strauss S, Horn U, Langner I, Usichenko T, Neumann N, et al. Differences in 
neuronal representation of mental rotation in patients With Complex Regional Pain 
Syndrome and healthy controls. The Journal of Pain. 2019. 
doi:10.1016/j.jpain.2019.01.330 
62.  Reinersmann A, Haarmeyer GS, Blankenburg M, Frettlöh J, Krumova EK, Ocklenburg S, 
et al. Left is where the L is right. Significantly delayed reaction time in limb laterality 
recognition in both CRPS and phantom limb pain patients. Neuroscience Letters. 
2010;486: 240–245. doi:10.1016/j.neulet.2010.09.062 
63.  Breimhorst M, Dellen C, Wittayer M, Rebhorn C, Drummond PD, Birklein F. Mental 
load during cognitive performance in complex regional pain syndrome I. European 
Journal of Pain. 2018;22: 1343–1350. doi:10.1002/ejp.1223 
64.  Wang AP, Butler AA, Valentine JD, Rae CD, McAuley JH, Gandevia SC, et al. A novel 
finger illusion reveals reduced weighting of bimanual hand cortical representations in 
people with Complex Regional Pain Syndrome. The Journal of Pain. 2019;20: 171–180. 
doi:10.1016/j.jpain.2018.08.008 
65.  Robinson G, Cohen H, Goebel A. A case of complex regional pain syndrome with 




66.  Verfaille C, Filbrich L, Cordova Bulens D, Lefèvre P, Berquin A, Barbier O, et al. Robot-
assisted line bisection in patients with Complex Regional Pain Syndrome. Philip BA, 
editor. PLOS ONE. 2019;14: e0213732. doi:10.1371/journal.pone.0213732 
67.  Sumitani M, Misaki M, Kumagaya S, Ogata T, Yamada Y, Miyauchi S. Dissociation in 
accessing space and number representations in pathologic pain patients. Brain and 
Cognition. 2014;90: 151–156. doi:10.1016/j.bandc.2014.07.001 
68.  Sumitani M, Shibata M, Iwakura T, Matsuda Y, Sakaue G, Inoue T, et al. Pathologic pain 
distorts visuospatial perception. Neurology. 2007;68: 152–154. 
doi:10.1212/01.wnl.0000250335.56958.f0 
69.  Sumitani M, Rossetti Y, Shibata M, Matsuda Y, Sakaue G, Inoue T, et al. Prism 
adaptation to optical deviation alleviates pathologic pain. Neurology. 2007;68: 128–133. 
doi:10.1212/01.wnl.0000250242.99683.57 
70.  Uematsu H, Sumitani M, Yozu A, Otake Y, Shibata M, Mashimo T, et al. Complex 
regional pain syndrome (CRPS) impairs visuospatial perception, whereas post-herpetic 
neuralgia does not: Possible implications for supraspinal mechanism of CRPS. Annals 
Academy of Medicine Singapore. 2009;38: 931.  
71.  Cohen H, McCabe CS, Harris N, Hall J, Lewis J, Blake DR. Clinical evidence of parietal 
cortex dysfunction and correlation with extent of allodynia in CRPS type 1: Parietal lobe 
dysfunction in CRPS. European Journal of Pain. 2013;17: 527–538. doi:10.1002/j.1532-
2149.2012.00213.x 
72.  Moseley GL, Gallace A, Iannetti GD. Spatially defined modulation of skin temperature 
and hand ownership of both hands in patients with unilateral complex regional pain 
syndrome. Brain. 2012;135: 3676–3686. doi:10.1093/brain/aws297 
73.  Moseley GL, Gallace A, Spence C. Space-based, but not arm-based, shift in tactile 
processing in complex regional pain syndrome and its relationship to cooling of the 
affected limb. Brain. 2009;132: 3142–3151. doi:10.1093/brain/awp224 
74.  Filbrich L, Alamia A, Verfaille C, Berquin A, Barbier O, Libouton X, et al. Biased 
visuospatial perception in complex regional pain syndrome. Scientific Reports. 2017;7: 
9712. doi:10.1038/s41598-017-10077-8 
75.  Filippopulos FM, Grafenstein J, Straube A, Eggert T. Complex regional pain syndrome 
(CRPS) or continuous unilateral distal experimental pain stimulation in healthy subjects 
does not bias visual attention towards one hemifield. Experimental Brain Research. 
2015;233: 3291–3299. doi:10.1007/s00221-015-4397-3 
76.  Reid E, Wallwork SB, Harvie D, Chalmers KJ, Braithwaite FA, Spence C, et al. 
Spatially-defined motor deficits in people with unilateral complex regional pain 
syndrome. Cortex. 2018;104: 154–162. doi:https://doi.org/10.1016/j.cortex.2017.06.024 
77.  Kuttikat A, Noreika V, Chennu S, Shenker N, Bekinschtein T, Brown CA. Altered 
neurocognitive processing of tactile stimuli in patients with Complex Regional Pain 
Syndrome. The Journal of Pain. 2018;19: 395–409. doi:10.1016/j.jpain.2017.11.008 
78.  Libon DJ, Schwartzman RJ, Eppig J, Wambach D, Brahin E, Lee Peterlin B, et al. 
Neuropsychological deficits associated with Complex Regional Pain Syndrome. Journal 
of the International Neuropsychological Society. 2010;16: 566. 
doi:10.1017/S1355617710000214 
79.  Head H, Holmes G. Researches into sensory disturbances from cerebral lesions. The 
Lancet. 1912;179: 79–83.  
80.  Schwoebel J, Coslett HB. Evidence for multiple, distinct representations of the human 
body. Journal of Cognitive Neuroscience. 2005;17: 543–553. 
doi:10.1162/0898929053467587 




82.  Coslett HB. Evidence for a disturbance of the body schema in neglect. Brain and 
Cognition. 1998;37: 527–544. doi:10.1006/brcg.1998.1011 
83.  Feinberg TE, Venneri A, Simone AM, Fan Y, Northoff G. The neuroanatomy of 
asomatognosia and somatoparaphrenia. Journal of Neurology, Neurosurgery & 
Psychiatry. 2010;81: 276–281. doi:10.1136/jnnp.2009.188946 
84.  Bartolomeo P, de Vito S, Seidel Malkinson T. Space-related confabulations after right 
hemisphere damage. Cortex. 2017;87: 166–173. doi:10.1016/j.cortex.2016.07.007 
85.  Pleger B, Tegenthoff M, Ragert P, Förster A-F, Dinse HR, Schwenkreis P, et al. 
Sensorimotor returning in complex regional pain syndrome parallels pain reduction: 
Sensorimotor Treatment in CRPS. Annals of Neurology. 2005;57: 425–429. 
doi:10.1002/ana.20394 
86.  Pleger B, Ragert P, Schwenkreis P, Förster A-F, Wilimzig C, Dinse H, et al. Patterns of 
cortical reorganization parallel impaired tactile discrimination and pain intensity in 
complex regional pain syndrome. NeuroImage. 2006;32: 503–510. 
doi:10.1016/j.neuroimage.2006.03.045 
87.  Parsons LM. Imagined spatial transformations of one’s hands and feet. Cognitive 
Psychology. 1987;19: 178–241.  
88.  Ionta S, Blanke O. Differential influence of hands posture on mental rotation of hands 
and feet in left and right handers. Experimental Brain Research. 2009;195: 207–217.  
89.  de Lange FP, Helmich RC, Toni I. Posture influences motor imagery: An fMRI study. 
NeuroImage. 2006;33: 609–617. doi:10.1016/j.neuroimage.2006.07.017 
90.  Parsons LM. Temporal and kinematic properties of motor behavior reflected in mentally 
simulated action. Journal of Experimental Psychology: Human Perception and 
Performance. 1994;20: 709–730. doi:10.1037/0096-1523.20.4.709 
91.  Parsons LM, Gabrieli JDE, Phelps EA, Gazzaniga MS. Cerebrally Lateralized Mental 
Representations of Hand Shape and Movement. Journal of Neuroscience. 1998;18: 6539–
6548. doi:10.1523/JNEUROSCI.18-16-06539.1998 
92.  Bonda E, Petrides M, Frey S, Evans A. Neural correlates of mental transformations of the 
body-in-space. PNAS. 1995;92: 11180–11184. doi:10.1073/pnas.92.24.11180 
93.  Parsons LM, Fox PT, Downs JH, Glass T, Hirsch TB, Martin CC, et al. Use of implicit 
motor imagery for visual shape discrimination as revealed by PET. Nature. 1995;375: 
54–58. doi:10.1038/375054a0 
94.  Kendall SE, Sjøgren P, de Mattos Pimenta CA, Højsted J, Kurita GP. The cognitive 
effects of opioids in chronic non-cancer pain. Pain. 2010;150: 225–230.  
95.  Landrø NI, Fors EA, V\a apenstad LL, Holthe Ø, Stiles TC, Borchgrevink PC. The extent 
of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a 
relation between reported and tested neuropsychological functioning? PAIN®. 2013;154: 
972–977.  
96.  Farnè A, Ponti F, Ladavas E. In search of biased egocentric reference frames in neglect. 
Neuropsychologia. 1998;36: 611–623.  
97.  Tajadura-Jiménez A, Basia M, Deroy O, Fairhurst M, Marquardt N, Bianchi-Berthouze 
N. As Light as your Footsteps: Altering Walking Sounds to Change Perceived Body 
Weight, Emotional State and Gait. Proceedings of the 33rd Annual ACM Conference on 
Human Factors in Computing Systems - CHI ’15. Seoul, Republic of Korea: ACM Press; 
2015. pp. 2943–2952. doi:10.1145/2702123.2702374 
98.  Botvinick M, Cohen J. Rubber hands’ feel’touch that eyes see. Nature. 1998;391: 756.  
99.  de Vignemont F. Embodiment, ownership and disownership. Consciousness and 
Cognition. 2011;20: 82–93. doi:10.1016/j.concog.2010.09.004 
Chapter 1 
66 
100.  Fiorio M, Weise D, Önal-Hartmann C, Zeller D, Tinazzi M, Classen J. Impairment of the 
rubber hand illusion in focal hand dystonia. Brain. 2011;134: 1428–1437. 
doi:10.1093/brain/awr026 
101.  Körding KP, Wolpert DM. Bayesian integration in sensorimotor learning. Nature. 
2004;427: 244.  
102.  Ernst MO, Banks MS. Humans integrate visual and haptic information in a statistically 
optimal fashion. Nature. 2002;415: 429–433. doi:10.1038/415429a 
103.  Samad M, Chung AJ, Shams L. Perception of body ownership is driven by bayesian 
sensory inference. Lebedev MA, editor. PLOS ONE. 2015;10: e0117178. 
doi:10.1371/journal.pone.0117178 
104.  Tsakiris M. My body in the brain: A neurocognitive model of body-ownership. 
Neuropsychologia. 2010;48: 703–712. doi:10.1016/j.neuropsychologia.2009.09.034 
105.  Serino A, Haggard P. Touch and the body. Neuroscience & Biobehavioral Reviews. 
2010;34: 224–236. doi:10.1016/j.neubiorev.2009.04.004 
106.  Ehrsson HH, Holmes NP, Passingham RE. Touching a rubber hand: feeling of body 
ownership is associated with activity in multisensory brain areas. Journal of 
Neuroscience. 2005;25: 10564–10573. doi:10.1523/JNEUROSCI.0800-05.2005 
107.  Makin TR, Holmes NP, Ehrsson HH. On the other hand: Dummy hands and peripersonal 
space. Behavioural Brain Research. 2008;191: 1–10. doi:10.1016/j.bbr.2008.02.041 
108.  Chechlacz M, Rotshtein P, Humphreys GW. Neuroanatomical dissections of unilateral 
visual neglect symptoms: ALE meta-analysis of lesion-symptom mapping. Frontiers in 
Human Neuroscience. 2012;6.  
109.  Molenberghs P, Sale MV, Mattingley JB. Is there a critical lesion site for unilateral 
spatial neglect? A meta-analysis using activation likelihood estimation. Frontiers in 
Human Neuroscience. 2012;6.  
110.  Mort DJ, Malhotra P, Mannan SK, Rorden C, Pambakian A, Kennard C, et al. The 
anatomy of visual neglect. Brain. 2003;126: 1986–1997.  
111.  Vallar G. Extrapersonal visual unilateral spatial neglect and its neuroanatomy. 
Neuroimage. 2001;14: S52–S58.  
112.  Parton A, Malhotra P, Husain M. Hemispatial neglect. Journal of Neurology, 
Neurosurgery & Psychiatry. 2004;75: 13–21.  
113.  McCabe CS. Mirror Visual Feedback therapy. A practical approach. Journal of Hand 
Therapy. 2011;24: 170–179. doi:10.1016/j.jht.2010.08.003 
114.  Punt TD, Riddoch MJ. Motor neglect: implications for movement and rehabilitation 
following stroke. Disability and Rehabilitation. 2006;28: 857–864. 
doi:10.1080/09638280500535025 
115.  Obersteiner H. On allochiria: A peculiar sensory disorder. Brain. 1881;4: 153–163.  
116.  Kawamura M, Hirayama K, Shinohara Y, Watanabe Y, Sugishita M. Alloaesthesia. 
Brain. 1987;110: 225–236.  
117.  Halligan PW, Marshall JC, Wade DT. Left on the right: allochiria in a case of left visuo-
spatial neglect. Journal of Neurology, Neurosurgery & Psychiatry. 1992;55: 717–719.  
118.  Lepore M, Conson M, Ferrigno A, Grossi D, Trojano L. Spatial transpositions across 
tasks and response modalities: exploring representational allochiria. Neurocase. 2004;10: 
386–392. doi:10.1080/13554790490892275 
119.  Schenkenberg T, Bradford DC, Ajax ET. Line bisection and unilateral visual neglect in 
patients with neurologic impairment. Neurology. 1980;30: 509–509.  
120.  Bowers D, Heilman KM. Pseudoneglect: effects of hemispace on a tactile line bisection 
task. Neuropsychologia. 1980;18: 491–498.  
Chapter 1 
67 
121.  Brooks JL, Sala SD, Darling S. Representational pseudoneglect: A review. 
Neuropsychology Review. 2014;24: 148–165. doi:10.1007/s11065-013-9245-2 
122.  Jewell G, McCourt ME. Pseudoneglect: a review and meta-analysis of performance 
factors in line bisection tasks. Neuropsychologia. 2000;38: 93–110. doi:10.1016/S0028-
3932(99)00045-7 
123.  Ferber S, Karnath H-O. Parietal and occipital lobe contributions to perception of straight 
ahead orientation. Journal of Neurology, Neurosurgery & Psychiatry. 1999;67: 572–578.  
124.  Rossetti Y, Rode G, Pisella L, Farné A, Li L, Boisson D, et al. Prism adaptation to a 
rightward optical deviation rehabilitates left hemispatial neglect. Nature. 1998;395: 166–
169. doi:10.1038/25988 
125.  Spence C, Parise C. Prior-entry: A review. Consciousness and Cognition. 2010;19: 364–
379. doi:10.1016/j.concog.2009.12.001 
126.  Titchener EB. Lectures on the elementary psychology of feeling and attention. 
Macmillan; 1908.  
127.  De Renzi E, Gentilini M, Barbieri C. Auditory neglect. Journal of Neurology, 
Neurosurgery & Psychiatry. 1989;52: 613–617.  
128.  Rossetti Y, Jacquin-Courtois S, Rode G, Ota H, Michel C, Boisson D. Does action make 
the link between number and space representation?: Visuo-manual adaptation improves 
number bisection in unilateral neglect. Psychological Science. 2004;15: 426–430. 
doi:10.1111/j.0956-7976.2004.00696.x 
129.  Cutini S, Scarpa F, Scatturin P, Dell’Acqua R, Zorzi M. Number–space interactions in the 
human parietal cortex: Enlightening the SNARC effect with functional near-infrared 
spectroscopy. Cerebral Cortex. 2014;24: 444–451. doi:10.1093/cercor/bhs321 
130.  Dehaene S, Bossini S, Giraux P. The mental representation of parity and number 
magnitude. Journal of Experimental Psychology: General. 1993;122: 371–396. 
doi:10.1037/0096-3445.122.3.371 
131.  Hubbard EM, Piazza M, Pinel P, Dehaene S. Interactions between number and space in 
parietal cortex. Nature Reviews Neuroscience. 2005;6: 435–448. doi:10.1038/nrn1684 
132.  Doricchi F, Guariglia P, Gasparini M, Tomaiuolo F. Dissociation between physical and 
mental number line bisection in right hemisphere brain damage. Nature Neuroscience. 
2005;8: 1663–1665. doi:10.1038/nn1563 
133.  Zorzi M, Priftis K, Meneghello F, Marenzi R, Umiltà C. The spatial representation of 
numerical and non-numerical sequences: Evidence from neglect. Neuropsychologia. 
2006;44: 1061–1067. doi:10.1016/j.neuropsychologia.2005.10.025 
134.  Zorzi M, Priftis K, Umiltà C. Brain damage: neglect disrupts the mental number line. 
Nature. 2002;417: 138–139. doi:10.1038/417138a 
135.  de Jong JR, Vlaeyen JW, de Gelder JM, Patijn J. Pain-related fear, perceived harmfulness 
of activities, and functional limitations in complex regional pain syndrome type I. The 
Journal of Pain. 2011;12: 1209–1218.  
136.  Pfannmöller J, Strauss S, Langner I, Usichenko T, Lotze M. Investigations on 
maladaptive plasticity in the sensorimotor cortex of unilateral upper limb CRPS I 
patients. Restorative Neurology and Neuroscience. 2019;37: 143–153. doi:10.3233/RNN-
180886 
137.  Pleger B, Tegenthoff M, Schwenkreis P, Janssen F, Ragert P, Dinse HR, et al. Mean 
sustained pain levels are linked to hemispherical side-to-side differences of primary 
somatosensory cortex in the complex regional pain syndrome I. Experimental Brain 
Research. 2004;155: 115–119.  
Chapter 1 
68 
138.  Juottonen K, Gockel M, Silén T, Hurri H, Hari R, Forss N. Altered central sensorimotor 
processing in patients with complex regional pain syndrome. Pain. 2002;98: 315–323. 
doi:10.1016/S0304-3959(02)00119-7 
139.  Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Patterns of cortical 
reorganization in complex regional pain syndrome. Neurology. 2003;61: 1707–1715. 
doi:10.1212/01.WNL.0000098939.02752.8E 
140.  Vartiainen NV, Kirveskari E, Forss N. Central processing of tactile and nociceptive 
stimuli in complex regional pain syndrome. Clinical Neurophysiology. 2008;119: 2380–
2388. doi:10.1016/j.clinph.2008.06.008 
141.  Krause P, Forderreuther S, Straube A. TMS motor cortical brain mapping in patients with 
complex regional pain syndrome type I. Clinical Neurophysiology. 2006;117: 169–176. 
doi:10.1016/j.clinph.2005.09.012 
142.  Di Pietro F, Stanton TR, Moseley GL, Lotze M, McAuley JH. Interhemispheric 
somatosensory differences in chronic pain reflect abnormality of the healthy side. Human 
Brain Mapping. 2015;36: 508–518.  
143.  Mancini F, Wang AP, Schira MM, Isherwood ZJ, McAuley JH, Iannetti GD, et al. Fine-
grained mapping of cortical somatotopies in chronic Complex Regional Pain Syndrome. 
Journal of Neuroscience. 2019; 2005–18. doi:10.1523/JNEUROSCI.2005-18.2019 
144.  Fogassi L, Luppino G. Motor functions of the parietal lobe. Current Opinion in 
Neurobiology. 2005;15: 626–631. doi:10.1016/j.conb.2005.10.015 
145.  Makin TR, Wilf M, Schwartz I, Zohary E. Amputees “neglect” the space near their 
missing hand. Psychological Science. 2010;21: 55–57. doi:10.1177/0956797609354739 
146.  Bassolino M, Finisguerra A, Canzoneri E, Serino A, Pozzo T. Dissociating effect of 
upper limb non-use and overuse on space and body representations. Neuropsychologia. 
2015;70: 385–392. doi:10.1016/j.neuropsychologia.2014.11.028 
147.  Guariglia C, Antonucci G. Personal and extrapersonal space: A case of neglect 
dissociation. Neuropsychologia. 1992;30: 1001–1009. doi:10.1016/0028-3932(92)90051-
M 
148.  Halligan PW, Marshall JC. Left neglect for near but not far space in man. Nature. 
1991;350: 498–500. doi:10.1038/350498a0 
149.  Cowey A, Small M, Ellis S. Left visuo-spatial neglect can be worse in far than in near 
space. Neuropsychologia. 1994;32: 1059–1066. doi:10.1016/0028-3932(94)90152-X 
150.  Vuilleumier P, Valenza N, Mayer E, Reverdin A, Landis T. Near and far visual space in 
unilateral neglect. Annals of Neurology. 1998;43: 406–410. doi:10.1002/ana.410430324 
151.  Beschin N, Cocchini G, Della Sala S, Logie RH. What the eyes perceive, the brain 
ignores: A case of pure unilateral representational neglect. Cortex. 1997;33: 3–26. 
doi:10.1016/S0010-9452(97)80002-0 
152.  Beschin N, Basso A, Sala SD. Perceiving left and imagining right: Dissociation in 
neglect. Cortex. 2000;36: 401–414. doi:10.1016/S0010-9452(08)70849-9 
153.  Costello AD, Warrington EK. The dissociation of visuospatial neglect and neglect 
dyslexia. Journal of Neurology, Neurosurgery & Psychiatry. 1987;50: 1110–1116. 
doi:10.1136/jnnp.50.9.1110 
154.  Dove ME, Eskes G, Klein RM, Shore D. A left attentional bias in chronic neglect: A case 
study using Temporal Order Judgments. Neurocase. 2007;13: 37–49. 
doi:10.1080/13554790601174146 
155.  Van der Stoep N, Visser-Meily JM, Kappelle LJ, de Kort PL, Huisman KD, Eijsackers 
AL, et al. Exploring near and far regions of space: distance-specific visuospatial neglect 




156.  de Vignemont F, Iannetti GD. How many peripersonal spaces? Neuropsychologia. 
2015;70: 327–334. doi:10.1016/j.neuropsychologia.2014.11.018 
157.  Bufacchi RJ, Iannetti GD. An action field theory of peripersonal space. Trends in 
Cognitive Sciences. 2018;22: 1076–1090. doi:10.1016/j.tics.2018.09.004 
158.  Serino A. Peripersonal space (PPS) as a multisensory interface between the individual 
and the environment, defining the space of the self. Neuroscience & Biobehavioral 
Reviews. 2019;99: 138–159. doi:10.1016/j.neubiorev.2019.01.016 
159.  de Haan AM, Smit M, Van der Stigchel S, Dijkerman HC. Approaching threat modulates 
visuotactile interactions in peripersonal space. Experimental Brain Research. 2016;234: 
1875–1884. doi:10.1007/s00221-016-4571-2 
160.  Somervail R, Bufacchi RJ, Guo Y, Kilintari M, Novembre G, Swapp D, et al. Movement 
of environmental threats modifies the relevance of the defensive eye-blink in a spatially-
tuned manner. Scientific Reports. 2019;9. doi:10.1038/s41598-019-40075-x 
161.  Bufacchi RJ, Sambo CF, Di Stefano G, Cruccu G, Iannetti GD. Pain outside the body: 
defensive peripersonal space deformation in trigeminal neuralgia. Scientific Reports. 
2017;7. doi:10.1038/s41598-017-12466-5 
162.  Serino A, Noel J-P, Galli G, Canzoneri E, Marmaroli P, Lissek H, et al. Body part-
centered and full body-centered peripersonal space representations. Scientific Reports. 
2015;5. doi:10.1038/srep18603 
163.  Noel J-P, Pfeiffer C, Blanke O, Serino A. Peripersonal space as the space of the bodily 
self. Cognition. 2015;144: 49–57. doi:10.1016/j.cognition.2015.07.012 
164.  Schilder JCM, Schouten AC, Perez RSGM, Huygen FJPM, Dahan A, Noldus LPJJ, et al. 
Motor control in complex regional pain syndrome: A kinematic analysis: Pain. 2012;153: 
805–812. doi:10.1016/j.pain.2011.12.018 
165.  Graziano MS, Botvinick MM. How the brain represents the body: insights from 
neurophysiology and psychology. Common mechanisms in perception and action: 
Attention and performance XIX. 2002;19: 136–157.  
166.  Ventre J, Flandrin JM, Jeannerod M. In search for the egocentric reference. A 
neurophysiological hypothesis. Neuropsychologia. 1984;22: 797–806. doi:10.1016/0028-
3932(84)90104-0 
167.  Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein F, et al. Quantitative 
sensory testing in the German Research Network on Neuropathic Pain (DFNS): 
Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. 
PAIN. 2010;150: 439–450. doi:10.1016/j.pain.2010.05.002 
168.  Joseph R. Neuropsychology, Neuropsychiatry, and Behavioral Neurology. New York: 
Springer US; 1990.  
169.  Sakurai Y, Onuma Y, Nakazawa G, Ugawa Y, Momose T, Tsuji S, et al. Parietal 
dysgraphia: characterization of abnormal writing stroke sequences, character formation 
and character recall. Behavioural Neurology. 2007;18: 99–114.  
170.  Pflugshaupt T, Nyffeler T, von Wartburg R, Wurtz P, Lüthi M, Hubl D, et al. When left 
becomes right and vice versa: Mirrored vision after cerebral hypoxia. Neuropsychologia. 
2007;45: 2078–2091.  
171.  Schott GD. Mirror writing: neurological reflections on an unusual phenomenon. Journal 
of Neurology, Neurosurgery & Psychiatry. 2007;78: 5–13.  
172.  Gainotti G, Marra C. Differential contribution of right and left temporo-occipital and 
anterior temporal lesions to face recognition disorders. Frontiers in Human Neuroscience. 
2011;5. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108284/ 
173.  Karnath H-O, Ferber S, Bülthoff HH. Neuronal representation of object orientation. 
Neuropsychologia. 2000;38: 1235–1241. doi:10.1016/S0028-3932(00)00043-9 
Chapter 1 
70 
174.  Turnbull OH, Beschin N, Della Sala S. Agnosia for object orientation: Implications for 
theories of object recognition. Neuropsychologia. 1997;35: 153–163.  
175.  Fujinaga N, Muramatsu T, Ogano M, Kato M. A 3-year follow-up study of ‘orientation 
agnosia.’ Neuropsychologia. 2005;43: 1222–1226. 
doi:10.1016/j.neuropsychologia.2004.10.010 
176.  Husain M, Rorden C. Non-spatially lateralized mechanisms in hemispatial neglect. 
Nature Reviews Neuroscience. 2003;4: 26.  
177.  Van Vleet TM, DeGutis JM. The nonspatial side of spatial neglect and related approaches 
to treatment. Progress in brain research. Elsevier; 2013. pp. 327–349.  
178.  Maihofner C, Baron R, DeCol R, Binder A, Birklein F, Deuschl G, et al. The motor 
system shows adaptive changes in complex regional pain syndrome. Brain. 2007;130: 
2671–2687. doi:10.1093/brain/awm131 
179.  Hotta J, Saari J, Koskinen M, Hlushchuk Y, Forss N, Hari R. Abnormal brain responses 
to action observation in Complex Regional Pain Syndrome. The Journal of Pain. 
2017;18: 255–265. doi:10.1016/j.jpain.2016.10.017 
180.  Behrmann M, Geng JJ, Shomstein S. Parietal cortex and attention. Current Opinion in 
Neurobiology. 2004;14: 212–217. doi:10.1016/j.conb.2004.03.012 
181.  Husain M, Nachev P. Space and the parietal cortex. Trends in Cognitive Sciences. 
2007;11: 30–36. doi:10.1016/j.tics.2006.10.011 
182.  Moseley GL, Gallace A, Di Pietro F, Spence C, Iannetti GD. Limb-specific autonomic 
dysfunction in complex regional pain syndrome modulated by wearing prism glasses: 
Pain. 2013;154: 2463–2468. doi:10.1016/j.pain.2013.07.026 
183.  Moseley GL, Parsons TJ, Spence C. Visual distortion of a limb modulates the pain and 
swelling evoked by movement. Current Biology. 2008;18: R1047–R1048. 
doi:10.1016/j.cub.2008.09.031 
184.  Cohen H, Hall J, Harris N, McCabe CS, Blake DR, Jänig W. Enhanced pain and 
autonomic responses to ambiguous visual stimuli in chronic Complex Regional Pain 
Syndrome (CRPS) type I. European Journal of Pain. 2012;16: 182–195. 
doi:10.1016/j.ejpain.2011.06.016 
185.  Hall J, Harrison S, Cohen H, McCabe CS, Harris N, Blake DR. Pain and other symptoms 
of CRPS can be increased by ambiguous visual stimuli – An exploratory study. European 
Journal of Pain. 2011;15: 17–22. doi:10.1016/j.ejpain.2010.04.009 
186.  Brun C, Mercier C, Grieve S, Palmer S, Bailey J, McCabe CS. Sensory disturbances 
induced by sensorimotor conflicts are higher in complex regional pain syndrome and 
fibromyalgia compared to arthritis and healthy people, and positively relate to pain 
intensity. European Journal of Pain. 2019;23: 483–494. doi:10.1002/ejp.1322 
187.  de Klaver MJ, van Rijn MA, Marinus J, Soede W, de Laat JA, van Hilten JJ. Hyperacusis 
in patients with complex regional pain syndrome related dystonia. Journal of Neurology, 
Neurosurgery & Psychiatry. 2007. 
188.  Acerra NE, Moseley GL. Dysynchiria: Watching the mirror image of the unaffected limb 
elicits pain on the affected side. Neurology. 2005;65: 751–753. 
doi:10.1212/01.wnl.0000178745.11996.8c 
189.  Matamala-Gomez M, Diaz Gonzalez AM, Slater M, Sanchez-Vives MV. Decreasing Pain 
Ratings in Chronic Arm Pain Through Changing a Virtual Body: Different Strategies for 
Different Pain Types. The Journal of Pain. 2019;20: 685–697. 
doi:10.1016/j.jpain.2018.12.001 
190.  Tsay A, Allen TJ, Proske U, Giummarra MJ. Sensing the body in chronic pain: A review 
of psychophysical studies implicating altered body representation. Neuroscience & 
Biobehavioral Reviews. 2015;52: 221–232. doi:10.1016/j.neubiorev.2015.03.004 
Chapter 1 
71 
191.  Suhnan AP, Finch PM, Drummond PD. Hyperacusis in chronic pain: neural interactions 
between the auditory and nociceptive systems. International Journal of Audiology. 
2017;56: 801–809. doi:10.1080/14992027.2017.1346303 
192.  Catley MJ, O’Connell NE, Berryman C, Ayhan FF, Moseley GL. Is Tactile Acuity 
Altered in People With Chronic Pain? A Systematic Review and Meta-analysis. The 
Journal of Pain. 2014;15: 985–1000. doi:10.1016/j.jpain.2014.06.009 
193.  Hart RP, Martelli MF, Zasler ND. Chronic pain and neuropsychological functioning. 
Neuropsychology Review. 2000;10: 131–149.  
194.  Crombez G, Van Ryckeghem DML, Eccleston C, Van Damme S. Attentional bias to 
pain-related information: A meta-analysis: Pain. 2013;154: 497–510. 
doi:10.1016/j.pain.2012.11.013 
195.  Kirveskari E, Vartiainen NV, Gockel M, Forss N. Motor cortex dysfunction in complex 
regional pain syndrome. Clinical Neurophysiology. 2010;121: 1085–1091. 
doi:10.1016/j.clinph.2010.01.032 
196.  Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Cortical reorganization during 
recovery from complex regional pain syndrome. Neurology. 2004;63: 693–701. 
doi:10.1212/01.WNL.0000134661.46658.B0 
197.  Antal A, Terney D, Kühnl S, Paulus W. Anodal Transcranial Direct Current Stimulation 
of the motor cortex ameliorates chronic pain and reduces short intracortical inhibition. 
Journal of Pain and Symptom Management. 2010;39: 890–903. 
doi:10.1016/j.jpainsymman.2009.09.023 
198.  Knotkova H, Soto E, Leuschner Z, Greenberg A, Stock V, Das D, et al. Transcranial 
direct current stimulation (tDCS) for the treatment of chronic pain. The Journal of Pain. 
2013;14: S64.  
199.  Gaertner M, Kong J-T, Scherrer KH, Foote A, Mackey S, Johnson KA. Advancing 
Transcranial Magnetic Stimulation methods for Complex Regional Pain Syndrome: An 
open-label study of paired theta burst and high-frequency stimulation. Neuromodulation: 
Technology at the Neural Interface. 2018;21: 409–416. doi:10.1111/ner.12760 
200.  Picarelli H, Teixeira MJ, de Andrade DC, Myczkowski ML, Luvisotto TB, Yeng LT, et 
al. Repetitive Transcranial Magnetic Stimulation is efficacious as an add-on to 
pharmacological therapy in Complex Regional Pain Syndrome (CRPS) type I. The 
Journal of Pain. 2010;11: 1203–1210. doi:10.1016/j.jpain.2010.02.006 
201.  Pleger B, Janssen F, Schwenkreis P, Völker B, Maier C, Tegenthoff M. Repetitive 
transcranial magnetic stimulation of the motor cortex attenuates pain perception in 
complex regional pain syndrome type I. Neuroscience Letters. 2004;356: 87–90. 
doi:10.1016/j.neulet.2003.11.037 
202.  Ramachandran VS, Rogers-Ramachandran D. Synaesthesia in phantom limbs induced 
with mirrors. Proceedings of the Royal Society of London B: Biological Sciences. 
1996;263: 377–386.  
203.  Cacchio A, De Blasis E, De Blasis V, Santilli V, Spacca G. Mirror therapy in Complex 
Regional Pain Syndrome type 1 of the upper limb in stroke patients. Neurorehabilitation 
and Neural Repair. 2009;23: 792–799. doi:10.1177/1545968309335977 
204.  Cacchio A, De Blasis E, Necozione S, Orio F di, Santilli V. Mirror therapy for chronic 
complex regional pain syndrome type 1 and stroke. New England Journal of Medicine. 
2009;361: 634–636.  
205.  Vural SP, Yuzer GFN, Ozcan DS, Ozbudak SD, Ozgirgin N. Effects of mirror therapy in 
stroke patients with complex regional pain syndrome type 1: a randomized controlled 
study. Archives of Physical Medicine and Rehabilitation. 2016;97: 575–581.  
Chapter 1 
72 
206.  McCabe CS. A controlled pilot study of the utility of mirror visual feedback in the 
treatment of complex regional pain syndrome (type 1). Rheumatology. 2002;42: 97–101. 
doi:10.1093/rheumatology/keg041 
207.  Moseley GL. Graded motor imagery for pathologic pain: a randomized controlled trial. 
Neurology. 2006;67: 2129–2134.  
208.  Moseley GL. Graded motor imagery is effective for long-standing complex regional pain 
syndrome: a randomised controlled trial: Pain. 2004;108: 192–198. 
doi:10.1016/j.pain.2004.01.006 
209.  Moseley GL. Is successful rehabilitation of complex regional pain syndrome due to 
sustained attention to the affected limb? A randomised clinical trial. Pain. 2005;114: 54–
61. doi:10.1016/j.pain.2004.11.024 
210.  Ramachandran VS, Altschuler EL. The use of visual feedback, in particular mirror visual 
feedback, in restoring brain function. Brain. 2009;132: 1693–1710. 
doi:10.1093/brain/awp135 
211.  Barbin J, Seetha V, Casillas JM, Paysant J, Pérennou D. The effects of mirror therapy on 
pain and motor control of phantom limb in amputees: A systematic review. Annals of 
Physical and Rehabilitation Medicine. 2016;59: 270–275. 
doi:10.1016/j.rehab.2016.04.001 
212.  Redding GM, Wallace B. Adaptive coordination and alignment of eye and hand. Journal 
of Motor Behavior. 1993;25: 75–88. doi:10.1080/00222895.1993.9941642 
213.  von Helmholtz H. Treatise on Physiological Optics. New York: Dover Publications; 
1909.  
214.  Bultitude JH, Rafal RD. Derangement of body representation in complex regional pain 
syndrome: report of a case treated with mirror and prisms. Experimental Brain Research. 
2010;204: 409–418. doi:10.1007/s00221-009-2107-8 
215.  Halicka M, Vittersø AD, Proulx MJ, Bultitude JH. Pain Reduction by Inducing Sensory-
Motor Adaptation in Complex Regional Pain Syndrome (CRPS PRISMA): Protocol for a 
Double-blind Randomized Controlled Trial. medRxiv. 2019 [cited 13 Jul 2019]. 
doi:10.1101/19000653 
216.  Tsakiris M, Hesse MD, Boy C, Haggard P, Fink GR. Neural signatures of body 
ownership: a sensory network for bodily self-consciousness. Cerebral Cortex. 2006;17: 
2235–2244.  
217.  Gerardin E, Sirigu A, Lehéricy S, Poline J-B, Gaymard B, Marsault C, et al. Partially 
overlapping neural networks for real and imagined hand movements. Cerebral Cortex. 
2000;10: 1093–1104.  
218.  Sirigu A, Duhamel J-R, Cohen L, Pillon B, others. The mental representation of hand 
movements after parietal cortex damage. Science. 1996;273: 1564.  
219.  Grefkes C, Fink GR. The functional organization of the intraparietal sulcus in humans 
and monkeys. Journal of Anatomy. 2005;207: 3–17. doi:10.1111/j.1469-
7580.2005.00426.x 
220.  Maihofner C, Peltz E. CRPS, the parietal cortex and neurocognitive dysfunction: An 
emerging triad: Pain. 2011;152: 1453–1454. doi:10.1016/j.pain.2011.03.018 
221.  Henry DE, Chiodo AE, Yang W. Central Nervous System Reorganization in a Variety of 
Chronic Pain States: A Review. PM&R. 2011;3: 1116–1125. 
doi:10.1016/j.pmrj.2011.05.018 
222.  Roldán-Tapia L, Cánovas-López R, Cimadevilla J, Valverde M. Cognition and 
Perception Deficits in Fibromyalgia and Rheumatoid Arthritis. Reumatología Clínica 
(English Edition). 2007;3: 101–109. doi:10.1016/S2173-5743(07)70224-1 
Chapter 1 
73 
223.  Martínez E, Guillen V, Buesa I, Azkue JJ. A Distorted Body Schema and Susceptibility 
to Experiencing Anomalous Somatosensory Sensations in Fibromyalgia Syndrome. The 
Clinical Journal of Pain. 2019;35: 887–893. 
doi:info:doi/10.1097/AJP.0000000000000754 
224.  Moseley GL, Flor H. Targeting Cortical Representations in the Treatment of Chronic 




Chapter 1 – Conclusions 
In this chapter, I outlined behavioural evidence of altered body representation, lateralised spatial 
cognition, and non-spatially-lateralised cognitive functions in people with CRPS. Notably, the 
current evidence is neither fully consistent, nor does it provide a complete understanding of 
neuropsychological changes in CRPS. However, integration of findings that suggest either 
impaired or intact cognitive domains facilitated the discussion about proposed mechanisms of 
reviewed neuropsychological symptoms. Although Chapter 1 provides a broad range of insights 
and directions for further investigation, the following points are particularly pertinent to the rest 
of this thesis.  
Among the reviewed neuropsychological changes, those of body representation have been studied 
most extensively in CRPS. Here, interventions targeting these changes, such as graded motor 
imagery, have already been integrated into CRPS management practices. The remainder of this 
thesis, on the other hand, primarily concerns the changes in spatial cognition. One reason for this 
is that although “neglect-like” symptoms were first reported almost 25 years ago (Galer et al., 
1995), it appears that this domain received less attention in subsequent research compared to body 
representation. Considering the evidence reviewed in this chapter, there appear to be many 
inconsistencies regarding the prevalence of “neglect-like” symptoms in CRPS, as well as 
direction and magnitude of spatial biases. Furthermore, experimental research on movement-
related spatial biases is sparse. Chapters 2 and 4 will aim to reconcile some of the mixed findings 
about spatial attention biases in CPRS, and Chapters 4 and 5 will also provide an assessment of 
motor “neglect-like” symptoms. Further rationale for focusing particularly on spatial cognition in 
this thesis is its relatively untapped potential for treatment. Considering some neuropsychological 
similarities between CRPS and hemispatial neglect summarised in this chapter, prism adaptation 
treatment has been applied to CRPS with promising results. However, we need more robust 
evidence of the efficacy of prism adaptation for CRPS to be able to make any treatment 
recommendations. Chapters 3 and 5 will address this gap in the existing literature.  
The discrepancies regarding the prevalence of “neglect-like” symptoms in CRPS highlighted in 
this chapter could arise partly because the researchers had not yet used methods sensitive enough 
to capture spatial biases in people with chronic pain, which are likely to be subtle because these 
patients are otherwise neurologically healthy. One common objective across all the following 
experimental chapters is to quantify spatial biases in CRPS using sensitive measures, drawing 
from methodology used to measure subtle spatial biases in brain lesioned patients and healthy 
controls. Chapter 2 will additionally explore the advantages of sensitive computer-based measures 
versus less sensitive “pen-and-paper” tests of spatial cognition. 
In this chapter, I discussed potential mechanisms through which neuropsychological symptoms 
can arise in CRPS. Considering the manifestation of “neglect-like” symptoms, distorted body 
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representation and underutilisation of the affected limb, and distinct cognitive representation of 
near and far space seem particularly relevant. Chapter 2 will investigate these proposed 
mechanisms of spatial biases in CRPS.  
Another key question highlighted in the literature review was whether higher cognitive functions 
contribute to the clinical signs of CRPS. This chapter demonstrated that sensory, autonomic, and 
motor functions can be modulated by spatial or multisensory manipulations, implying the role of 
cognitive representations of space in the manifestation of clinical signs of CPRS. Furthermore, 
neurocognitive treatments were found to relieve CRPS symptoms. There is also evidence linking 
the severity of neuropsychological symptoms to severity of pain and other signs of CRPS, yet 
these relationships are not consistently found. In Chapters 2, 4 and 5 I will further explore 
potential associations between neuropsychological functions and clinical manifestations and 
treatment of CRPS. 
This literature review revealed that most previous research on neuropsychological functioning in 
CRPS is limited by small sample sizes, lack of control groups or conditions, and paucity of 
longitudinal assessments. While comprehensive case studies, such as the one I will present in 
Chapter 2, can provide important proof of concept of potential mechanisms of the 
neuropsychological symptoms, underpowered and uncontrolled group studies might lead to 
overestimation of the neuropsychological deficits or exacerbate replication problems. In this 
thesis, I will avoid these limitations by testing a relatively large cohort of people with CRPS given 
the syndrome’s rarity (Chapters 4 and 5). I will also use healthy individuals as a reference against 
which any cognitive deviations in people with CRPS can be assessed (Chapters 2 and 4).  
Furthermore, I will include a control treatment condition to assess the “true” effects of prism 
adaptation on CRPS in a double-blind randomised trial (Chapter 5). Finally, I will provide a 
longitudinal assessment of neuropsychological functions in CRPS (Chapters 2 and 5) allowing to 




Chapter 2: Attention upturned: Bias toward and away from 
the affected side of the body and near space in a case of 
Complex Regional Pain Syndrome  
Chapter 2 – Introduction 
This chapter presents a case study of a woman with CRPS affecting her left wrist, who has 
previously presented to our laboratory with reduced attention to and distorted representation of 
her affected limb. This patient’s neuropsychological symptoms were unusual in that they were 
more severe than is usually found in people with CRPS and therefore more closely resembled 
what is typically shown by patients with hemispatial neglect after brain injury. This extreme case 
of neuropsychological symptoms in the absence of any brain lesions presented an opportunity to 
disentangle some of the proposed mechanisms of spatial attention biases in CRPS that were 
discussed in Chapter 1 (e.g. that these biases are driven by body perception, reduced movement 
in the affected side of near space, or distinct cortical representations of near and far space). Any 
dissociations between the regions of space or tested modalities in which attention biases manifest 
should be more apparent in such a single case than in a heterogeneous group of individuals with 
CRPS. The current work was prompted by this patient’s unusual symptoms in a previously 
published group study (Bultitude et al., 2017). Hence, I include her individual data collected as 
part of that study as the first research session in this chapter. I believe this is appropriate because 
the emphasis of the previously published work was on comparisons of group-averaged data rather 
than individual data, and presenting this patient’s individual data from this session in the current 
case study is necessary for illustrating the development of her spatial attention bias over time. 
Independent of the group study by Bultitude and her colleagues (2017), I present a comprehensive 
examination of this patient over two further research sessions.  
The second session aims to confirm that the patient does not have generalised cognitive deficits 
that could account for her impaired performance on spatial attention tests. To follow up on the 
problem I identified with the sensitivity of available methods used to test spatial attention bias in 
CRPS (Chapter 1), I also investigate if her severe spatial attention biases are apparent on standard 
confrontation testing and “pen-and-paper” tests of neglect (i.e. Behavioural Inattention Test 
battery). This enables me to evaluate her performance on tests of spatial cognition with different 
degrees of sensitivity. I also test whether her performance on spatial attention tasks in the first 
session can be explained by response bias (i.e. a preference for reporting the stimuli on her 
unaffected side due to aversion to her affected side). Response bias has rarely been considered or 
controlled for in previous studies of spatial bias in CRPS, despite evidence that patients can have 




To expand on the findings from the first research session, I further quantify the patient’s visual 
attention biases in body (personal) space and near space using an adjusted temporal order 
judgement task. Assuming that spatial attention biases are driven by distorted representation of 
the affected limb, they should be more severe in body than near space. Furthermore, if limited 
action of the affected limb contributes to spatial attention deficits, the latter should be stronger in 
near space where most movements are performed, compared to the far space, which extends 
beyond one’s reach. Thus, I test her attention in these three regions of space. This session also 
examines any biases in mental representation of space (independent of body representation and 
movement), presence of which would suggest generalised impairment of spatial cognition. 
Moreover, in Chapter 1 I suggested that neuropsychological symptoms in CRPS (including spatial 
attention biases) could be driven by cortical reorganisation in similar networks to those that are 
disrupted in individuals with hemispatial neglect. In this case, the CRPS patient might also present 
with other symptoms typical of right-hemisphere disturbance (contralateral to her affected limb), 
such as a bias towards processing of local relative to global level of information.  
The third research session aims to address several outstanding questions. To further investigate 
the potential impact of underutilisation of the affected limb on spatial attention, I test whether 
visual attention bias differs between two vertical regions of near space: hands working space and 
near space of eye level. To quantify any tactile spatial biases, suggested by the patient’s 
performance on confrontation tests, I also administer a tactile temporal order judgement task. 
Moreover, this session examines if any local relative to global processing biases can be quantified 
using a task adjusted for the patient’s visual acuity. Finally, I assess whether the patient’s spatial 
attention biases can be explained by any primary lateralised visual or somatosensory deficits.  
Overall, the investigations in this chapter allow me to characterise the conditions under which 
spatial attention biases can manifest in CRPS, control for several potentially confounding factors 
(e.g. response bias, visual acuity loss) that are rarely (if ever) considered in other studies of CRPS, 
and explore potential mechanisms of spatial bias based on known dissociations identified in post-
stroke neglect patients.  
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Objective: People with Complex Regional Pain Syndrome (CRPS) can show inattention to their 
affected limb and its surrounding space, resembling post-stroke hemispatial neglect. Although 
this inattention appears to relate to physical signs of CRPS, little is known about the specific 
conditions under which it manifests. Method: In this case study of a woman with CRPS in her 
left arm, we tested spatial attention to different regions of space across three sessions spanning 
three years. Results: The patient showed visual and tactile neglect and extinction on her affected 
side on confrontation tests, but no attention deficits on “bedside” tests of neglect. On sensitive 
experimental measures, attention biases were found in the patient’s body and near space (in 
Temporal Order Judgements), but not far or imagined space (on the Greyscales task and Mental 
Number Line Bisection). Unique to the current literature, the patient showed a reversal in her 
Temporal Order Judgement bias from inattention (first and second session) to hyperattention 
(third session) to her affected side. Its direction might be independent of pain and body 
representation distortion, which were similar across the three sessions. Conclusions: Spatial 
attention bias in CRPS can generalise across different sensory modalities and extend beyond the 
affected limb to the external space around it. This bias is not necessarily directed away from the 
affected side or stable over time. Present findings support the conclusion that people with CRPS 
can demonstrate neuropsychological changes, and have potential implications for treatments of 
CRPS that target attention biases. 
Keywords 
Complex Regional Pain Syndrome; spatial attention; temporal order judgement; body 
representation; hemispatial neglect 
Key points 
Question: Similar to patients who had a stroke, people with certain chronic pain conditions can 
pay less attention to the affected side of their body, yet little is known about how such shifts in 
attention manifest in the absence of brain damage. Findings: A patient with chronic pain in her 
left arm showed altered attention to her body and the external space within her reach, however, 
the direction of attention bias shifted over time from reduced to increased attention to her affected 
side, despite no changes in pain intensity and cognitive representation of her body. Importance: 
Treatments that aim to bring the attention back to the affected side to reduce chronic pain must 
consider that attention shift may not be stable over time or related to pain, and that its direction 
can vary among patients. Next steps: Further research should investigate longitudinal changes in 





Complex Regional Pain Syndrome (CRPS) is characterised by pain, sensory and motor 
abnormalities, swelling, temperature changes, and trophic alterations in one or more limbs. This 
chronic pain disorder typically arises following a trauma to the limb; however, the pain and other 
symptoms are disproportionate to any inciting injury. People with CRPS can present with 
distorted body representation (Lewis & McCabe, 2010; Lewis & Schweinhardt, 2012), and 
changes in attention to their affected limb and its surrounding space that resemble hemispatial 
neglect (“neglect”) following a brain lesion (Legrain et al., 2012; Punt et al., 2013; Torta et al., 
2016). The distorted representations of body and near space could be interrelated with pain in 
CRPS. For example, placing the affected limb in the unaffected side of space reduced pain and 
increased subjective limb ownership (Moseley et al., 2012). Pain intensity also predicted the 
magnitude of spatial bias in processing body relevant information in the affected side of space 
(Reid et al., 2016). These changes in bodily and spatial representations might contribute to the 
development and maintenance of CRPS (Bultitude & Rafal, 2010; Marinus et al., 2011; McCabe 
& Blake, 2008; Sumitani, Rossetti, et al., 2007), and treatments targeting them can relieve 
symptoms (Bultitude & Rafal, 2010; Christophe, Chabanat, et al., 2016; Sumitani, Rossetti, et al., 
2007). Therefore, it would be beneficial to gain a better understanding of the circumstances under 
which such changes can arise and the extent to which they resemble known conditions such as 
neglect.  
To this end, we conducted a case study of a woman with CRPS who presented with signs of 
inattention to her affected left limb and body representation distortion in our previous study 
(Bultitude et al., 2017). Her attention bias was more pronounced than for any other patient tested 
and, unusually for CRPS, manifested in confrontation testing, reminiscent of post-stroke neglect. 
Although people with CRPS often report “neglect-like” symptoms regarding the affected limb 
(Frettlöh et al., 2006; Galer et al., 1995), they usually do not show attention deficits on classic 
“bedside” tests of neglect (Christophe, Chabanat, et al., 2016; Förderreuther et al., 2004; Kolb et 
al., 2012; Reid et al., 2016; Reinersmann et al., 2012), with rare possible exceptions (Cohen et 
al., 2013; Robinson et al., 2011). Yet subtle changes have been reported when more sensitive 
measures of attention are used (Bultitude et al., 2017; Filbrich et al., 2017; Moseley et al., 2009). 
This patient’s particularly strong attention bias presented an opportunity to test specific 
predictions about how attention bias can manifest in CRPS, since any differences between tested 
conditions would be more apparent, whereas potential dissociations between spatial biases might 
easily be lost in a group study due to the heterogeneity of CRPS (Caramazza, 1986). Therefore, 
we conducted a case study over two further sessions to evaluate the nature of this patient’s spatial 
attention deficits with respect to different regions of space and sensory modalities. Although it 
was not our objective to demonstrate what is typical of general CRPS population, a case study of 
a patient with strong signs of neglect could guide further research regarding the 
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neuropsychological changes in CRPS and their causes. Furthermore, examination of the patient’s 
unique cognitive and sensory changes bears theoretical relevance to understanding how spatial 
attention can be disrupted in the absence of brain damage.  
In contrast to CRPS, lateralised spatial attention deficits in post-stroke neglect have been 
extensively described. They can manifest across different regions of space and sensory modalities 
(Kerkhoff, 2001; Vallar, 1998). Furthermore, dissociations between neglect of body and external 
space (Committeri et al., 2007; Guariglia & Antonucci, 1992), near and far space (Aimola, 
Schindler, Simone, & Venneri, 2012; Cowey, Small, & Ellis, 1994; Halligan & Marshall, 1991; 
Keller, Schindler, Kerkhoff, Rosen, & Golz, 2005; Vuilleumier, Valenza, Mayer, Reverdin, & 
Landis, 1998), perceptual and motor performance (Bisiach et al., 1990; Buxbaum et al., 2004; Liu 
et al., 1992), and different senses (Barbieri & De Renzi, 1989; Bisiach et al., 2004; Cubelli et al., 
1991; Marsh & Hillis, 2008), have been also found. Here we sought to determine if some such 
classic dissociations identified in post-stroke neglect also arise in CRPS, with a view to 
understanding the mechanisms through which attention can come to be altered in this population. 
Specifically, we (1) used confrontation tests, “bedside” tests of neglect, and experimental 
measures to study spatial attention across different modalities in body space (vision and touch), 
near and far space (vision), and imagined space (mental representation); (2) tested for potential 
response biases and hemisensory deficits to rule out alternative explanations of lateralized 
attentional biases; and (3) examined cognitive biases typical of right hemisphere damage that 
often co-occur with post-stroke neglect. The background evidence and rationale for the above 
objectives are outlined below. 
In healthy individuals, nociceptive stimulation on one side of the body can bias visual attention 
towards the corresponding side of near space (Filbrich et al., 2016), yet the relationships between 
chronic pain and spatial cognition appear to be more complex. There is some conflicting evidence 
regarding the direction of attention bias in CRPS (Moseley et al., 2009; Sumitani, Rossetti, et al., 
2007), and in which regions of space and sensory modalities it can be present (Filbrich et al., 
2017). Judgements of the subjective body midline that require relating the orientation of one’s 
body to visual stimuli presented in far space, tend to be biased towards the CRPS-affected side 
(Christophe, Chabanat, et al., 2016; Jacquin-Courtois et al., 2017; Sumitani, Rossetti, et al., 2007; 
Sumitani et al., 2014; Uematsu et al., 2009). Processing of visual or tactile stimuli in near 
(Bultitude et al., 2017; Filbrich et al., 2017) and body space (Bultitude et al., 2017; Moseley et 
al., 2009, 2012), on the other hand, tends to be biased in the opposite direction. It is unclear 
whether these conflicting findings reflect an underlying neuropsychological diversity in CRPS, 
and / or if the spatial biases change over time or with recovery. Thus far, few studies tested 
attention in near and far space in the same CRPS patient(s) using the same tasks, with the 
exception of Filbrich et al. (2017), who found a visual attention bias away from the affected side 




distance from the body, out of reach. The present study aimed to test the direction and magnitude 
of the patient’s spatial attention biases in body (personal) space, near hands working space and 
near space on eye-level, and far space, across three sessions. 
These particular regions of space were drawn from existing evidence in the post-stroke neglect 
and CRPS literature, as outlined below. One attempt to conceptualize why attention bias in CRPS 
could vary across space links to its relationship to distorted body representation (Bultitude et al., 
2017; Lewis & Schweinhardt, 2012; Moseley, 2005; Schwoebel et al., 2001). It has been shown 
that the extent of body perception disturbance predicts the visual spatial attention bias in CRPS 
patients (Bultitude et al., 2017), and that spatial deficits are most evident on measures which 
involve body-relevant information (Reid et al., 2016). Specifically, “somatospatial inattention” 
hypothesis (Reid et al., 2016) postulates that attention bias should be more pronounced within the 
interactions between body and near space. This hypothesis prompted investigating whether our 
patient’s attention bias would be stronger in body space compared to near space. Alternatively, 
some have argued that attention bias might be driven by a limited amount of action in the affected 
side of near space (Punt et al., 2013), consistent with previous evidence that spatial perception in 
near space is shaped by one’s actions within it (Makin et al., 2010). Most proximal hand 
movements are performed in near space, whereas CRPS symptoms include motor impairments, 
such as weakness, limited range of movement, or dystonia of the affected limb. Both the 
“somatospatial inattention” and action-related theories lead to the prediction that attention bias 
away from the affected side should be limited to near space - where the hands can be located – 
compared to far space. Furthermore, people generally perform most daily tasks that involve hand 
movements in the region of near space inferior to their eye level (e.g. at desk or table level). 
Considering that there are distinct mechanisms for attention to the inferior (stronger neglect) and 
superior (stronger pseudo-neglect) part of the visual field (Làdavas et al., 1994; McCourt & 
Jewell, 1999; Pitzalis et al., 1997), and attention bias in CRPS may be action-driven, we tested 
spatial attention in hands working space as well as at eye level within near space. 
In addition to representations of the body and external space, there is also evidence that spatial 
biases can manifest in mental representations. Indeed, neglect of the contralesional side of imaged 
space was previously found in stroke patients (Priftis et al., 2006; Rossetti et al., 2004; Zorzi et 
al., 2002, 2006), and similar changes have been reported in CRPS (Christophe, Delporte, et al., 
2016; Jacquin-Courtois et al., 2017; Sumitani et al., 2014). Importantly, attention in imagined 
space can be biased in the opposite direction to subjective body midline judgements in far space 
in the same CRPS patients (Sumitani et al., 2014). An unusual case of hyperattention to the 
affected side, consistent across near, far, and imaged space, has also been reported (Christophe, 
Delporte, et al., 2016; Jacquin-Courtois et al., 2017). It is conceivable that the biases in the 
representations of real and imagined space might be driven by distinct mechanisms, e.g., mental 
representations could be unaffected by movement of the affected limb, in contrast to biases in 
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near space. This study therefore investigated the patient’s spatial bias in imagined space and 
whether it would be consistent with other perceptual biases. 
Primary experimental evidence of spatial attention biases in CRPS was derived from temporal 
order judgements in the tactile modality (Moseley et al., 2009, 2012; Reid et al., 2016), and was 
further corroborated by similar studies in vision (Bultitude et al., 2017; Filbrich et al., 2017). Post-
stroke neglect generalized across different senses is a well-documented phenomenon (Bisiach et 
al., 1985; Weintraub & Mesulam, 1987), which would support supramodal mechanisms of spatial 
attention (Kinsbourne, 1970). However, commonly found dissociations between visual and tactile 
neglect (Barbieri & De Renzi, 1989; Bisiach et al., 2004; Marsh & Hillis, 2008) would suggest 
involvement of independent, modality-specific attentional mechanisms (Rizzolatti & Camarda, 
1987). Similar dissociations have been found in CRPS, whereby patients displayed signs of visual, 
but not tactile inattention to their affected side, implying modality-specific attentional deficits 
(Filbrich et al., 2017). Our objective was to test if neglect in vision generalizes to tactile 
processing, especially considering that the latter inherently entails body-relevant information. 
When investigating spatial attention, it is important to control for potential confounding factors. 
For example, spatial attention deficits are prone to over-estimation if response biases are not 
controlled for (Spence & Parise, 2010). Considering that body representation distortion in CRPS 
can involve misoplegia-like symptoms, such as aversion, disgust, and hostility towards the 
affected limb and concepts related to that limb (Bartolomeo et al., 2017; Critchley, 1974; Lewis 
et al., 2007), it is likely that verbal left/right judgements could introduce a bias in the perceptual 
estimates. Response bias in this case would entail a preference of one verbal response over the 
other (e.g. preferring to say ”right” when the left limb is affected) when uncertain about spatial 
judgements. A second type of possible confounding factor when measuring attention bias in 
CRPS are hemisensory deficits, which are known to extend beyond the CRPS-affected limb 
(Rommel et al., 1999). Similar to how one would account for hemianopia or hemiplegia when 
testing for neglect in post-stroke patients, it is important to assess potential sensory deficits that 
could impair the ability to see or feel stimuli on the CRPS-affected side relative to the non-affected 
side. In this study, we aimed to separately account for attentional and response biases, as well as 
hemisensory deficits. 
Neglect is not the only cognitive syndrome occurring after right hemisphere lesions. Patients often 
present with associated disorders such as asomatognosia (impaired awareness or recognition of a 
body part; Bartolomeo et al., 2017); and deficits in sustained and selective attention, spatial 
working memory (Van Vleet & DeGutis, 2013), and temporal resolution (Battelli et al., 2001). 
Right hemisphere lesions are also typically associated with a bias towards processing of local 
information relative to the global forms, which can be more pronounced for stimuli presented in 
the contralesional visual field (Bultitude et al., 2009; Lamb et al., 1990; Robertson et al., 1988). 




identification, Cohen et al., 2013; Förderreuther et al., 2004; and temporal acuity, Bultitude et al., 
2017; Filbrich et al., 2017), suggesting that spatial attention bias could be one aspect of broader 
changes to right hemisphere functioning. In the context of previous evidence of neuroplasticity 
affecting the hemisphere contralateral to the CRPS-affected limb (Di Pietro et al., 2013b; 
Juottonen et al., 2002; Maihofner et al., 2003; Pleger et al., 2006; Vartiainen et al., 2008), we 
aimed to determine if our left-CRPS patient presents with cognitive changes consistent with right 
hemisphere dysfunction (Bultitude et al., 2009; Navon, 1977) other than “neglect-like” 
symptoms, such as biased processing of local object features, relative to global forms (Robertson 
et al., 1988). 
To summarize the hypotheses set out in the current investigation, we predicted that the patient’s 
attention deficits would manifest on “bedside” tests of neglect and confrontation tests, in addition 
to sensitive experimental measures of attention. We further hypothesized that the patient would 
show inattention to her affected side in different regions of space (body-, near-, and imagined 
space, but not far space). We predicted that attention bias would be stronger in body (i.e. personal) 
space compared to near space, stronger in near hands working space at table level compared to 
near space on eye level, and absent or reversed in far space compared to near space. We further 
hypothesized that visual neglect would generalize to touch. We expected that the patient would 
show a response bias in spatial judgements (i.e. reluctance to give the verbal response “left”, 
which refers to her affected side), but that attention bias would be seen even when response bias 
was accounted for. We similarly examined potential sensory deficits to rule out alternative 
explanations for the spatial biases. Finally, we hypothesized that the patient would present with a 
local processing bias. 
2. Materials and methods 
2.1. Design 
We tested the patient’s spatial attention over three sessions spanning three years. The first session 
(T1) was part of our previously published group study of 24 people with CRPS that provided 
evidence for a visual attention bias away from the affected side of space (Bultitude et al., 2017). 
Although results from this session have been reported previously, relevant information from T1 
is included in this article so that we can provide a complete overview of the development of the 
patient’s performance over time. The second session (T2; pre-registered at osf.io/zx8ad) took 
place 27 months after T1, and the third session (T3; pre-registered at osf.io/n6qgv) was conducted 
10 months after T2 to address outstanding questions. The spacings of the research sessions were 
determined pragmatically, dependant on the timeline of finalising the design and pre-registrations 
of T2 and T3, and the researchers’ and the patient’s availability and ability to travel to the 
University for testing. 
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On each occasion, the patient completed self-report questionnaires regarding pain, body 
representation, fear of movement, and handedness. Across the three sessions, we also tested her 
attention to different regions of her body and space using three groups of measures: (1) 
confrontation tests of visual, tactile, and motor neglect and extinction; (2) classic 
neuropsychological “bedside” tests of neglect; and (3) sensitive experimental measures of 
attention, including Temporal Order Judgements (TOJs), Greyscales task, Mental Number Line 
Bisection, and a Global-Local Processing task. Finally, the patient underwent tests of her sensory 
functions, including central and peripheral visual field acuity, and tactile detection and 
discrimination thresholds. The timing of the administration of each measure is presented in Table 
1. Note that examining any changes in the neuropsychological functions over time was not an a 
priori objective of this study. The consecutive sessions rather aimed to test distinct hypotheses 
and address the new research questions arising from the preceding assessments. Therefore, 
majority of administered tests is not consistent across all three sessions. Groups of control 
participants also completed questionnaires about body representation and handedness, 
experimental measures of attention, and sensory tests. Written informed consent was obtained 
from all participants and the study was approved by Oxford A Research Ethics Committee 
(12/SC/0557). 
Table 1 Test administration across three sessions 
Measure T1 T2 T3 
Self-report questionnaires    
Brief Pain Inventory, BPI (Cleeland, 1996) ● ● ● 
Pain Detect Questionnaire, PDQ (Freynhagen et al., 2006) ● ● ● 
Edinburgh Handedness Inventory, EHI (Oldfield, 1971) ● ● ● 
Tampa Scale for Kinesiophobia, TSK (Miller et al., 1991) ● ● ● 
Profile of Mood States, POMS (McNair et al., 1971) ●   
Revised Life Orientation Test, LOTR (Scheier et al., 1994) ●   
Bath CRPS Body Perception Disturbance Scale, BPDS (Lewis & McCabe, 2010) ● ● ● 
General cognitive assessments    
Montreal Cognitive Assessment, MoCA (Nasreddine et al., 2005)  ●  
Animal semantic fluency (Goodglass & Kaplan, 1983)  ●  
Calculation  ●  
Sensory tests    
Mechanical Detection Thresholds, MDT (Rolke et al., 2006)   ● 
Two-Point Discrimination, TPD   ● 




Measure T1 T2 T3 
RareBit Perimetry (Frisén, 2002)   ● 
Landolt C test   ● 
Confrontation tests    
Visual neglect / extinction ● ● ● 
Tactile neglect / extinction   ● ● 
Motor neglect / extinction  ●  
Neuropsychological “bedside” tests of neglect    
Behavioural Inattention Test battery (Wilson et al., 1987)  ●  
Bells cancellation (Gauthier et al., 1989)  ●  
Fluff test (Cocchini et al., 2001)  ●  
Room description (Zoccolotti & Judica, 1991)  ●  
Experimental measures of attention    
Visual Temporal Order Judgement, TOJ (Bultitude et al., 2017) – Uncrossed Hands ● ●  
Visual TOJ – Crossed Hands ● ●  
Visual TOJ – Board ● ● ● 
Visual TOJ – Wall   ● 
Tactile TOJ – Knees   ● 
Greyscales task (Nicholls et al., 1999)– Near  ● ● 
Greyscales task – Far  ●  
Mental Number Line Bisection (Sumitani et al., 2014; Zorzi et al., 2002)  ●  
Global-Local Processing task (Bultitude et al., 2009; Navon, 1977)  ● ● 
Note. T1 = Session 1; T2 = Session 2; T3 = Session 3. 
2.2. Participants 
2.2.1. Case summary 
The patient was a right-handed woman, aged 63 years at T1, with CRPS affecting her left arm for 
eight years. Due to a fall, she suffered multiple fractures and dislocations to her left wrist, arm, 
and shoulder, requiring surgery and seven weeks of cast immobilisation. She reported 
experiencing “excruciating burning pain” and sensory disturbances in her left arm during post-
operative recovery (e.g., feeling and hearing the fingers of her injured hand scratching a pillow, 
although they were not touching it), as well as tightness of the cast in the weeks that followed. 
Her description of the period following the injury suggests distorted body representation, that is, 
her left arm felt bigger, heavier, and misshapen, she had difficulty recognising her arm, and found 
mirror visual feedback therapy (McCabe, 2002) very confusing. The patient described the inciting 
injury as a traumatic experience and presented with a reluctance to look at her affected limb and 
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aversion to certain associated words (e.g., “left”, and “wrist”, preferring to use the term “the base 
of the forearm”). In T2, we observed that she was reluctant to look at her affected limb, in 
particular when it was uncovered (the patient kept her left wrist covered in a bandage, but agreed 
to remove it for the time of the assessments). She expressed a desire to amputate the left arm, 
accompanied by feelings of disgust, and at the same time described and exhibited strong guarding 
and protective behaviours towards that arm. For instance, she reported wearing a make-shift sling 
and intentionally walking with her left side facing the buildings or walls to avoid anyone touching 
her affected arm. In T2, we also observed that the patient kept her left arm close to her chest while 
walking. However, in T3, she was no longer wearing a sling. Self-report measures across three 
sessions indicate that her body representation was severely distorted, relative to that of healthy 
controls (Table 2). For instance, in T2 she described the mental image of her affected hand as “a 
grotesque blob that has got not necessarily edges to it (…), does not seem to have a definition like 
the other hand, it is very big in comparison to the unaffected side”, and the rest of her arm as “a 
stick that connects to the blob, just holding it there, but it has a problem supporting itself (…), it 
is not connected at the top, it is too high up”. The patient provided a similar description in T3, 
which is illustrated in Figure 1. Moreover, her pain-related fear of movement across three sessions 
was stronger than is usually found in chronic pain patients (Roelofs et al., 2004) (Table 2).   
 
Figure 1. Body representation distortion. A sketch of the patient’s cognitive representation of her 




Table 2 The patient’s scores on self-report questionnaires of pain, body representation, and limb 
use; tests of cognitive functions; and sensory testing 
Clinical / Sensory / Cognitive 
tests 
Measure Patient’s score 
T1 T2 T3 
Pain severity BPI (Cleeland, 1996) – severity (/10) 7.75 8.25 7.00 
Pain interference with daily life BPI (Cleeland, 1996) – interference (/10) 8.28 7.00 7.86 
Neuropathic pain component PDQ (Freynhagen et al., 2006) (/38) 29a 35a 27a 
Recalled handedness before CRPS EHI (Oldfield, 1971) (-100 to +100) 100 73 -b 
Current handedness EHI (Oldfield, 1971) (-100 to +100) 100 100 100 
Pain-related fear of movement and 
re-injury 
TSK (Miller et al., 1991) (/68) 45a 42a 46a 
Mood disturbance POMS (McNair et al., 1971) (/200) 104
a 
- - 
Depression POMS - Depression (/60) 34a - - 
Anxiety POMS - Anxiety (/30) 26a - - 
Optimism LOTR (Scheier et al., 1994) (/24) 6a - - 
Body representation BPDS (Lewis & McCabe, 2010) (/57) 55c 55c 52c 
General cognitive functions MoCA (Nasreddine et al., 2005) (/30) - 29 - 
Semantic verbal fluency Animal fluency (Goodglass & Kaplan, 
1983) 
- 22 - 
Arithmetic abilities / numerical 
processing 
Calculationd (/12) - 12 - 
Tactile detection threshold MDT (Rolke et al., 2006) – handse - - -6.09c 
MDT (Rolke et al., 2006) – kneese - - 0.50 
Tactile discrimination threshold TPD – handse - - -1.17c 
TPD – kneese - - -0.98 
Note. T1 = Session 1; T2 = Session 2; T3 = Session 3; BPI = Brief Pain Inventory; PDQ = Pain Detect 
Questionnaire; EHI = Edinburgh Handedness Inventory, scored from -100 (extreme left-handedness) to 
+100 (extreme right-handedness); BPDS = Bath CRPS Body Perception Disturbance Scale; TSK = Tampa 
Scale for Kinesiophobia (compared to mean scores of chronic lower back pain and fibromyalgia patients; 
Roelofs et al., 2004); POMS = Profile of Mood States (compared to mean scores of healthy 60-69 years old 
adults; Gibson, 1997); LOTR = Revised Life Orientation Test (compared to normative values for healthy 
61-70 years old females; (Glaesmer et al., 2012); MoCA = Montreal Cognitive Assessment; MDT = 
Mechanical Detection Threshold; TPD = Two-Point Discrimination.  
a Significantly different to normative cut-off score, indicating pathology. b Not tested. c Significantly 
different from control participants. d Non-standardised measure with arbitrary cut-off score of < 9 correctly 
resolved mathematic equations indicating arithmetic skills impairment. e Calculated as side ratio: [(left-
right)/left], where a negative number indicates higher sensitivity (MDT) or better precision (TPD) on the 
left (affected) side. 
In addition to her recounted sensory disturbances in her affected arm, the patient reported double 
vision and loss of peripheral vision. She reported visiting the optometrist every six months to 
update her prescription and was using custom-made corrective lenses during each research 
session. The patient described having problems with balance for several years up to and including 
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the research sessions. Until inpatient rehabilitation six months prior to T2 she had relied on a 
crutch to help her walk straight, as she tended to “veer off to the left”. At the time of T3, the 
patient reported that her balance was still impaired and she experienced falls, yet with no need to 
return to using a crutch. Magnetic Resonance Imaging scans performed two and five years prior 
to T1 to investigate her problems with vision and balance ruled out any observable lesions or 
other brain pathologies. Other neurological disorders were also ruled out by a neurologist. Her 
performance on the Montreal Cognitive Assessment (Nasreddine et al., 2005), Animal Fluency 
Test (Goodglass & Kaplan, 1983), and a Calculation test in T2 did not indicate any cognitive 
impairment (Table 2). 
The patient reported a history of post-traumatic stress disorder and depression following the 
inciting injury. No psychiatric evaluation for mood disorders was conducted during the research 
sessions. However, according to the Profile of Mood States (McNair et al., 1971) and Revised 
Life Orientation Test (Scheier et al., 1994) completed in T1, the patient’s depression and anxiety 
scores were above, and optimism below, normative values for her age range (Table 2). The patient 
reported no other neurological or psychological comorbidities.  
Pain medications taken at the time of the assessments were tramadol (400mg/day) at T1; 
gabapentin (2100mg/day), tapentadol (300mg/day), and amitriptyline (75mg/day) at T2 and T3; 
and aspirin (75mg/day) at T2. The patient had stellate ganglion blocks for shoulder pain 
approximately once per year (the last one 3 months before T3). She also attended three two-week 
inpatient multidisciplinary pain management programmes for CRPS (twice between T1 and T2, 
and once between T2 and T3). The pain management programmes involved physiotherapy, 
hydrotherapy, occupational therapy, psychological support, patient-centred goal-setting, 
education about CRPS, and consultation about pain medication. 
The patient’s CRPS symptoms fulfilled the Budapest research diagnostic criteria (Harden et al., 
2010) in each session of the study. She reported severe, persistent pain (Numerical Rating Scale 
[NRS] T1 = 8; T2 = 8; T3 = 7 / 10) in her left wrist that radiated up to the shoulder (Figure 2). 
According to the patient’s description, the left shoulder also felt heavy, like it was being pulled 
down. In T2, the patient was not willing to allow the researchers to touch her left wrist and hand 
due to severe allodynia, however, in T3 she was able to undergo sensory assessments on the 
affected hand. The only other changes in her physical pain symptoms across the three sessions 
were that she had pain in her right shoulder in T1 that was not present in T2 or T3, and that she 
injured her left foot (trip and fall) five months before T3. According to the patient’s description, 
her leg was badly bruised below the knee down to the foot and swollen for several weeks. In T3 
the patient reported – in addition to the symptoms in her left arm – discontinuous pain in her left 
leg (NRS = 5 / 10 at the time of assessment), tingling in the toes of her left foot, difficulty 
distinguishing between the toes of her left foot, and altered cognitive representation of that limb 




part of her foot while walking. She disclosed that her General Practitioner attributed these 
symptoms to peripheral neuropathy. As the pain in her foot was not continuous, it would not meet 
the Budapest diagnostic criteria for CRPS. 
 
Figure 2. Areas of pain shaded on the body diagrams. Images were taken from the Brief Pain 
Inventory in T1, T2, and T3 (from left to right, respectively). A cross represents the region of 
worst pain. 
We tested for hemisensory changes on the patient’s upper and lower limbs in T3. We used Von 
Frey filaments to establish mechanical detection thresholds on the hands and knees according to 
a standardised protocol from Quantitative Sensory Testing (Rolke et al., 2006). The patient had 
lower detection threshold, i.e. increased sensitivity to touch on the left hand (0.079g) than the 
right one (0.557g). A staircase assessment of tactile discrimination thresholds on her index fingers 
and knees was conducted using a Two-Point Discrimination disk (see Supplemental Material). 
The patient had a lower threshold, i.e. more precise tactile discrimination on the left hand 
(3.86mm) than right one (8.38mm). Side ratios [(left-right)/left] of the patient’s sensory 
thresholds were significantly different from control participants on the hands, but not on the knees 




2.2.2. Control participants 
Healthy, pain-free participants with normal or corrected-to-normal vision and no history of 
neurological disorders were recruited to provide control data for experimental and non-
standardised measures. The control samples were in T1: 19 females, 5 males, mean age 46.21 
years, SD = 14.96, 2 left-handed, 22 right-handed (age- and sex-matched to the group of CRPS 
patients in the original study; Bultitude et al., 2017); in T2: 12 females, mean age 62.42 years, SD 
= 3.23, all right-handed; in T3: 11 females, 1 male, mean age 50.50 years, SD = 13.09, all right-
handed. The size of control groups for T2 and T3 was determined to statistically compare data 
from a single case to a control sample. Crawford and Garthwaite (2005) examined control of the 
Type I error rate for the Revised Standardised Difference Test (RSDT) through Monte Carlo 
simulation and found that control samples of n = 10 were necessary to limit Type I error rates to 
5% or lower. We used samples of n = 12 in case any control participants would need to be 
excluded from individual analyses due to incomplete data. The mean age of control participants 
was not significantly different from the patient’s age across the three sessions (p = .26; p = .46; p 
= .28, respectively). Despite modest effect of sex differences on visuospatial attention (Jewell & 
McCourt, 2000), it is unlikely that the inconsiderable number of male participants in the control 
samples in T1 (5/24) and T3 (1/12) would bias the results of this study. 
2.3. Procedures 
2.3.1. Confrontation tests 
We tested for visual and tactile neglect and extinction using confrontation testing (unilateral or 
bilateral finger movements or light taps to the knees). The presence of motor neglect and 
extinction was assessed by asking the patient to lift her left arm, right arm, or both arms, with her 
eyes open or closed (T2). These tests were performed according to the standard procedures for 
neurological assessment (Bender, 1952; Karnath et al., 1993) by trained psychologists. Any 
number of omissions in the patient’s performance on the confrontation tests was considered 
abnormal. 
2.3.2. Neuropsychological tests 
Classic “bedside” tests of neglect, including the conventional Behavioural Inattention Test battery 
(Wilson et al., 1987), were administered by trained psychologists. This set of measures comprised 
tests of visual-motor neglect in near space (e.g., line bisection, bell cancellation; Gauthier, Dehaut, 
& Joanette, 1989), representational and visual-motor neglect in near space (representational 
drawing; Wilson et al., 1987), visual neglect in near (article reading; Wilson et al., 1987) and far 
space (room description; Zoccolotti & Judica, 1991), and neglect in body space (fluff test; 
Cocchini, Beschin, & Jehkonen, 2001). The results obtained in neuropsychological tests by the 




2.3.3. Experimental measures of attention 
The type and purpose of all computer-based experimental measures of spatial attention, mental 
representation of space, and global and local processing are summarised in Table 3. 
Table 3 Summary of the experimental tasks and conditions with operationalization of measured 
constructs and time points of assessments 
Task Condition Time 
points 












attention to body 
(personal) space and 
near space (in hands 
working space). 
Body and near space 
are congruent. 
Point of Subjective Simultaneity 
(amount of time by which stimulus 
on the left side must precede or 
follow the stimulus on the right side 
for the two stimuli to be perceived 
as simultaneous), averaged across 
two response conditions (“which 







attention to body 
(personal) space and 
near space (in hands 
working space). 






attention to near 
space (in hands 
working space) 
Wall T3 Visual spatial 
attention to near 





Knees T3 Tactile spatial 








attention in near 
space (on eye level) 
Bias index = (Number of responses 
where the participant chose the 
stimulus that is darker on the right 
side as being darker overall – 
number of responses where the 
participant chose the stimulus that is 
darker on the left side as being 
darker overall) / Total number of 
responses 
Far T2 Visual spatial 
attention in far space 





Zorzi et al., 
2002) 
 T2 Mental 
representation of 
space 
Mean deviation of subjective 
midpoint of mental number line 
from the actual midpoint 
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Task Condition Time 
points 









towards global / local 
information; local 
interference 
Mean reaction times and accuracy 
rates for congruent and incongruent 
trials Local T2, 
T3 
 
2.3.3.1. Temporal Order Judgment (TOJ) 
The TOJ task is a sensitive psychophysical measure of spatial attention (Spence & Parise, 2010). 
In brief, two identical stimuli are presented, one on each side of the body or external space with 
different onsets, and participants report their temporal order. We conducted this task in several 
different conditions across the three sessions, the rationale for which are outlined below. 
Visual TOJs in T1 and T2 were conducted in three Presentation conditions (Uncrossed Hands, 
Crossed Hands, and Board), designed to test if any bias was restricted to the patient’s body; 
extended to near external space; or if it was near space- or body-specific. In the Uncrossed Hands 
condition, the visual stimuli were presented on the participants’ hands (body space), which they 
placed on the left and right side of their body midline on a table. In that condition, both spatial 
and body coordinates were available and congruent. In the Crossed Hands condition, the visual 
stimuli appeared on the participants’ hands, which were crossed over their body midline, thus 
spatial and body coordinates were incongruent (e.g., the left hand was in the right side of space). 
In the Board condition, the stimuli were presented on the left and right side of a blank board (near 
/ hands working space), thus only spatial coordinates were available. In T3, visual TOJs were 
conducted in two Presentation conditions to test whether the patient’s attention bias is stronger in 
inferior hands working space (Board), compared to superior near space on eye level (Wall). The 
Board condition was identical to that described for T2. In the Wall condition, the visual stimuli 
were projected onto a wall in front of the participants (near space on eye-level). In addition to 
visual TOJ tasks, we also administered tactile TOJ tasks on the participants’ knees in T3 to 
provide a measure of tactile spatial attention to suprathreshold tactile stimulation in body space 
that would be more sensitive than the tactile confrontation tests. 
The TOJ tasks in the three sessions followed the same general method of constant stimuli. In the 
visual TOJ tasks, participants were seated at a table with their head stabilised by a chin-rest. Pairs 
of brief (10ms), identical red point-light stimuli (3mm diameter) were projected 9cm to the left 
and to the right of the central fixation point on a white background. In the Board condition, the 
stimuli were projected onto the surface of a 46.5 x 35.5cm board that lay on the table in landscape 
orientation such that the fixation point was approximately 28cm from the torso. In the Uncrossed 
/ Crossed Hands conditions, the participants placed their hands on top of this board such that the 
lights projected to the same spatial locations, but were seen on the dorsal surface of the 




fixation point and lights were presented at eye level on a white wall at a 50cm viewing distance. 
In all visual TOJ tasks, the pairs of lights, one on each side, were presented with different Stimulus 
Onset Asynchronies (SOAs) in pseudo-random order using custom-built laser pointers that were 
triggered by Eprime 2.0 software running on Windows 7 operating system (T1 and T2); or via an 
Arduino platform that was integrated with PsychoPy version 1.85.1 software (Peirce, 2007), 
running on Windows 10 operating system (T3). In the tactile TOJ tasks, pairs of brief tactile 
stimuli were delivered as static indentations (“single taps”) using miniature electromagnetic 
solenoid-type stimulators (© Dancer Design) attached to each of participants’ knees (centre of 
kneecaps; 1.8 diameter contact surface) with adhesive rings. The stimulators were controlled via 
Tactamp amplifier (© Dancer Design) integrated with MATLAB R2013b software (MathWorks 
Inc., Natick, MA, USA), running on Windows 7 operating system. The participants were seated 
at the table with their head supported by a chin-rest, eyes closed, and arms hanging loosely next 
to the torso such that the arms were straight and the fingers pointed to the floor. During each 
tactile TOJ block, they listened to white noise via headphones to prevent their decisions from 
being influenced by auditory information. The SOAs were ±5, 15, 30, 60 and 120ms in T1; and 
±10, 30, 60, 120, and 240ms for both the visual TOJ tasks in T2 and T3 and the tactile TOJ task 
in T3. Negative values represent the trials in which the stimulus was presented on the left side 
first. The SOAs in T2 and T3 were doubled compared to T1 because the patient’s responses in 
the Board condition of T1 suggested that the range of SOAs was insufficient for quantifying her 
attention bias. Specifically, she indicated that the right light appeared first in 95% of the trials 
(see Results section). In each session, each SOA was presented 15 times in pseudorandom order, 
giving 150 trials per block. Each trial began with a pause that varied in length randomly between 
500ms and 1000ms. Then the two stimuli were presented with SOAs as detailed above. Following 
presentation of the two stimuli, participants gave a verbal response to indicate the perceived 
temporal order of the stimuli. In T1, participants reported “which side occurred first”. Given the 
patient’s discomfort with the word “left”, it was important to separately account for attentional 
and response biases (Filbrich et al., 2016; Shore et al., 2001). Hence two Response blocks per 
Presentation condition were added in T2 and T3, that is, participants reported “which side 
occurred first” in one block, and “which side occurred second” in another block. They had 
unlimited time to give their response and were instructed to guess if they were unsure. The 
researcher keyed the responses into the computer, initiating the next trial. Every block (except for 
the tactile TOJs) was preceded by a training session with six trials using the maximum SOA to 
ensure the participants understood the instructions and could perceive the stimuli. If necessary, 
the training session was repeated until 100% accuracy was achieved.  Each block of the task lasted 
approximately seven minutes.  
Overall, there were three visual TOJ blocks in T1 constituting the three Presentation conditions 
(Board, Uncrossed Hands, Crossed Hands). There were six visual TOJ blocks in T2: 3 
Presentation conditions (Board, Uncrossed Hands, Crossed Hands) x 2 Response conditions 
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(“which side occurred first”, “which side occurred second”). There were four visual TOJ blocks 
in T3: 2 Presentation conditions (Board, Wall) x 2 Response conditions; and two tactile TOJ 
blocks: 1 Presentation condition (Knees) x 2 Response conditions. The order of the blocks was 
counterbalanced across participants in all sessions.  
For every “which side occurred first” block, the proportion of “right occurred first” responses to 
each SOA was fitted with a cumulative Gaussian using the criterion of maximum likelihood to 
derive the Point of Subjective Simultaneity (PSS). PSS represents the temporal offset between the 
two stimuli at which “right” and “left” responses would be equally probable (i.e. at which the 
psychometric function crosses the proportion of .5). Thus, PSS indicates the amount of time by 
which the stimulation on the left side should precede (negative PSS) or follow (positive PSS) the 
stimulation on the right side for the two stimuli to be perceived as simultaneous. For every “which 
side occurred second” block, the proportion of “left occurred second” responses to each SOA was 
used to calculate the PSS. By fitting the data in this way, a negative PSS value indicates inattention 
to the left side, i.e. relative slowing in noticing the stimulation on the left side, regardless of the 
Response condition. For the primary analysis, the PSS values for each Presentation condition 
were averaged across the two Response conditions. Additional analyses of the Just Noticeable 
Difference index, which provides a measure of temporal acuity, are presented in the Supplemental 
Material. 
2.3.3.2. Greyscales 
We administered a Greyscales task (Nicholls et al., 1999) to measure visual spatial attention in 
near and far space. Pairs of identical, vertically aligned, short (9.95° x 1.95°) or long (12.00° x 
1.95°) horizontal bars with brightness gradients changing gradually from white to black across 
their horizontal length were presented simultaneously such that one was the mirror-reverse of the 
other. One bar was darker on its left side, and the other bar, positioned immediately above or 
below, was darker on its right side. The bars were on constant display until the participants 
indicated which bar appeared darker overall. In T2 they gave verbal responses (“top bar was 
darker” or “bottom bar was darker”) that were keyed into the computer by the researcher, and in 
T3 the participants pressed “up” or “down” arrow keys with their right hand. Following the 
response, an 18° x 8° random dot pixel mask was displayed for 150ms, and then the next trial 
began. There were 40 trials per condition, preceded by five demonstration trials. Bias scores were 
calculated for each participant by subtracting the number of times the participants chose the bar 
that was darker on the left (the patient’s affected) side from the number of times they chose the 
bar that was darker on the right side, and dividing the difference by the total number of trials. 
According to this formula, positive score would indicate a bias for making the darkness 
judgements based on the right side of the stimuli, suggesting inattention to the left side. In T2, the 
Greyscales task was conducted with the participants standing Near (50cm) and Far (150cm) from 




allowing to use equivalent stimuli to compare these two regions of space within the same task. 
Such manipulation would not be possible for the visual TOJ set-up using the available equipment. 
In T3, the Greyscales task was repeated in Near space, with the participants seated at the table 
with their head stabilised by a chinrest. This was to provide comparative testing conditions to the 
TOJ tasks from within the same session (T3), and to determine whether the patient’s performance 
on the Greyscales task was stable over time. In all conditions the stimuli were displayed at the 
participants’ eye-level. 
2.3.3.3. Mental Number Line Bisection  
To measure mental representation of space, a Mental Number Line Bisection task (Sumitani et 
al., 2014; Zorzi et al., 2002) was used. This task takes advantage of evidence that people implicitly 
represent numbers in a linear arrangement, with smaller numbers on the left, and larger numbers 
on the right side of space (Cutini et al., 2014). The participants had to indicate the midpoint 
numbers between given number intervals (e.g., the midpoint between 11 and 19 is 15), without 
making any calculations. Our procedure followed those described in previous papers (Rossetti et 
al., 2004; Zorzi et al., 2002). There were 40 number pairs separated by different intervals (3, 5, 7, 
and 9) selected from the 1 – 49 number range. The same pairs were presented once in ascending, 
and once in descending order, giving 80 trials in total. The mean deviation of the perceived 
midpoint from the actual midpoint between pairs of numbers was calculated. Analogously to the 
classic line bisection task, positive score would indicate a rightward bias. 
2.3.3.5. Global-Local Processing 
To test whether the CRPS patient showed neuropsychological deficits typical of right-hemisphere 
lesions other than inattention to the left side of space, we administered a Global-Local Processing 
task (Bultitude et al., 2009; Navon, 1977). Participants were asked to identify the global or local 
levels of hierarchical stimuli (Navon letters; Navon, 1977) presented in the left and right visual 
fields. The stimuli in T3 were small letters (0.92° x 1.26°) that formed the shape of the same 
(Congruent) or a different (Incongruent) larger letter (5.13° x 7.10°). Four types of Navon letters 
(Navon, 1977) were used in each block (two Congruent: small A’s forming a large A; small S’s 
forming a large S; and two Incongruent: small A’s forming a large S; and small S’s forming a 
large A). The task was conducted in two Target Level conditions over separate blocks: in the 
Local condition, the participants identified the local level of the stimuli (small letters); in the 
Global condition, they identified the global level of the stimuli (large letters). The combination 
of Target level and Stimulus types constituted four conditions: Global Congruent, Global 
Incongruent, Local Congruent, and Local Incongruent. 
Each trial started with a black fixation cross (0.57° x 0.57°) displayed in the centre of a white 
screen. After 1000ms one of the hierarchical stimuli was presented with its centre located 3.38° 
to the left (left visual field, LVF) or right (right visual field, RVF) of the fixation cross. The 
stimulus was presented for 200ms. If the participants identified the local / global stimulus as A, 
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they pressed the “up” arrow key, and if they identified it as S, they pressed the “down” arrow key. 
The response keys were aligned with the participant’s body midline. Reaction time and accuracy 
were recorded. Each trial ended with the participant’s response without time limit (see Figure 3). 
Each of the four types of stimuli (two Congruent and two Incongruent) was presented 16 times in 
each visual field (LVF, RVF) in pseudorandom order, giving 128 trials per Target Level 
condition. There were 16 training trails before each Target Level condition, with a requirement 
to achieve at least 75% accuracy level before proceeding to the task. 
 
Figure 3. Global-Local Processing task. The time course of two example trials is presented. The 
right inset panel illustrates four types of stimuli used. 
The patient had low accuracy in the Local Incongruent condition in T2 (< 20%) suggesting that 
she was not able to perform the task as instructed (see Supplemental Material). We inferred that 
poor peripheral visual acuity could have diminished the patient’s ability to perceive the local level 
(small letters) of the hierarchical stimuli. Therefore, in T3 we measured the patient’s peripheral 
vision, adjusted the size of the visual stimuli (see Supplemental Material), and confirmed that the 
patient was able to discriminate its local features before administering the main Global-Local 
Processing task. Thus, only the final procedure of the Global-Local Processing task in T3 is 
presented in the main text, whereas the procedures used in T2 and to determine the size of the 
stimuli in T3 can be found in the Supplemental Material. 
2.3.4. Visual acuity and peripheral vision 
We conducted a set of vision tests, prompted by the patient’s self-reported problems with visual 
acuity and loss of peripheral vision, and her difficulty completing the Global-Local task in T2. 
The Freiburg visual acuity test (FrACT) was administered in T2 to assess participants’ central 




recognise Sloan letters presented in the centre of the screen, in varying size, and at a viewing 
distance of 50 cm. Participants gave verbal free-choice responses that were keyed into the 
computer by the researcher. The results were expressed as decimal visual acuity (decVA) and 
Snellen fraction (normal decVA = 1, equivalent to 20/20 Snellen fraction). 
In T3, RareBit Perimetry was used (following the original procedure; Frisén, 2002) to test 
participants’ monocular peripheral vision in both eyes (see Supplemental Material). The 
participants completed two conditions – one using their left eye, and one using their right eye. 
The results were expressed in percentages as hit rates in each quadrant of the visual field. The 
upper and lower quadrants of each visual field were averaged for analysis. 
Participants’ binocular peripheral visual acuity was also tested in T3. With a key press response, 
they indicated the orientation (left, right, up, or down) of Landolt C optotypes that were presented 
at 6 different horizontal distances from a central fixation cross from 3° to 23° eccentricity in both 
visual fields (12 stimuli per location). The accuracy (%) of responses was calculated for each 
visual field and position relative to central fixation. Detailed description of the stimuli and 
procedure is included in Supplemental Material. 
2.4. Analyses 
The patient’s performance was compared to either pre-existing normative data or clinical cut-offs 
where available; or to data sets from the control participants for each session using Crawford t-
tests (Crawford & Howell, 1998) or RSDTs (Crawford & Garthwaite, 2005). These methods 
enable the comparison of single case data with a control sample while controlling for Type I error 
rate. The Crawford t-test provides a point estimate of the deviation of the patient’s score relative 
to the control sample mean, equivalent to the p value for the significance test. Crawford t-tests 
were used to compare the patient’s scores to those of the controls on the following measures: Bath 
CRPS Body Perception Disturbance scale, TOJ tasks, Greyscales tasks, Mental Number Line 
Bisection task, Global-Local Processing tasks, Freiburg visual acuity test, and Landolt C task. 
The RSDT compares the differences between patient’s scores in two different conditions of a task 
to the distribution of these differences in the control sample data. The RSDTs were performed for 
the following measures: TOJ tasks (for comparing results for different Presentation conditions 
and Response conditions), Greyscales task in T2 (Near vs Far), Global-Local Processing tasks 
(Global vs Local, Global Congruent vs Global Incongruent, and Local Congruent vs Local 
Incongruent in each Visual Field; LVF vs RVF for global precedence, local interference, and 
global interference), and RareBit Perimetry (LVF vs RVF). Both Crawford t-test and RSDTs 
provide point and interval estimates of effect sizes (Crawford et al., 2010). Following the 
recommendations for reporting statistical results involving comparisons of a single case to 
controls (Crawford et al., 2010), the raw scores of the patient, and the means and SDs of the 
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control samples and associated effect sizes are reported. Detailed statistical analysis plans with 
specified comparisons were pre-registered at osf.io/zx8ad (T2) and osf.io/n6qgv (T3). 
3. Results 
3.1. Confrontation tests 
The results of the confrontation tests for visual and tactile neglect and extinction are presented in 
Table 4. In line with our hypothesis, when the patient was presented with unilateral visual 
stimulation in T2, she omitted (failed to detect) twice as many stimuli on her left (affected) side 
than on the right, suggesting neglect of the left side. However, she omitted no (left or right) 
unilateral stimuli in T3. Omissions of some left-sided visual stimuli during bilateral presentation 
in T2 and T3 are indicative of extinction. In T3, there were also signs of extinction of right-sided 
visual stimuli. A pattern of neglect and extinction similar to that in visual tests was also found for 
tactile stimulation in T2, however, there were only signs of tactile extinction on the left side in 
T3. The patient also reported some referred sensations (unilateral touch was concurrently 
perceived bilaterally) and allochiria (unilateral stimulation to the left side was only perceived on 
the right side of the body). There were no other visual or tactile false detections. Contrary to our 
predictions, the patient showed no signs of motor neglect or motor extinction when they were 
assessed in T2. 
Table 4 Percentage of omissions, referred sensations, and allochiria on the confrontation tests 
Note. T1, = Session 1; T2 = Session 2; T3 = Session 3. In T1 the experimenter presented 6 left, 5 right, and 
6 bilateral stimuli. In T2 and T3 the experimenter presented 5 right, 5 left, and 5 bilateral stimuli in a pre-
defined pseudorandom order for all tests. 
3.2. Neuropsychological tests 
As presented in Table 5, no systematic lateralised attention bias was found on standard 
neuropsychological assessments of neglect in T2.  
Time point Left extinction Left neglect Right extinction Right neglect Referred Allochiria 
Visual 
T1 17% 50% 0% 0% 0% 0% 
T2 40% 80% 0% 40% 0% 0% 
T3 40% 0% 20% 0% 10% 0% 
Tactile (knees) eyes closed 
T2 40% 20% 0% 0% 10% 10% 
T3 60% 0% 0% 0% 20% 0% 
Tactile (knees) eyes open 




Table 5 The patient's scores on the subtests the Behavioural Inattention Test battery and other 
“bedside” tests of neglect administered in T2 
Measure (region tested) Patient’s scores Cut-off scores 
Behavioural Inattention Test battery – 
conventional (near space) 
144 < 129 
Line crossing 0% > 70% omissions 
Letter cancellation 2 > 4 omissions 
Star cancellation 0.5 
< 0.46 or > 0.54 side-to-
side ratio 
Figure copying 0 Any major lateral 
omissions or distortions Shape copying 0 
Line bisection 
5.6% left, 0.2% left, 
5.1% right 
> 14% deviation from the 
centre 
Man, clock, and butterfly drawing 0 
Any lateral omissions or 
distortions 
Behavioural Inattention Test battery – 
behavioural: Article reading (near space) 
< 1% > 42% omitted words 
Bells cancellation (near space) 1 
Side-to-side difference of 3 
omissions 
Fluff test (body space)   
Left side 
14 (eyes closed); 15 
(eyes open) 
< 13 detached targets 
Right side 
7 (eyes closed); 9 
(eyes open) 
< 9 detached targets 
Room description (far space)   
 Left side 2 > 2 omitted items 
Right side 2 > 2 omitted items 
3.3. Experimental measures of attention 
3.3.1. Temporal Order Judgements 
For the Crossed Hands condition of the visual TOJ tasks (T1 and T2), the lack of systematic 
pattern of the patient’s responses across different temporal offsets prevented fitting the cumulative 
Gaussian to determine the PSS. Thus, the hypotheses regarding the Crossed Hands condition 
could not be addressed and no results are presented for this. In T1, the patient responded “right” 
on 95% of trials (to the question “which side occurred first?”) in the Uncrossed Hands condition 
and thus there was insufficient variability in the responses to fit the cumulative Gaussian and 
determine the PSS. For this condition, the patient’s visual attention bias was conservatively 
estimated using nearest neighbour replacement with the PSS value of the patient with the most 
extreme fittable data in the same group study (Bultitude et al., 2017). Her pattern of responses 
suggests marked inattention to the left side of her body, but could also be attributed to response 
bias, which was not controlled for in T1. The cumulative Gaussian was successfully fitted for all 
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the remaining TOJ tasks administered across the three research sessions, indicating that the patient 
and control participants were able to complete these tasks as instructed.  
The analyses confirmed a significant response bias, that is, differences between Response 
conditions (“which side occurred first?” and “which side occurred second?”) on visual TOJs in 
hands working space in T2, t(11) = 2.64, p = .011, zcc = -2.939, 95% CI [-4.502, -1.617], and on 
tactile TOJs in T3, t(11) = 2.54, p = .027, zcc = -2.802, 95% CI [-5.217, -0.841]. The direction of 
the differences between PSS values from the two Response conditions (Table S1 in Supplemental 
Material) suggests that the patient was less likely to give “left” responses regardless of the 
Response condition. No significant response bias was found in other TOJ task conditions in T2 
and T3. The patient’s and controls’ mean PSS values in each Response condition, and PSS values 
averaged across two Response conditions in each Presentation condition, are reported in 
Supplemental Material (Table S1). The effects of response bias on all attained responses in T2 
and T3 were removed through averaging PSS values across two Response conditions. The PSS 
results are illustrated in Figure 4.  
 
Figure 4. Temporal Order Judgement task (TOJ) - Point of Subjective Simultaneity (PSS). The 
patient’s and controls’ mean PSS values for each Presentation condition (right inset panel) across 
the three sessions. T2 and T3 data are averaged over Response conditions (“which side occurred 
first?” and “which side occurred second?”; see Table S1 in Supplemental Material for un-
averaged data) to control for response bias. A negative PSS value indicates inattention to the left 
(affected) side. Thus, negative PSS values for the patient’s visual TOJs in T1 and T2 relative to 
controls’ are consistent with inattention to the left (affected) side of the body and near space. 
Positive PSS values for the patient relative to controls’ in T3 are consistent with hyperattention 
to the left side of her body (tactile stimulation) and near space on eye level and hands working 
space (visual stimulation). Error bars represent standard deviations of the controls’ mean PSSs 
and are not presented for the patient’s single PSS values. Due to “right” response on 95% of trials 
in the Uncrossed Hands condition in T1, nearest neighbour replacement was used to 
conservatively estimate the patient’s PSS from other patient responses, and an arrow indicates 
that the bias could be more extreme. *p < .05; **p < .01; ***p < .001. T1 = Session 1; T2 = 




onset asynchronies compared to T2 and T3, and without controlling for response bias (see 
Materials and Methods section for further details). 
In T2, we used a larger range of SOAs than in T1 to increase the likelihood of being able to 
quantify the patient’s attention bias, and controlled for response bias. The results for the 
Uncrossed hands condition in T2 were broadly consistent with inattention to the left side in T1, 
and were significantly different to controls’ mean score, t(11) = -2.96, p = .006, zcc = -3.083, 95% 
CI [-4.463, -1.682]. The patient showed significant inattention to the left side of hands working 
space (Board) in T1 and T2 compared to controls, t(11) = -2.00, p = .038, zcc = -2.045, 95% CI [-
3.048, -1.017], but hyperattention to that side in T3, t(11) = 3.04, p = .011, zcc = 3.160, 95% CI 
[1.730, 4.568], demonstrating a reversal in the direction of the spatial attention bias between T2 
and T3. In T3, the patient also showed significant hyperattention to the left side of near space on 
eye level (Wall), t(11) = 2.83, p = .016, zcc = 2.943, 95% CI [1.594, 4.270], and hyperattention to 
touch delivered to the knees on the left side of the body, t(11) = 4.41, p = .001, zcc = 4.594, 95% 
CI [2.613, 6.561]. In summary, the patient’s PSS scores were significantly different to control 
participants in all TOJ conditions across all sessions. We found inattention to the affected side in 
all tested conditions in T1 and T2 and hyperattention to the affected side in all tested conditions 
in T3. These attention biases were present even when response bias was controlled for in T2 and 
T3.  
Contrary to our hypotheses, the magnitude of the patient’s visual spatial attention bias was not 
larger in body space (Uncrossed Hands) compared to hands working space (Board) in T2, t(11) = 
0.94, p = .188, zcc = 1.058, 95% CI [-0.361, 2.618]. There was also no significant difference in the 
magnitude of attention bias between hands working space (Board) and near space on eye level 
(Wall) in T3, t(11) = 0.17, p = .435, zcc = 0.186, 95% CI [-1.363, 1.756]. Thus, within these 
sessions, the magnitude of the attention bias shown by the patient was similar regardless of which 
modality / spatial domain was tested, although the direction of attention bias for T3 was different 
to T1 and T2.  
3.3.2. Greyscales  
Counter to our hypotheses, the patient’s attention bias scores in the Near condition of the 
Greyscales task (T2 = -0.30; T3 = -0.45) were not significantly different from the mean (±SD) 
scores of the healthy controls (T2 = -0.23±0.41; T3 = -0.06±0.39), neither in T2, t(11) = -0.18, p 
= .432, zcc = -0.182, 95% CI [-0.749, 0.393], nor in T3, t(11) = -0.96, p = .360, zcc = -0.995, 95% 
CI [-1.679, 0.281]. This was also the case for the Far condition of the Greyscales task (patient T2 
= -0.40; controls T2 = -0.25±0.36), t(11) = -0.39, p = .350, zcc = -0.41, 95% CI [-0.993, 0.189]. 
The difference between bias scores for Near vs Far condition for the patient was not significantly 




3.3.3. Mental Number Line Bisection 
Contrary to what we predicted, the patient did not demonstrate spatial bias in the bisections of 
mental number line (bias score = 0.13) compared to healthy controls (mean bias score = 
0.10±0.09), t(11) = 0.31, p = .764, zcc = 0.321, 95% CI [-0.268, 0.894].  
3.3.4. Global-Local Processing  
Since the patient’s results from T2 suggest the stimuli were too small for her to be able to perform 
the task as instructed (see Supplemental Material), only the results from T3 are reported in the 
main text. The patient’s accuracy rates for incongruent trials in the Global and Local conditions 
in T3 were ≤ 50% (Figure 5). Thus, only 15/32 LVF trials, and 14/32 RVF trials were included 
in the reaction time analyses for these conditions (Figure 6).  
 
Figure 5. Global-Local Processing task (T3) – accuracy. The patient’s and controls’ mean 
accuracy rates (%) for congruent and incongruent stimuli in left and right visual field (LVF and 
RVF, respectively) in T3. Error bars represent standard deviations of the controls’ means and are 





Figure 6. Global-Local Processing task (T3) – reaction times. The patient’s and controls’ mean 
reaction times (ms) for congruent and incongruent stimuli in left and right visual field (LVF and 
RVF, respectively) in T3. Error bars represent between-subjects standard deviations of the 
controls’ means and within-subject standard deviations for the patient. 
To test whether the patient showed a local processing bias, we first compared her performance in 
Global Congruent vs Local Congruent conditions to the control sample performance in these 
conditions. Contrary to our predictions, the patient’s reactions times were significantly faster for 
the Global vs Local levels compared to controls in the LVF, t(11) = 9.94, p < .001, zcc = -14.291, 
95% CI [-28.550, -1.198] and the RVF, t(11) = 20.19, p < .001, zcc = -43.099, 95% CI [-68.051, -
21.745]. The differences in the patient’s accuracy rates for Global vs Local levels compared to 
controls were not significant in either visual field (ps > .05).  
Expecting that the patient would show greater interference from irrelevant local level information, 
we used RSDTs to determine if the difference in performance for Global Congruent vs Global 
Incongruent conditions was higher for the patient compared to the controls. The patient had larger 
local interference relative to the controls, both in accuracy rates for the LVF, t(11) = 13.61, p < 
.001, zcc = 14.447, 95% CI [9.100, 25.624], and the RVF, t(11) = 7.34, p < .001, zcc = 9.344, 95% 
CI [5.565, 13.961], and reaction times in the LVF, t(11) = 27.38, p < .001, zcc = -75.574, 95% CI 
[-114.677, -42.652], and the RVF, t(11) = 17.81, p < .001, zcc = -34.616, 95% CI [-56.115, -
16.074]. This suggests that, in line with our hypothesis, the patient was significantly less accurate 
and slower in Global Incongruent than Global Congruent trials relative to controls.  
To evaluate whether the patient would show smaller interference from irrelevant global level 
information (consistent with a local processing bias), we used RSDTs to determine if the 
difference in performance for Local Congruent vs Local Incongruent conditions was lower for 
the patient compared to the controls. Contrary to this prediction, the patient showed higher global 
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interference compared to controls. This is evidenced by significant results of RSDTs for accuracy 
rates in the LVF, t(11) = 15.26, p < .001, zcc = 20.878, 95% CI [11.741, 32.300], and the RVF, 
t(11) = 9.90, p < .001, zcc = 13.005, 95% CI [7.329, 20.013], and reaction times in the LVF, t(11) 
= 33.19, p < .001, zcc = -106.477, 95% CI [-162.723, -59.128], and the RVF, t(11) = 25.38, p < 
.001, zcc = -65.559, 95% CI [-107.019, -29.188]. That is, the patient was less accurate and slower 
in Local Incongruent than Local Congruent trials, and these differences were larger than in the 
control sample.  
Finally, we derived the local / global interference ratios from the reaction time data. The patient’s 
ratios were 0.88 (LVF) and 0.86 (RVF), consistent with a global processing bias (greater global 
than local interference) and contradicting our predictions. However, this was not significantly 
different to the ratios of the controls (LVF = -1.97; RVF = -0.46). Overall, the patient showed 
larger local and global interference than controls in both visual fields. Statistical comparisons 
between LVF and RVF are reported in the Supplemental Material. 
3.4. Visual acuity and peripheral vision 
The results of the FrACT and the Rarebit perimetry tests showed that the patient had significantly 
impaired monocular and binocular visual acuity compared to the control groups (Table 6). 
Perimetry also showed that in both eyes, the patient had significantly greater asymmetry between 
her LVF and RVF acuity compared to controls, with better peripheral vision in the left (affected) 
visual field.  
Table 6 The patient’s results for visual acuity test in T2 and perimetry in T3 compared to healthy 
controls 

















-3.89a 11 .003 -4.046 -5.797,  
-2.279 
RareBit Perimetry (hit rate, %) 
Left eye T3   3.88b 82 .005 -4.928 -10.867, 
0.360 
LVF  46.85 93.72±5.01      
RVF  44.17 95.74±8.29      
Right eye T3   6.05b 82 <.001 -8.473 -16.593,  
-1.358 
LVF  45.00 96.20±4.25      




Note. FrACT = Freiburg visual acuity test; LVF = left visual field; RVF = right visual field. 1 Normal 
decimal visual acuity (decVA) equals 1 (equivalent of 20/20 Snellen fraction), with lower scores indicating 
impaired visual acuity. 2 Due to results saving error, only 9 out of 12 complete data sets from control 
participants were obtained for this test. a Crawford t test. b Revised Standardised Difference Test. 
Figure 7 illustrates the percentage accuracy of the patient’s and controls’ responses on the test of 
binocular peripheral vision over different eccentricities, as tested in T3. The patient had worse 
than normal performance for eccentricities of 12º or greater, and there was little difference 
between her performance for the LVF and RVF. 
 
Figure 7. Landolt C test. The patient’s and controls’ mean accuracy rates for different positions 
of Landolt C optotypes, showing that the patient had impaired visual acuity in more peripheral 
locations. Negative distance indicates positions in the left (affected) visual field. Error bars 
represent standard deviation of the controls’ means. *p < .05; **p < .01; ***p < .001. 
4. Discussion 
We examined spatial attention changes in a woman with CRPS affecting her left arm, who has 
previously presented with pronounced attention bias, yet she had no known brain pathology and 
scored within the normal range on general cognitive assessments. In the current study, she showed 
neglect and extinction of visual and tactile stimulation on her affected side on confrontation tests, 
but no motor neglect. Based on her severe attention bias in T1, we hypothesised that the patient 
would show attention bias on classic “bedside” tests when tested in T2. However, her  
performance was normal, consistent with previous studies (Christophe, Chabanat, et al., 2016; 
Förderreuther et al., 2004; Kolb et al., 2012; Reid et al., 2016) and the conclusion that any 
attention bias shown by people with CRPS is likely to be subtle and only detected using sensitive 
tasks (Bultitude et al., 2017; Filbrich et al., 2017; Moseley et al., 2009, 2012; Reid et al., 2016). 
Also in keeping with this conclusion, her visual and tactile attention was biased on TOJ tasks that 
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required judging the order of pairs of visual and tactile stimuli that were presented in body and / 
or near space. These attention biases were present even when we controlled for response bias. 
They cannot be explained by hemisensory impairment because the patient’s peripheral vision, 
although impaired overall, was better in the affected hemifield, and her tactile sensitivity was 
equal on both lower limbs (where we tested tactile spatial attention). Contrary to our hypotheses, 
the attention biases were not stronger in body space compared to near space, or in near hands 
working space compared to near space on eye level. No evidence of attention bias in near, far, or 
imagined space was found on two other experimental measures of spatial cognition (the 
Greyscales task and Mental Number Line Bisection). Although there was no specific local 
processing bias, often associated with right hemisphere dysfunction (Bultitude et al., 2009; 
Navon, 1977), the patient had non-lateralised cognitive difficulties in processing incongruent 
hierarchical visual information. These were evidenced by larger than normal global and local 
interference effects in the Global-Local task.  
The most striking result of our study is that the CRPS patient presented with a dramatic change 
in TOJs from inattention to the affected side in T1 and T2, to hyperattention in T3, despite no 
change in pain or body representation distortion. The direction of the bias (inattention or 
hyperattention to the affected side) was consistent across the different conditions of the TOJ task 
within each session, and only the direction of bias changed between the second and third session. 
However, it should be noted that only one presentation condition (visual stimuli appearing on a 
blank board in near space) was consistent across all three sessions. No previous study has 
investigated whether spatial attention bias in CRPS is stable over time, and there are only a 
handful of cases of brain-lesioned patients showing opposite directions of attention bias (on 
different assessments: Beschin, Basso, & Sala, 2000; Costello & Warrington, 1987; Dove, Eskes, 
Klein, & Shore, 2007; Van der Stoep et al., 2013; or over time: Kim et al., 1999; Kwon & 
Heilman, 1991). To the best of our knowledge, the only study that involves repeated testing of 
spatial cognition in CRPS patients was that of Christophe, Chabanat, et al. (2016), who did not 
find any deficits in spatial attention in seven patients with CRPS, neither before nor after they 
underwent treatment that resulted in pain reduction. Together with these results, our findings 
suggest that the direction of attention bias can be independent of pain and body representation 
distortion. Moreover, the direction of attention bias may not be stable over time, despite sustained 
pathology.  
4.1. Attention in body space and near space 
Post-stroke neglect can manifest in one or multiple sensory modalities (Barbieri & De Renzi, 
1989; Bisiach et al., 2004; Cubelli et al., 1991; Kerkhoff, 2001; Marsh & Hillis, 2008; Vallar, 
1998). Although most previous studies on CRPS investigated one modality at a time (Bultitude 
et al., 2017; Moseley et al., 2009), there is also evidence that attention bias can dissociate, being 




patient’s attention bias on confrontation tests and TOJ tasks generalised across visual and tactile 
modalities. No signs of motor neglect were found, consistent with the evidence of dissociations 
between perceptual and motor neglect as has been shown in post-stroke patients (Bisiach et al., 
1990; Buxbaum et al., 2004; Liu et al., 1992), although it is possible that motor neglect would 
become evident if a more sensitive test was used (Reid et al., 2018). 
It has been proposed that spatial cognition deficits in CRPS are driven by distorted body 
perception (“somatospatial inattention” hypothesis; Bultitude et al., 2017; Reid et al., 2016) and 
/ or limited amount of action in the affected side of space (Punt et al., 2013). The patient in the 
current study showed severe distortions in body representation. These were evidenced by high 
BPDS scores, the patient’s own descriptions of her affected hand (see Figure 1), her aversion to 
the words “wrist” and “left”, preference for keeping her arm out of sight (reminiscent of 
misoplegia; Bartolomeo et al., 2017; Critchley, 1974; Lewis et al., 2007), and the evidence of a 
significant response bias in some TOJ tasks. She also reported high pain-related fear of 
movement. If such specific relationships existed between body representation, action in near 
space, and attention bias, the patient’s bias should be greater in body space compared to near 
space, and in hands working space (where the arms are more frequently positioned and moved) 
compared to near space on eye level.  
Partly in line with our predictions, the patient showed significant attention biases in body space 
and near hands working space in T1 and T2 in TOJ tasks. However, the bias was not significantly 
stronger when the TOJs involved the patient’s hands compared to other conditions, nor for hands 
working space compared to near space on eye level in T3. The patient also presented with biased 
attention to tactile stimuli on her left side of the body when the stimulation was delivered to her 
lower limbs, which were unaffected by CRPS. Finally, the direction of her attention bias changed 
from inattention to hyperattention to the affected side, while pain intensity, body representation, 
and fear of movement remained the same between sessions. This suggests that there might not be 
a direct association between pain intensity, severity of body representation distortion, and 
direction of spatial attention bias. These findings are not fully consistent with the “somatospatial 
inattention” hypothesis suggesting that the relationship between spatial attention and body 
representation is also interrelated with pain in CRPS (Moseley et al., 2012; Reid et al., 2016), the 
idea of action-driven inattention (Punt et al., 2013), or our predictions regarding the magnitude of 
bias in different regions of space. Nonetheless, current results corroborate our previous conclusion 
that visual attention bias can be present both when the body related information is involved in the 
task, and when it is not relevant (Bultitude et al., 2017). 
Attention biases can be generalised or specific to certain regions of space. Post-stroke neglect can 
arise for the external space within (near) and beyond (far) the patients’ reach (Kerkhoff, 2001; 
Pizzamiglio et al., 1989). Considering previous evidence of mislocating visual stimuli in far space 
relative to one’s body in the opposite direction to the spatial bias often found in near space in 
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CRPS (Christophe, Chabanat, et al., 2016; Jacquin-Courtois et al., 2017; Sumitani, Rossetti, et 
al., 2007; Sumitani et al., 2014; Uematsu et al., 2009), we predicted that the patient’s attention 
bias in far space would be absent or opposite to the bias in near space. She reported previous 
problems with veering off to the left while walking, which could suggest difficulties with 
integrating the sense of the position and orientation of her whole body with external visual 
information. When the patient’s attention in far space was formally tested using the Greyscales 
task, she showed no attention bias (consistent with our prediction). However, contrary to our 
prediction, she also showed no bias when tested on the same task in near space, despite evidence 
of attention biases on TOJ tasks in near space. This difference in the results could be because the 
participants performed the Greyscales task under free viewing conditions, thus employing overt 
attention, whereas TOJs of brief stimuli employ covert attention (Wright & Ward, 2008). The 
same explanation would apply to the discrepancy between normal performance on “bedside” tests 
of neglect, and evidence of neglect and / or extinction on confrontation tests. In our study, the 
attention bias appeared to be present only when the patient had to quickly, covertly attend to visual 
or tactile information, but not when she had the opportunity to explore the visual display freely 
over longer periods. Further research to examine attention in far space could use a TOJ task, 
which was not possible using the available equipment in the current study.  
One possible limitation to interpreting the results of the visual tasks is the patient’s impaired 
visual acuity and loss of peripheral vision, combined with her complaints about double vision. 
We must consider that the patient’s visual deficits could have contributed to her impaired 
performance on visual confrontation tests, TOJs, and Global-Local Processing task, despite her 
using corrective glasses during each session. Indeed, our interpretation of the results from the 
Global-Local Processing task administered in T2 was that the patient was unable to discern the 
local level of the Navon stimuli (see Supplemental Material). However, the patient’s performance 
on the same task in T3 cannot be attributed to her visual acuity impairments because in this session 
we systematically increased the size of the Global-Local stimuli until the patient could 
consistently discriminate their local features before we proceeded with the main Global-Local 
Processing task, and she had similar accuracy for identifying the Local and Global levels of the 
stimuli. The patient showed deficits in her peripheral visual acuity as measured in T3. This was 
slightly worse in the right visual hemifield for monocular vision, but approximately the same for 
the left and right visual fields when tested binocularly. This primary visual deficit cannot explain 
the biases away from her affected side that she showed in confrontation testing and previous TOJ 
tasks. It might have contributed to the bias towards her affected side on the visual TOJ tasks in 
T3, although it appears unlikely that such a small difference in peripheral vision in the left and 
right visual fields could completely explain the bias on the TOJ task. Co-morbid eye diseases and 
conditions have been scarcely reported in CRPS literature, despite their prevalence in clinical 
anecdotes (Hall et al., 2011). Viewing ambiguous images has been found to exacerbate pain and 




al., 2012), possibly through supraspinal interactions between pain networks and somatomotor and 
autonomic pathways. These previous and present findings advocate an idea that centrally 
modulated visual symptoms might be associated with pain and other diagnostic signs of CRPS. 
The aetiology of the patient’s visual impairment is unknown and based on the available data it is 
not possible to differentiate between central and peripheral mechanisms; yet the similar patterns 
in both eyes and visual fields suggest that central mechanisms cannot be ruled out. 
We considered the possibility that the patient’s peripheral vision loss could account for the lack 
of evidence of spatial attention bias in the Greyscales tasks. The most discriminating parts of the 
greyscale stimuli are their edges, thus if the patient made her judgements based on the central 
parts of the stimuli alone then she would be less likely to show a bias. However, this is unlikely 
because the entirety of the images was presented within the range of the patient’s visual field that 
was not significantly impaired relative to controls (see Figure 7), and this task was performed 
under free-viewing conditions. 
In contrast to previous findings in patients with CRPS (Christophe, Delporte, et al., 2016; Jacquin-
Courtois et al., 2017; Sumitani et al., 2014) and post-stroke neglect (Priftis et al., 2006; Rossetti 
et al., 2004; Zorzi et al., 2002, 2006), there was no evidence of a bias in the mental representation 
of space assessed using Mental Number Line Bisection. Overall, the CPRS patient presented with 
spatial attention biases only in body and near space (as often found in neglect; Buxbaum et al., 
2004; Committeri et al., 2007), while far and imagined space were not affected by spatial deficits. 
Similar dissociations in attention bias in different regions of space and / or across different tasks 
have been demonstrated in neglect following a stroke, which can manifest in near, but not far 
space (Aimola et al., 2012; Halligan & Marshall, 1991; Keller et al., 2005).  
4.2. Implications of reversal of the attention bias 
We propose two speculative explanations of the “reversal” of attention bias observed between 
sessions. First, people with CRPS can be hypervigilant to potential spreading of CRPS symptoms 
to other limbs (Rijn et al., 2011), thus any new pain might lead to increased monitoring of 
sensations and other information on the affected parts of the body. The patient injured her left leg 
five months prior to the third session of this study, and at that time reported discontinuous pain 
and other symptoms. These could have attracted her attention back to the left side, after years of 
neglecting her CRPS-affected arm. One possible mechanism of such a change is that new pain 
ipsilateral to the patient’s affected arm could have increased the level of arousal that facilitated 
orienting of attention towards the CRPS-affected side. For instance, people who had a right 
hemisphere stroke often present with a non-spatial deficit of alertness, and phasic alerting of 
attention has been found to improve their perception of usually “neglected” contralesional stimuli 
(Robertson, Mattingley, Rorden, & Driver, 1998). Alternatively, our patient’s attention towards 
the affected side could have been directly driven by increased somatosensory input from that side 
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of the body due to new pain in the lower limb (Sumitani, Shibata, et al., 2007). Hyperattention to 
the affected side could also be considered a strategy to cope with this exaggerated input and avoid 
further escalation of pain. For instance, Christophe, Delporte, et al. (2016) and Jacquin-Courtois 
et al. (2017) attributed the hyperattention of their CRPS patient to avoidance of external 
(hyperalgesia, allodynia) or movement induced painful stimulation (kinesiophobia), as protective 
attention bias towards the affected side. Such an interpretation, however, could not explain the 
hyperattention shown by our patient in the third session, since her kinesiophobia was comparable 
in all three sessions, including T1 and T2 in which she showed inattention to the affected side.  
The second possible explanation is that by T3 the patient might have been undergoing adaptive 
reengagement with the affected limb, thanks to comprehensive pain management programmes 
she attended throughout the entire three-year period of this study. These are focused on CRPS 
rehabilitation, including physiotherapy, hydrotherapy, occupational therapy, and psychological 
support. During the sessions, patients are encouraged to actively focus on their affected limb and 
move it, they work towards reconditioning normal movement (as compared to compensatory 
movements), learn strategies aimed at restoring the normal level of daily function (including 
work, personal care, leisure activities), coping with emotional disturbances, and self-managing 
CRPS in long-term. Thus, the “reversal” of attention bias could have been an effect of increasing 
attention and functional use of the affected limb during the inpatient programme that the patient 
completed between T2 and T3. During the months following the final research session we learned 
that, for the first time since her injury, the patient had begun to take part in leisure and sporting 
activities that involved her affected arm and whole body, despite having experienced no reduction 
in pain and other CRPS symptoms. That is, the patient underwent psychological and behavioural 
change. A limitation of this study is that no data on the patient’s emotional state was collected 
during T2 and T3, as mood could potentially exert effects on attention (Tucker et al., 1999).  
Paradoxically, although the patient’s TOJ responses in T3 indicated hyperattention to her affected 
side, confrontation testing revealed visual and tactile extinction of the affected side in the same 
session. Yet the pattern of changes in the patient’s performance on visual confrontation tests is 
more complex and demonstrates amelioration of left neglect in T3 compared to previous sessions, 
and emergence of right extinction in T3, which was not present in the previous sessions. This 
trend to some extent appears to follow the changes over time observed on the TOJ tasks, although 
extinction of the left stimuli in T3 was still twice as frequent as for the right stimuli. In line with 
the patient’s behavioural change one could speculate a development of compensatory strategy to 
endogenously orient attention towards the affected side (Dove et al., 2007), which was effective 
on TOJs in T3, but less so on confrontation tests, potentially due to chronicity of her inattention 
or task specificity. Similarly, patients who had a stroke can develop ipsilesional neglect over time, 
which is thought to arise due to compensatory left-sided scanning strategies and non-lateralised 




which was not intended to examine changes in the direction of attention bias over time, is limited 
in that only the visual confrontation tests and the Board condition of the TOJ task were consistent 
across all testing sessions. It could be informative to investigate whether the patient’s reversed 
attention bias persisted or generalized across other measures over longer time periods; however, 
it was not feasible to arrange another follow-up session. 
Our conclusion that the attention bias reversed over time has implications for treatments that 
attempt to reduce CRPS pain through addressing this bias, such as prism adaptation. Prism 
adaptation is a sensory-motor rehabilitation method that is commonly used to reduce spatial 
attention deficits in post-stroke neglect patients (Rossetti et al., 1998). There is evidence of pain 
reduction following prism adaptation in a total of 13 CRPS patients across three independent 
studies (Bultitude & Rafal, 2010; Christophe, Chabanat, et al., 2016; Sumitani, Rossetti, et al., 
2007). Although the mechanism of prism adaptation treatment of CRPS is as yet unclear, pain 
reduction is thought to rely on increasing attention to the CRPS-affected side. For example, when 
a CRPS patient underwent prism adaptation to induce an attention shift away from the affected 
side, her pain increased (Sumitani, Rossetti, et al., 2007). If the direction of prismatic shift relative 
to the attention bias of the patient is an important mechanism for treatment, then the variability in 
attention bias demonstrated in the current case study has ramifications for how to implement 
prism adaptation for CRPS. For example, patients presenting with hyperattention to their affected 
side may respond to the treatment differently to those presenting with inattention.  
Nonetheless, in our patient the direction of attention bias appears to be independent of pain 
intensity. Despite substantial evidence suggesting that unilateral chronic pain such as CRPS 
affects the perception of body and near space in the form of inattention to the affected side 
(Bultitude et al., 2017; Filbrich et al., 2017; Moseley et al., 2009, 2012; Reid et al., 2016), the 
present finding gives rise to a question of whether these two outcomes (pain and inattention) are 
dependent upon each other in CRPS. In conjunction with the evidence of the beneficial effects of 
prism adaptation on pain in patients without apparent deficits in spatial cognition (Christophe, 
Chabanat, et al., 2016), and reports of pain intensity being unrelated to spatial attention bias 
(Bultitude et al., 2017; Reinersmann et al., 2012), it appears that the emergence of these biases in 
CRPS does not simply depend on sensory information from the affected limb (or vice versa). This 
suggests that prism adaptation reduces pain through some mechanism(s) other than by increasing 
attention to the affected limb. Alternatively, since none of the published studies on prism 
adaptation in CRPS used control treatment conditions, it is possible that its previously reported 
effects on pain are due to a placebo response.  
4.3. Cortical underpinnings of neuropsychological symptoms in CRPS 
Although in CRPS the symptoms of attention bias can occur without any brain damage, they could 
be related to the disruption of the same attentional networks that give rise to post-stroke neglect. 
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The posterior parietal cortex (PPC; in particular the supramarginal gyrus at the temporal-parietal 
junction) has been implicated as a crucial lesion site for neglect (Halligan, Fink, Marshall, & 
Vallar, 2003). The PPC is involved in spatial processing such as orienting of attention and target 
detection, and constructing spatial representations of the body and external space (Carter et al., 
2017; Corbetta & Shulman, 2002; Grefkes & Fink, 2005; Posner et al., 1984; Vallar et al., 1999). 
Neglect in body space has been linked to lesions of the supramarginal gyrus (important for 
egocentric representation of our body in space; Committeri et al., 2007; Galati, Committeri, 
Sanes, & Pizzamiglio, 2001) and to functional disconnection between parietal regions involved 
in integrating proprioceptive and somatosensory information (Committeri et al., 2007; Coslett, 
1998). In contrast, neglect in near space has been associated with lesions to fronto-temporal 
regions that form part of the ventral circuit for exogenous allocation and reorienting of attention 
in space (Committeri et al., 2007; Corbetta & Shulman, 2011).  
Neuroimaging studies in CRPS predominantly considered primary sensory and motor cortices as 
regions of interest (Di Pietro et al., 2013b, 2013a). However, one magnetoencephalography study 
showed weaker PPC activation in CRPS patients compared to healthy controls in response to 
tactile and nociceptive stimulation to the dorsum of the digits and hand, respectively. This 
activation difference could be a correlate of “neglect-like” symptoms, although these were not 
systematically assessed (Vartiainen et al., 2008). Functional magnetic resonance imaging studies 
of people with CRPS (as compared to healthy controls) demonstrated abnormal activation of PPC 
and supplementary motor cortices related to action observation (Hotta et al., 2017) and impaired 
reach to grasp movements (Maihofner et al., 2007). The findings are consistent with disrupted 
integration of visual and proprioceptive information, as found in neglect of body space 
(Committeri et al., 2007). Parietal dysfunction in CRPS has also been implied from behavioural 
research in which patients showed impairments on a test battery of cognitive functions known to 
be related to parietal lobe function (Joseph, 1990), such as spatial orientation, constructional 
abilities, object recognition, numerical and language processing, and imitating complex 
movements (Cohen et al., 2013; Maihofner & Peltz, 2011; Robinson et al., 2011).  
Despite clinical and experimental evidence of changes in attention and visuospatial processing in 
CRPS, suggesting disruptions of parietal cortical networks, research looking into their neural 
correlates is scarce. The present study demonstrates behavioural evidence implying functional 
cortical changes in a case of CRPS without any known brain damage. The signs of patient’s 
distorted body representation resembling misoplegia (shown by patients with right hemisphere 
damage; Bartolomeo et al., 2017; Critchley, 1974; Lewis et al., 2007), and a bias of exogenous 
attention in TOJs in body and near space are consistent with PPC dysfunction. Our observation 
of “reversal” of the direction of the attention bias suggests the role of plastic functional changes 
in parietal attentional networks that are not necessarily lateralised, in contrast to primarily 





Recognizing that the present findings may not apply to all individuals with CRPS, this 
longitudinal single case study demonstrates several ways in which neuropsychological changes 
can manifest in CRPS, and generates novel hypotheses that could be addressed in further research 
on larger patient samples. We conclude that cognitive spatial biases can be independent of 
response bias and low-level sensory deficits. Our patient showed significant spatial attention bias 
only in body and near space. However, it seems unlikely that this could be connected to body 
representation (as suggested by the “somatospatial inattention” hypothesis; Reid et al., 2016) or 
reduced movement of the affected limb (Punt et al., 2013) given that the direction of attention 
bias shifted between sessions whereas body representation and kinesiophobia remained similar. 
Further insights into the mechanisms of the distortions in spatial cognition in CRPS could be 
gained from investigating whether similar patterns of dissociations between body and near space 
versus far and imagined space replicate on a group level, or whether different patterns occur in 
other individuals with CRPS. The change from inattention to hyperattention to the affected side 
shown in this study suggests that attention bias in CRPS is not necessarily stable over time. This 
novel finding prompts further longitudinal research on cognitive changes in CRPS and how they 
might be relevant for treatments. Although there is substantial previous evidence of inattention to 
the CRPS-affected side (Bultitude et al., 2017; Filbrich et al., 2017; Moseley et al., 2009, 2012; 
Reid et al., 2016), our findings add to the existing literature that attention can be biased towards 
the affected side (Christophe, Delporte, et al., 2016; Jacquin-Courtois et al., 2017). This has 
implications for exploring individualized approaches to neurocognitive rehabilitation such as 
prism adaptation. Differential response to treatment dependant on the direction of attention bias 
could advance our understanding of the working mechanism of such interventions.  
In line with previous CRPS research (Bultitude et al., 2017; Filbrich et al., 2017; Lewis & 
Schweinhardt, 2012; Moseley et al., 2009; Reid et al., 2016), we found distortions in body 
representation. Some changes in spatial attention and body representation also appear to be 
present in lateralised chronic pain syndromes other that CRPS (Förderreuther et al., 2004; Galer 
& Jensen, 1999; Kolb et al., 2012; Reinersmann et al., 2012), for example, phantom limb pain. 
Understanding the abnormalities in spatial attention and body representation in CRPS, and their 
neural correlates, could therefore facilitate our understanding of cognitive changes in other 
chronic pain conditions. Our patient showed deficits in processing incongruent information, 
which are similar to cognitive changes (impaired response inhibition) also found in other chronic 
pain conditions (Berryman et al., 2014). Thus, it appears that neuropsychological symptoms 
associated with pain are not necessarily unique to CRPS, yet they can be more pronounced in this 
population compared to other chronic pain conditions. It is yet unknown whether CRPS involves 
cortical aetiology that other pain conditions do not, or if this difference is related to general factors 
such as pain severity, number and dosage of medications, or sleep disruption specific to CRPS. 
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Although behavioural evidence for changes in attention and processing body-relevant information 
from the present and previous studies imply potentially abnormal parietal function in CRPS, 
research on the neural correlates of spatial attention bias in this population is lacking, in contrast 
to extensive investigations of sensory and motor cortex function (Di Pietro et al., 2013b, 2013a). 
Whether changes to spatial attention and body representation in CRPS are primary or secondary 
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Chapter 2 – Conclusions 
This case study offers several noteworthy conclusions regarding how CRPS can affect cognition. 
The patient presented with non-spatially-lateralised difficulty with processing incongruent visual 
information. As discussed in Chapter 1, people with CRPS can show abnormal physiological 
responses when viewing ambiguous visual stimuli (Cohen et al., 2012; Hall et al., 2011) and 
report increased sensory disturbances when exposed to visuo-motor-proprioceptive incongruence 
(Brun et al., 2019). These findings could suggest that people with CRPS are particularly sensitive 
to sensory conflicts.  
In Chapter 1, I discussed the limited sensitivity of traditional “pen-and-paper” tests of neglect for 
assessing spatial biases in CRPS. In line with this conclusion, the patient’s performance on the 
Behavioural Inattention Test battery was normal, despite her apparent spatial biases on 
experimental test and upon confrontation testing. Although the sensitivity of confrontation testing 
could also be questioned, it shares certain features with the current experimental measure 
(temporal order judgements): the presentation of brief, lateralised, suprathreshold stimuli. Greater 
temporal demands and task difficulty can enhance a test’s sensitivity to detect spatial attention 
deficits, for example, in chronic neglect patients (Bonato, 2012; Bonato & Deouell, 2013; Priftis 
et al., 2019). The following three chapters describe and implement such methods to study spatial 
cognition in CRPS and how it can be altered by prism adaptation. 
Furthermore, this case study extends previous findings from the temporal order judgement tasks 
in CRPS by systematically controlling for response bias, visual impairment or any hemisensory 
deficits. Controlling for such potential confounds is considered best practice when studying 
spatial attention bias but has not commonly been implemented in previous studies of people with 
CRPS. In this case study, the demonstrated biases on the temporal order judgement task and 
confrontation testing cannot be attributed to these cognitive or lower-level sensory mechanisms, 
suggesting that they do reflect changes in lateralised spatial attention.  
Although this study set out to test specific possible mechanisms of spatial biases, the results did 
not provide definitive insights into these. The patient presented with biases of covert spatial 
attention in bodily and near space, which are consistent with functional changes in posterior 
parietal cortex proposed in Chapter 1. The absence of any biases in far space or its mental 
representation agrees with the hypothesis that spatial deficits can arise due to limited movement 
in the affected side of near space. However, there was no evidence of any dissociations between 
the inferior and superior region of near space to further support this notion. In fact, in the third 
session, the patient showed increased attention to her affected side, which would counter the 
movement-related hypothesis. Although it is possible that the attentional shift was driven by 
adaptive re-engagement with the affected limb achieved through CRPS management 




space, and the shift from reduced to increased attention to the affected side occurred regardless 
of unchanged self-reported pain and distorted representation of the CRPS-affected limb. Thus, it 
is unlikely that CRPS pain or body representation distortion drive spatial attention biases. The 
magnitude and direction of spatial biases in temporal order judgements were consistent within 
each research session and across visual and tactile modalities in the third session, however, their 
direction was reversed between the second and third session. One possible explanation of this 
change is that additional injury of the ipsilateral lower limb between these two time points could 
increase attention to the affected side in this patient. 
Individual variability in spatial attention bias can have implications for CRPS treatment, 
particularly the use of prism adaptation. The results of this case study indicate that attention bias 
might be independent of pain severity, nonetheless, prism adaptation appears to reduce pain in 
CRPS (Bultitude & Rafal, 2010; Christophe, Chabanat, et al., 2016; Sumitani, Rossetti, et al., 
2007). This suggests that prism adaptation, if it is truly effective, might work through a 
mechanism other than normalising spatial attention, for instance, through correcting sensory-
motor incongruence (see general introduction, and Chapters 3 and 5. Two of the following 
chapters aim to address this problem by proposing a protocol for (Chapter 3) and reporting results 
of (Chapter 5) a randomised controlled trial to test the effects of prism adaptation compared to 
sham treatment on pain and other CRPS symptoms, and to explore the hypothesised mechanisms 





Chapter 3: Pain Reduction by Inducing Sensory-Motor 
Adaptation in Complex Regional Pain Syndrome (CRPS 
PRISMA): Protocol for a Double-blind Randomized 
Controlled Trial 
Chapter 3 – Introduction 
Over a century of research (von Helmholtz, 1909) on patients with hemispatial neglect and 
neurologically healthy volunteers demonstrates that the effects of prism adaptation are not limited 
to low-level sensory-motor function, but can extend to higher cognitive functions (Michel, 2016; 
Redding & Wallace, 1993). This highlights the promise of treatment not only for people with 
brain injuries, but also those with other pathological conditions, such as chronic pain. Despite 
encouraging preliminary evidence illustrated in the Introduction, so far there are no solid 
empirical grounds to support incorporating prism adaptation treatment into CRPS management 
programmes. Furthermore, as I summarised in Chapter 1, there is an increasing number of studies 
reporting null results regarding spatial biases in people with CRPS. In Chapter 2, I also showed 
that biases in spatial cognition can change independent of pain severity. These two points indicate 
that in addition to the need to robustly test prism adaptation treatment, there is also a need to 
further investigate the relationships between neuropsychological changes and clinical signs of 
CRPS. This understanding would be crucial for explaining the enigmatic working mechanisms of 
prism adaptation in CRPS, that is, how it can reduce pain. Addressing these issues could 
ultimately aid in developing new neurocognitive treatments, and improving or individually 
tailoring the existing interventions, to maximise their therapeutic effects. Having that in mind, in 
this chapter I present a protocol for a double-blind randomised controlled trial. The primary aim 
is to provide a robust test of the effects of prism adaptation treatment for CRPS, and the secondary 
aim is to assess and describe the patterns of neuropsychological abnormalities in people with 
CRPS compared to healthy individuals, and explore their clinical relevance. 
To achieve these goals, the outcome measures proposed in the trial protocol comprise a battery 
of recommended patient-reported outcomes; clinical assessments of sensory, motor, and 
autonomic functions; and experimental computer-based and psychophysical measures of 
neuropsychological functions. Studies using some of these sensitive tests of spatial cognition 
(temporal order judgment, greyscales, and mental number line bisection tasks) and body 
representation (hand laterality recognition task) have previously provided evidence of reduced 
attention to the affected relative to unaffected side of space and distorted representation of the 
affected limb, as discussed in Chapter 1. The abovementioned tests of spatial cognition were also 
used in Chapter 2, with mixed results, demonstrating that people with CRPS might present with 




of spatial cognition might be necessary to fully capture the hypothesised neuropsychological 
deficits in people with CRPS and how these might be affected by prism adaptation. Thus far, the 
temporal order judgement task appears to provide the most consistent evidence of spatial attention 
biases in CRPS. For the purpose of this study, I also adapted a landmark test of visual 
representation of space, similar to those previously used to study spatial cognition in patients with 
brain injury and amputees (Bisiach et al., 1998; Harvey et al., 1995; Makin et al., 2010). Relative 
to research on perceptual “neglect-like” symptoms in CRPS, experimental investigations into 
motor neglect are scarce and, thus far, directional motor deficits have not been tested. Therefore, 
to examine potential slowing of movements directed towards the affected relative to unaffected 
side of space, I adapted a spatially-defined motor function task, based on a method previously 
used in hemispatial neglect research (Sapir et al., 2007). The devised battery of 
neuropsychological tests allows me to assess any biases in visuospatial attention, mental 
representation of space, spatially defined motor function, and body representation. 
Manifestation and treatment of CRPS should be considered within a biopsychosocial framework 
of chronic pain (Turk & Okifuji, 2002). While the clinical assessments, patient-reported 
psychological outcomes, and neuropsychological tests address the biological and psychological 
aspects of the condition, the social domain might seem overlooked. In chronic pain literature, 
several psychosocial and socioeconomic factors, including overprotective family members, lack 
of social support, low socioeconomic status, work conflicts, and compensation issues, among 
others, have been associated with poor pain and disability outcomes (Geertzen et al., 2006; 
Hoogendoorn et al., 2000). It has been suggested that socioeconomic factors associated with 
response to treatment or development of disability might be common across different chronic pain 
conditions (Turk & Okifuji, 2002). Yet their contribution to CRPS outcomes has been rarely 
considered or controlled for in the investigations of other prognostic factors (e.g. Bean et al., 
2016; de Mos et al., 2009). Previous systematic reviews found no evidence of relationships 
between socioeconomic factors and CRPS (Marinus & Hilten, 2006; Wertli et al., 2013), and 
clinicians considered psychosocial factors much less relevant for poor CRPS prognosis than 
clinical factors (Brunner et al., 2011). However, there is some evidence of higher rates of CRPS 
among more affluent patients (Clement et al., 2017; Elsharydah et al., 2017), in contrast to poor 
outcomes predicted by lower socioeconomic status in other chronic pain conditions. Considering 
insufficient evidence of the relevance of socioeconomic factors for CRPS, substantial number of 
variables of interest included in the current trial protocol, and the scope of this study, 
socioeconomic measures are not included. 
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Background: Complex Regional Pain Syndrome (CRPS) presents as chronic, continuous pain and 
sensory, autonomic, and motor abnormalities affecting one or more extremities. People with 
CRPS can also show changes in their perception of and attention to the affected body part and 
sensory information in the affected side of space. Prism Adaptation (PA) is a behavioural 
intervention targeted at reducing attention deficits in post-stroke hemispatial neglect. PA also 
appears to reduce pain and other CRPS symptoms; however, these therapeutic effects have been 
demonstrated only in small unblinded studies. This paper describes the protocol for an ongoing 
double-blind, randomized, sham-controlled clinical trial that will evaluate the efficacy of PA 
treatment for CRPS. The secondary aims of the study are to examine the relationships between 
neuropsychological changes (such as spatial attention, space and body representation, and motor 
spatial performance) and clinical manifestations of CRPS, as well as symptom improvement. 
Methods: Forty-two participants with upper-limb CRPS type I will undergo two weeks of twice-
daily PA treatment or sham treatment. The primary outcome measures are current pain intensity 
and CRPS severity score, measured immediately before and after the treatment period. Secondary 
outcome measures include the results of self-report questionnaires about pain, movement, 
symptoms interference, and body representation; clinical assessments of sensory, motor, and 
autonomic functions; and computer-based psychophysical tests of neuropsychological functions. 
Data are collected in four research visits: four weeks and one day before treatment, and one day 
and four weeks after the end of treatment. Additional follow-up through postal questionnaires is 
conducted three and six months post-treatment. 
Discussion: It is hypothesised that participants undergoing PA treatment, compared to those 
receiving sham treatment, will show greater reduction in pain and CRPS severity score, and 
improvements on other clinical and neuropsychological measures. Also, more pronounced 
neuropsychological symptoms are predicted to correlate with more severe clinical CRPS 
symptoms. This study will provide the first randomized double-blind evaluation of the therapeutic 
effects of PA that could be implemented as a rehabilitation method for CRPS, and will contribute 
to the understanding of how neuropsychological changes in body representation and attention 
pertain to the manifestation and treatment of CRPS.  
Trial registration (27/03/2017): ISRCTN46828292 [1]. 
Keywords: Randomized Controlled Trial, Complex Regional Pain Syndrome (CRPS), Prism 






People with Complex Regional Pain Syndrome (CRPS) experience continuous pain and a range 
of sensory, autonomic, and motor signs and symptoms. The condition primarily affects one or 
more extremities, which can become swollen and present with asymmetric changes in hair, nail 
and skin growth, sweating, limb temperature, and skin colour. Further clinical features of CRPS 
include allodynia (non-nociceptive stimulation perceived as painful) and hyperalgesia (mildly 
noxious stimulation experienced as extremely painful), as well as motor disturbance in the 
affected limb (e.g., decreased range of movement, weakness, tremor, and muscle contractions [2, 
3]). Although CRPS usually develops after an injury to the limb (e.g., a fracture [4]), it can also 
develop spontaneously [5], and the symptoms are disproportionate to any inciting trauma [3]. 
There is no known cause of CRPS, however, several pathophysiological mechanisms are 
suggested to play a role in the development and maintenance of this syndrome, including 
neuroinflammation, nociceptive sensitization, vasomotor dysfunction, and maladaptive 
neuroplasticity [2].  
CRPS patients have shown reduced attention to tactile [6–8] and visual stimulation on the affected 
limb and in external space near it [9, 10]. These biases appear to be associated with the side of 
space in which the limb usually resides [7, 9] rather than a tendency to pay less attention to the 
affected body parts per se. These space-based attention changes resemble those found in post-
stroke hemispatial neglect patients [11]. 
One emerging treatment for CRPS is Prism Adaptation (PA). PA is a form of a sensory-motor 
training used to reduce lateralised attention deficits in post-stroke hemispatial neglect. The 
treatment involves performing a pointing task while wearing goggles fitted with prismatic lenses 
that induce a lateral deviation of the visual image. Due to this visual shift, patients’ pointing 
initially errs in the direction of prismatic displacement. With repeated movements, pointing 
becomes more accurate through an adjustment of pointing movements in the opposite direction 
to the optical shift, indicating a realignment of the sensory-motor reference frames [12, 13]. Once 
the goggles are removed, a negative after-effect is observed whereby pointing movements err in 
the opposite direction to the earlier optical shift. Using PA to induce pointing after-effects towards 
the neglected side reduces post-stroke hemispatial neglect [14–22].  
The apparent attention bias in CRPS patients led to investigations of whether PA could also have 
therapeutic effects on chronic pain, as it does in post-stroke hemispatial neglect. Results of three 
studies have shown that PA performed with the affected hand to produce pointing after-effects 
towards the CRPS-affected side reduced pain and other CRPS symptoms [23–25]. One proposed 
mechanism of these apparent therapeutic effects is that PA reduces pain through correcting the 
lateralised spatial attention bias in people with CRPS. The magnitude of spatial biases has been 
previously linked to the severity of pain and other clinical signs of CRPS [7, 8, 26–30]. Moreover, 
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PA leading to the after-effects away from the affected limb appears to increase pain in CRPS [25], 
further supporting the role of lateralised attention effects. Another potential mechanism is that PA 
restores normal sensory-motor integration. Although empirical evidence to support this 
mechanism is limited, it has been proposed that discrepancies between motor commands and 
sensory feedback can contribute to pathological pain, including CRPS [25, 31–33]. 
However, the studies demonstrating therapeutic effects of PA in CRPS [23–25] included only 
small numbers of patients (13 in total across all three studies), no sham treatment conditions, and 
were not blinded. Thus, to date there are no sufficient grounds for implementing PA as a standard 
rehabilitation method for CRPS [12]. The aim of this study is to provide a robust evaluation of 
the effects of PA on CRPS through a double-blind, randomized-controlled trial. 
1.1. Research questions and hypotheses 
1.1.1. Primary research question (RQ) and hypothesis 
RQ 1. Is two weeks of twice-daily PA treatment more effective in reducing pain and CRPS 
symptom severity than an identical regime using sham prism adaptation (“sham 
treatment”)? 
Sham prism adaptation has an identical procedure to PA treatment, except that pointing 
movements are performed without any optical deviation and therefore no adaptation takes place. 
This will allow us to dissociate the effects of the additional movement of the affected limb 
imposed by the treatment, to isolate the true effects of PA.  
Hypothesis: There will be greater reductions in pain and CRPS symptom severity in the 
participants who receive PA treatment compared to the participants who receive sham 
treatment. 
1.1.2. Secondary research questions and hypotheses 
RQ 2. Are there any improvements in other clinical signs of CRPS, psychological functioning, 
and neuropsychological symptoms following PA treatment? 
In addition to the primary outcome measures of pain and CRPS symptom severity, we aim to 
evaluate the effects of PA treatment on secondary outcomes (listed below) that are relevant to 
participants’ daily physical and psychological functioning, and for understanding the mechanisms 
of the therapeutic effects of PA (e.g., through establishing which neuropsychological symptoms 
might be affected by treatment). 
Hypothesis: Compared to the sham treatment group, participants in the PA group will have 
a reduction in spatial attention bias (consistent with its primary applications), as well as 
bias in cognitive representation of space and spatially-modulated motor function; body 




pain, movement restriction, and symptoms interference; and sensory, motor, and autonomic 
signs of CRPS following treatment. 
RQ 3. How long are any benefits sustained for after the cessation of PA treatment? 
We will determine this through assessment of all primary and secondary outcomes immediately 
and four weeks after the completion of treatment, and through additional assessment of a subset 
of self-reported secondary outcomes at three and six months post-treatment. The time course of 
any improvements will be also analysed at more granular level through participants’ daily 
subjective ratings of pain, range of movement, and the extent to which their symptoms interfere 
with daily life over a period of 10 weeks.  
RQ 4. Are there factors that can predict the CRPS progression over time and / or the response to 
PA treatment? 
Finally, the current study aims to explore potential predictors of the course of the disease and 
therapeutic response by tracking the symptoms of the same individuals over the course of 7.5 
months. We plan to identify possible markers that would account for the individual differences in 
the progression of CRPS over time and / or in response to PA treatment. Due to insufficient 
evidence to support any specific predictions and limited sample size, we will perform exploratory 
analyses to address this research question. Factors such as demographic characteristics, pain 
intensity, CRPS symptom severity, sensory, motor and autonomic functions, and the extent of 
neuropsychological changes will be taken into consideration. 
RQ 5. Are the neuropsychological changes in CRPS related to clinical signs and symptoms of 
CRPS? 
A secondary aim of this study is to investigate the relationships between the severity of clinical 
symptoms of CRPS and the extent of neuropsychological changes in spatial attention, space and 
body representations, and motor functions.  
Hypothesis: Baseline abnormalities in perception of and attention to the affected limb and 
its surrounding space in participants with CRPS (compared to the perception and attention 




This study has a double-blind, randomized, sham-controlled design. The schedule of enrolment, 
interventions, and assessments is presented in Table 1 and consists of four in-person Research 
Sessions (RS), two weeks of twice-daily home-based treatment, and two sets of long-term postal 
follow-up questionnaires. After provisional eligibility assessment through a structured phone 
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interview, 42 participants with CRPS will undergo two baseline research sessions. Two baseline 
assessments (RS1 and RS2) are conducted to give an indication of normal fluctuations in CRPS 
symptoms (or lack thereof) prior to the treatment period. This will allow us to assess whether any 
change over the treatment period is meaningful, that is, greater than baseline fluctuations1. 
Research Session 1 (RS1) commences the timeline of the study at week 1 and includes in-person 
assessment of the eligibility criteria, informed consent, and collection of the outcome measures 
that are described in the “Measurements” section. Treatment allocation takes place 1-5 days 
before Research Session 2 (RS2), where the participants with CRPS are randomly allocated to 
one of the two groups of equal size: the PA treatment group or the sham treatment group. RS2 at 
the end of week 4 involves revisiting eligibility criteria and collecting outcome measurements. 
Immediately after completing RS2, the participants are instructed in how to carry out the treatment 
by a researcher who is not involved in any part of data collection. They then perform their first 
treatment under the guidance of that researcher. All other elements of the study (telephone 
screening, symptom assessment, experiment administration, and input of questionnaire data) are 
performed by researchers who are blind to the conditions that the participants have been allocated 
to. The treatment period spans weeks 5 and 6 of the study, where the participants perform twice-
daily treatment in a self-guided manner. Outcome measurements are collected in two post-
treatment assessments (RS3 and RS4) to evaluate differences in PA versus sham treatment effects, 
and whether any benefits of treatment are maintained at 4 weeks after treatment. The first post-
treatment Research Session (RS3) takes place at the beginning of week 7 (i.e., the day 
immediately following the final treatment session). Research Session 4 (RS4) takes place in the 
beginning of week 11. Each research session is expected to last between 2 and 4 hours, including 
breaks between the assessments. During the first 10 weeks of the study, the participants also 
record their self-reported daily ratings of pain intensity, range of movement, and the extent to 
which their symptoms interfere with daily life in a provided logbook, which will allow us to track 
the time course of any changes between research sessions. Long Term Follow-Up 1 at 3 months 
(LTFU1; week 19) and Long Term Follow-Up 2 at 6 months (LTFU2; week 31) post-treatment 
are conducted through questionnaires sent and returned by post. RS3 marks the primary endpoint 
and LTFU2 marks the secondary and final endpoint of the study. 
Deviations from the schedule of consecutive Research Sessions and Follow-Ups will be accepted 
within the following time windows: up to 2-weeks deferral of RS2 and RS4, up to 1-week deferral 
of RS3, up to 3-weeks deferral of LTFU1 and LTFU2. If the times that the participant can attend 
RS2 and RS3 are planned to be longer than 14 days apart, the participant would commence the 
 
1 Note that we will not exclude any participants based on having large fluctuations in symptoms between 
two baseline assessments (RS1 ad RS2), if they meet the CRPS diagnostic research criteria (see “Eligibility 




treatment 2 weeks before RS3. If the participant already started the treatment and has to postpone 
RS3, they would continue the treatment until RS3.  
Twenty-one healthy control participants are being recruited for a single research session to obtain 
normative data. They undergo testing only once and do not receive any treatment.  
Table 1 Schedule of enrolment, interventions, and assessments for the participants with CRPS 





PA treatment or 

























ENROLMENT:           
Eligibility assessment X X X       
Informed consent  X        
Allocation   X       
INTERVENTIONS (one of 
two, twice-daily): 
         
PA treatment OR          
Sham treatment          
ASSESSMENTS:          
Self-report questionnaires  X X   X X X X 
Clinical assessments  X X   X X   
Computer-based tests  X X   X X   
Daily logbook***          
RS: Research Session; LTFU: Long Term Follow-Up (postal questionnaires only); PA: Prism Adaptation; 
* Primary endpoint of the study. 
** Secondary endpoint of the study. 
*** Self-reported average levels of pain, range of movement and symptoms interference with daily life in 
the last 24 hours, rated daily on 0-10 Numeric Rating Scales 
2.1.1. Setting of the study 
All research centres and recruitment sites are located in the United Kingdom. The University of 
Bath is the main research centre and one of the research sites, and research sessions can also take 
place at the Universities of Oxford, Exeter, or Liverpool; or in participants’ homes. 
2.2. Participants 
2.2.1. Eligibility criteria 
2.2.1.1. Participants with CRPS 
This study enrols both male and female individuals, who:  
1) are willing and able to give informed consent to take part in the trial, 
2) are aged 18-80,  
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3) have a diagnosis of CRPS type I based on the Budapest diagnostic research criteria [3] as 
assessed at RS1 and revisited at RS2,  
4) have CRPS type I primarily affecting one upper limb, 
5) have had CRPS for a minimum of 3 months at the time of RS1, 
6)  and report current pain intensity ≥2 on a 0-10 Numeric Rating Scale at RS1 and RS2.  
Participants are excluded from the CRPS group if they:  
1) lack sufficient English language ability to provide informed consent,  
2) are classified as legally blind,  
3) have a history of neurological disorder (e.g. stroke, neurodegenerative disease, or 
traumatic brain injury),  
4) have CRPS meeting the Budapest diagnostic clinical or research criteria affecting both 
sides of the body2,  
5) report that they have confirmed presence of nerve damage (CRPS type II) based on the 
results of nerve conduction test,  
6) have dystonia or any other physical limitation severe enough to prevent satisfactory 
execution of PA / sham treatment,  
7) or have a severe psychiatric comorbidity (such as schizophrenia) that in the researchers’ 
opinions would compromise participation in the study.  
2.2.1.2. Healthy control participants  
The inclusion criteria for healthy control participants of this trial are: 
1) willingness and ability to give informed consent,  
2) age 18-80,  
3) and being neurologically healthy and without current or chronic pain.  
Criteria that would exclude an individual from the study are: 
1) insufficient English language ability to provide informed consent,  
2) being classified as legally blind,  
3) physical disability or injury limiting normal mobility, 
4) or a history of a neurological or severe psychiatric illness.  
 
2 We will not exclude participants who have CRPS in ipsilateral lower limb if the upper limb is the primarily 
affected site and pain and other symptoms are not less severe than in the lower limb. Those participants, as 
well as participants with diagnoses of other chronic pain conditions (as long as these are less severe than 
CRPS), will complete the relevant self-reported outcome measures (i.e. questionnaires about pain) 
separately for the primary CRPS-affected upper limb, and separately for other chronic pain. We will 
measure the primary outcome of CRPS symptom severity only for the upper limb. Anecdotally, CRPS 
participants previously studied by our research group can easily differentiate CRPS pain and other 
symptoms in one extremity from another, and from other chronic pain conditions. Our primary analyses 
will only concern the pain and CRPS severity data regarding the CRPS-affected upper limb, however, data 




Each healthy control participant is matched to one participant with CRPS by sex, self-reported 
handedness prior to the onset of CRPS, and age (± 5 years).  
2.2.2. Recruitment and participant retention strategies 
The recruitment commenced on 31 March 2017 and is ongoing at the time of submission. People 
with CRPS are recruited through the National CRPS-UK Registry, Oxford University Hospitals 
NHS Foundation Trust, the Walton Centre NHS Foundation Trust, and other hospitals in the UK 
by post and clinicians’ referrals. Information about the trial is also disseminated through word of 
mouth, print and online advertisements and articles, and social media. Trial webpages have been 
set up on the funder’s and research centre’s websites. All the above information channels provide 
potential participants with contact details of the authors, should they be interested in more 
information and / or taking part in the study. 
To promote retention, participants are sent reminders before each RS and LTFU. Since 
recruitment takes place over a broad geographic area, their travel costs are reimbursed, or the 
research sessions are conducted in their own home. In recognition of the inconvenience of 
participation, which is heightened due to the burden of CRPS, participants receive a financial 
compensation of £250 for their time and contribution to the study once they complete RS4, and 
further financial compensation once they return the completed LTFU2 questionnaires by post 
(£50). Healthy control participants are reimbursed for their time and contribution at a rate of £10 
per hour of their involvement. 
Since the assessments and treatment are non-invasive and do not interfere with the participants’ 
ongoing standard treatment, and there are potential benefits from taking part, we expect good 
participant retention. Some participants may directly benefit from reduction in pain and CRPS 
symptom severity due to treatment. All participants will have an opportunity to undergo the PA 
treatment after the trial is completed, should the trial support the effectiveness of the treatment.  
In the event of the participant’s withdrawal from the study, their data from any completed research 
sessions will be included in the analysis as far as possible. Participants who withdraw after RS2 
will be considered lost to follow-up. For any participant who withdraws before RS4, an additional 
participant will be recruited to the trial such that there will be 42 full datasets for RS1-RS4. 
Recruitment will be terminated only once we reach sufficient number of participants in each 
treatment arm, or if we are not able to collect 42 full datasets for RS1-RS4 by 1 March 2019. To 
address any potential selection bias, we will use intention to treat as our primary analysis, and 
per-protocol as supportive analysis (see “Treatment outcome analyses” section). Should 
participants deviate from the intervention protocol (e.g., missed treatment sessions), the number 




Treatment allocation is conducted by method of randomisation with minimisation of baseline 
(RS1) group differences. Eligible participants with CRPS are allocated in equal numbers to one 
of the two treatment groups: PA treatment group or sham treatment group. Group allocation is 
performed using MINIM computer program [34] by a researcher who is not involved in data 
collection (JHB). Following allocation of the first participant using simple randomisation, 
allocation of each next participant considers the characteristics of those participants who are 
already allocated. Specifically, the minimisation procedure controls for the baseline (RS1) 
participant characteristics that are listed in Table 2. In the event of participant’s withdrawal after 
treatment allocation, but before RS3, their data shall be removed from the minimisation procedure 
and any subsequent participants recruited for the trial shall be allocated based on the current 
number and pool of participants in each treatment arm. This strategy is implemented to assure 
equal numbers of full datasets with any post-intervention data in the two groups and minimisation 
of baseline between-group differences. 
Table 2 Criteria for minimisation as recorded in RS1 
Factor Weight Categories 
Current pain intensity (0 – 10 Numerical Rating Scale) 2 ≤ 6 
> 6 
CRPS severity score (1 - 16) [35] 2 ≤ 12 
> 12 
Primarily affected arm 1 Left 
Right 
Pre-CRPS dominant hand (writing) 1 Left 
Right 
Sex 1 Male 
Female 
Age 1 18 - < 40 
40 - < 61 
61 - 80 
Presence of CRPS in body parts other than the primary affected arm 1 Yes 
No 
Presence of other non-CRPS pain 1 Yes 
No 
CRPS duration 1 < 1 year 
1 - < 5 years 
5 - < 10 years 
≥ 10 years 
2.4. Treatment 
Participants in the PA treatment group are provided with welding goggles fitted with 35-diopter 




side. The optical displacement is of a similar magnitude as in previous CRPS studies that reported 
significant reductions in pain [23–25]. In contrast, no pain reduction was observed when a CRPS 
patient underwent two weeks of PA using lenses that shifted the visual image only by 5° [25]. 
Furthermore, prisms strength of 10°-15° was found to be sufficient to induce lasting amelioration 
of hemispatial neglect after brain injury [15, 18, 19, 36, 37], whereas weaker prisms did not 
improve neglect [38]. During each treatment session, the participant is seated in front of a vertical 
surface, such as a wall, upon which an A4 laminated page in landscape orientation is positioned. 
The page displays two visual targets (red circles 2cm in diameter), in each top corner. The page 
is mounted approximately at eye-level, hence targets are located 12.5cm (approximately 10°) to 
the left and to the right of the participant’s body midline. The distance between their torso and the 
wall is established individually, such that the participant can touch the targets with an almost fully 
extended arm (approximately 60cm). Participants put on the goggles and use their CRPS-affected 
arm to perform a total of 50 pointing movements (a number sufficient to induce sensory-motor 
adaptation [16]), alternating between the two targets (25 per side) and returning the pointing hand 
to their chest between each movement. The participants are instructed and trained to move as 
quickly as possible, and the goggles occlude the vision of the participant’s arm for approximately 
the first half of the movement. Both these steps limit on-line correction of movement trajectory 
(strategic component of PA) and reinforce adaptive realignment, which is thought to maximise 
the effects of PA [13, 39, 40]. One treatment session takes approximately 5 minutes. The 
participant performs the treatment once under the guidance of an experimenter, and then twice 
daily for two weeks in a self-guided manner in their own home (giving a total of 29 treatment 
sessions). The intensity and duration of the treatment regime have been established based on 
previous studies evaluating the effects of PA on attention in hemispatial neglect following stroke, 
and on pain in CRPS. In particular, previous studies suggest that repeated sessions of PA are 
required to obtain a significant reduction in CRPS symptoms [23, 25] and that intense treatment 
(2 sessions a day for 4 days or more) produces symptom reduction that is sustained for at least 
two weeks post-treatment [23, 24]. 
Participants in the sham treatment group carry out the same procedure as the PA treatment group, 
except they are provided with goggles fitted with neutral lenses that do not induce optical 
deviation of the visual field. This is a standard control treatment for PA [18, 41]. Both prismatic 
and neutral lenses distort the acuity and clarity of vision, and both sets of goggles occlude the first 
part of the reaching movement. This factor ensures similarity of the two treatment arms in all 
aspects of the treatment aside from the sensory-motor adaptation.  
To improve their adherence to the treatment protocol the participants receive in-person training, 
in which they complete the first treatment session guided by JHB or ADV, who ensure 
participants’ competence in performing the exercise according to the protocol. Furthermore, 
participants are provided with written instructions and a video tutorial. The researcher who trained 
Chapter 3 
142 
them in the treatment is also available to address any questions or concerns about the procedure 
by phone or email. In order to monitor participants’ compliance and adherence, they keep a daily 
logbook throughout the treatment period, in which they record the time and duration of each 
treatment session. We will report the adherence to treatment as a percentage of participants in 
each treatment group who did not miss more than 6 treatment sessions. The extent of exposure in 
each group will be reported as average number of logged treatment sessions. Protocol deviations 
are defined as missed or additional treatment sessions, and sessions for which logbook entries 
suggest that anything other than the trained procedure has been used. We will report the total 
number of treatment sessions per group in which deviations other than missed or extra sessions 
are suspected. We will also compare the average number of logged treatment sessions between 
the two groups, and if significantly different, the number of logged treatment sessions will be 
used as a covariate in the analyses of the primary outcomes.  
The participants are instructed to continue their standard pharmaceutical, physical, and / or other 
treatments during the trial, and are encouraged not to make any significant alterations to these 
treatments (e.g., major changes in medication, commencing new physiotherapy programmes). 
Medications and other treatments are noted during every research session to monitor any changes.  
Criteria for discontinuing the allocated treatment before the 2 weeks have elapsed are a 
participant’s withdrawal from the study or reports of experiencing an increase in CRPS symptoms 
that significantly heightens their discomfort or distress. As the treatment procedures require 
repeated movements of the CRPS-affected arm, participants may experience pain related to 
movement. However, this is expected to be temporary and no greater than the pain that could 
accompany standard physiotherapy or daily activities. To date, there have been no publications 
reporting serious adverse events related to PA in healthy controls or clinical populations (patients 
with stroke, Parkinson’s disease [41], or CRPS). In one case study exploring the effects of 
different PA directions and strengths, one CRPS patient experienced a small, temporary increase 
in pain when they performed PA using optical deviation towards the affected side [25]. Similar 
events in the current study are highly unlikely, as all PA is conducted with optical deviation away 
from the CRPS-affected side, i.e., in the direction thought to achieve therapeutic effects. Each 
participant is assigned their own dedicated set of prism goggles in a bag labelled with their 
participant code. The direction of optical deviation is independently checked by two people before 
the goggles are placed in a labelled bag. Any unexpected serious adverse events related to the 
administration of any study procedures will be reported to the researcher responsible for blinding 
(JHB) who will then make any decisions about discontinuing an individual’s participation and / 
or the trial, in consultation with the protocols for dealing with adverse events as outlined by the 





Table 3 Measures 
Measurement domain Measurement tool Time points Research question* / justification for use 
Self-report measures 
Pain and symptom interference Current pain intensity (Item 6 of the Brief Pain 
Inventory) 
Weeks 1, 4, 7, 11, 19 & 31 RQ1, RQ3, RQ4, RQ5; group matching on 
baseline pain 
Brief Pain Inventory† (BPI; short form; pain intensity 
and interference) [42] 
RQ2, RQ3, RQ4, RQ5 
Pain Detect Questionnaire [43] RQ2, RQ3, RQ4, RQ5 
Average pain intensity (Logbook) Weeks 1 to 11 (daily) RQ2, RQ3 
Average symptom interference (Logbook) RQ2, RQ3 
Physical functioning Average range of movement (Logbook) Weeks 1 to 11 (daily) RQ2, RQ3 
Edinburgh Handedness Inventory (current and 
change) [44] 
Week 1 RQ4, RQ5; participant characteristics 
Body representation Bath CRPS Body Perception Disturbance Scale 
(BPDS) [45] 
Weeks 1, 4, 7, 11, 19 & 31 RQ2, RQ3, RQ4, RQ5 
Emotional functioning Tampa Scale for Kinesiophobia† [46] Weeks 1, 4, 7, 11, 19 & 31 RQ2, RQ3, RQ4, RQ5; group matching on 
baseline fear of movement 
Profile of Mood States [47] RQ2, RQ3, RQ4, RQ5; group matching on 
baseline mood disturbance 
Revised Life Orientation Test [48]  Week 1 RQ4; group matching on baseline levels of 
optimism 





Measurement domain Measurement tool Time points Research question* / justification for use 
Impression of treatment 
outcome 
Patient’s Global Impression of Change [50] Weeks 7, 11, 19 & 31 RQ2, RQ3 
Treatment adherence Treatment sessions (Logbook) 
 
Weeks 4 to 6 (twice-daily) Monitoring treatment adherence 
Clinical assessments 
CRPS diagnosis Budapest diagnostic research criteria assessment [51] Weeks 1, 4, 7 & 11 Verification of CRPS diagnosis and 
assessment of eligibility 
Symptom severity CRPS severity score [52] Weeks 1, 4, 7 & 11 RQ1, RQ3, RQ4, RQ5; group matching on 
baseline symptom severity 
Autonomic functions Limb temperature asymmetry Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
Oedema 
Motor functions Grip strength Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
Δ Finger-To-Palm distance (ΔFTP) 
Sensory functions Mechanical Detection Threshold (MDT) Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
Mechanical Pain Threshold (MPT) 
Mechanical Allodynia 
Two-Point Discrimination [53] 
Computer-based tests of neuropsychological changes 
Visuospatial attention 
 
Visual Temporal Order Judgement (TOJ) [9] Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
Landmark task [54] 




Measurement domain Measurement tool Time points Research question* / justification for use 
Mental representation of space Mental Number Line Bisection task [56] Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
Spatially-defined motor 
function 
Directional Hypokinesia [57] Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
Body representation Hand Laterality Recognition task [58] Weeks 1, 4, 7 & 11 RQ2, RQ3, RQ4, RQ5 
* RQ1, effects of treatment on the primary outcome measures; RQ2, effects of treatment on the secondary outcome measures; RQ3, time course / duration of any changes; RQ4, 
predictors of CRPS progression over time and/or response to treatment; RQ5, baseline abnormalities in neuropsychological functions in participants with CRPS compared to pain-free 
controls, and their relationships with clinical signs of CRPS (only Week 1 data). 




Tests and measures used in the current study and time points at which they are administered are 
listed in Table 3. These are categorised as self-report questionnaires, clinical assessments, or 
computer-based tests.  
2.5.1. Baseline descriptors 
Age, sex, and handedness of all the participants are recorded as demographic characteristics. An 
interview regarding their medical history is conducted to collect information about the date and 
type of any inciting injury or insult, CRPS duration in months from diagnosis to RS1, the presence 
of CRPS in body parts other than the primarily affected upper limb, the presence of non-CRPS 
pain conditions and other co-morbidities, and current treatments.  
A hand laterality index is calculated using the Edinburgh Handedness Inventory [44] in RS1. The 
scoring can range from -100 (extreme left-handedness) to 100 (extreme right-handedness). All 
participants respond regarding their current hand preference, and the participants with CRPS 
additionally complete another version of the Edinburgh Handedness Inventory based on their 
recalled hand preference prior to the onset of CRPS symptoms. A “change in handedness” score 
(Handedness after CRPS – Handedness before CRPS) is calculated to give an approximation of 
the functional impact of the CRPS. 
2.5.2. Primary outcomes  
A change between RS2 (immediately before the commencement of treatment) and RS3 
(immediately after the end of the treatment period) in current self-reported pain intensity and 
CRPS severity score [35, 52] are the primary outcomes. People with CRPS consider pain relief 
to be the highest priority for recovery [59], and pain intensity is the most common primary 
outcome in chronic pain trials [60]. Current pain intensity is measured using item 6 of the Brief 
Pain Inventory (BPI; short form) [42], which is a Numerical Rating Scale (NRS) ranging from 0 
– “no pain” to 10 – “pain as bad as you can imagine”. The BPI has high reliability [42]. In addition 
to pain, CRPS involves a range of other debilitating symptoms, some of which were also affected 
by PA in previous studies [23, 25]. Therefore, we included a comprehensive measure of symptoms 
severity as the second primary outcome. The CRPS severity score assessment protocol follows 
the 16-points scoring system published by Harden and colleagues [35]. This continuous index of 
CRPS symptom severity has good discrimination abilities, concurrent validity and adequate 
sensitivity to change [35, 52], and has been recommended as one of the core outcome measures 




2.5.3. Secondary outcomes 
2.5.3.1. Self-report questionnaires 
There is a lack of validated outcome measures for CRPS (however, see recently published 
recommendations [62]). Therefore, the choice of the measures for the current trial was guided by 
general recommendations of core outcome measures for chronic pain clinical trials (IMMPACT; 
[60]) and the existing literature on CRPS implicating other relevant questionnaires. 
There are 10 self-report questionnaire measures of pain, physical and emotional functioning, body 
representation, expectations about treatment, and impressions of treatment outcome. The BPI 
[42], Pain Detect Questionnaire [43], Bath CRPS Body Perception Disturbance Scale (BPDS; 
[45]), Tampa Scale for Kinesiophobia, and Profile of Mood States [47] are completed in every 
research session and long-term follow-up (RS1-RS4, LTFU1-LTFU2). A Revised Life 
Orientation Test [48] and a Patient-Centred Outcomes Questionnaire [49] are administered only 
in RS1. The Patient’s Global Impression of Change questionnaire [50] is completed only at post-
treatment research sessions and long-term follow-ups (RS3-RS4, LTFU1-LTFU2). Finally, a 
daily logbook of self-reported average pain, range of movement, and symptom interference is 
kept by the participants during the baseline, treatment, and post-treatment periods (i.e., every day 
for the 10 weeks that elapse between RS1 and RS4). 
Participants use the short-form of the BPI [42] to rate their pain intensity (current, average, and 
worst and least pain over the last 24 hours) and the extent to which pain interferes with their 
physical, social and psychological functioning on 0-10 NRSs (0 – “no pain” or “does not 
interfere”; 10 – “pain as bad as you can imagine” or “completely interferes”, respectively). The 
pain intensity component of BPI can result in an average score between 0 and 10; an average 
interference component score can also range from 0 to 10. The Pain Detect Questionnaire is a 
validated measure of the neuropathic features of experienced pain [43] scored from -1 to 38, with 
higher scores indicating a greater neuropathic component of pain. 
The BPDS [45] includes seven self-reported items to assess subjective detachment, awareness, 
attention to, and feelings about the CRPS-affected limb; the perceived changes in size, 
temperature, pressure, and weight of the limb; and any desire to amputate the limb. The BPDS 
includes a mental imagery task in which the mental representation of both limbs (affected and 
unaffected) is sketched by a researcher based on the participants’ description. Total score ranges 
from 0 (no disturbance) to 57 (most severe disturbance of body perception). Since BPDS is not a 
validated measure, normative data is also collected from healthy control participants who are 
responding to the self-report components regarding the limb that corresponds to the CRPS-
affected limb of their matched participant with CRPS. 
The Tampa Scale for Kinesiophobia [46] is administered to measure pain-related fear of 
movement and re-injury. The participants choose the extent to which they agree with each of 17 
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statements about fear of movement and physical activity that could (subjectively) cause pain and 
/ or injury (1 – “strongly disagree”, 4 – “strongly agree”). The final score varies from 17 to 68 
points, with higher numbers indicating more severe kinesiophobia. The Tampa Scale for 
Kinesiophobia is included as a measure of the likely extent to which participants use their affected 
limb and their beliefs and emotions about those movements. 
Considering that mood can exert effects on pain [63–65] and attention [66–68], the Profile of 
Mood States is administered in the current trial to verify that the two treatment groups are matched 
according to mood disturbance, and to enable evaluation of whether treatment results in any 
significant differences in mood improvements between the groups. The Profile of Mood States is 
a 64-item scale indicating the extent to which the respondent is experiencing various transient, 
distinct mood states (1 – “not at all”, 5 – “extremely”). High reliability and validity of Profile of 
Mood States [47, 69] has been reported. This measure is also completed by healthy control 
participants at a single research session. 
The Revised Life Orientation Test [48] assesses levels of optimism and pessimism. Participants 
rate to what extent they agree with 10 statements on a scale from 0 – “strongly disagree” to 4 – 
“strongly agree”. The Patient Centred Outcomes Questionnaire [49] is also administered to 
measure patient-centred expectations and criteria for success in chronic pain treatment. Rating 
scales from 0 to 10 are used to indicate the usual, desired, expected and considered successful 
levels of pain, fatigue, emotional distress, and interference with daily activities (0 – “none”, 10 – 
“worst imaginable”), and the importance of improvement in each of these areas (0 – “not at all 
important”, 10 – “most important”). The decision to include the Revised Life Orientation Test 
and the Patient Centred Outcomes Questionnaire in the current trial was driven by the fact that 
optimism and expectations of outcome have been known to influence the success of novel 
treatments [70–72]. Thus, it is important to confirm that the two treatment groups are matched on 
these extraneous factors, or to include these variables as covariates in the analysis of outcome 
measures if they are not. 
The participants keep daily logbooks for weeks 1-11 in which they use 0-10 NRSs to record their 
average level (over the preceding 24 hours) of pain (0 – “no pain at all”, 10 – “pain as bad as it 
could be”), the range of movement in the affected arm (0 – “no movement at all”, 10 – “normal 
movement”), and the degree to which their symptoms have interfered with their daily life (0 – “no 
interference at all”, 10 – “complete interference”). These measures are designed to track the time-
course of any change in pain, movement, and interference during the first 10 weeks of the study 
(i.e. four-week baseline period, two-week treatment period, and four-week immediate post-
treatment period). 
Finally, the Patient Global Impression of Change questionnaire [50] is administered to measure 
participants’ impression of how much their symptoms have changed due to treatment. It produces 




Impression of Change is a widely recommended measure of perceived global improvement and 
satisfaction with treatment [60, 62]. 
2.5.3.2. Clinical assessments 
The clinical measures include examination of CRPS signs and symptoms, sensory thresholds, 
autonomic changes, and motor functions. Participants with CRPS undergo all clinical assessments 
in RS1-RS4, whereas healthy control participants undergo the same clinical assessments during 
a single research session. Locations for sensory testing are the most painful site on the CRPS-
affected limb and the corresponding site on the unaffected limb, always beginning with the 
unaffected limb so that participants can be familiarised with the test procedures and sensations 
before the tests are administered on their painful limb. For sensory testing in control participants, 
measures taken from the limb corresponding to the CRPS-affected limb of their matched 
participant with CRPS are compared to measures taken from the other limb. 
CRPS diagnosis is confirmed in RS1 and RS2 during the baseline period, before commencement 
of the treatment, based on the Budapest research criteria [51]. These criteria are also assessed in 
the post-treatment period (RS3-RS4) to determine if the participants still meet the CRPS 
diagnosis. 
The severity of symptoms is assessed and quantified as CRPS severity score in RS1-RS4, 
according to a recently validated protocol [35, 52]. Each of the 16 items is recorded as present 
(“1”) or absent (“0”) based on the self-reported symptoms and the signs confirmed at the time of 
examination through sensory testing, visual, and manual assessments. These include continuing, 
disproportionate pain; allodynia; hyperalgesia and / or hypoesthesia; temperature, colour, and 
sweating asymmetry; oedema; dystrophic changes; and motor abnormalities. Summed scores 
indicate the overall CRPS severity score. Where possible, criteria are evaluated based on a 
comparison between the affected and unaffected upper limb for a sign to be classified as present, 
including objective quantification of limb temperature asymmetry, oedema, muscle weakness, 
and active range of movement.  
Photographs of the dorsal and palmar surface of both hands and forearms are taken so that the 
presence of skin colour and trophic changes can be double-scored by a researcher who is not 
involved in data collection and who is blind to the time point at which the photographs were taken, 
to which limb is affected by CRPS, and to which group the participant is allocated. Video 
recordings of both limbs performing the movements of fist closure and opening, wrist flexion and 
extension, and radial and ulnar wrist deviation are taken so that the motor abnormalities can be 
double-scored according to the same protocol. We will use Cohen’s kappa statistic to report inter-
rater agreement. 
An infrared thermometer is used to measure temperature asymmetry. Temperature measurements 
are taken to the nearest 0.1°C from the dorsal and palmar surface of both hands (over the thenar 
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muscle) and the centre of the region of worst pain as indicated by the participant. An arithmetic 
mean of the 3 measurements on each limb is calculated. According to the Budapest diagnostic 
criteria [51], an absolute difference between the affected and unaffected side greater than 1°C is 
classed as a temperature asymmetry. When available, thermal images of both limbs are 
additionally taken (camera FLIR T620 that is sensitive to changes in temperature as small as 
0.04°C). 
Oedema is measured using the figure-of-eight procedure that uses a soft tape measure. The 
detailed protocol for hand and wrist size measurement is described elsewhere [73]. This measure 
has excellent intra- and interrater reliability and concurrent validity compared with water 
volumetry [74]. Hand size is calculated as an arithmetic mean of 3 measurements performed on 
each hand. Presence of asymmetric oedema is considered if the average measure taken from the 
CRPS-affected hand is at least 0.56cm larger compared to the unaffected hand, which was 
suggested to be a clinically relevant difference in a previous study [75]. 
Grip strength is measured as a marker of muscle weakness, using an electronic hand dynamometer 
(Constant, model 14192-709E). Participants are seated in a chair with their elbows flexed at 90°, 
forearms in neutral position, and wrists at between 0 and 30° extension. They are instructed to 
squeeze the dynamometer’s handle as hard as they can and perform three such trials with each 
hand, alternating between the hands and allowing a pause of at least 15 seconds between each 
trial. An arithmetic mean of the 3 measurements (kg force) for each hand is calculated. Muscle 
weakness of the affected hand is indicated if the ratio of grip force in the affected to unaffected 
side is smaller than 0.95 for left-handed participants or smaller than 0.85 for right-handed 
participants. These criteria take into account the normal difference between dominant and non-
dominant hands for left- and right-handed individuals [76, 77]. 
Active range of movement in the hands is assessed by measuring a change in Finger-To-Palm 
(∆FTP) distance (cm). A detailed measurement protocol is described elsewhere [78]. ∆FTP is an 
index of the extent to which a person can fully flex their fingers (e.g., to make a fist) relative to 
the extent to which they can extend them (e.g., to make their hand flat). ∆FTP was selected as a 
measure of range of movement as it takes into account both these aspects of motor function, unlike 
classic FTP that only regards the maximum flexion. A significant decrease in the range of 
movement in the affected hand is defined as ∆FTPaffected / ∆FTPunaffected < 0.9.  
In addition to those limb differences that are assessed through clinical examination for the CRPS 
severity score, differences between the affected and unaffected limbs are also objectively 
quantified through elements of a standard Quantitative Sensory Testing (QST) procedure to assess 
hypoesthesia, pinprick hyperalgesia, and allodynia. Participants undergo the assessment of 
Mechanical Detection Threshold (MDT) that follows the standardized protocol [79] using von 
Frey filaments of 0.008g to 300g force (Bioseb, model Bio-VF-M). Then the ratio of thresholds 




indicates hypoesthesia (increased tactile detection threshold) on the affected side. Based on 
relative QST reference data comparing both sides of the body, hypoesthesia is confirmed if the 
ratio is ≥ 0.38 [80]. We also assess Mechanical Pain Threshold (MPT) according to the 
standardized protocol [79] on both limbs, using pinprick stimulators of 8mN to 512mN intensities 
(MRC Systems PinPrick Stimulator Set). A positive thresholds ratio [(MPTunaffected-
MPTaffected)/MPTunaffected] indicates hyperalgesia (decreased pain threshold) on the affected side. 
Hyperalgesia is confirmed if the ratio is ≥ 0.4, based on relative QST reference data comparing 
both sides of the body [80]. Allodynia is examined using a procedure adapted from the dynamical 
mechanical allodynia test of the QST [79]: the cotton ball, Q-tip and brush (MRC Systems 
PinPrick Stimulator Set) are applied to the skin five times each, in a random order, with a single 
1-2cm long sweeping motion lasting approximately 1 second. Participants rate each sensation on 
a scale from 0 – “no pain, no sharp, pricking, stinging, or burning sensation” to 100 – “most 
intense pain sensation imaginable”. Any sharp, pricking, stinging, or burning sensation is defined 
as painful and given a rating above 0. Allodynia is quantified as an arithmetic mean of 15 ratings 
on each limb. Its presence is indicated by scores greater than zero.  
A Two-Point Discriminator disk (Exacta, North Coast Medical) is used to record tactile 
discrimination thresholds [53]. The participant’s index fingertip is touched either with one tip or 
two tips of the disk for 3 seconds per touch, with consistent pressure, and while the participant 
has their eyes closed. On each trial, participant reports whether they perceived touch on one point 
or two points of their finger. The procedure starts with two points separated by 7mm distance, 
and the distance between points is increased or decreased (down to a single tip) across trials 
according to the staircase procedure. For example, if the participant initially reports two touches, 
smaller distances are applied until the participant reports the sensation of only one point. The 
distance is then increased until a sensation on two points is reported again. The procedure 
continues until 5 subthreshold and 5 suprathreshold values are obtained. The tactile discrimination 
index is calculated as a geometric mean of these 10 turning points for each hand. To quantify the 
difference between the two sides of the body, we derive the tactile discrimination thresholds ratio 
[(affected-unaffected)/affected]. Positive score indicates less precise tactile discrimination ability 
on the affected limb. 
2.5.3.3. Computer-based / psychophysical tests 
Six computer-based measures are used in the present study to assess the following 
neuropsychological functions: visuospatial attention, cognitive representation of space, spatially-
defined motor function, and body representation. To test for spatial attention bias in near space, 
we administer versions of three tasks that have been used to measure spatial attention in 
hemispatial neglect: a visual Temporal Order Judgement (TOJ) task [9], a Landmark task [54], 
and a Greyscales task [55]. The fourth task is a Mental Number Line Bisection task, which 
measures the mental representation of space [56, 81]. The fifth task is a Directional Hypokinesia 
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task, a measure of motor “neglect-like” impairment. The final computer-based task is a Hand 
Laterality Recognition task, which is thought to be indicative of body representation [58].   
All measures presented in this section are collected in RS1-RS4 from the participants with CRPS 
and during a single research session from healthy control participants. Hand and side of space for 
all tasks are coded as affected or unaffected (for controls, the “affected” and “unaffected” hand / 
side is coded based on their matched participant with CRPS). Each task is preceded by a short 
practice session to familiarise the participant with the task. If they do not appear to follow the 
instructions during practice, these are explained again, and the practice is repeated. 
2.5.3.3.1. Visuospatial attention 
The following three computer-based tests are used to measure visuospatial attention: the visual 
TOJ task, the Landmark task, and the Greyscales task.  
2.5.3.3.1.1. The visual TOJ task 
TOJ tasks are sensitive measures of covert spatial attention, used both in clinical populations [82–
88] and healthy people [89–93]. The usual procedure involves presenting pairs of identical 
stimuli, one on each side of space, with different onsets but the same duration. The participant’s 
task is to report which of the two stimuli they perceived first. According to the prior entry 
hypothesis [94], stimuli that are subject to greater attention are perceived earlier relative to stimuli 
that are subject to lesser attention. The TOJ task takes advantage of this premise. The visual 
variant of the TOJ used in this study is similar to that described in a previous article [9]. The 
participants keep their hands uncrossed on their laps under the table, and have their head stabilised 
by a chinrest. They are instructed to maintain their gaze on a black fixation point (3mm in 
diameter), approximately 28cm from their torso, located in the centre of a 46.5 x 35.5cm white 
board laid on a table. Pairs of brief (10ms) red light stimuli (3mm in diameter) are presented using 
laser pointers controlled via an Arduino platform that is integrated with PsychoPy software [95]. 
The lights are presented 9cm (approximately 18°) to the left and 9cm to the right of the fixation 
point (one on each side), using a range of ten temporal offsets: 10, 30, 60, 120 and 240ms 
(with negative numbers representing the trials in which the light on the affected side appeared 
first). Each temporal offset is presented 15 times in pseudorandom order, giving a total of 150 
trials. To account for any response bias [96] the participants complete the TOJ task once while 
indicating which of the two lights appeared first, and a second time while indicating which light 
appeared second (order counterbalanced between participants). Participants’ verbal responses 
(“Left” or “Right”) are inputted via the computer keyboard by the researcher. The relative number 
of left-right responses to different offsets of the stimuli is re-expressed as the number of affected-
unaffected responses. To derive the Point of Subjective Simultaneity (PSS) for each participant 
and each condition, these data are then fitted with a cumulative Gaussian using a criterion of 
maximum likelihood. The PSS expresses the amount of time (ms) by which the light that appears 




the light that appears in the unaffected side of space for the two stimuli to be perceived as 
simultaneous. For the analysis, PSSs from the two response blocks (which light appeared first or 
second) will be averaged to obtain a single index of attention bias. A negative PSS value indicates 
a bias of attention away from the affected side, whereas a PSS value of 0 indicates equal 
distribution of attention to both sides of space. 
2.5.3.3.1.2. The Landmark task 
In addition to the TOJ task, participants complete four tasks involving presentation of visual 
stimuli on a computer screen. For these, participants are seated with their head in a chinrest that 
is aligned with the centre of the screen. Stimuli are presented on a laptop touch screen (34.5cm x 
19.4cm size, 1920 x 1080 pixels resolution) using PsychoPy software [95] on the Windows 10 
operating system. The laptop screen is positioned at a viewing distance of 50cm. The responses 
are recorded using a custom-made button box positioned such that the buttons are aligned 
vertically.  
We use a modified version of a Landmark task to measure bias in attention to or the representation 
of relative horizontal distance in near space. The task is adapted from a previous study [54] and 
involves simultaneous presentation of two stimuli (“landmarks”; white circles 1.1° in diameter) 
to the left and to the right of a central fixation cross. The total distance between the two landmarks 
is kept constant across trials (15°), however, their position relative to the fixation cross varies by 
0.1° increments from ±8.1° to ±6.9° away from the fixation cross in the horizontal plane (Figure 
1). Thus, there are 6 stimulus pairs in which the right landmark is closer to the fixation cross, 6 
stimulus pairs in which the left landmark is closer, and 1 stimulus pair in which the distance of 
both landmarks from the fixation cross is equal. Each stimulus pair is presented 15 times during 
one block resulting in 195 trials per block, presented in pseudorandom order. The participant is 
instructed to maintain their gaze on a white, 1.4° high fixation cross presented in the centre of a 
grey screen. After 500ms, the fixation cross is joined by the two stimuli which are displayed for 
300ms. Then a 200ms mask is presented, consisting of a white 1.6° high line extending 
horizontally across the entire screen, with a grey fixation cross in the same location as the previous 




Figure 1. Representation of the stimuli in the Landmark task. White filled circles represent the 
stimulus pair in which the left landmark is farther from the fixation cross (-8.1° away) and the left 
landmark is closer (6.9° away). Circles with dashed lines in matched colours represent other 
possible stimulus pair locations. 
 
Figure 2. The time course of a single trial in the Landmark task. 
Participants are instructed to indicate whether the left or the right landmark was closer to the 
fixation cross. They give their responses by pressing the green (“left”) or red (“right”) button 
(using the index and middle finger of the unaffected hand). The button press ends the trial and 
initiates the next trial. To control for response bias, in a separate, second block of the task, they 
are instructed to indicate which target was further away from the fixation cross by pressing the 
same buttons. The order of the two blocks is counterbalanced between participants. Attention bias 
is calculated from a relative number of “Left” and “Right” responses to each stimulus pair 
(landmarks position relative to the fixation cross). This is re-expressed in terms of affected versus 
unaffected sides of space and converted to a Point of Subjective Equality (PSE) using a 




affected side of space should be further from (negative PSE values) or closer to (positive PSE 
values) the fixation cross for the two landmarks to be perceived as appearing at equal distance 
from the fixation cross. A negative PSE value indicates an attention bias away from the affected 
side and / or under-representation of that side of space. For example, if a participant with a left-
affected limb indicates that the left landmark is appearing closer to the fixation cross more often 
than the right landmark (i.e., underestimating distance on left side), their PSE value will be 
negative and indicate reduced attention to or under-representation of the left (affected) side. We 
will average the PSEs from the two response blocks (which landmark was closer or further away 
from the fixation cross) to obtain a single spatial bias index for our analyses. 
2.5.3.3.1.3. The Greyscales task 
The Greyscales task is a sensitive measure of overt spatial attention bias. The task used in the 
present study follows a previously developed procedure [55]. Forty pairs of short (9.95° x 1.95°) 
and long (12° x 1.95°) greyscale bars (Figure 3) are presented in the centre of a white screen in a 
free-viewing condition until the response is given. Participants indicate if the top or the bottom 
bar appears overall darker by pressing the upper or lower button, respectively (using the index 
and middle fingers of their unaffected hand). The trials are separated by an 18° x 8° mask (random 
dot 1111 x 362 black and white pixel pattern of static) displayed for 150ms, after which the next 
trial begins. An attention bias score is calculated by subtracting the number of “rightward” 
responses (choosing whichever bar is darker on its right side, regardless of its vertical position) 
from the number of “leftward” responses and dividing the difference by a total number of trials. 
Negative scores indicate rightward bias, i.e. reduced attention to the left side. This will be re-
expressed as bias relative to the affected / unaffected side. 
 
Figure 3. Example pair of stimuli in the Greyscales task. A person who has reduced attention to 
the left side of space would judge the upper bar as having overall greater average darkness.  
2.5.3.3.2. Mental representation of space 
The Mental Number Line Bisection task aims to measure spatial bias in the mental representation 
of space. This is based on the evidence that people implicitly represent numbers in a linear 
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arrangement in which smaller numbers are located to the left side of space, and larger numbers 
are located to the right side of space [97]. The procedure is adapted from a previous study [56] in 
which pairs of numbers were read aloud to the participants and they were required to indicate the 
number that would fall midway between the two without making any calculations. The current 
task uses the same intervals (9, 16, 25, 36, 49 and 64) between two numbers that ranged from 2 
to 98. For example, the midpoint number between 54 and 70 (16-interval) would be 62 (Figure 
4). The only deviation from the previous procedure [56] is that every pair of numbers is presented 
twice – once in ascending and once in descending order, to reduce response bias. There are 84 
trials presented in pseudorandom order and participants’ verbal responses are inputted to the 
computer via the keyboard by the researcher. We subtract the subjective midpoint number from 
the objective midpoint number in each trial (for example, see Figure 4), and the average score is 
transformed to indicate the relative bias in the mental representation of space away (negative 
values) or towards (positive values) the affected hand-side. A bias away from the affected side 
was previously found in CRPS patients on Mental Number Line Bisection [56], as well as a 
rightward bias in post-stroke hemispatial (left) neglect patients [81, 98–100], and a leftward bias 
in healthy participants (“pseudoneglect”) [56, 101, 102]. 
 
Figure 4. A pictorial representation of a theoretical trial from the Mental Number Line Bisection 
task. The participant is asked to indicate the midpoint number between the numbers 54 and 70, 
which are verbally presented by the experimenter. A negative bias score indicates that the centre 
of the participant’s mental number line is shifted towards larger numbers, consistent with an 
under-representation of the left side of space relative to the right side of space. 
2.5.3.3.3. Spatially-defined motor function 
We use the Directional Hypokinesia task to assess two distinct forms of motor neglect – 
directional hypokinesia, i.e. relative slowing in the initiation of movements directed toward the 
affected side, and directional bradykinesia, i.e. relative slowing in the execution of movements 
directed toward the affected side of space [103]. The task measures movement initiation and 
execution times to targets that appear on the left or the right side of the screen. The task follows 
the exact procedure previously used for research with hemispatial neglect patients [57]. A black 
1.4° fixation cross and two black 3° x 3° squares, one 12° to the left and one 12° to the right of 
the fixation cross, are on constant display (locations are re-expressed as affected and unaffected 
Visual Field, VF). Each trial is initiated by the participant pressing and holding a button with their 




target (1.4° high “X”) appears inside one of the squares, in a pseudorandomized order, for 
2000ms. The target onset initiates the response window and the participant is required to release 
the button, touch the screen in the location where the target appeared, and then return their index 
finger to the button as fast as possible, which initiates the next trial. There are 30 trials per block. 
A touch screen is used to monitor the accuracy of pointing-to-target movements. The Reaction 
Times (RTs) to release the button after the target onset (Movement Initiation Time, MIT) are 
recorded, as well as time taken between releasing the button and touching the screen (Movement 
Execution Time, MET). There are three different hand Starting Positions (location of the button 
box): 25cm to the left from body midline, central (aligned with the body midline), and 25cm to 
the right from body midline (the locations are re-expressed as the affected, central, and unaffected 
side). Manipulating the hand Starting Position allows dissociation between perceptual component 
of the task (e.g., slower detection of the targets on the affected side) and the true directional 
hypokinesia. Participants perform each condition once with each hand in separate blocks, giving 
a total of 6 conditions (unaffected hand from the unaffected side, unaffected hand from the centre, 
unaffected hand from the affected side, affected hand from the unaffected side, affected hand 
from the centre, affected hand from the affected side). The order of the Starting Positions is 
counterbalanced between participants, with the only restriction that they alternate between the 
unaffected and the affected hand in each subsequent block to reduce fatigue.  
We will calculate mean MITs and METs for each combination of VF in which the target appeared 
(affected and unaffected) and hand Starting Position (affected, central, and unaffected location), 
separately for each hand used to complete the task. Directional hypokinesia would be indicated 
by slower initiation of movements (MIT) towards the affected side of space, independent of which 
arm is used [57, 103, 104]. Directional bradykinesia would be indicated by slower movement 
execution times (MET) towards targets appearing in their affected side of space, even when using 
the unaffected arm. 
To dissociate any signs of directional hypokinesia from potential mechanical constraints, two 
indices of directional hypokinesia will be derived based on the analyses described in previous 
research [57]. Movement pathways and indices are illustrated in Figure 5. The first index (A) 
quantifies the difference in MITs to the targets in the affected vs. unaffected VF as a function of 
the direction of the movements [i.e. reaching toward the affected side (from central Starting 
Position) relative to reaching toward the unaffected side (from affected Starting Position). Index 
A will be calculated as: [central Starting Position (MIT affected VF – MIT unaffected VF) – 
affected Starting Position (MIT affected VF – MIT unaffected VF)]. Thus, a larger value on this 
index will indicate greater directional hypokinesia. A potential drawback of Index A is that it 
involves planning a movement across body midline (from the affected Starting Position to the 
unaffected VF) that covers a longer distance and may be more difficult than other movement 
trajectories. Therefore, we will also derive a second index (B) that directly quantifies the relative 
Chapter 3 
158 
slowing in the ability to initiate movements to the targets in the affected VF when making 
movements of the same physical length toward the affected side (from central Starting Position), 
versus toward the unaffected side (from affected Starting Position). Index B will be calculated as 
[central Starting Position (MIT affected VF) – affected Starting Position (MIT affected VF)]. 
Positive values on each index (A and B) would indicate hypokinesia for the affected side. 
Analogous indices A and B will be calculated for METs, and positive values of each index would 
indicate directional bradykinesia for the affected side. 
 
 
Figure 5. Indices of the Directional Hypokinesia task. Target locations (affected and unaffected 
Visual Field, VF) and hand Starting Positions (affected, central, and unaffected) are presented as 
an example of a participant with CRPS of left arm. Index A is calculated as initiation time of the 
movements represented by arrows [(1 – 2) – (3 – 4)]. Index B is calculated as initiation time of 
movements (1 – 3). 
2.5.3.3.4. Body representation 
As an objective measure of body representation, we use a modified Hand Laterality Recognition 
task based on a procedure described elsewhere [58]. The stimulus set was developed specifically 
for the current study (examples shown in Figure 6) and the final images were chosen based on the 
results of a pilot study reported in Additional file 2. The images depict gender-neutral right and 
left (mirror-reversed) hands in different postures and are presented at four different orientations 
(0°, 90°, 180° and 270°). In each trail, a black 0.1° fixation cross on a white background is on 
constant display. After 1000ms a colour image of a hand (12.9° x 12.9° ) is randomly presented 
8° to the left or to the right of the fixation cross (i.e., in the left or the right VF, as in a previously 
published similar procedure [8]) for 180ms. This period is short enough to prevent foveation of 
the stimuli, ensuring that the images are presented to one visual hemifield. The participants are 
required to indicate whether the image represented the right or the left hand by pressing the red 
or green button using the index and middle fingers of their unaffected hand. Speed and accuracy 
are both emphasised but there is no upper time limit for the response, and the button press initiates 




2000ms stimulus presentation times) that includes feedback, until they reach at least 75% 
accuracy across the entire practice block. They repeat the practice to ensure that they are able to 
perform the task above chance level. In the main task, there is a total of 100 trials (25 images x 2 
hemifields x 2 depicted hands) conducted in a single block. Accuracy rates and RTs of the correct 
responses are calculated separately for the images of hands corresponding to the participant’s 
affected and unaffected limbs, and for the VFs corresponding to their affected and unaffected side 
of space (matched sides in healthy controls). As the task requires mental rotation of the images of 
hands, slower RTs and lower accuracy rates are considered to be an indicator of a distorted 
representation of the depicted limb [8, 58, 105]. To obtain single Hand Laterality Recognition 
indices, we will also calculate the differences in accuracy rates and RTs between depicted affected 
and unaffected hands. Positive accuracy index (unaffected – affected) and positive RT index 
(affected – unaffected) would indicate distorted representation of the affected limb. 
 
Figure 6. Example stimuli in the Hand Laterality Recognition task. Images of hands in four 
postures and rotation angles were included in the task. 
2.6. Blinding 
All outcome measurements are recorded by a researcher who is blind to group allocations (MH). 
A researcher (JHB) who is not involved in data collection allocates participants with CRPS to 
treatment groups 1-5 days before RS2. JHB or another researcher not involved in data collection 
(ADV) trains the participants in how to carry out the PA treatment or sham treatment in a self-
guided manner at the end of RS2. The participants return the goggles in sealed opaque bags after 
completing the treatment in RS3 so that the primary researcher (MH) remains blind to their 
treatment allocation. MH will be unblinded as to the group allocations of the participants once the 
last person has completed RS4, as there will be no further research sessions in which she will 
assess symptoms. Follow-up measurements in weeks 19 (LTFU1) and 31 (LTFU2) will be carried 
out via postal questionnaires scored by research assistants who are blind to the group allocations. 
The participants will be blind to their group allocations as they are not made aware of the specific 
nature of the intervention beyond that it involves sensory-motor coordination, nor the type of 
goggles used in the other treatment arm. In the information sheet and the training materials, the 
same terms are used to describe both treatment arms. For instance, all participants will be 
informed that sensory-motor training involves reaching out to targets with their affected arm while 
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wearing glasses fitted with lenses that distort vision. For ethical reasons, participants have to be 
told that they might receive either real or control treatment, and the meaning of double-blind 
randomized control trial will be explained to them in the information sheet and during training in 
how to carry out the treatment. A more general term “sensory-motor adaptation” is used to refer 
to PA in all study documents and instructions that the participants receive, to reduce the possibility 
that they could determine their treatment condition based on descriptions of PA on the Internet. 
At the end of the last in-person session (RS4) they will also be asked whether they have a belief 
about which condition they were allocated to, and their degree of confidence about this belief. 
They will be unblinded once data collection for this study is completed for all participants. Also, 
a participant might be unblinded before this time should they experience any worsening of 
symptoms that causes them concerns. If so, that participant will be withdrawn from the study in 
that no further data will be collected from them.  
2.7. Statistical analyses 
To process and analyse the data we will use IBM SPSS Statistics [106], R [107], and MATLAB 
[108] software. Hypotheses will be tested using a significance level of α = .05. We will control 
type I errors in the primary analyses using Holm-Bonferroni corrections for multiple comparisons 
within each outcome analysis. No correction for multiple testing will be made in the exploratory 
analyses. We will report 95% bias-corrected and accelerated (BCa) bootstrap confidence intervals 
around all mean values. 
Outliers are defined as scores outside ±3 SDs from the participant’s mean score for a task 
condition (participant-level data) or from the group mean (group-level data) for a particular test 
or task condition. We will examine participant-level and group-level RT data in the Hand 
Laterality Recognition and Directional Hypokinesia tasks for the presence of outliers and use 
nearest neighbour replacement if any are identified. We will use the same method of nearest 
neighbour replacement for the group-level outliers identified on the remaining outcome measures. 
T-tests and ANOVAS will be conducted to compare mean values between groups and between 
data collection time points. Statistically significant interactions will be interrogated through 
follow-up contrasts. Wilcoxon signed-rank tests and Mann-Whitney U tests will be used if 
assumptions of t-tests are violated; however, ANOVAs are robust to moderate violations of 
normality and homogeneity of variance. Therefore, we will use ANOVAs unless severe violations 
of normality, homogeneity of variance, and sphericity assumptions are present, in which case we 
will use linear mixed models analyses with bootstrapping procedures. 
2.7.1. Sample size and power calculation 
The required sample size was calculated based on the primary outcome measure of self-reported 
pain [109]. A meta-analysis defined a clinically significant reduction in pain as a change of Δ = -




between RS2 and RS3 was estimated. The risk of type I error was set at 5% and the risk of type 
II error was set at 10%, giving 90% power to detect a significant change in the pain. The standard 
deviation expected in the current study was estimated as 1.98 based on pain intensity ratings 
obtained by our group in recent research [9]. Given these parameters, a minimum of 42 
participants with CRPS (21 per group) is required to evaluate the effects of the PA treatment on 
the primary outcome measure of pain. Taking into account an anticipated drop-out rate of 20%, 
up to 52 participants with CRPS will be enrolled in order to obtain a total of at least 21 complete 
datasets for RS1-RS4 per treatment group. To provide normative data, 21 healthy (pain-free) 
control participants will be recruited. 
2.7.2. Timing 
No interim analyses are planned. The timing of the final analyses will be stratified by planned 
length of follow-up for the relevant outcome measures. Once all participants have completed RS4, 
we will analyse the RS1-RS4 data to address our research questions regarding the efficacy of PA 
treatment in reducing CRPS symptom severity (RQ1) and the relationships between the severity 
of clinical symptoms of CRPS and neuropsychological changes in perception of and attention to 
the affected limb and its corresponding side of space in RS1 (RQ5). We will conduct separate 
analyses of current self-reported pain intensity, the BPI, the Pain Detect Questionnaire, the BPDS, 
the Tampa Scale for Kinesiophobia, the Profile of Mood States, and the Patient’s Global 
Impression of Change scores once all participants meet the secondary endpoint (LTFU2).  
2.7.3. Treatment outcome analyses 
We will conduct intention to treat (ITT) as our primary analysis to examine the overall effects of 
prism adaptation. The ITT analysis will include all participants with CRPS who were allocated to 
either treatment arm, regardless of their treatment adherence and completion of outcome 
measurements. ITT analysis is the recommended approach to evaluating treatment outcomes in 
randomized trials because it minimizes potential selection bias related to the fact that outcome 
data is rarely missing completely at random (e.g. loss to follow-up might be related to a patient’s 
response to treatment) [111]. To account for missing data from participants who withdraw from 
the trial after treatment allocation, their baseline post-randomisation observation (RS2) will be 
carried forward as a conservative estimation of their outcomes in ITT analysis, as the participants 
are expected to return to pre-treatment baseline over time. The exception is the Patient Global 
Impression of Change questionnaire that is only completed in the post-treatment research 
sessions, in which case the RS3 observation will be carried forward, if available. Missing data 
from the computer-based tasks within each research session will be replaced by group mean for 
the particular task condition (with an exception of Directional Hypokinesia task, where some 
participant with CRPS may not be able to complete the task using the affected limb; in such cases 
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only the conditions completed with the unaffected limb will be analysed). Missing daily logbook 
ratings will be interpolated using linear regression. 
The ITT analysis is a relatively conservative approach, which might underestimate potential 
treatment benefit [111]. Therefore, we will also conduct a supportive per-protocol (PP) analysis, 
also known as complete case analysis, to see whether PA treatment can benefit the participants 
with CRPS who were able to perform it according to the trained protocol compared to those 
participants who were able to complete the sham treatment according to trained protocol [112]. 
The PP population will be the subset of the ITT population who provided complete outcome data 
for RS1-RS4 (i.e. attended all in-person research sessions and completed the primary outcome 
measures) and missed no more than 6 treatment sessions.  
We will use confidence intervals to compare the RS1 primary outcomes scores of the participants 
with CRPS who withdrew and those who remained in the trial until RS4 to assess any potential 
selection bias. The flow of participants, including timing and reasons for withdrawal, as well as 
number of participants included in the ITT and PP analyses of each primary outcome, will be 
presented in a CONSORT diagram.  
2.7.4. Descriptive characteristics 
We will report baseline characteristics for individual participants with CRPS such as affected 
limb, type of inciting injury, CRPS duration, co-morbidities, prescribed medications and other 
treatments, and change in handedness score. 
Minimisation factors listed in Table 2 will be presented as group means for continuous factors or 
proportion of participants in each group who are classed positive on each categorical factor. We 
will conduct a series of contrasts and chi-square tests to confirm that the minimisation procedure 
successfully equated the two groups on these factors. Contrasts will also be used to confirm that 
the PA and sham treatment groups are matched on mean Profile of Mood States, Tampa Scale for 
Kinesiophobia, Revised Life Orientation Test, and Patient Centred Outcomes Questionnaire 
scores. 
2.7.5. Efficacy of PA treatment in reducing pain and CRPS symptom severity (RQ1) 
A 2x6 ANOVA with Group as a between-subjects factor (PA treatment, sham treatment), and 
Time (RS1, RS2, RS3, RS4, LTFU1, LTFU2) as a within-subject factor will be conducted for the 
first primary outcome of pain intensity rating.  We will also conduct sixteen a-priori contrasts to 
compare RS1 vs. RS2, RS2 vs. RS3, RS3 vs. RS4, RS2 vs. RS4, RS2 vs. LTFU1, RS4 vs. LTFU1, 
LTFU1 vs. LTFU2, and RS2 vs. LTFU2 within each group. We will also conduct a 2x4 ANOVA 
with the factors Group (PA treatment, sham treatment) and Time (RS1, RS2, RS3, RS4) for the 
second primary outcome of CPRS severity score, followed by eight a-priori contrasts comparing 




interested in detecting any changes between RS2 and RS3 which would represent immediate 
effects of treatment.  
Minimisation factors (see Table 2) may be included as covariates in the ANOVAs if there are 
significant differences at RS1. Similarly, if we find significant group differences in the Profile of 
Mood States, Tampa Scale for Kinesiophobia, or Revised Life Orientation Test RS1 scores, these 
variables may be used as covariates in the ANOVAs on pain and CRPS severity score.  
We will also calculate the Number Needed to Treat (NNT) separately for pain and CRPS severity 
score. The NNT will be based on the proportion of participants in each treatment arm that 
achieved clinically significant pain relief (≥2 points on 0-10 NRS scale [110]) and reduction in 
CRPS symptom severity (≥4.9 points [35]) in RS3 compared to RS2. 
2.7.6. Effects of PA treatment on neuropsychological changes and other secondary 
outcomes (RQ2) and time course of any improvements (RQ3) 
To analyse between-group (PA treatment vs. sham treatment) differences on the secondary 
outcome measures (see Table 3) across four (RS1-RS4) or six (RS1-LTFU2) time points, we will 
conduct 2x4 or 2x6 ANOVAs as described for the analyses of the primary outcomes. Specifically, 
a 2x4 ANOVA will be run on each clinical assessment outcome (limb temperature asymmetry, 
hands size difference, grip strength and ΔFTP ratios, MDT, MPT, two-point discrimination 
threshold ratios, and allodynia) and mean group scores in the following computer-based 
measures: PSSs in the TOJ task, PSEs in the Landmark task, attention bias scores in the 
Greyscales task, and bias scores in the MNLB task. We will also use 2x4 ANOVAS to analyse 
between-group differences on indices A and B for the affected and unaffected hand performance 
in the Directional Hypokinesia task, as well as on hand laterality recognition accuracy and RTs 
indices in the Hand Laterality Recognition task across RS1-RS4. Separate 2x6 ANOVAs will be 
run on mean group scores on each of the self-reported questionnaire measures: pain intensity and 
interference components of the BPI, the Pain Detect Questionnaire, The BPDS, the Tampa Scale 
for Kinesiophobia, and the Profile of Mood States. 
We will plot group means of daily ratings of average pain, range of movement, and interference 
over time and use contrasts to identify the time points of significant group differences. We will 
also identify for both groups and for each measure the average number of days to reach peak 
improvement from the start of treatment, and the average number of days from the peak 
improvement to return to baseline.  
2.7.7. Predictors of the response to PA treatment and / or CRPS progression over time 
(RQ4) 
We will conduct exploratory analyses of the potential factors that can predict response to 
treatment for the PA group. First, we will calculate reduction scores as a change in current pain 
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scores and CRPS severity scores from the immediate pre-treatment to immediate post-treatment 
sessions (RS3 – RS2). Second, we will conduct two separate linear mixed models regressions on 
pain reduction scores and CRPS severity reduction scores including the pertinent explanatory 
factors such as demographic characteristics; current pain intensity; CRPS severity score; and 
scores on the self-report questionnaires, clinical assessments, and computer-based tests. In the 
first instance, we will consider those outcomes that differed the most from the healthy control 
participants in RS1 (see statistical analyses for RQ5 in the next section).  
The same factors will be considered potential explanatory variables in linear mixed models 
regressions on current pain scores and CRPS severity scores across four research sessions (RS1-
RS4). These exploratory analyses will be conducted for data from all the participants with CRPS 
to examine possible predictors of CRPS progression over time (including but not limited to 
treatment group). 
2.7.8. Baseline neuropsychological symptoms and their relationships with the clinical 
symptoms of CRPS (RQ5) 
We will conduct a series of contrasts to compare mean age, proportion of males and females, and 
proportion of left- and right-handed individuals between participants with CRPS in RS1 (total 
CRPS sample, regardless of subsequent treatment allocation) and healthy controls. Participants’ 
mean scores on self-report questionnaires and clinical assessments in RS1 will also be compared 
between the two groups. Specifically, we will conduct contrasts to compare participants with 
CRPS and healthy controls groups on the BPDS and Profile Of Mood States scores; the hand 
laterality indices (current for healthy controls, and handedness before CRPS for the participants 
with CRPS); limb temperature asymmetry and hands size difference (affected – unaffected), grip 
strength and ΔFTP ratios (affected / unaffected), MDT, MPT, two-point discrimination threshold 
ratios, and mean allodynia score on the affected side.  
To test whether the participants with CRPS in RS1 show visuospatial attention bias compared to 
healthy controls, we will use four separate contrasts. Specifically, we will conduct four between-
group comparisons of the following variables: PSSs in the TOJ task, PSEs in the Landmark task, 
attention bias scores in the Greyscales task, and bias scores in the MNLB task.  
The Directional Hypokinesia task conditions performed with the affected and unaffected hand 
will be analyzed separately. After excluding incorrect and missed trials, we will use mean 
movement initiation times (MITs) and movement execution times (METs) for each combination 
of VF in which the target appeared and hand Starting Position to test if the participants with CRPS 
show signs of directional hypokinesia compared to the healthy controls. We will conduct two 
three-way ANOVAs on MITs for each hand with the following factors: Group (participants with 
CRPS, healthy controls), VF (affected, unaffected), and Starting Position (affected, central, 




participants with CRPS are slower to initiate movements toward the targets in their affected side 
of space (regardless of the direction of reaching movement required) and / or in the direction 
toward their affected side of space (regardless of the location of the target). Specifically, we will 
examine if participants with CRPS have slower MITs to the targets in the affected VF than in the 
unaffected VF; to the affected VF compared to healthy controls; to the affected VF from central 
compared to affected Starting Position; and to the affected VF from central Starting Position 
compared to healthy controls. Analogous analyses will be conducted on METs to test if 
participants with CRPS show signs of directional bradykinesia compared to healthy controls. We 
will also examine differences between Groups (participants with CRPS, healthy controls) on 
MITs and METs through separate contrasts for each index (A and B) of directional hypokinesia 
and bradykinesia. As further exploratory analyses we will examine how many participants with 
CRPS are impaired on both indices (A and B) of directional hypokinesia and bradykinesia by 
identifying which participants obtained positive A and B indices and by comparing each CPRS 
patient’s indices to the mean indices for healthy controls using Crawford t-tests [113].  
To test for differences in body representation as measured by the Hand Laterality Recognition 
task between the participants with CRPS and healthy controls, we will conduct two three-way 
ANOVAS with the factors Group (participants with CRPS, healthy controls), depicted Hand 
(affected, unaffected), and VF (affected, unaffected) on accuracy rates and RTs to accurate 
responses. If there are significant three-way interactions, we will conduct a-priori contrasts to test 
whether the participants with CRPS are less accurate and / or slower in responding to: the depicted 
hands corresponding to their affected hand compared to those corresponding to their unaffected 
hand when the hands are presented in the affected VF; the affected hands presented in the affected 
VF compared to the unaffected VF; the affected hands compared to the unaffected hands; the 
affected hands presented in the affected VF compared to healthy controls; the affected hands 
compared to healthy controls; and the hands presented in the affected VF compared to healthy 
controls. If there is no effect of VF, we will only consider accuracy rates / RTs to recognize 
affected and unaffected hands averaged across both VFs in follow-up contrasts and any further 
correlation / regression analyses.  
2.7.8.1. Relationships between neuropsychological changes and clinical symptoms of 
CRPS 
Correlation and regression analyses will be conducted to test relationships between 
neuropsychological changes (as measured by computer-based tasks) and clinical symptoms of 
CRPS (as measured by self-report questionnaires and clinical assessments). These analyses will 
depend on which outcomes show significant differences between participants with CRPS and 




Considering the poor overall response to conventional medical treatments for CRPS [114], it is 
important to seek novel methods of pain relief and symptoms improvement. PA is an emerging 
treatment that targets spatial attention deficits, has shown early promise as an intervention for 
CRPS, and might operate through different mechanisms to mirror visual feedback (another 
neurocognitive treatment for CRPS [23, 115]).  
The ongoing trial that is described in this protocol is the first to investigate the effects of PA 
treatment on pain and CRPS symptom severity using a double-blind, randomized, and sham-
controlled design in a patient sample that is large enough to detect a clinically significant 
reduction in pain. These aspects of our design, as well as stratified randomisation and intention 
to treat and per-protocol analyses will allow unbiased evaluation of a brief, low-cost treatment 
that can be easily self-administered by the participant in a home setting.  
However, self-guided administration of the treatment might also be its limitation in the resent 
study, as it prevents us from directly monitoring participants’ compliance. This is considered a 
necessary trade-off to test the treatment as it would be most likely integrated into CRPS 
management. Furthermore, opting for home-based treatment will aid the recruitment of a 
sufficient number of participants, who are drawn from a broad geographical area, as it would not 
be feasible for them to travel to the research centre for each treatment session, or for another 
researcher to repeatedly assess their compliance. We put in place several measures to encourage 
adherence to treatment, such as in-person training, instructions and guidance in multiple media, 
and easy access to advice. To avoid adding another layer of difficulty and increasing potential 
burden of treatment (especially for those participants who do not have very good technical 
competence), we decided against asking participants to video-record their treatment sessions. 
Thus, we rely solely on self-reported adherence, that is, recording the timing and completion of 
each treatment session in daily logbooks. This could limit the interpretation of our findings; 
however, we will evaluate them considering the possibility that participants may have not 
complied with the treatment regimen as expected.  
While clearly defining our primary outcome measures, the trial includes a wide range of 
secondary outcome measures to assess the impact of treatment on pain and other clinical CRPS 
symptoms, as well as neuropsychological and emotional functioning, and symptoms’ interference 
with daily life. These measures will allow us to explore relationships between self-reported, 
clinical, and neuropsychological manifestations of CRPS from baseline data, independent of the 
primary research aim of testing the efficacy of PA.  
Despite their informative value, large number of secondary outcomes might reduce the quality of 
data. To mitigate the potential impact of long duration and burden of research sessions, we 




including breaks between assessments. We also provide the participants with overnight 
accommodation near the research centre in cases when long travels are required, to minimise their 
fatigue during research sessions. In light of how little is known about cognitive changes in CRPS 
and effects of PA on these changes, broad battery of neuropsychological tests seems appropriate. 
Furthermore, this research may identify potential individual differences accounting for the course 
of CRPS and response to treatment. The findings could provide an indication of how to identify 
the patients who are most likely to benefit from PA based on their cognitive and physical 
symptoms. This would inform subsequent research and therapies. 
If PA brings benefits beyond that of the sham treatment on the primary outcome measures of the 
ongoing trial, this treatment should be developed as a recommended method to reduce pain and 
other CRPS symptoms. The study is likely to expand on our limited understanding of this 
debilitating condition and its neuropsychological components. 
4. List of abbreviations 
BPDS: Bath CRPS Body Perception Disturbance Scale; BPI: Brief Pain Inventory; CRPS: 
Complex Regional Pain Syndrome; FTP: Finger-To-Palm distance; LTFU1: Long Term Follow-
Up 1 (week 19) by post; LTFU2: Long Term Follow-Up 2 (week 31) by post; MDT: Mechanical 
Detection Threshold; MET: Movement Execution Time; MIT: Movement Initiation Time; MPT: 
Mechanical Pain Threshold; NRS: Numerical Rating Scale; PA: Prism Adaptation; PSE: Point of 
Subjective Equality; PSS: Point of Subjective Simultaneity; RS1: Research Session 1 (week 1);  
RS2: Research Session 2 (week 4); RS3: Research Session 3 (week 7); RS4: Research Session 4 
(week 11); RSDSA: Reflex Sympathetic Dystrophy Syndrome Association; RT: Reaction Time; 
QST: Quantitative Sensory Testing; TOJ: Temporal Order Judgement; VF; Visual Field. 
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Chapter 3 – Conclusions 
The design of this double-blind, randomised, controlled trial meets the gold standard of clinical 
research for evaluating the effectiveness of interventions. Prospective trial registration 
(ISRCTN46828292) and submission of the trial protocol and analysis plan for publication prior 
to any data analyses facilitate unbiased evaluation of outcomes. The major advantage of this trial 
compared to previous studies of prism adaptation treatment for CRPS is that it includes a control 
treatment that will allow me to dissociate any effects of prism adaptation treatment from other 
non-specific effects, such as placebo or mere increased movement of the affected limb. It also 
employs blinding of participants and the researcher, which minimizes the effects of expectations 
and biased assessment and reporting of treatment outcomes. Moreover, the CRPS PRISMA trial 
is sufficiently powered to detect a clinically significant reduction in the primary outcome of pain 
intensity. Although it is not specifically powered to detect a significant change in the second 
primary outcome of CRPS symptom severity score, this relatively new measure has not been 
previously used in any interventional studies. Therefore, the results of this pioneer trial could 
contribute important information, such as effects size of any treatment-related change in CRPS 
severity score, which would be useful for planning future clinical trials. The CRPS PRISMA trial 
tracks the long-term progression of clinical manifestations of CRPS, patients’ psychological 
functioning, and performance on the neuropsychological tests over 2.5 to 7.5 months. This 
expands on the longitudinal case study described in Chapter 2 by assessing any fluctuations in 
neuropsychological symptoms in a large representative group of people with CRPS. In fact, this 
trial recruits one of the largest CRPS samples that has been thus far involved in experimental 
research.  
Notwithstanding the abovementioned significant contributions to the field of CRPS research, the 
design of the trial has its limitations. One potential issue is related to the randomisation procedure, 
which is restricted by minimisation of baseline group differences according to a considerable 
number of participant characteristics. However, in contrast to traditional stratification approach, 
minimisation ensures good balance between groups even when several factors are considered 
(Altman & Bland, 2005). Furthermore, the primary objective of randomisation is to ensure equal 
representation of any factors other than active treatment component in two groups, so that any 
difference in outcomes can be attributed to the effect of treatment. Yet this assumption is rarely 
realistic in practice when simple randomisation is used, especially in heterogeneous samples such 
as people with CRPS. Therefore, to ensure balance of potential confounders between groups, 
minimisation has been suggested as the platinum standard of allocation techniques in clinical 
trials (Treasure & MacRae, 1998). As discussed in this chapter, the main potential limitation of 
the trial design is monitoring participants’ compliance with treatment regimen based solely on 
self-reported completion of each treatment session. This is, however, a necessary trade-off to 
accommodate pragmatic considerations (i.e. the lack of resources to monitor every treatment 
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session), as well as the likely way that the treatment would be applied if it was incorporated into 
CRPS management. Following the chronological order in which the data were collected, I will 
first present the baseline performance of participants with CRPS compared to healthy controls on 
experimental tests of spatial cognition and spatially-defined motor function, and explore the 
relationships between the severity of clinical and neuropsychological symptoms (Chapter 4). This 




Chapter 4: Disputing space-based biases in unilateral 
Complex Regional Pain Syndrome 
Chapter 4 – Introduction 
In Chapter 1, I reviewed the existing (often contrasting) evidence of a range of neuropsychological 
symptoms found in people with CRPS. I concluded that there appears to be substantial 
heterogeneity regarding intact and impaired cognitive functions, and that we need large, 
controlled studies, using sensitive tests, to characterise the nature and prevalence of any 
deviations. Furthermore, Chapter 2 provided proof of concept that people with CRPS can present 
with spatial biases beyond any response biases or primary sensory deficits, and that we can 
quantify them using sensitive psychophysical tasks. In this chapter, I will use similar experimental 
methods to investigate any deviations in perceptual, representational, and motor aspects of spatial 
cognition in a relatively large cohort of people with CRPS, compared to a group of pain-free 
controls. The CRPS sample size in this study is considered large relative to previous experimental 
studies on spatial biases in CRPS, which recruited two-to-five times smaller samples, and relative 
to pragmatic consideration of the difficulty to recruit participants with this rare chronic disease. 
Although I summarised evidence for changes to a broad range of neuropsychological functions 
in Chapter 1, this study specifically focuses on changes in spatial cognition and motor control that 
resemble those typical of hemispatial neglect after brain injury. These neuropsychological 
symptoms are particularly relevant for prism adaptation treatment, which I will assess in Chapter 
5. 
This chapter will address the question of whether people with CRPS show systematic “neglect-
like” symptoms, and what domains of spatial cognition and / or motor function are affected. 
Previous research suggested that people with CRPS tend to pay less attention to information in 
the affected side of space rather than on the affected limb itself (Bultitude et al., 2017; Moseley 
et al., 2009; Moseley, Gallace, & Iannetti, 2012; Reid et al., 2016). The case study in Chapter 2 
further indicated that spatial biases might be independent of body representation. Thus, in the 
present study, I aim to obtain a measure of lateralised visual biases in near space without potential 
confounding of body-related information that could be introduced by, for example, tests of 
attention to tactile stimuli. To assure that any effects are not task-specific, for instance, related to 
temporal acuity or demands of fast processing speed, I will administer three visual tests of 
different aspects of spatial cognition: covert and overt visual spatial attention, and the visual 
representation of space. Furthermore, I will assess two other “neglect-like” symptoms that have 
not been extensively studied in CRPS before: biases in mental representation of space using 
mental number line bisection, and directional aspect of motor neglect using a spatially-defined 
motor function task. This battery of neuropsychological tasks will allow a systematic assessment 
of multiple domains of spatial cognition to identify any significant areas of dysfunction.  
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This chapter will also address the question of the clinical relevance of neuropsychological 
symptoms in CRPS. Investigating the relationships between spatial cognition and clinical 
manifestations of CRPS has two potential implications. First, it could help to account for the 
heterogeneity across groups of individuals with CRPS, both in terms of clinical and 
neuropsychological presentations. Second, it might allow researchers and clinicians to identify 
individuals who would be most likely to benefit from neurocognitive rehabilitation. As I discussed 
in Chapter 1, the evidence of clinical relevance of neuropsychological changes is mixed. 
Recognizing the multifactorial mechanisms of CRPS, in this study, I will take an exploratory 
approach to consider a wide range of possible predictors of two key clinical outcomes: pain 
intensity and CRPS symptom severity. These predictors include self-report measures of 
psychological functioning, objective assessments of sensory, autonomic, and motor function, and 
experimental tests of spatial cognition. I will additionally explore the potential clinical and 
psychological predictors of biases in spatial cognition to provide preliminary evidence of what 
might be driving any neuropsychological changes. 
While a number of studies reported “neglect-like” symptoms in people with CRPS, based on self-
report and experimental measures, there is also emerging evidence contradicting these findings. 
Furthermore, we currently lack a complete understanding of the nature and clinical relevance of 
these neuropsychological symptoms, yet they already formed the basis of new rehabilitation 
approaches. In order to maximise the effectiveness of such treatments, we must understand the 
extent of neuropsychological changes in CRPS and evaluate their relation to clinical signs of the 
disorder. This chapter will contribute to this knowledge and provide a basis for interpreting the 
effects of prism adaptation on clinical symptoms and neuropsychological functions in CRPS, 
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There is some evidence that people with Complex Regional Pain Syndrome (CRPS) show reduced 
attention to the affected relative to unaffected limb and its surrounding space, resembling 
hemispatial neglect after brain injury. These neuropsychological symptoms could be related to 
central mechanisms of pathological pain and contribute to its clinical manifestation. However, the 
existing evidence of changes in spatial cognition is limited and often inconsistent. We examined 
visuospatial attention, the mental representation of space, and spatially-defined motor function in 
54 people with unilateral upper-limb CRPS and 22 pain-free controls. Contrary to our hypotheses 
and previous evidence, individuals with CRPS did not show any systematic spatial biases in 
visuospatial attention to or representation of the side of space corresponding to their affected limb 
(relative to the unaffected side). We found very little evidence of directional slowing of 
movements towards the affected relative to unaffected side that would be consistent with motor 
neglect. People with CRPS were, however, slower than controls to initiate and execute 
movements with both their affected and unaffected hands, which might suggest disrupted central 
motor networks or overall psychomotor slowing. Finally, we found no evidence of any clinical 
relevance of changes in spatial cognition because there were no relationships between the 
magnitude of spatial biases and the severity of pain or other CRPS symptoms. The results did 
reveal potential relationships between CRPS pain and symptom severity, subjective body 
perception disturbance, and extent of motor impairment, which would support treatments focused 
on normalizing body representation and improving motor function. Our findings suggest that 
previously reported spatial biases in CRPS might have been overstated. 
Keywords 
Complex Regional Pain Syndrome; neuropsychological symptoms; spatial cognition; motor 
function; body representation 
Abbreviations 
BPDS = Bath CRPS Body Perception Disturbance Scale; BPI = Brief Pain Inventory; CRPS = 
Complex Regional Pain Syndrome; EHI = Edinburgh Handedness Inventory; MNLB = Mental 
Number Line Bisection; POMS = Profile of Mood States; PSE = Point of Subjective Equality; 




Growing evidence supports the notion that chronic pain is a disease of the central nervous system 
involving functional and structural reorganisation of the brain (for reviews, see Henry, Chiodo, 
& Yang, 2011; Lee, Nassikas, & Clauw, 2011; Seifert & Maihöfner, 2008). One condition in 
which such reorganisation has been observed is Complex Regional Pain Syndrome (CRPS), a 
disorder that can affect one or more limb(s) and involves pain and other sensory, motor, and 
autonomic symptoms that are disproportionate to any inciting injury. Abnormal higher-order 
cortical processing in CRPS is further evidenced by cognitive changes in the representation of 
and attention to the CRPS-affected limb and the corresponding side of external space (e.g. 
Bultitude, Walker, & Spence, 2017; Legrain, Bultitude, De Paepe, & Rossetti, 2012; Lewis, 
Kersten, McCabe, McPherson, & Blake, 2007; Moseley, Gallace, & Spence, 2009; Schwoebel, 
Coslett, Bradt, Friedman, & Dileo, 2002). These changes have been referred to as “neglect-like” 
because they resemble those typical of hemispatial neglect that can occur after brain injury. For 
example, deficits in attention to or representation of the affected (relative to unaffected) side have 
been found on tests of tactile attention (Moseley et al., 2009, 2012; Reid et al., 2016), visual 
attention (Bultitude et al., 2017; Filbrich et al., 2017), and the mental representation of space 
(Sumitani et al., 2014). Furthermore, similar to people with hemispatial neglect after brain injury, 
people with CRPS reported or presented with underutilisation of the affected limb during 
spontaneous movements that could not be fully explained by primary motor deficits (Galer et al., 
1995; Galer & Jensen, 1999). Systematic measurement of motor performance of people with 
CRPS revealed slower and more variable movements when they used their affected hand, but also 
when movements were performed in the affected side of space regardless of which hand they used 
(Reid et al., 2018). Thus, there is evidence that people with CRPS can show space-based 
neuropsychological changes that resemble perceptual, representational, and motor neglect. 
Previous studies suggest that there is a relationship between spatial biases and the manifestation 
and maintenance of CRPS symptoms. For example, the severity of self-reported “neglect-like” 
symptoms (Frettlöh et al., 2006) was associated with greater pain intensity, worse long-term pain 
outcomes, sensory loss, and motor impairment in the affected limb (Frettlöh et al., 2006; Kolb et 
al., 2012; Wittayer et al., 2018). Also, the magnitude of perceptual and motor spatial biases on 
experimental tasks correlated with greater pain intensity and longer CRPS duration (Reid et al., 
2016, 2018). Furthermore, larger temperature asymmetry between the affected and unaffected 
arms was related to greater magnitude of tactile spatial attention bias (Moseley et al., 2009, 2012). 
This asymmetry was reduced by resting the affected hand in the unaffected side of space, and by 
using prismatic lenses to produce the illusion of such positioning (Moseley et al., 2012, 2013). 
Reduction of pain and other CRPS symptoms following prism adaptation treatment (Bultitude & 
Rafal, 2010; Christophe, Chabanat, et al., 2016; Sumitani, Rossetti, et al., 2007), which is thought 




relevance of spatial attention in CPRS. Therefore, understanding spatial biases in CRPS, and how 
they relate to clinical symptoms, could provide insights into the prevention and treatment of the 
disorder. 
Some findings, however, have called into question the presence of spatial biases in CRPS, or the 
extent to which they resemble hemispatial neglect. There is a share of research showing no 
evidence of spatial biases in CRPS (e.g. Christophe, Chabanat, et al., 2016; Filbrich et al., 2017; 
Filippopulos, Grafenstein, Straube, & Eggert, 2015; Förderreuther, Sailer, & Straube, 2004; Kolb 
et al., 2012; Reid et al., 2016; Reinersmann et al., 2012; Wittayer et al., 2018). Furthermore, some 
researchers found that people with CRPS presented with spatial biases in the opposite direction 
to what would be considered “neglect-like”. The best example of such findings is that the 
representation of external space relative to one’s body was shifted towards the CRPS-affected 
side in several group studies (Sumitani et al., 2014; Sumitani, Rossetti, et al., 2007; Sumitani, 
Shibata, et al., 2007; Uematsu et al., 2009). Two case reports also described a CRPS patient who 
consistently showed higher attention to her affected side relative to her unaffected side across a 
battery of tests of spatial cognition (Christophe, Delporte, et al., 2016; Jacquin-Courtois et al., 
2017). Some of these negative findings could be due to insufficient sensitivity of the tests used. 
For example, subtle spatial biases in people with CRPS, who typically do not have any brain 
injury, might not be evident on tasks such as classic pen-and-paper line bisection. Small sample 
sizes, in combination with the known heterogeneity of CRPS presentation (Bruehl et al., 2016; 
Marinus et al., 2011), could also account for some of the inconsistencies between studies 
regarding the observed presence or direction of spatial biases. Furthermore, very few previous 
studies tested different aspects of neglect (i.e. perceptual, representational, and motor) in the same 
group of participants (see Christophe, Chabanat, et al., 2016; Reid et al., 2016; Sumitani et al., 
2014 for exceptions). Therefore, it can be difficult to ascertain if discrepancies between the 
demonstrated spatial biases (or lack thereof) across studies are due to differences between the 
participants, or because CRPS can affect one aspect of spatial cognition and not another. The aim 
of the present study was therefore to use sensitive measures to examine multiple aspects of spatial 
cognition in a large sample of individuals with CRPS. 
We designed a battery of tests based on established approaches used to measure hemispatial 
neglect following a stroke, as well as pseudoneglect (the mild leftward bias that is commonly 
found in groups of healthy participants when performing certain spatial tasks; Jewell & McCourt, 
2000). We used three experimental tasks to test for visuospatial biases. The first, the Temporal 
Order Judgement (TOJ) task, requires participants to indicate the relative timings of pairs of 
spatial stimuli (one presented in each visual field). The TOJ measures covert spatial attention, 
based on the premise that information that is subject to greater attention is perceived earlier 
relative to information that is subject to lesser attention (Spence & Parise, 2010). The second, the 
Landmark task, requires participants to judge the relative distance of two stimuli and is thought 
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to measure visuospatial representations (Makin et al., 2010). A tendency to underestimate the 
distance on one side of space (relative to the other) would be consistent with diminished visual 
representation of that side. The third, the Greyscales task (Nicholls et al., 1999), requires 
participants to judge the relative luminance of two equally shaded greyscale stimuli that are 
arranged one above the other such that one stimulus has greater luminance on the left and one has 
greater luminance on the right. Participants with an attention bias will tend to show greater 
reliance on the luminance difference on one side of the stimulus display when making their 
decision. This tests for any bias in overt spatial attention without posing temporal demands on the 
task. In addition to the tests of visuospatial biases, our battery also included a Mental Number 
Line Bisection (MNLB) task designed to measure any biases in mental representations of space. 
This is based on the existing evidence that numbers are mentally represented in a linear 
arrangement (with smaller numbers located to the left, and larger numbers to the right side of 
space; Dehaene, Bossini, & Giraux, 1993). Thus, individuals with biased mental representation 
of space will tend to underestimate or overestimate the midpoint of number intervals on a mental 
number line. Finally, to test for any spatial biases in motor function, we measured the speed of 
movement initiation and execution when participants reached from different starting locations 
towards targets appearing either in the affected or unaffected side of space. Slower initiation of 
movements directed towards the affected relative to unaffected side of space, even with the 
unaffected hand, defines directional hypokinesia towards the affected side, whereas slower 
execution of the same movements defines directional bradykinesia. This test of spatially-defined 
motor function was identical to that used previously to measure directional hypokinesia in right-
hemisphere stroke patients (Sapir et al., 2007). We hypothesised that participants with CRPS 
(compared to pain-free controls) would present with spatial biases in attention to and 
representations of the affected side of space, and with slowed initiation and execution of 
movements directed towards the affected relative to unaffected side of space.  
In addition to evaluating group differences in spatial cognition, we also explored relationships 
between pain, CRPS severity, and the extent of any neuropsychological changes in people with 
CRPS. Previously discussed literature shows that changes in spatial cognition correlate with 
clinical features of CRPS such as pain intensity, sensory and motor impairment, and temperature 
asymmetry (Frettlöh et al., 2006; Kolb et al., 2012; Moseley et al., 2009, 2012, 2013; Reid et al., 
2016, 2018; Wittayer et al., 2018). There is also evidence to suggest that they are associated with 
other cognitive abnormalities (e.g. body perception disturbance; Bultitude et al., 2017) and 
psychological distress (e.g. depression, anxiety; Michal et al., 2016; Wittayer et al., 2018). 
However, the relationships between spatial biases and clinical CRPS symptoms are not 
consistently found (Bultitude et al., 2017; Filbrich et al., 2017; Frettlöh et al., 2006; Michal et al., 
2016; Reid et al., 2016; Reinersmann et al., 2012; Vittersø et al., 2020). Considering that some 
potentially relevant outcomes might be overlooked in the existing literature, we explored our data 




age, CRPS duration, and change in hand preference), clinical outcomes (sensory, motor, and 
autonomic function), self-reported pain, and psychological factors (body perception disturbance, 
pain-related fear of movement, and mood disturbance). We hypothesised that the magnitude of 
any observed neuropsychological symptoms would be related to the severity of clinical signs of 
CRPS. 
2. Methods 
This study involved a single study visit that was a part of a randomised controlled trial to evaluate 
the effects of prism adaptation on pain and severity of CRPS symptoms (CRPS PRISMA Trial, 
ISRCTN46828292; see Halicka et al., 2020 for the trial protocol; Chapter 3). The same 
participants also completed a hand laterality recognition task, which will be reported elsewhere 
as this was designed to measure lateralised body representation distortion rather than spatial 
cognition per se. The data reported in this article were collected prior to any trial-related 
intervention. During the single study visit, participants completed self-report questionnaires; 
underwent assessment of sensory, motor, and autonomic function; and completed experimental 
tests of neuropsychological function. The study visit lasted between two to four hours, including 
breaks between the assessments. The results of the randomised controlled trial will be reported 
elsewhere. All procedures were carried out in accordance with the Declaration of Helsinki and 
received ethical approval from National Health Service Oxfordshire Research Ethics Committee 
A (ref. 12/sc/0557).  
Participants were recruited through the National CRPS-UK Registry, internal registry of the 
Walton Centre NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, and 
other NHS clinics in the UK, word of mouth, advertisements on the funder’s and research centre’s 
websites, and social media. Participants were screened for eligibility through a telephone 
interview. To obtain a sample size meeting the trial requirements (21 patients completing the trial 
for each of the two treatment groups; Halicka et al., 2020; Chapter 3), we enrolled 54 adults with 
CRPS-I affecting primarily one upper limb for at least three months, who met the Budapest 
research diagnostic criteria at the time of testing (Harden et al., 2010). The control sample 
consisted of 22 adults without current or chronic pain, who were matched to 22 individual 
participants with CRPS (i.e. size of one treatment group) by sex, self-reported handedness, and 
age (±5 years). One limb of each control participant was labelled as the “matched” (i.e. “affected”) 
limb according to the affected limb of their matched participant with CRPS. Note that although 
sample sizes are imbalanced, we would expect more variability in the heterogeneous (but larger) 
sample of participants with CRPS than in healthy control participants (Rusticus & Lovato, 2014). 
All participants enrolled in the study had no history of neurological disorders, no severe 
psychiatric disorders that might be associated with perceptual changes (e.g. schizophrenia), were 
not legally blind, and had sufficient English language ability to provide informed consent. 
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Participants completed their study visit at the Universities of Bath (36 participants with CRPS, all 
controls), Liverpool (10 participants with CRPS), or at participants’ homes if unable to travel (8 
participants with CRPS).  
2.1. Questionnaire measures 
All participants completed the Edinburgh Handedness Inventory (EHI; Oldfield, 1971) on which 
negative scores (< -40) indicate left-handedness and positive scores (> 40), right-handedness. 
Mood can affect the pain experience (e.g. Tang et al., 2008) and performance on attentional tasks 
(e.g. Moriya & Nittono, 2011). Therefore, all participants also completed the Profile of Mood 
States (POMS; McNair, Lorr, & Droppleman, 1971). The Bath CRPS Body Perception 
Disturbance Scale (BPDS; Lewis & McCabe, 2010) was used to assess subjective cognitive 
representation of the CRPS-affected / matched limb. This was completed by all participants 
because it is a non-validated scale with no normative data currently available. Participants with 
CRPS answered additional questionnaires that were not completed by the control participants. 
They answered the EHI a second time to rate their recalled handedness prior to the onset of CRPS 
symptoms. An absolute difference between the current and recalled handedness scores (∆EHI) 
was calculated to approximate the functional impact of the disorder. Pain severity and interference 
were assessed using a short form of the Brief Pain Inventory (BPI; Cleeland, 1996) and the 
neuropathic component of pain was measured using the Pain Detect Questionnaire (Freynhagen 
et al., 2006). Participants with CRPS also completed the Tampa Scale for Kinesiophobia (Miller 
et al., 1991), which measures pain-related fear of movement and re-injury. Higher scores on the 
abovementioned questionnaires indicate greater mood disturbance (POMS), more severe 
distortion of body representation (BPDS), greater pain severity and interference (BPI), greater 
neuropathic component of pain (Pain Detect), and more severe kinesiophobia (Tampa Scale).  
2.2. Sensory, motor, and autonomic function 
We used a validated protocol to confirm that participants met the CRPS research diagnostic 
criteria, to quantify CRPS severity (Harden et al., 2017), and to confirm that the control 
participants did not present with signs or symptoms of CRPS on their matched limb. We 
objectively quantified the CRPS signs described below. Temperature asymmetry was quantified 
as a difference between an average of three hand temperature measurements on the unaffected 
and affected side (in the centre of the most painful site, and on the dorsal and palmar hand surface 
over the thenar muscle) using an infrared thermometer (Duratool, thermal resolution 0.1°C). We 
quantified oedema as a difference between an average of three hands size measurements on the 
affected and unaffected side using the figure-of-eight procedure (Pellecchia, 2003) with a soft 
tape measure (cm). Weakness was quantified as a ratio of grip strength in the affected to the 
unaffected hand, measured as an average of three maximum strength grips of an electronic 




range of movement as a ratio of delta finger-to-palm distance (cm; delta refers to the difference 
between full extension and full flexion of fingers; Torok et al., 2010) in the affected hand to the 
unaffected hand. 
Hypoesthesia, hyperalgesia, and allodynia were additionally quantified using elements of a 
standardized Quantitative Sensory Testing protocol (Rolke et al., 2006), administered to the 
centre of most painful region on the affected / matched limb and the corresponding site on the 
unaffected limb. Mechanical Detection Thresholds were assessed with von Frey filaments (0.008-
300g force; Bioseb, model Bio-VF-M). A positive ratio of thresholds for affected vs. unaffected 
side indicates hypoesthesia (i.e. increased tactile detection threshold) on the affected limb. We 
used pinprick stimulators (8mN-512mN; MRC Systems Pin Prick Stimulator Set) to quantify 
Mechanical Pain Thresholds. A positive thresholds ratio for affected vs. unaffected side indicates 
hyperalgesia (i.e. decreased pain threshold) on the affected limb. Allodynia was assessed by 
applying with a single sweeping motion a cotton ball, Q-tip, and a brush to the skin, five times 
each in a random order. Allodynia was quantified as an arithmetic mean of 15 ratings for each 
sensation from 0 (“no pain, no sharp, pricking, stinging, or burning sensation”) to 100 (“most 
intense pain sensation imaginable”) on the affected limb. This procedure was adapted from the 
Dynamical Mechanical Allodynia test (Rolke et al., 2006). We also examined tactile 
discrimination thresholds on index fingertips of each hand using a Two-Point Discriminator disk 
(Exacta, North Coast Medical; Pleger et al., 2006). Using a staircase procedure, the participant’s 
finger was touched with either one tip or two tips of the disk, starting with two points separated 
by 7mm distance and then increasing or decreasing the distance (down to a single tip) across trials 
depending on participant’s responses (i.e. whether they reported feeling one or two tips, 
respectively). The thresholds were calculated as a geometric mean of five subthreshold and five 
suprathreshold values. A positive thresholds ratio for the affected vs. unaffected side indicates 
decreased precision of tactile discrimination ability of the affected limb.  
2.3. Experimental tests of neuropsychological changes 
Participants completed three experimental tests of visuospatial attention (the TOJ, Landmark, and 
Greyscales tasks; see Figure 1a-c), one test of the mental representation of space (the MNLB task; 
see Figure 1d), and one test of spatially-defined motor function (see Figure 3). For convenience, 
these tasks were completed in the following order: the Landmark task, the Greyscales task, the 
test of spatially-defined motor function, the TOJ task, and the MNLB. All tasks except the MNLB 
were administered via PsychoPy software (Peirce, 2007) using a touch-screen laptop computer 
(Windows 10 operating system, screen dimensions 34.5cm x 19.4cm, resolution 1920 x 1080 
pixels). For the tests of visuospatial attention and spatially-defined motor function, the 
participant’s head was stabilised by a chinrest aligned with a central fixation and positioned at 
50cm distance from the screen. Note that the TOJ stimuli were not presented on the computer 
screen (see section 2.3.2.1.), but participants did use the chinrest. Key-press and key-release 
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responses were recorded using a custom-made button-box. The button-box was aligned with the 
centre of the screen for all tasks, except for specific blocks of the test of spatially-defined motor 
function in which it was also placed to the left or right of the screen (see section 2.3.4.). 
Participants used their unaffected hand to press the buttons in the Landmark and Greyscales tasks, 
and both hands (one at the time per block) in the test of spatially-defined motor function. When 
manual responses were not required (i.e. in the TOJ and MNLB tasks), participants rested their 
uncrossed hands in their lap under the table. 
The data from the computer tasks were transformed to reflect the participants’ performance 
relative to their affected / unaffected side of the body or visual field. For example, participants 
with CRPS whose right limb was affected would have their responses to left-sided stimuli coded 
as “unaffected side”, and responses to right-sided stimuli as “affected side” (and vice versa for 
participants whose left limb was affected). To enable comparison of both groups relative to 
affected and unaffected side, control participants’ limbs were coded as “affected” and 






Figure 1. Experimental tests of visuospatial attention (A-C) and the mental representation of 
space (D). Text within the illustrated screenshots did not appear during the study and is for 
illustration purposes only. (A) In the Temporal Order Judgement (TOJ) task, the participant 
maintained their gaze on the central fixation point and verbally reported which light flash (“left” 
or “right”) appeared first or second, depending on the response block. In each trial, the two lights 
were presented onto a white table surface with one of ten possible Stimulus Onset Asynchronies 
(SOAs). (B) In the Greyscales task, the stimuli were on constant display until the participant 
pressed a button to indicate which of the two greyscale bars (upper or lower) appeared overall 
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darker. Then the stimuli were replaced by a mask, and the next trial began. (C) In the Landmark 
task, the participant maintained their gaze on the fixation cross and pressed a button to indicate 
which landmark (left or right) appeared further from or closer to the fixation cross, depending on 
the response block. The right inset panel illustrates three out of 13 possible arrangements of the 
landmark stimuli (lines and numbers are for illustration purposes only). The top rectangle 
corresponds to the left landmark being furthest from, and the right landmark being closest to 
fixation; the middle rectangle corresponds to both landmarks being equidistant from fixation; and 
the bottom rectangle corresponds to the left landmark being closest to, and the right landmark 
begin furthest from fixation. The distance between the two landmarks was constant (15°), while 
their relative horizontal distance from fixation varied by 0.1° across trials. In each trial, the 
landmarks were replaced by a mask after 300ms. (D) In the Mental Number Line Bisection task, 
the experimenter presented each trial verbally, e.g. “What is the midpoint number between 13 and 
29?”. The participant verbally reported their subjective midpoint number (e.g. “24”) without 
making any calculations. Deviation from the objective midpoint (e.g. “21”) on each trial was 
calculated by subtracting the subjective midpoint from the objective midpoint. In all four tasks, 
participant’s non-speeded response initiated the next trial. 
2.3.2. Visuospatial attention 
2.3.2.1. The Temporal Order Judgement (TOJ) task 
For the TOJ task, participants verbally reported the order of two brief (10ms) identical lights that 
were projected onto a white table surface using laser pointers controlled via an Arduino platform. 
The lights appeared one 9cm to the left and one 9cm to the right of a central fixation point located 
approximately 28cm away from participant’s torso. Pairs of lights were presented 15 times for 
each of the ten temporal offsets (10, 30, 60, 120 and 240ms; negative values represent the 
trials in which the left light appeared first) in pseudorandom order, resulting in 150 trials (Figure 
1a). To account for potential response biases (Filbrich et al., 2016), participants completed the 
TOJ task twice: once indicating which light appeared first, and once indicating which light 
appeared second (block order was counterbalanced). For each block, the relative number of 
participant’s “right light appeared first” or “left light appeared second” responses to the range of 
temporal offsets was fitted with a cumulative Gaussian using a criterion of maximum likelihood 
to obtain the Point of Subjective Simultaneity (PSS). Following the transformation from left / 
right to affected / unaffected, the PSS values were averaged between the two response blocks to 
give a single value for each participant. The PSS is an index of spatial attention bias and indicates 
the amount of time (ms) by which the light on the affected side must precede (negative PSS) or 
follow (positive PSS) the light on the unaffected side for the two stimuli to be perceived as 
simultaneous. Therefore, negative PSS values indicate reduced attention to the affected relative 
to the unaffected side and positive numbers indicate greater attention to the affected relative to 
the unaffected side.  
2.3.2.2. The Landmark task 
We designed a version of the Landmark task based on one previously used to demonstrate 




(Makin et al., 2010). In each trial, two identical landmarks (white circles) were simultaneously 
presented on a computer screen with a fixed distance between them (15°), but in different 
positions relative to central fixation. The stimulus locations varied from ±8.1° to ±6.9° away from 
fixation in the horizontal plane by 0.1° increments (e.g. -8.1° and +6.9°, -8.0° and +7.0°, -7.9° 
and +7.1°, etc., up to -6.9° and +8.1°; see Figure 1c for example stimulus pairs). Negative values 
represent the location of the left landmark, and positive values the location of the right landmark, 
with reference to central fixation at 0°. Each pair of landmarks was presented 15 times in each of 
13 possible arrangements (including equidistant), resulting in 195 trials. Similar to the TOJ task, 
participants completed the Landmark task twice to account for any response biases: once 
indicating which landmark appeared further from fixation, and once indicating which landmark 
appeared closer to fixation (block order was counterbalanced). For each block, the relative number 
of participant’s keypress responses to the range of spatial offsets indicating “right landmark 
appeared further” or “left landmark appeared closer” was fitted with a cumulative Gaussian to 
derive the Point of Subjective Equality (PSE). Following the transformation from left / right to 
affected / unaffected, the PSE values were averaged between the two response blocks to give a 
single value for each participant. The PSE is an index of spatial bias that represents the relative 
distance (°) at which the landmark on the affected side should be further from (negative PSE) or 
closer to (positive PSE) central fixation for the two landmarks to be perceived as equidistant. 
Therefore, negative PSE values indicate under-representation of the affected side of space relative 
to the unaffected side and positive values indicate over-representation of the affected side of space 
relative to the unaffected side.  
2.3.2.3. The Greyscales task 
In each trial of the Greyscales task (Nicholls et al., 1999), participants were presented with two 
vertically aligned greyscale bars that were positioned one on top of the other. Each bar was darker 
at one end than the other, and the two bars were mirror images of each other such that one was 
darker on the left and the other was darker on the right even though both bars had the same average 
luminance (Figure 1b). Participants indicated with a button press which bar (top or bottom) was 
darker overall (in free-viewing conditions). The number of times the participant chose a bar that 
was darker on its right side, regardless of its vertical position, was subtracted from the number of 
times the participant chose a bar that was darker on its left side. We then divided this value by 
total number of trials (i.e. 40) to calculate an index of spatial attention bias. Transformed negative 
scores indicate reduced attention to the affected side of space, consistent with making higher 
proportion of relative darkness judgements based on the side of the stimuli corresponding to the 
unaffected limb. 
2.3.3. Mental representation of space 
We used a Mental Number Line Bisection (MNLB) task based on that of Sumitani et al. (2014). 
In each trial, participants were instructed to verbally estimate, without calculating, the midpoint 
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number between a given pair of numbers (Figure 1d). There were 84 trials with pairs of numbers 
separated by intervals of 9, 16, 25, 39, 49, and 64 digits, with the individual numbers ranging 
from 2 to 98. Number pairs were read aloud by the researcher in pseudorandom order. To account 
for potential response bias, each numbers pair was presented once in ascending (e.g., 54 and 70) 
and once in descending (e.g., 70 and 54) order. Individual spatial bias scores were computed by 
subtracting participant’s subjective midpoint number from the objective midpoint number in each 
trial and averaging the results across trials. A negative index indicates a relative bias towards 
guessing larger numbers as the midpoint number. That is, following the transformation from left 
(smaller numbers) / right (larger numbers) to affected / unaffected, a negative index indicates a 
bias away from the affected side of the mental representation of space.  
2.3.4. Spatially-defined motor function 
We adapted a test for directional hypokinesia previously used in research on hemispatial neglect 
(Sapir et al., 2007) to test for spatially-defined (directional) motor deficits in CRPS patients. Each 
trial was initiated by the participant holding down a button with an index finger, while maintaining 
their gaze on a central fixation cross flanked by two squares located 12° to the left (left Visual 
Field, VF) and 12° to the right (right VF) from fixation (see the inset panel in Figure 3). After a 
time interval that randomly varied between 1500ms and 3000ms, a target (“X”) appeared in one 
of the squares for 2000ms. The target location was pseudorandomized across 30 trials within each 
block and expressed relative to the CRPS-affected / matched side (i.e. in terms of the affected and 
unaffected VFs rather than left and right VFs). Participants were instructed to make speeded 
movements to release the button and touch the target location on the touch-screen using the same 
finger, and then return their hand to hold down the button, which initiated the next trial. We 
recorded the reaction time to release the button after target onset (movement initiation time) and 
the time between releasing the button and touching the screen (movement execution time). There 
were three hand Starting Positions in which the button box was either aligned with the body 
midline or located 25cm to the left or to the right from the body midline. These locations were 
expressed relative to the CRPS-affected (or matched “affected”) limb, that is, as the central, 
affected, and unaffected Starting Positions. Participants completed six blocks of the task in total: 
two blocks from each Starting Position (order counterbalanced), one with each Hand (alternating 
between the affected and unaffected hand between consecutive blocks). Slower initiation and 
execution of movements directed towards the affected side of space, independent of the hand 
used, would be taken to indicate directional hypokinesia and bradykinesia, respectively. 
2.4. Data handling and statistical analyses 
The data was processed and analysed using MATLAB 2018b, IBM SPSS Statistics 25, R 3.5.3, 
and JASP 0.9.2.0 software. The significance level for frequentist hypotheses testing was α = .05. 




Wagenmakers, 2014). We used Holm-Bonferroni correction for multiple comparisons to control 
for family-wise type I error in the primary analyses. Corrections were not implemented in 
exploratory analyses.  
Pre-processing of the data from the spatially-defined motor function task involved removing 
invalid trials from individual data sets, i.e. trials in which the screen touch did not match the target 
location or the button was released before target onset (for movement initiation time analysis), 
and additionally the trials in which screen touch time was not recorded (for movement execution 
time analysis). In total, 7.25% of all completed trials were removed across all participants. 
Outliers in participant-level data in this task were identified as scores outside ±3 SDs from the 
participant’s score for a task condition and replaced with the nearest non-outlier values (0.84% of 
all valid data replaced). Missing questionnaire items in participant-level data were replaced with 
participant’s mean rating for the specific subscale calculated without the missing items (person 
mean replacement; 0.08% of all questionnaire items replaced across all participants). 
For group-level data, scores outside ±3 SDs from the group mean for each test or task condition 
were identified as outliers and replaced with the nearest non-outlier values. Missing data points 
on clinical measures and computer-based tasks were replaced with a group mean for particular 
test or task condition, with the exception of the test of spatially-defined motor function (six 
participants with CRPS could only complete the task using the unaffected limb, thus they were 
excluded from the affected limb analysis). In group-level data, 1.22% of all data points were 
replaced as missing or outlying values across all measures and all participants. 
Bootstrapping was implemented for descriptive and inferential statistics using 1000 bootstrap 
samples and calculating bias corrected and accelerated 95% confidence intervals (BCa 95% CIs). 
For non-parametric tests, we used Monte Carlo estimation of 95% CIs based on 1000 samples. 
Between-group differences on categorical variables were estimated through chi-square statistics. 
To compare mean scores on the continuous variables between participants with CRPS and control 
participants, we conducted t tests and ANOVAs, and interrogated significant interactions through 
contrasts. Where assumptions of t-tests were violated, we carried out Wilcoxon signed-rank tests 
and Mann-Whitney U tests and reported median scores. Due to missing data and violations of 
normality, homogeneity of variance, and sphericity assumptions for ANOVAs in the data from 
the test of spatially-defined motor function, bootstrapped linear mixed models analyses were 
conducted instead to investigate the interactions of interest. To investigate any potential 
relationships between neuropsychological changes and clinical signs of CRPS in the data from 




3.1. Participant characteristics; questionnaire measures; and sensory, motor, and 
autonomic function 
A small proportion of participants reported CRPS symptoms in body parts other than the primarily 
affected upper limb - most commonly the ipsilateral lower limb (7% of total sample), with single 
instances of contralateral lower limb (not meeting the CRPS diagnostic criteria), and both lower 
limbs. A quarter of the CRPS sample reported other, non-CRPS pain. In most cases it was 
fibromyalgia (13% of total sample), but there were also single instances of joint hypermobility; 
shoulder, hip, and back pain; migraine; hernia; peripheral neuropathy in the ipsilateral lower limb; 
and contralateral upper limb pain. The most common comorbidities other than pain included 
depression (35% of total sample), anxiety (20%), asthma (13%), hypertension (9%), polycystic 
ovaries (7%), diabetes, irritable bowel syndrome, and arthritis (6%). There were also single cases 
of hypothyroidism, tachycardia, endometriosis, psoriasis, contralateral carpal tunnel syndrome, 
epilepsy, anaemia, incontinence, Fowler’s syndrome, and Crohn’s disease. Ongoing treatments 
and medications for CRPS at the time of the study involved opioids (56%), anti-depressants 
(48%), anticonvulsants (46%), paracetamol (44%), physiotherapy and / or occupational therapy 
(39%), nonsteroidal anti-inflammatory drugs (33%), local anaesthetics (15%), other medication 
(6%), spinal cord stimulation (4%), and transcutaneous electrical nerve stimulation (4%). 
Group-level participant characteristics are reported in Table 1, including average scores on the 
self-reported measures of pain, kinesiophobia, body perception disturbance, mood, and hand 
preference; and tests of sensory, motor, and autonomic function. Participants with CRPS and 
controls were equally matched on mean age, proportion of males and females, and proportion of 
left- and right-handed participants in each group (ps > .05).  
Participants with CRPS reported moderate pain severity and interference on the BPI (Li et al., 
2007) and their mean score on the Pain Detect Questionnaire (≥ 19 cut-off) suggested a likely 
neuropathic pain component (Freynhagen et al., 2006). Despite comparable pain intensity, median 
CRPS severity score in our sample was higher than in a group of people with chronic (on average 
35 months) CRPS tested in the severity score validation study (Harden et al., 2017). This could 
be because we only included people who met more stringent Budapest research (compared to 
clinical) diagnostic criteria. The mean score on the Tampa Scale for Kinesiophobia indicated high 
pain-related fear of movement, comparable with previous CRPS research (Velzen et al., 2019). 
BPDS scores of participants with CRPS were significantly higher compared to controls, 
indicating significantly distorted perception of the CRPS-affected limb. POMS scores were also 
significantly higher among participants with CRPS than controls, indicating greater mood 
disturbance. There was no difference between the median handedness index of the control 




of those whose dominant arm was affected by CRPS, or who were ambidextrous before the 
symptoms onset, showed a change in hand preference towards the unaffected arm according to 
the absolute difference in the scores on the EHI answered with regard to current and pre-CRPS 
handedness.  
Participants with CRPS presented with significantly larger asymmetries between the affected and 
unaffected limbs compared to controls in limb temperature (both signed and absolute difference), 
grip strength, finger-to-palm distance, and mechanical pain threshold (see Table 1). Specifically, 
the affected limb was on average characterised by lower temperature, weaker grip strength, more 
limited range of movement, and greater hyperalgesia. Participants with CRPS also had 
significantly more severe allodynia on the affected limb than the control participants. There were 
no significant between-group differences in oedema, mechanical detection thresholds, and two-
point discrimination thresholds. 
Table 1 Group-level participant characteristics; scores on questionnaire measures; and 
quantification of sensory, motor, and autonomic function of the affected limb relative to the 
unaffected limb in participants with CRPS compared to healthy controls 
Measure CRPS Control Contrast 
Participant characteristics 
Age (years) M 
45.94 [42.65, 49.28] 45.95 [40.23, 51.41] t(74) < 0.01, p = 
.998, d < 0.01 
Sex (% female) 85% 77% χ2(1) = .69, p = 
.406, ϕ = 0.10 
Handedness (% right-dominant 
pre-CRPS) 
93% 96% χ2(1) = .21, p = 
.648, ϕ = -0.05 
Primarily affected / matched limb 
(% left) 
59% 64% χ2(1) = .13, p = 
.723, ϕ = 0.04 
CRPS in other body parts (%) 11% N.A.  
Other non-CRPS pain (%) 26% N.A.  
CRPS duration (months since 
diagnosis) Mdn 
47.00 [37.00, 65.00] N.A.  
Current pain intensity (0 – 10 
NRS) Mdn 
6.00 [6.00, 7.00] N.A.  
CRPS severity score (/16) Mdn 12.50 [12.00, 13.00] N.A.  
Self-report questionnaires 
BPI – Pain severity (/10) M 5.80 [5.34, 6.22] N.A.  
BPI – Pain interference (/10) M 5.57 [4.96, 6.13] N.A.  
Pain Detect Questionnaire (/38) 
M 
24.13 [22.55, 25.63] N.A.  
Tampa Scale for Kinesiophobia 
(/68) M 
39.28 [36.79, 41.74] N.A.  
BPDS (/57) M *** 28.20 [25.11, 31.31] 14.00 [11.55, 16.27] t(74) = -7.19, p < 
.001, d = -1.55 
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Measure CRPS Control Contrast 
POMS (/200) M *** 88.54 [79.54, 97.96] 36.96 [32.19, 41.95] t(74) = -8.97, p < 
.001, d = -1.85 
EHI (-100 – 100; pre-CRPS) Mdn 100.00 83.00 [71.00, 
100.00] 
U = 502.00, p = 
.300, d = 0.24 
∆ EHI (absolute change pre- to 
post-CRPS) Mdn 
42.00 [20.00, 54.50] N.A.  
Sensory, motor, and autonomic function 
Temperature asymmetry (°C)a 
Mdn *** 
-0.42 [-0.77, -0.23] 0.02 [-0.15, 
0.25] 
U = 286.50, p < 
.001, d = 0.88 
Absolute temperature asymmetry 
(°C) Mdn ** 
0.52 [0.30, 0.83] 0.23 [0.17, 0.33] U = 346.00, p = 
.002, d = 0.69 
Oedema (figure-of-eight; cm)a M -0.02 [-0.30, 0.29] -0.13 [-0.36, 0.11] t(74) = -0.44, p = 
.659, d = -0.12 
Grip strength (dynamometry; 
kg)b Mdn *** 
0.35 [0.25, 0.39] 1.00 [0.99, 1.10] U = 57.00, p < 
.001, d = 1.99 
Range of movement (∆ Finger-
To-Palm distance; cm)b Mdn 
*** 
0.70 [0.62, 0.89] 1.00 [1.00, 1.00] U = 37.50, p < 
.001, d = 2.14 
Mechanical Detection Threshold 
(g force)c Mdn 
-0.04 [-0.44, 0.21] -0.01 [-0.24, 0.46] U = 548.00, p = 
.605, d = 0.12 
Mechanical Pain Threshold 
(mN)d Mdn ** 
0.58 [0.38, 0.67] 0.00 [-0.29, 0.13] U = 357.50, p = 
.005, d = 0.65 
Allodynia (0 – 100 NRS) Mdn 
*** 
17.83 [9.53, 28.33] 0.00 U = 87.00, p < 
.001, d = 1.79 
Two-Point Discrimination 
threshold (mm)c M 
-0.06 [-0.19, 0.07] -0.06 [-0.18, 0.07] t(74) = 0.02, p = 
.983, d < 0.01 
Note. **p < .01; ***p < .001. BPI = Brief pain inventory; BPDS = Bath CRPS Body Perception Disturbance 
Scale; POMS = Profile of Mood States; EHI = Edinburgh Handedness Inventory (score -100 indicates 
extreme left-handedness, and 100 extreme right-handedness). [BCa 95% CI]. 
aSide difference (affected – unaffected), where positive numbers indicate that the affected limb is warmer 
/ larger; bSide ratio (affected / unaffected), where numbers < 1 indicate weakness / limited range of 
movement in the affected limb; cSide ratio [(affected - unaffected) / affected], where positive numbers 
indicate hypoesthesia / less precise tactile discrimination on the affected limb; dSide ratio: [(unaffected - 
affected) / unaffected], where positive numbers indicate hyperalgesia on the affected limb. 
 
3.4. Experimental tests of neuropsychological changes 
3.4.2. Visuospatial attention 
Two-tailed contrasts showed that the performance of participants with CRPS on the three tasks 
measuring visuospatial attention did not significantly differ from the performance of healthy 
controls. Specifically, the PSS values in the visual TOJ task were not significantly different 
between the participants with CRPS (Mdn = -0.27; BCa 95% CI [-7.61, 3.97]) and controls (Mdn 
= -5.17, BCa 95% CI [-10.97, 0.27]), U = 472.00, p = .152, d = 0.33 (Figure 2a). Similarly, the 
PSEs of participants with CRPS in the Landmark task (Mdn = 0.05; BCa 95% CI [-0.04, 0.10]) 




0.15, 0.26]), U = 551.00, p = .624, d = 0.11 (Figure 2b). Finally, there were no between-group 
differences in the bias scores on the Greyscales task (CRPS: M = 0.11, BCa 95% CI [-0.02, 0.23]; 
controls: M = 0.01, BCa 95% CI [-0.17, 0.19]), t(74) = -0.81, p = .422, d = -0.20; Figure 2c). 
Follow up Bayesian analyses using a Cauchy prior width of 0.707 indicated anecdotal evidence 
of no difference between groups for PSSs (BF10 = 0.44) and Greyscales bias scores (BF10 = 0.34), 
and moderate evidence of no difference between groups for PSEs (BF10 = 0.27) (Lee & 
Wagenmakers, 2014). CRPS participants’ performance on the TOJ task did not correlate with the 
other visuospatial tasks, but there was a moderate positive relationship between their scores on 
the Greyscale and Landmark tasks (r = 0.40; see Figure S2). 
3.4.3. Mental representation of space 
MNLB bias scores of the participants with CRPS (M = 0.02, BCa 95% CI [-0.39, 0.43]) were not 
significantly different to those of the healthy controls (M = 0.09, BCa 95% CI [-0.52, 0.65]; t(74) 
= 0.18, p = .860, d = 0.05; Figure 2d), suggesting unbiased mental representation of space. A 
Bayesian independent-samples t-test indicated moderate evidence of no difference (BF10 = 0.26). 
CRPS participants’ performance on the MNLB task was moderately positively correlated with 




Figure 2. Results of the experimental tests of visuospatial attention (A-C) and the mental 
representation of space (D). Smaller circles represent individual data from participants with CRPS 
(orange) and pain-free control participants (blue). Larger black circles represent the group median 
(A, B) and mean (C, D) scores with bootstrapped 95% confidence intervals (error bars). (A) The 
Point of Subjective Simultaneity on the Temporal Order Judgement task indicates by how many 
milliseconds the light on the affected side should precede (negative values) or follow (positive 
values) the light on the unaffected side for the two lights to be perceived as simultaneous. (B) The 




the pair of landmarks should be offset from being truly equidistant to central fixation towards the 
affected side (negative values) or towards the unaffected side (positive values) for the two 
landmarks to be perceived as equidistant. (C) The bias score on the Greyscales task indicates to 
what extent the participants were basing their darkness judgements on the side of the stimuli 
corresponding to their unaffected side (negative values) or to their affected side (positive values). 
(D) The bias score on the Mental Number Line Bisection task indicates to what extent 
participants’ subjective midpoint of the mental number line was shifted towards the numbers 
corresponding to their unaffected side (e.g. higher numbers for participants with left-CRPS; 
negative values) or to their affected side (e.g. smaller numbers for participants with left-CRPS; 
positive values). Negative scores for each of the measures depicted in this figure would indicate 
reduced attention to or (mental) representation of the affected side of space. 
3.4.4. Spatially-defined motor function 
3.4.4.1. Linear mixed models regressions on movement initiation and execution times 
After excluding incorrect and missed trials, we computed mean movement initiation time and 
movement execution time for each combination of VF and hand Starting Position. The tasks 
performed with the affected (CRPS n = 43 [initiation], 45 [execution]; control n = 21) and 
unaffected limb (CRPS n = 50; control n = 18) were analysed separately. 
The data for this task were analysed using four bootstrapped linear mixed models regression 
analyses. The four outcome measures were initiation times and execution times for both the 
affected and unaffected limb. The fixed effects for each analysis were Group (participants with 
CRPS, healthy controls), Starting Position (affected, central, unaffected), VF (affected, 
unaffected) and their interactions. Participant ID was entered as a random effect in each analysis. 
As this method is robust to the presence of outliers and missing values (Wu, 2009), we used 
unprocessed data (i.e. data prior to replacement of group-level outliers and missing values). A 
variable made a significant contribution to predicting the outcome variable when the 95% CI 
around the regression coefficient (B) did not include zero. As our main objective was to assess 
the differences in motor function between participants with CRPS and healthy controls, here we 
only summarise those significant main effects and interactions that involved Group. The full 
results for all four regression analyses are reported in Supplementary Material. 
The terms of the regression analyses that were of most interest in the present study were the 
interactions between Group and VF; and between Group, Starting Position, and VF. The results 
showed that these terms did not significantly contribute to the prediction of movement initiation 
and execution times for either the affected or unaffected hand (i.e. all confidence intervals around 
the relevant regression coefficients included 0; see Supplementary Table S1).  
We found significant main effects of Group on initiation times for both limbs (affected B = 0.19, 
BCa 95% CI [0.16, 0.22]; unaffected B = 0.07, BCa 95% CI [0.05, 0.10]), indicating that, 
regardless of the hand Starting Position or the VF in which the target appeared, participants with 
CRPS were slower to initiate movements with their affected (Mdn = 553.28, BCa 95% CI [488.40, 
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582.85]) and unaffected (Mdn = 459.50, BCa 95% CI [438.19, 485.04]) limbs compared to the 
initiation times of the control participants with their matched “affected” (Mdn = 416.09, BCa 95% 
CI [403.52, 435.54]) and “unaffected” (Mdn = 412.74, BCa 95% CI [394.47, 438.38]) limbs. The 
analyses of movement execution times also showed significant main effects of Group for both 
limbs (affected B = 0.44, BCa 95% CI [0.36, 0.52]; unaffected B = 0.11, BCa 95% CI [0.08, 
0.15]). Specifically, execution of movement with the affected (Mdn = 970.45, BCa 95% CI 
[907.66, 1012.56]) and unaffected (Mdn = 820.14, BCa 95% CI [733.29, 858.03]) limbs among 
participants with CRPS was slower compared to execution times with the matched “affected” 
(Mdn = 677.37, BCa 95% CI [620.88, 746.19]) and “unaffected” (Mdn = 678.87, BCa 95% CI 
[586.43, 756.35]) limbs in the control group. These effects are consistent with overall slowing of 
initiation and execution of movements with both affected and unaffected limbs in participants 
with CRPS relative to healthy controls.  
The regression model for movement execution times with the unaffected limb showed that the 
term for the interaction between Group and affected versus unaffected Starting Position was 
significant (B = 0.06, BCa 95% CI [0.002, 0.12]). For participants with CRPS, the difference in 
execution times for movements originating from the unaffected (Mdn = 858.14, BCa 95% CI 
[795.38, 887.98]) compared to affected (Mdn = 801.83, BCa 95% CI [722.31, 811.46]) Starting 
Positions was larger relative to the same difference for controls (unaffected Mdn = 692.69, BCa 
95% CI [643.87, 769.59]; affected Mdn = 658.19, BCa 95% CI [590.84, 771.66]), regardless of 
the VF in which the targets appeared (Figure 3). This pattern is consistent with directional 
bradykinesia for the affected space: slowing of movements directed toward the affected side of 
space relative to movements directed toward the unaffected side of space. In the same regression 
model, the term for the Group by affected versus central Starting Position interaction was not 





Figure 3. Interaction between Group and Starting Position on execution times of movements 
performed with the unaffected limb starting from the affected compared to unaffected positions. 
Bars represent CRPS and control participants’ median execution times (error bars: BCa 95% CIs) 
with the unaffected hand from affected (yellow) and unaffected (blue) Starting Positions, 
averaged across two Visual Fields. **The interaction is significant at the level of padjusted < .01. 
The inset panel (right) illustrates slower execution of movements to the targets (X) in either Visual 
Field from the unaffected Starting Position (blue dashed arrows), relative to the affected Starting 
Position (yellow solid arrows). 
3.4.4.2. Analyses of directional hypokinesia and bradykinesia indices 
To dissociate any signs of directional hypokinesia and bradykinesia from potential visual 
“neglect-like” deficits, biomechanical constraints, and lengths of movement pathways from 
different starting positions, we additionally analysed specific indices for each limb separately. We 
calculated two indices of directional hypokinesia towards the affected side based on those used 
in previous research on spatial motor biases in stroke patients (Sapir et al., 2007). The relevant 
movement pathways and formulae are represented in Figure 4. The first index (A; Figure 4a) 
describes the difference in initiation times towards the affected VF with respect to the unaffected 
VF, depending on the direction of movements (that is, as a function of starting position). We 
derived a second index (B; Figure 4b), which in contrast to Index A, does not involve comparing 
a movement within one side of space to one across the body midline (and therefore over a longer 
pathway). Index B directly describes the relative slowing (if any) of initiations of movements to 
the affected VF when making movements of the same physical length directed toward the affected 
side compared to movements directed toward the unaffected side (Figure 4b). Larger (more 
positive) values of Indices A and B indicate greater directional hypokinesia towards the affected 
side. To account for the possibility of directional hypokinesia towards the unaffected side (i.e. in 
the direction opposite to hypothesized “neglect-like” motor deficits), we computed two additional 
indices (C and D; Figure 4c,d), which were not considered in Sapir et al.'s (2007) study. Indices 
C and D are analogous to Indices A and B, respectively, and describe relative slowing of 
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movement initiation toward the unaffected side with respect to the affected side. Larger values of 
Indices C and D indicate greater directional hypokinesia towards the unaffected side. We 
calculated the same four indices for movement execution times to examine any signs of 
directional bradykinesia. We examined differences between participants with CRPS and healthy 
controls on each index and for each hand through separate between-group contrasts. 
 
Figure 4. Movement pathways and formulae used to calculate indices of directional hypokinesia 
and bradykinesia towards the affected (A, B) and unaffected (C, D) side of space. The arrows 
indicate the direction of movement from hand Starting Position (affected, AP; central, CP; and 
unaffected, UP) to the targets (X) appearing in the affected (AVF) or unaffected (UVF) Visual 
Field. Indices for each hand were computed using movement initiation (hypokinesia) or execution 
(bradykinesia) times according to the formulae represented in the bottom segments of each panel. 
More positive values for Indices A (A) and B (B) would indicate greater directional 
hypokinesia/bradykinesia towards the affected side; more positive values for Indices C (C) and D 
(D) would indicate greater directional hypokinesia/bradykinesia towards the unaffected side. 
After Holm-Bonferroni correction, Mann-Whitney U tests did not show significant differences 
between the CRPS participants’ and controls’ indices of directional hypokinesia and bradykinesia 
towards the affected side (Us ≥ 323.00, psadjusted ≥ .062, ds ≤ 0.47), with one exception. Index A 
(Figure 4a) for movement execution with the unaffected limb was significantly more positive 
among the CRPS participants (Mdn = 100.16, BCa 95% CI [84.22, 125.09]) compared to control 
participants (Mdn = 59.42, BCa 95% CI [39.37, 73.29]), U = 294.00, padjusted = .032, d = 0.55. 
Analysis of the indices of directional hypokinesia and bradykinesia towards the unaffected side 
showed that the CRPS participants’ Index C (Figure 4c) for movement initiation with the affected 




Index C (Mdn = 0.19, BCa 95% CI [-13.01, 8.25]), U = 272.00, padjusted = .016, d = 0.63. There 
were no other significant between-group differences (Us ≥ 318.00, psadjusted ≥ .072, ds ≤ 0.46). 
Overall, these results indicate that there was some evidence for participants with CRPS showing 
significant directional bradykinesia towards the affected side (Index A) when using the unaffected 
limb, but also for significant directional hypokinesia towards the unaffected side (Index C) when 
using the affected hand, compared to controls. 
Considering that only a subset of stroke patients in Sapir et al.'s (2007) study presented with 
significant directional hypokinesia (9 out of 52 patients, i.e. 17%, in a task performed only with 
the unaffected hand; identified based on z-scores compared to controls’ distribution), we explored 
whether there was a subgroup of CRPS patients showing this deficit. For this purpose, we 
compared each individual patient’s Indices A and B for movement initiation and execution with 
the affected and unaffected hand to the controls’ mean indices using Crawford t-tests (Crawford 
& Howell, 1998). A patient was classified as showing signs of directional hypokinesia or 
bradykinesia towards the affected side if both their Indices (A and B) were significantly more 
positive than controls’ mean indices (ps < .05). For balance, we used the same method to explore 
what proportion of patients presented with significant directional hypokinesia or bradykinesia 
towards the unaffected side, that is, had more positive Indices C and D. Table 2 summarises the 
results. Overall, when the affected limb was used, directional hypokinesia and bradykinesia 
towards the unaffected side was more prevalent than towards the affected side, and the opposite 
tendency was seen when the unaffected limb was used. However, the absolute number of patients 
with signs of directional hypokinesia and bradykinesia when the unaffected limb was used was 
low. 
Table 2 Proportion of participants with CRPS who showed signs of directional hypokinesia or 
bradykinesia towards the affected side (Indices A and B) or towards the unaffected side (Indices 









 for the affected sidea for the unaffected sideb 
Affected hand 3 / 43 (6.98%) 4 / 45 (8.89%) 8 / 42 (19.05%) 7 / 43 (16.28%) 
Unaffected hand 4 / 50 (8.88%) 1 / 50 (2.00%) 0 / 50 (0.00%) 0 / 49 (0.00%) 
aNumber of individual participants with CRPS (out of the total number of participants with CRPS with 
complete data on the specific indices) whose Indices A and B were both significantly more positive 
compared to mean indices of control participants; bNumber of individual participants with CRPS whose 
Indices C and D were both significantly more positive compared to mean indices of control participants. 
3.4.5. Relationships between neuropsychological changes and clinical symptoms of 
CRPS 
To investigate the relationships between neuropsychological changes and clinical symptoms of 
CRPS, we conducted best subsets regression analyses on the data from participants with CRPS. 
Due to the exploratory nature of this analysis, we took this automated approach to avoid any 
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biased selection of the predictors. The pool of potential predictors of each outcome included all 
measures of neuropsychological, sensory, motor, autonomic, and psychological changes, as 
measured by computer-based tasks, clinical and sensory assessments, and self-reported 
questionnaires. Best subsets regressions were determined for the outcome variables BPI pain 
severity and CRPS severity score, as key measures of clinical severity of this condition. We also 
performed regressions on those neuropsychological outcomes on which participants with CRPS 
differed from controls: BPDS, movement initiation time with the affected hand, movement 
initiation time with the unaffected hand, movement execution time with the affected hand, and 
movement execution time with the unaffected hand. The only pre-selection involved removing 
the variables that were not linearly related to the outcome of interest, to satisfy the assumption of 
linearity. To address co-linearity, when two variables were highly correlated with each other 
(Pearson’s r > .70; see Figure S2), only the one with higher correlation with the outcome was 
entered into regression analysis. This was the case for the following pairs of variables: current 
pain intensity and BPI pain severity; BPI pain severity and BPI pain interference; movement 
initiation time of the affected and unaffected hand; and signed and absolute temperature 
difference. Considering our sample size (N = 54), we compared best subsets regression models 
that included up to five predictors of each outcome. The best model was chosen based on the 
combination of the highest adjusted R2, lowest Bayesian Information Criterion (BIC), lowest 
Akaike Information Criterion (AIC), and lowest Mallows’ Cp. Because each of these criteria may 
favour different models, and to address the issue of potential overfitting, we also considered the 
criterion of the lowest prediction error (CV) based on five-fold cross-validation (Lever et al., 
2016). That is, we divided the data set into five subsets, whereby each subset (20%) served as test 
data and the remaining subsets (80%) as training data. The coefficients and related statistics for 
the chosen predictors of the best fits regression models for all outcome variables are summarised 
in Table 3. In the text we also reported adjusted R2, AIC, and CV as the most consistent indicators 




Table 3 Model summaries for best subsets regression analyses 
Outcome Predictors B SE B ß t p 
BPI - Pain severity (Intercept) 1.45 1.18 
 
1.23 0.227 
BPDS* 0.08 0.02 0.52 3.83 < 0.001 
Grip strength* -2.79 0.95 -0.47 -2.94 0.006 
Pain Detect 
Questionnaire* 0.11 0.04 0.37 2.86 0.007 
Finger-to-palm distance* 2.32 1.01 0.35 2.30 0.027 
Movement initiation time 
(affected hand) -0.002 0.001 -0.23 -1.59 0.121 
CRPS severity score (Intercept) 11.90 0.61 
 
19.64 < 0.001 
Grip strength* -2.38 0.61 -0.45 -3.89 < 0.001 
BPI - Pain interference* 0.22 0.08 0.33 2.81 0.007 
BPDS (Intercept) -8.67 4.37 
 
-1.98 0.055 
Movement initiation time 
(affected hand)* 0.02 0.01 0.37 3.80 0.001 
Current pain intensity* 2.12 0.60 0.37 3.53 0.001 
Profile of Mood States* 0.12 0.04 0.36 3.34 0.002 
Two-Point 
Discrimination* -6.81 2.32 -0.28 -2.93 0.006 




(Intercept) 494.99 92.35 
 
5.36 < 0.001 
BPDS* 8.32 2.47 0.46 3.36 0.002 
CRPS duration* 2.27 0.63 0.38 3.59 0.001 
Current pain intensity* -35.64 13.96 -0.34 -2.55 0.015 
Grip strength* -220.71 77.74 -0.32 -2.84 0.007 




(Intercept) 239.35 76.47 
 
3.13 0.003 
BPDS* 5.25 1.63 0.44 3.23 0.002 
CRPS duration* 1.38 0.40 0.42 3.48 0.001 
Current pain intensity* -20.54 9.05 -0.30 -2.27 0.028 
∆ EHI  0.49 0.25 0.24 1.99 0.053 




(Intercept) 2133.83 819.75 
 
2.60 0.013 
Grip strength* -775.09 295.88 -0.43 -2.62 0.013 
∆ EHI * 2.97 1.30 0.36 2.28 0.028 
CRPS severity score -94.19 56.09 -0.28 -1.68 0.101 
Greyscales bias score -252.45 159.76 -0.20 1.58 0.122 




(Intercept) 980.25 295.65 
 
3.32 0.002 
Finger-to-palm distance* -296.99 97.50 -0.44 -3.05 0.004 
Age* 4.57 2.05 0.29 2.23 0.031 
CRPS severity score -29.23 19.22 -0.24 -1.52 0.135 
Pain Detect Questionnaire 8.22 4.94 0.23 1.67 0.103 
MNLB score -19.05 16.06 -0.15 1.19 0.242 
Note. *Statistically significant predictors. BPI = Brief Pain Inventory; BPDS = Bath CRPS Body Perception 
Disturbance Scale; ∆ EHI = absolute pre- to post-CRPS change in Edinburgh Handedness Inventory score; 
MNLB = Mental Number Line Bisection. 
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3.4.5.1. Predictors of pain and CRPS symptoms severity 
The best fits regression models for the predictions of BPI pain severity and CRPS severity score 
are summarised in Table 3. Higher pain severity (as measured by BPI) was best predicted by more 
severe body perception disturbance, weaker grip strength in the affected hand, a greater 
neuropathic component of pain, greater range of movement in the affected hand, and faster 
movement initiation with the affected hand (non-significant predictor), F(5, 37) = 9.12, p < .001, 
adj. R2 = .49, AIC = 29.33, CV = 1.31. Larger CRPS severity scores were best predicted by weaker 
grip strength in the affected hand and higher pain interference, F(2, 51) = 20.59, p < .001, adj. R2 
= .43, AIC = 26.30, CV = 1.22. 
3.4.5.2. Predictors of cognitive changes in CRPS 
The best fits regression models for the predictions of BPDS and overall movement initiation and 
execution times with the affected and unaffected hands are summarised in Table 3. More severe 
body perception disturbance (higher BPDS score) was best predicted by slower movement 
initiation time with the affected hand, higher current pain intensity, higher mood disturbance 
score, more precise two-point discrimination on the affected limb, and greater swelling of the 
affected limb (non-significant predictor), F(5, 37) = 15.73, p < .001, adj. R2 = .64, AIC = 175.30, 
CV = 7.51. Slower initiation of movements with the affected hand was best predicted by more 
severe body perception disturbance, longer CRPS duration, lower current pain intensity, weaker 
grip strength in the affected hand, and more severe allodynia on the affected limb, F(5, 37) = 
10.58, p < .001, adj. R2 = .53, AIC = 434.52, CV = 152.47. Movement initiation times with the 
unaffected hand shared some of the same predictors. Specifically, slower movement initiation 
was best predicted by more severe body perception disturbance, longer CRPS duration, lower 
current pain intensity, greater change in handedness after CRPS onset, and a greater neuropathic 
component of pain, although the latter two factors were not significant predictors, F(5, 44) = 6.59, 
p < .001, adj. R2 = .36, AIC = 475.81, CV = 129.60. Slower movement execution when using the 
affected hand was best predicted by weaker grip strength in the affected hand, greater change in 
handedness after CRPS onset, lower CRPS severity score, greater attention to the affected side of 
space on greyscales task, and older age, F(5, 39) = 4.81, p = .002, adj. R2 = .30, AIC = 559.36, 
CV = 492.89. However, only the first two factors were statistically significant predictors of 
movement execution time. For the unaffected hand, slower movement execution was best 
predicted by smaller range of movement in the affected hand, older age, lower CRPS severity 
score, greater neuropathic component of pain, and greater bias toward the affected side of the 
mental representation of space, F(5, 44) = 4.23, p = .003, adj. R2 = .25, AIC = 524.46, CV = 






We conducted a detailed examination of changes in spatial cognition in CRPS using sensitive 
experimental methods in a larger than previous research has used sample. Contrary to our 
hypotheses, our findings across measures of visuospatial attention and mental representation of 
space consistently showed no evidence of any spatial biases among people with CRPS compared 
to pain-free control participants, and there was very little evidence for directional motor deficits. 
We also found no support for any clinical relevance of changes in spatial cognition for the severity 
of pain and other symptoms of CRPS. 
4.1. Visuospatial attention 
Although previous studies have used TOJs to provide evidence for reduced tactile (Moseley et 
al., 2009, 2012; Reid et al., 2016) and visual (Bultitude et al., 2017; Filbrich et al., 2017) attention 
to the affected relative to unaffected side in people with CRPS, we found no such visuospatial 
attention bias on our TOJ task. One notable difference between these previous studies and ours is 
that most of them (Bultitude et al., 2017; Moseley et al., 2009; Reid et al., 2016) asked participants 
only to indicate which stimulus occurred first. This might mean that previous results were 
influenced by response bias, that is, a preference of one response over the other when the 
participant is uncertain about temporal order of the stimuli (Filbrich et al., 2016; Spence & Parise, 
2010). Distorted perception of the CRPS-affected limb can involve hostile feelings, such as 
repulsion and hate (Lewis et al., 2007), which resemble misoplegia after brain injury (Bartolomeo 
et al., 2017). Thus, particularly when a verbal response is required (Bultitude et al., 2017), 
participants with CRPS might be reluctant to say “left” or “right”, depending on the side 
corresponding to their affected limb. Here we controlled for potential response bias by including 
a separate block of the TOJ in which participants were asked to indicate which stimulus occurred 
second (in addition to “which occurred first” block). The two previous studies that also controlled 
for response bias in a similar way, reported mixed findings regarding spatial biases on tactile 
TOJs (reduced attention to the affected side, Moseley et al., 2012, and normal performance, 
Filbrich et al., 2017). Thus, the response bias might be an important factor in the performance of 
CRPS patients on the TOJ task. Consistent with our findings, Filbrich et al. (2017) found no 
apparent shift of visual attention when the participants’ hands were kept close to the trunk (outside 
of the visual field). However, when the stimuli appeared in immediate proximity of participants’ 
hands, they found a significant visuospatial bias even when controlling for response bias. This is 
in keeping with a proposal that spatial biases might only be present (or exacerbated) when body-
relevant information is highly salient to the task (Reid et al., 2016). Thus, our results do not rule 
out the possibility that people with CRPS might still present with spatial biases in the tactile 
modality and / or related to other bodily information.  
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We also found that people with CRPS did not present with any biases on two additional tests of 
visual attention to and representation of near space. The Greyscales and Landmark tasks have not 
been previously tested in CRPS, but have sufficient sensitivity to detect visuospatial biases in 
brain-injured neglect patients (Mattingley et al., 2004), neurologically healthy individuals 
(Nicholls et al., 1999), and upper-limb amputees (Makin et al., 2010). Overall, consistently 
unbiased performance on the experimental tests of covert and overt attention to and representation 
of near visual space in this study suggests normal visuospatial cognition in CRPS. These findings 
agree with another study that also did not demonstrate any visuospatial biases in the speed of 
orienting saccades towards targets in either side of space (Filippopulos et al., 2015). 
4.2. Mental representation of space 
Representational neglect has not been extensively studied in CRPS, and not in combination with 
sensitive tests of visuospatial attention. One group study reported a shift of subjective midpoint 
of mental number line in the direction corresponding to the unaffected side (Sumitani et al., 2014), 
consistent with representational neglect after brain injury (Zorzi et al., 2002). However, a shift in 
the opposite direction was also reported in a single CRPS patient (Christophe, Delporte, et al., 
2016; Jacquin-Courtois et al., 2017). While using the same MNLB task as Sumitani et al. (2014), 
we additionally presented number pairs not only in ascending, but also in descending order. 
Averaging the responses from these two conditions accounts for a potential tendency to report 
subjective midpoints as numbers closer to the starting point on mental number line, that is nearer 
the first number from a pair. Having controlled for these potential response biases, we did not 
find any systematic deviations from objective midline in participants with CRPS, nor any 
differences between the performance of participants with CRPS and controls.  
4.3. Spatially-defined motor function 
In general, there are four potential explanations of impaired motor function in CRPS. First, 
diagnostic criteria for CRPS include motor signs, such as weakness, decreased range of 
movement, or dystonia (Harden et al., 2010); thus physical pathology of the affected limb itself 
can result in impaired motor performance. Second, learned underutilization of the affected limb 
can develop through initial immobilization following a trauma, pain avoidance, and compensatory 
use of the unaffected limb (Punt et al., 2013). These learned behaviours can reinforce reduced use 
of the CRPS-affected limb and further deter its motor function. Third, motor “neglect-like” 
impairment can account for reduced or slower movements of the affected limb that cannot be 
attributed to any peripheral pathology, as well as movements performed in / towards the affected 
side of space, regardless of which limb is used (Laplane & Degos, 1983; Mattingley et al., 1992). 
Thus, motor function can be impaired in a spatially-defined manner consistent with neglect of the 
CRPS-affected limb and side of space. Fourth, central deficit of motor control can account for 




deficits in spatial cognition. While the motor signs of CRPS and learned underutilization can only 
account for motor deficits specific to the CRPS-affected limb, the motor neglect and 
reorganization of central motor circuits additionally address spatially-defined and bilateral motor 
deficits found in CRPS, respectively. In the present study, we tried to dissect the motor neglect 
hypothesis from the alternative explanations of impaired motor function in CRPS. 
Consistent with motor neglect of the affected side, people with CRPS previously reported having 
to focus their attention on the painful limb to move it (Galer et al., 1995; Galer & Jensen, 1999). 
Furthermore, their motor performance on speeded button pressing and circle drawing tasks was 
slower, more variable, and less accurate when they used the affected limb, and also when 
movements were performed in the affected side of space regardless of which hand they used (Reid 
et al., 2018). These findings suggest spatially-defined disruption of motor control that cannot be 
explained by physical pathology or learned underutilization of the affected limb (although the 
bilateral spatially-defined motor deficits did not replicate in another group study, Christophe, 
Chabanat, et al., 2016, and a case study, Christophe, Delporte, et al., 2016, which both used 
similar motor tasks). We tested for the first time if people with CRPS show directional motor 
neglect, that is, slowing of initiation (directional hypokinesia) or execution (directional 
bradykinesia) of movements directed towards the affected relative to unaffected side of space, 
regardless of which limb is used (Heilman, Bowers, & Watson, 1983; Mattingley, Bradshaw, & 
Phillips, 1992; Sapir et al., 2007). 
People with CRPS in our study showed some evidence of slower execution of movements of the 
unaffected hand when they were directed towards the affected compared to unaffected side of 
space, consistent with hypothesised directional bradykinesia towards the affected side. This 
slowing cannot be attributed to perceptual neglect, as it occurred regardless of reaching to targets 
in the affected or unaffected side of space. Nor can it be attributed to physical pathology or learned 
underutilization of the CRPS-affected limb, as participants used the unaffected hand. On an 
individual level, some cases could be classified as showing consistent directional deficits towards 
the affected side with either hand, although the number was very few (< 10%). This is consistent 
with the finding that a relatively small proportion of brain-injured patients presented with 
directional hypokinesia towards the contralesional side when using their ipsilesional hand on the 
same task (17%, Sapir et al., 2007). However, in the present study a larger proportion of 
individuals with CRPS (16-19%) was classified as showing directional slowing towards the 
unaffected side, but only when using the affected hand. Furthermore, on a group level, people 
with CRPS showed no other signs of directional hypokinesia or bradykinesia towards the affected 
or unaffected side for either hand that would differentiate them from pain-free controls. Most of 
the effects observed in both groups could be explained by general (non-directional) biomechanical 
constraints such as differences in movement pathways and crossing the body midline (see 
Supplementary Material). Therefore, when the differences between participants with CRPS and 
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pain-free controls are considered as a whole, the results do not support the presence of directional 
motor deficits.  
Although we did not find systematic evidence for directional motor deficits resembling motor 
neglect, our results demonstrate that people with CRPS had overall slowing of initiation and 
execution of the movements of both limbs as compared to pain-free controls. Previous sensitive 
kinematic analyses also showed impairment on motor tasks performed with both hands (Schilder 
et al., 2012) or with the unaffected hand (Ribbers et al., 2002) in CRPS compared to pain-free 
individuals. This cannot be explained by peripheral pathology or learned underutilization of the 
CRPS-affected limb. Instead, bilateral slowing could either reflect a central motor deficit, or 
general decrease in psychomotor speed that is often found in patients with chronic pain. 
Neuroimaging evidence suggests that such movement deficits could be related to altered central 
motor circuits, that is decreased inhibition of bilateral motor cortex (Juottonen et al., 2002; 
Schwenkreis et al., 2003), and its increased bilateral activation during movements of the affected 
hand relative to rest (Maihofner et al., 2007) in CRPS. Therefore, slowing of initiation and 
execution of movements with both limbs could be related to functional reorganization in cortical 
motor networks. A likely alternative explanation is generalised impairment of psychomotor 
speed, which has been consistently reported in chronic pain conditions such as diabetic 
neuropathy, fibromyalgia, low back pain, or osteoarthritis (Higgins et al., 2018). Consistent with 
previous studies that associated slower psychomotor performance with higher pain intensity (Lee 
et al., 2010; Pulles & Oosterman, 2011), our results demonstrate its predictive value for slower 
movement initiation with both hands. We cannot rule out that fatigue or analgesic medication 
could also contribute to an overall decrease in psychomotor speed in individuals with chronic 
pain, although existing evidence does not support the latter alternative (Kendall et al., 2010; 
Landrø et al., 2013). The overall slowing of movement found in our sample might not be specific 
to CRPS but rather characterise people with chronic pain more generally, comparably to 
psychomotor slowing in patients after a stroke irrespective of hemispatial neglect (Harvey & 
Rossit, 2012; Konczak & Karnath, 1998; Rossit et al., 2009), or in other chronic diseases (Alosco 
et al., 2012; Perry et al., 2008). The current behavioural data does not allow us to dissociate the 
two alternative explanations of bilateral slowing of movement (altered cortical motor networks 
and overall psychomotor slowing), however, future studies could address this issue by 
implementing neuroimaging methods, pain-control groups, and controlling for fatigue. 
4.4. Relationships between clinical signs, motor deficits, and neuropsychological 
changes in participants with CRPS 
An additional aim of our study was to identify any relationships between clinical signs, motor 
deficits, and cognitive / psychological changes of our participants with CRPS. Recognizing that 
our analyses were exploratory, we offer only tentative explanations of the observed effects that 




performance of CRPS participants on our battery of spatial cognition tests did not contribute to 
the prediction of the clinical outcomes. Therefore, these neuropsychological changes might not 
pertain to the clinical signs of CRPS, which calls into question the role of cortical reorganisation 
in the manifestation of the disorder and potential benefits of neurocognitive treatments that target 
deficits in spatial cognition (e.g. prism adaptation, Torta, Legrain, Rossetti, & Mouraux, 2016). 
In fact, overall, the key clinical measures of pain and CRPS severity were predicted by other 
clinical measures. Specifically, both pain and CRPS symptom severity were predicted by weaker 
grip strength, and pain was additionally predicted by reduced range of movement in the affected 
hand, highlighting the relevance of motor impairment. More severe sensory abnormalities 
consistent with features of neuropathic pain also predicted greater pain severity. Furthermore, we 
found a relationship between the severity of CRPS symptoms and the extent to which pain 
interfered with daily life, including work, social life, mobility, sleep, or mood (however, as pain 
interference was co-linear with pain severity, CRPS severity could be related to either).  
From all the measures that could imply cortical reorganisation relevant to higher cognition, only 
self-reported body perception disturbance (BPDS scores) was related to pain severity and motor 
function. The BPDS measures subjective ownership of the affected limb; awareness of its 
position; attention to and valence of feelings towards the painful extremity; as well as perceived 
distortions of its size, shape, and / or weight (Lewis & McCabe, 2010). Higher pain intensity was 
previously linked to reporting greater distortions of body representation, both on the BPDS (Lewis 
& Schweinhardt, 2012) and neglect-like symptoms questionnaire (which measures partly 
overlapping construct of body ownership; Frettlöh et al., 2006; Wittayer et al., 2018). Distorted 
cognitive representation of the affected limb could reflect reorganization in the somatosensory 
cortical areas corresponding to that limb. People with weaker activation in the somatosensory 
cortex contralateral to the CRPS-affected hand (Pleger et al., 2006) and those with greater body 
perception disturbance (Lewis & Schweinhardt, 2012) had worse tactile discrimination abilities 
on the affected hand and higher levels of pain. However, there is no evidence of direct link 
between subjective representation of the affected limb and its somatosensory cortical 
representation. While previous evidence suggested that the cortical map of the affected hand in 
people with CRPS is smaller relative to the unaffected hand and healthy controls (Di Pietro et al., 
2013), a more recent, high quality study found that these maps are largely comparable and CRPS 
is not associated with reorganisation of the somatosensory cortex (Mancini et al., 2019). Our 
analyses showed that, in addition to pain and tactile discrimination thresholds, greater body 
perception disturbance was also predicted by greater mood disturbance. This is in line with 
previously demonstrated relationships between psychological distress and scores on the neglect-
like symptoms questionnaire (Michal et al., 2016; Wittayer et al., 2018). Therefore, subjective 
body representation might be related to sensory and psychological factors, but not necessarily 
taken as evidence of cortical reorganisation in CRPS.  
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Overall slowing of movements was the only outcome from our battery of spatial cognition and 
motor function tests that differentiated people with CRPS from healthy controls. We found that 
those with slower movement initiation with the affected and unaffected hands had more severely 
distorted body perception. This suggests that subjective cognitive representations can contribute 
to motor function in CRPS. Body representation relies on combined proprioceptive, vestibular, 
somatosensory, and visual information that interact with the motor control system to guide actions 
(Head & Holmes, 1912). Higher scores on the neglect-like symptoms questionnaire (which, like 
the BPDS, also regards disownership of the affected limb; Frettlöh et al., 2006) were previously 
linked to greater motor impairment and disability in individuals with CRPS (Kolb et al., 2012). 
While these distortions in body perception primarily concern the affected limb, arm position sense 
(which relies on proprioception) has been found to be impaired bilaterally in CRPS (Brun et al., 
2019; Lewis et al., 2010). Thus, deficits in proprioception in both limbs might slow down 
movement initiation due to uncertainty about their current positions. Slowing of movement 
initiation with both limbs was also predicted by longer CRPS duration, consistent with the ideas 
that central mechanisms would have greater contribution to CRPS symptomatology in more 
chronic stages of the disease (Birklein & Schlereth, 2015; Bruehl & Chung, 2015; Veldman et al., 
1993) or that psychomotor speed would decrease with longer duration of chronic pain (Jongsma 
et al., 2011; Ryan, 2005). We also found that people with more weakness in the affected hand and 
greater change in hand preference following CRPS onset (taken as an approximation of functional 
impact of CRPS) were slower to initiate and execute movements with the affected extremity. This 
is consistent with the “learned non-use” hypothesis (Punt et al., 2013): that ongoing 
underutilization of the CRPS-affected limb leads to atrophy, muscle weakness, and movement 
slowing, further exacerbating or maintaining motor deficits. Taken together, our results suggest 
that not only functional underutilization of the affected limb, but also bilateral central mechanisms 
of motor control or pain-related psychomotor slowing and subjective body perception, might 
contribute to the extent of motor impairment in CRPS.  
Overall, our exploratory analyses do not support the conclusion that changes in spatial cognition 
are relevant for the manifestation and severity of CRPS symptoms. Instead, body representation 
and motor abilities appear to be important determinants of CRPS pain and symptom severity.   
4.5. Strengths and limitations 
Our results suggest that previously reported “neglect-like” changes in spatial cognition in CRPS 
might have been overstated. There are several advantages of the present study that strengthen our 
confidence in this conclusion. We systematically tested for any visuospatial and spatially-defined 
motor biases using a battery of sensitive tests in a group of people with CRPS that was two-to-
five times larger than tested before on the TOJs or spatial motor tasks. One possible reason for 
the disparity between our results and those of previous studies is that there are individual 




variability in the clinical presentation of CRPS, different trajectories of symptom development 
and strategies to deal with pain might lead to distinct patterns of cognitive changes (Marinus et 
al., 2011). In other words, in heterogeneous conditions such as CRPS, effects might arise in small 
sample studies that may not replicate, potentially due to the chance selection of more individuals 
who happen to present with a certain deficit. Consistent with this account of variability in past 
results, our participants with CRPS showed a larger range of individual bias scores on the spatial 
tasks than the controls (Figure 2). However, since none of these measures were related to pain 
intensity or CRPS severity, their clinical relevance is unclear.  
Another strength of our study is that we controlled for potential response biases, which might 
have contributed to seemingly significant biases in previous TOJ studies. We also accounted for 
the fact that spatial attention might not normally be evenly distributed across space (see 
pseudoneglect, Jewell & McCourt, 2000) by obtaining comparative data from pain-free 
individuals. Follow-up Bayesian analyses showed anecdotal-to-moderate evidence of no 
differences between CRPS and pain-free participants on the visuospatial tasks (see also 
confidence intervals in Figure 2 illustrating no deviation from zero).  
Nonetheless, although we aimed to create a diverse battery of tests of spatial cognition, there are 
three limitations that might have prevented us from detecting previously-reported spatial biases 
in our participants with CRPS. First, we were unable to include measures of tactile attention or 
egocentric reference frame, two measures upon which biased performance has been previously 
reported in CRPS (Moseley et al., 2009, 2012; Reid et al., 2016; Reinersmann et al., 2012; 
Sumitani, Shibata, et al., 2007; Uematsu et al., 2009). This is because we designed our protocol 
such that it only required transportable equipment and thus could be administered at patients’ 
homes and in different research centres, in order to obtain large and representative sample. 
Second, most of our tasks did not involve body-relevant information, although it has been 
proposed that this might be critical for the manifestation of spatial biases in CRPS (Reid et al., 
2016). The exception is our motor task, which by definition involves the body, and which revealed 
very little evidence of any systematic spatial deficits. Considering the above-mentioned 
limitations, we cannot rule out the possibility that our participants with CRPS might have 
presented with deficits in other domains of spatial cognition than those assessed in our study. 
Third, fatigue due to long and cognitively demanding assessments and / or pain medication acting 
on the central nervous system could potentially affect our participants’ performance on the 
experimental tasks. For instance, these factors could be related to global detriment of attentional 
capacity and processing speed, leading to greater variability and cases of more extreme spatial 
biases in either direction among participants with CRPS compared to pain-free controls. Fatigue 
and medication could be also associated with decrease in psychomotor speed, potentially 
contributing to overall slowing of movements discussed in section 4.4. Notably, over half of the 
CRPS sample reported using opioid analgesics, which are often associated with subjective 
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experience of sedation or mental dullness. However, two systematic reviews of studies on the 
cognitive effects of opioid analgesia for chronic pain concluded that there is no evidence of 
significant detrimental effects on cognition (Ersek et al., 2004; Kendall et al., 2010). While some 
observational studies reported impaired processing and psychomotor speed and attention in 
patients with chronic pain treated with opioids, controlled studies rated as having higher quality 
showed either no effects of opioids on these cognitive functions, or some improvement. In fact, 
lower doses of opioids were associated with greater cognitive impairment (Kurita et al., 2012), 
while pain relief correlated with cognitive improvement (Byas-Smith et al., 2005; Sjøgren et al., 
2000, 2005), suggesting that adequate analgesia might improve cognition by means of reducing 
pain. Therefore, possible cognitive side effects of pain medication cannot fully explain greater 
variability in cognitive performance and psychomotor slowing in our participants with CRPS 
compared to healthy controls. 
Another limitation to the extent to which our results can be compared to those of previous studies 
that reported changes in spatial cognition in CRPS is that the duration of CRPS in our sample was 
on average longer (except when compared to Bultitude et al., 2017; 4 years vs. <1-3 years, Filbrich 
et al., 2017; Moseley et al., 2012, 2009; Reid et al., 2018, 2016; Sumitani et al., 2014). However, 
several arguments suggest that changes in spatial cognition should not become less apparent over 
time: (a) there are clinical indications of greater contribution of central mechanisms to the 
manifestation of CRPS in its more chronic stages (Birklein & Schlereth, 2015; Bruehl & Chung, 
2015; Veldman et al., 1993); (b) we found that longer CRPS duration predicted bilateral slowing 
of movement initiation, which could reflect central changes in motor circuits; (c) there is evidence 
of positive correlations between CRPS duration and the extent of body perception distortion, 
body-related visuospatial bias, and spatially-defined motor bias (Lewis & Schweinhardt, 2012; 
Moseley, 2004; Reid et al., 2016, 2018); and (d) other studies (Bultitude et al., 2017; Filbrich et 
al., 2017; Frettlöh et al., 2006; Michal et al., 2016; Reid et al., 2016; Reinersmann et al., 2012) 
found no relationship between CRPS chronicity and any biases in spatial cognition, including our 
own findings from spatial tasks (Pearson’s rs = 0.06 to 0.27; see Supplementary Figure S2). 
Another factor that could limit the extent to which our findings are comparable to previous 
experimental studies on spatial cognition in CRPS is that pain intensity reported by our 
participants was on average greater (except when compared to Bultitude et al., 2017, and Sumitani 
et al., 2014; 5.8/10 vs. 4.3-4.8/10, Filbrich et al., 2017; Moseley et al., 2012, 2009; Reid et al., 
2018). However, previous research reported either positive relationships between pain intensity 
and severity of “neglect-like” symptoms (Frettlöh et al., 2006; Reid et al., 2016; Wittayer et al., 
2018), or found no relationships between these factors (Bultitude et al., 2017; Filbrich et al., 2017; 
Michal et al., 2016; Moseley et al., 2009; Reid et al., 2016), including our own results (Pearson’s 
rs = -0.12 to 0.20; see Supplementary Figure S2). Therefore, it is unlikely that the longer average 
disease duration or greater average pain intensity in our sample compared to previous research 





Overall, the present findings suggest that unilateral upper-limb CRPS does not disrupt visual 
attention, mental representations, or motor function in a spatially-defined manner, and thus 
counter the analogy between CRPS and hemispatial neglect after brain injury. There were no 
behavioural indications of central changes in brain networks governing spatial cognition, 
suggesting that these are unlikely to be involved in the central mechanisms of CRPS. While 
bilateral slowing of movements could imply impairment of central mechanisms of motor control, 
it might simply reflect psychomotor slowing associated with chronic pain. Motor function appears 
to be related to some of the clinical features of CRPS rather than any spatial biases, although the 
extent of distorted cognitive representation of the affected limb seems to play a role in movement 
initiation speed and pain severity. These results support the promotion of treatments that aim to 
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Chapter 4 - Conclusions 
This study used a series of experimental measures to examine whether people with CRPS present 
with perceptual, representational, and motor “neglect-like” deficits, compared to pain-free 
individuals. However, I found no evidence of altered attention to and representation of the CRPS-
affected side of space, nor any systematic slowing of movements directed towards the affected 
relative to unaffected side. Furthermore, the extent of any changes in spatial cognition was not 
related to the severity of pain or other symptoms of CRPS. Instead, motor function and body 
representation appear to be associated with severity of pain and other symptoms. These findings 
question the presence and clinical relevance of “neglect-like” neuropsychological changes in 
CRPS, thus challenging the involvement of cortical reorganisation in the manifestation of the 
disorder.  
To place the findings of this chapter within the context of the rest of the thesis, this study did not 
replicate “neglect-like” deficits in CRPS while controlling for potential response biases, such as 
those reported in Chapter 2. This could suggest that some of the previously found deficits in 
spatial attention might be explained by participants’ decisional bias for reporting the stimuli on 
their unaffected side. Furthermore, in this study I aimed to test “pure” spatial biases and avoid 
potential overlap with distorted representation of the CRPS-affected limb. However, the 
“somatospatial inattention” hypothesis (Reid et al., 2016) discussed in Chapter 1 would suggest 
that spatial biases could be exacerbated in the presence of body-related information. Thus, the 
magnitude of any biases in this study could be too small to demonstrate any significant deviations 
from normal. However, the case study in Chapter 2 and one previous group study (Bultitude et 
al., 2017) demonstrated significant biases away from the affected side using the same 
experimental setup excluding body-relevant information. Therefore, it is unlikely that the specific 
task procedure would prevent the detection of any existing spatial bias. In the context of potential 
dissociations between biases in distinct domains of spatial cognition discussed in Chapters 1 and 
2, the findings described in this chapter were consistent across all measures of visuospatial 
cognition in near space and mental representation of space, suggesting that overall, people with 
CRPS did not present with lateralised deficits in spatial cognition.  
In addition to perceptual and representational signs of neglect, this study also tested for directional 
motor neglect, adding to the scant literature regarding movement related spatial biases discussed 
in Chapter 1. Although previous studies have tested for spatial motor biases in CRPS in the form 
of speed and accuracy of movements with either hand performed in the affected versus unaffected 
side of space, as well as a self-reported questionnaire, none had examined directional motor 
neglect (that is, slowing of movements directed towards the affected relative to unaffected side of 
space). While I found no systematic evidence of spatially-defined deficits on the motor task, 
participants with CRPS were generally slower than pain-free controls to initiate and execute 
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movements regardless of which hand they used. This deficit could not be explained by motor 
neglect, primary motor signs of CRPS, or learned underutilisation of the painful limb. Instead, 
slowing of movements affecting both limbs could be considered a sign of functional 
reorganisation in central motor networks, consistent with the conclusions from several previous 
behavioural and neuroimaging studies (Juottonen et al., 2002; Maihofner et al., 2007; Ribbers et 
al., 2002; Schilder et al., 2012; Schwenkreis et al., 2003). However, it also appears consistent with 
the impairment of psychomotor speed that is common in chronic pain more generally (Higgins et 
al., 2018). Overall, lack of any perceptual, representational, and motor spatial biases in the current 
study challenges the analogy between hemispatial neglect after brain injury and CRPS. Although 
central mechanisms of CRPS are thought to involve functional cortical reorganisation (Kuttikat 
et al., 2016; Reinersmann, Maier, et al., 2013), my behavioural findings suggest that such 
reorganisation, at least in the parietal cortical networks involved in spatial cognition, is unlikely.  
While recognising overall unbiased spatial cognition, the individual variability in the performance 
of participants with CRPS illustrated in this chapter has other theoretical implications. First, it 
could explain why the overall results of this study are not consistent with the findings from the 
case study reported in Chapter 2. That is, individual neuropsychological abnormalities can be 
easily lost in large group studies, due to the heterogeneity of CRPS (Caramazza, 1986). Second, 
the results presented in this chapter suggest greater than previously assumed variability in the 
direction of any spatial biases. Specifically, some participants showed biases towards their 
affected side, contrary to the hypothesised “neglect-like” bias. In fact, there are only two reported 
cases, including the one described in Chapter 2, of spatial biases towards the CRPS-affected side 
on measures similar to those reported in this chapter (Christophe, Delporte, et al., 2016; Jacquin-
Courtois et al., 2017). Using a different measure, studies from one research group suggest a 
deviation in the egocentric reference frame towards the CRPS-affected side (Sumitani et al., 2014; 
Sumitani, Rossetti, et al., 2007; Sumitani, Shibata, et al., 2007; Uematsu et al., 2009). Therefore, 
the inconsistencies in the direction of spatial biases discussed in Chapter 1 could be partly due to 
specific characteristics of CRPS participants available in particular research centres, or simply 
reflect chance findings. If there are any changes in spatial cognition, these might be more variable 
in broader CRPS population. 
Although on average participants with CRPS did not show any spatial biases, individual 
variability in their performance could still theoretically reveal some relationships between these 
biases and clinical symptoms of CRPS (for example, if spatial bias only significantly contributed 
to pathology for a subgroup of patients). However, exploratory analyses showed no such 
associations in this study, therefore questioning the clinical relevance of any changes in spatial 
cognition. Instead, the results indicated a potential role of self-reported body representation and 
motor function in clinical manifestation of CRPS, with greater motor deficits in more chronic 




the maintenance and severity of CRPS symptoms. While recognising the importance of using the 
affected limb, they also suggest that not all deficits might be overcome by physical exercise and 
multidisciplinary treatment should also address body perception and adequate pain control. 
Null results regarding the presence and clinical relevance of lateralised biases in spatial cognition 
in this study might have implications for the effects of prism adaptation tested in Chapter 5. If 
prism adaptation reduces pain through normalising spatial attention, it might not incur the 
expected benefits for participants who do not show the hypothesised neglect for their affected 
side. However, the findings reported in this chapter demonstrate substantial individual variability 
among participants with CRPS in their performance on the tests of spatial cognition and motor 
function. Namely, looking at the individual data, there were subgroups of participants who 
presented with biases away from, or towards their affected side on different tasks, in addition to 
those whose performance did not differ from pain-free controls. Thus, prism adaptation might 
still reduce pain through an attentional mechanism for the subgroup of participants with deficits 
in attention to their affected side at baseline.  
Yet presence of participants who showed a bias towards their affected side (opposite to “neglect-
like” deficit) has further implications for the applicability of the protocol of prism adaptation 
treatment proposed in Chapter 3. Participants allocated to the prism adaptation treatment arm are 
exposed to a uniform direction of visual shift, that is, away from their CRPS-affected side, so that 
the adaptation leads to after-effects towards their affected side. If this intervention aims to 
normalise baseline spatial bias, it could be argued that individuals showing a bias toward their 
affected side should perform the treatment using prism lenses that shift the visual image towards 
their affected side, and thus adapt in the opposite direction. However, participants in the first study 
of prism adaptation in CRPS (Sumitani, Rossetti, et al., 2007) showed baseline spatial shift of 
their egocentric reference frame towards the affected side, yet their pain decreased following 
prism adaptation in the direction that would induce after-effects towards their affected side. When 
one of these participants later underwent adaptation in the opposite direction, her pain increased. 
Therefore, there is currently insufficient evidence to support prescribing the direction of prismatic 
shift based on individual direction of baseline spatial bias. First, we should gain better 
understanding of the mechanisms of prism adaptation in CRPS. Among other things, in Chapter 
5 I will be able to test whether any benefit of prism adaptation is specific to those patients who 
show a bias away from their affected side. If so, then this could support further investigations to 
test whether patients with the opposite baseline bias benefit from adaptation to prismatic shifts in 
the opposite direction.  
Even though the majority of tested participants with CRPS showed balanced spatial performance, 
therapeutic benefits of prism adaptation might still be achieved through some mechanisms other 
than correcting spatial bias, such as normalising sensory-motor integration. This alternative 
mechanism relies on a hypothesis that distorted representation of the affected limb gives rise to 
Chapter 4 
226 
incongruencies between predicted and actual consequences of movement. Such sensory-motor 
conflicts are thought to contribute to pathological pain, including CRPS (Brun et al., 2019; Harris, 
1999; McCabe & Blake, 2008). Higher subjective disturbance of body perception among 
participants with CRPS described in this chapter compared to pain-free individuals, and its 
predictive value for pain severity, would support this potential mechanism. In Chapter 5 I will 
report more objective, experimental assessment of cognitive representation of the affected limb, 
and investigate both proposed mechanisms of prism adaptation and whether any individual 
differences in baseline spatial or body representation biases are related to changes in pain and 
CRPS symptom severity. Although the findings reported in the current chapter challenge the 
primary rationale for using prism adaptation as a potential treatment for CRPS, this intervention 
might still bring therapeutic effects though different mechanisms, and / or for a subset of 




Chapter 5: Prism adaptation treatment for upper-limb 
Complex Regional Pain Syndrome: a double-blind 
randomized controlled trial 
Chapter 5 – Introduction 
In this final chapter, I will present the findings from a randomised controlled trial of prism 
adaptation for CRPS, the protocol of which was described in Chapter 3. This treatment is thought 
to reduce pain and other CRPS symptoms (Bultitude & Rafal, 2010; Christophe, Chabanat, et al., 
2016; Sumitani, Rossetti, et al., 2007) by increasing attention to the affected side, consistent with 
its primary application in rehabilitation of hemispatial neglect (Rossetti et al., 1998). However, I 
also consider a second possible mechanism, based on normalising body representation and 
correcting sensory-motor incongruence. The key research question that has not been addressed 
thus far is whether prism adaptation can reduce pain and CRPS severity more than a control 
treatment. Since the mechanisms through which prism adaptation can relieve pain are still unclear, 
I will also report how it affects a range of secondary outcomes, including neuropsychological 
functions relevant to prism adaptation such as spatial cognition and body representation. Prism 
adaptation is expected to lead to greater reductions in neuropsychological symptoms, clinical 
signs of CRPS, and self-reported CRPS-related and psychological disturbances, compared to 
control treatment. To assess any fluctuations in the outcomes of interest, participants undergo two 
baseline assessments, one month apart. Participants’ performance in the first baseline session, 
compared to pain-free controls, was examined in Chapter 4 to address research questions separate 
from the main objective of this trial. The second baseline session takes place immediately before 
commencing two weeks of prism adaptation or sham treatment. The effects of these treatments 
on the primary and secondary outcomes are assessed immediately after completing the treatment. 
To examine how long any benefits of treatment are sustained for, participants are assessed again 
one month later, and a subset of self-reported outcomes is also collected three and six months 
after completing the treatment. Finally, in this chapter I explore any baseline characteristics of 
participants with CRPS that could predict how much their pain and symptom severity improve or 
deteriorate over time. I discuss the findings in the context of previous studies on prism adaptation, 
characteristics of our sample, specific features of the two treatment arms, different proposed 
mechanisms of prism adaptation, and relationships between clinical and neuropsychological 
symptoms. 
Similar to the procedures used in the previous studies of prism adaptation for post-stroke 
hemispatial neglect and CRPS, participants in this trial undergo two weeks of twice-daily prism 
adaptation treatment, performed using the affected limb, with prismatic lenses shifting visual 
image approximately 19° away from the affected side to obtain after-effects towards the affected 
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side. The major differences between this and previous studies on CRPS are (a) the random 
allocation of participants to either prism adaptation, or control treatment of the same intensity and 
duration, which uses neutral lenses that do not shift the visual image and thus the training does 
not induce any adaptation; (b) the blinding of the participants and the researcher to treatment 
allocation; and (c) the sample of participants allocated to prism adaptation treatment being three 
times greater than the largest sample of existing studies (Christophe, Chabanat, et al., 2016). 
Overall, this chapter presents a robust, well-controlled, and unbiased assessment of prism 
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Initial evidence suggested that people with Complex Regional Pain Syndrome (CRPS) have 
reduced attention to the affected side of their body and the surrounding space, which might be 
related to pain and other clinical symptoms. Three previous unblinded, uncontrolled studies 
showed pain relief following treatment with prism adaptation, an intervention that has been used 
to counter lateralised attention bias in brain-lesioned patients. To provide a robust test of its 
effectiveness for CRPS, we conducted a double-blind randomized controlled trial of prism 
adaptation for unilateral upper-limb CRPS-I. Forty-nine eligible adults with CRPS were 
randomized to undergo two-weeks of twice-daily home-based prism adaptation treatment (n = 
23) or sham treatment (n = 26). Outcomes were assessed in person four weeks prior to and 
immediately before treatment, and immediately after and four weeks post-treatment. Long-term 
postal follow-ups were conducted three and six months after treatment. We examined the effects 
of prism adaptation versus sham treatment on current pain intensity and CRPS symptom severity 
score (primary outcomes); as well as sensory, motor, and autonomic functions, self-reported 
psychological functioning, and experimentally tested neuropsychological functions (secondary 
outcomes). Primary and secondary outcomes did not differ between the prism adaptation and 
sham treatment groups when tested at either time point following treatment. Overall, CRPS 
severity significantly decreased over time for both groups, but we found no benefits of prism 
adaptation beyond sham treatment. Our findings do not support the efficacy of prism adaptation 
treatment for relieving upper-limb CRPS-I. This trial was prospectively registered 
(ISRCTN46828292). 
Keywords 
Complex Regional Pain Syndrome; Prism adaptation; Randomized controlled trial; Attention; 





Complex Regional Pain Syndrome (CRPS) is associated with continuous pain in one or more 
limbs accompanied by sensory, motor, and autonomic disturbances that are disproportionate to 
any inciting injury [34]. Individuals with CRPS can also show neuropsychological symptoms 
reminiscent of hemispatial neglect after brain injury [32] (see Chapter 1). These can present as 
distorted cognitive representations of the CRPS-affected limb(s) [44,51,74,90,99], reduced 
attention to the affected limb(s) and corresponding side of external space [12,21,24,26,78,89], 
poorer mental representation of the affected side of space [104], and spatially-defined motor 
deficits [89]. The extent of these neuropsychological changes has been associated with the 
severity of clinical signs of CRPS [24,46,51,77,78,89,90,113] and could pertain to its central 
mechanisms [91]. 
Prism adaptation (PA) is a sensorimotor training technique used to reduce lateralised biases in 
attention, spatial representations, and (ocular)motor performance in hemispatial neglect after 
brain injury [56,70,95]. Considering similar deficits in CRPS, three previous studies tested the 
efficacy of PA in a total of 13 patients with this condition. They reported significant relief of pain 
and other CRPS symptoms following eight to 20 PA sessions performed with the affected arm 
when participants adapted towards their affected side [10,13,105]. The reduction in pain lasted 
up to two weeks. Thus, PA has the potential to durably relieve pain and other symptoms of CRPS. 
Because PA is quick (5-10 minutes a day), inexpensive, and self-administered, it is an appealing 
intervention compared to more intensive neurocognitive treatments like graded motor imagery 
[75]. However, the strength of available evidence for PA is limited, because it was only previously 
tested in small samples, without any control treatments or blinding. 
The mechanisms through which PA could relieve pain are unclear. One possibility is that it 
increases attention to the CRPS-affected side relative to the unaffected side. Indeed, when one 
patient underwent adaptation in the opposite direction such that the theoretical attention bias away 
from the affected side would be exacerbated, their pain increased [105]. More severe self-reported 
“neglect-like” symptoms and spatial attention and motor biases have been related to greater pain 
intensity and worse long-term pain outcomes [24,89,90,113]. A potential second mechanism is 
that PA restores normal sensorimotor integration, the disruption of which is thought to contribute 
to pathological pain including CRPS [9,37,64,105]. This is consistent with the findings that 
individuals without spatial biases can also benefit from PA [13]. 
Despite promising preliminary evidence, no studies have attempted a robust test of the effects of 
PA on CRPS. Therefore, we conducted a double-blind, randomized, sham-controlled trial of PA 
for upper-limb CRPS-I. We hypothesised that two weeks of twice-daily PA treatment would 
reduce the primary outcomes of pain intensity and CRPS symptom severity more than sham 




of neuropsychological symptoms (i.e. biases in spatial cognition, motor control, and body 
representation), clinical signs of CRPS, and self-reported CRPS-related and psychological 
disturbances following PA compared to sham treatment. The outcomes were assessed at six time 
points: to establish a one-month pre-treatment baseline, and to examine any immediate effects of 
PA and their retention at one, three, and six months post-treatment. 
2. Methods 
2.1. Study design and participants 
The study was a two-arm parallel group RCT. It was prospectively registered (ISRCTN46828292) 
and the full details of the study are reported in the study protocol and analysis plan [33] (see 
Chapter 3). Any protocol deviations are specified in Text S1, Supplemental Material. The study 
was approved by the UK National Health Service (NHS) Oxfordshire Research Ethics Committee 
A and Health Research Authority (REC reference 12/SC/0557). 
Recruitment was conducted via post and clinicians’ referrals through the National CRPS-UK 
Registry, internal registries of the Royal United Hospitals and Walton Centre NHS Foundation 
Trusts, and clinicians’ referrals through the Oxford University Hospitals NHS Foundation Trust  
and other NHS pain clinics in the UK. Word of mouth, print and online advertisements, as well 
as social media were further used to disseminate information about the study. Participants were 
recruited between March 2017 and December 2018, and the final long-term follow-up took place 
in July 2019.  
Following provisional assessment of eligibility through a phone interview, recruited participants 
took part in four research sessions (RS) at the University of Bath (n = 33), University of Liverpool 
(n = 9), or in the participant’s home (for participants who were unable to travel; n = 7). Participants 
gave written informed consent at the beginning of RS1, prior to any study-related procedures. The 
research sessions involved in-person assessment of eligibility criteria and of the primary and 
secondary outcomes, including self-report questionnaires, clinical assessments, and tests of 
neuropsychological functions. Each RS lasted from two to four hours, including breaks between 
the assessments. The data collection schedule is presented in Figure 1. The baseline was measured 
over two research sessions (RS1 and RS2) separated by four weeks. Immediately after RS2, 
participants commenced a two-week home-based treatment period. Treatment outcomes were 
measured over two research sessions, one immediately (RS3) and one four weeks (RS4) after 
completing the treatment. Two long-term follow-ups were conducted via post – one at 12 weeks 
(LTFU1) and one at 24 weeks (LTFU2) after completing the treatment. The flow of participants 




Figure 1. Schedule of data collection and interventions. 
Participant inclusion criteria were: being aged 18-80 years; having a diagnosis of CRPS-I 
primarily affecting one upper limb based on the Budapest research criteria [34]; having a CRPS 
diagnosis for ≥3 months at the time of RS1; and having a current pain intensity ≥2 on a 0-10 
Numeric Rating Scale. Exclusion criteria were: lacking sufficient English language ability to 
provide informed consent; being classified as legally blind; reporting a history of neurological 
disorder (e.g. stroke, neurodegenerative disease, or traumatic brain injury); having CRPS in the 
opposite limb meeting the Budapest clinical or research criteria; reporting confirmed nerve 
damage (CRPS-II); reporting or showing dystonia or other physical impairment that would 
prevent satisfactory execution of PA/sham treatment; or reporting severe psychiatric comorbidity 
(e.g. schizophrenia [109]) that could be associated with perceptual changes. Inclusion and 
exclusion criteria were assessed in RS1 and RS2. 
Participants were primarily recruited for the current RCT of PA treatment, but we also collected 
measures of spatial cognition, motor control, and body representation at baseline (RS1) for 








Figure 2. CONSORT diagram. Flow of participants through the study. RS1, research session 1; 
RS2, research session 2; RS3, research session 3; RS4, research session 4; LTFU1, long-term 
follow-up 1; LTFU2, long-term follow-up 2; ITT, intention-to-treat analysis (received allocated 
intervention); PP, per-protocol analysis (completed allocated intervention, RS3-4 [CRPS 
severity], and LTFU1-2 [Pain intensity]). 
2.2. Interventions 
Both groups were instructed to continue any usual treatments (including medications) but were 
asked not to change their treatment regimens throughout the duration of the trial if possible. 
Current treatments and any changes are reported in Table S1, Supplemental Material. 
2.2.1. Prism adaptation treatment 
Participants randomised to the PA treatment used welding goggles fitted with 35-diopter Fresnel 
lenses that induced approximately 19° lateral optical deviation (visual shift) away from the CRPS-
affected side. In each treatment session, participants were seated approximately 50cm from a wall 
or other vertical surface (distance was adjusted individually to correspond to the participant’s 
almost fully extended arm). An A4 sheet was positioned on the wall in a landscape orientation at 
eye-level and in line with their body midline. There were two targets (2cm-diameter red circles) 
on the pointing sheet, located 12.5cm to the left and 12.5cm to the right of participant’s body 
midline. While wearing the prism goggles, participants used their CRPS-affected arm to perform 
50 pointing movements, as fast as possible, alternating between the left and right target.  
An example of prism adaptation is illustrated in Figure 3. Prismatic shifts were directed away 
from the CRPS-affected side, thus participants with left-CRPS would use rightward-shifting 
prism goggles as illustrated in the figure. Due to the rightward visual shift, pointing would initially 
err to the right. However, with repeated movement execution and motor learning, the pointing 
would become increasingly accurate, as the movements would adjust in the opposite direction (to 
the left). This adaptive realignment of sensorimotor reference frames [87,107] would produce 
movement after-effects towards the left (affected) side. That is, once the goggles were removed, 
pointing would temporarily err to the left. Conversely, participants with right-CRPS would use 
leftward-shifting prismatic goggles to induce adaptive realignment (movement after-effects) 
towards their affected side. Studies from neurologically healthy individuals and stroke patients 
show that these short-term movement after-effects are accompanied by a longer-lasting 
realignment of attention, spatial representations, and lateralised (ocular)motor performance in the 





Figure 3. Prism adaptation procedure. In this example, participant with left-CRPS is using 
rightward-shifting prisms (A-C), which induce adaptation towards the left (affected) side. For 
clarity of illustration, only one target (red circle) is represented in the figure. However, the 
treatment procedure involved two targets presented in the left and right side of space, and 
participants’ pointing movements alternated between the left and right targets. (A) Prism goggles 
shift visual image to the right. Blue triangle represents a shift of visual perspective and perceived 
target location (pale red circle), relative to real location of the target (light grey triangle, dark red 
circle). (B) Pointing movements initially err to the right. (C) Adaptive realignment results in 
correct pointing movements. (D) Goggles are removed and pointing movements err to the left 
(after-effect). 
The chosen direction of PA, inducing a visual shift away from the affected side and thereby an 
after-effect towards the affected side, is consistent with previous CRPS studies [10,13,105] and 
the technique’s application in rehabilitation of hemispatial neglect after brain injury [56,95]. To 
enhance the effects of PA, welding goggles occluded the first half of the arm movement and 
participants were encouraged to point as quickly as possible. Both these measures are thought to 
reduce any deliberate misaiming on behalf of the participants and encourage greater adaptive 
realignment (i.e. “true” sensorimotor adaptation) [19,87,88].  
Immediately after RS2, participants were trained in person in how to carry out the treatment by a 
research psychologist JHB or ADV (neither of whom were involved in any data collection) 
according to a standardised protocol (see training script in Text S2, Supplemental Material). Once 
the researcher was satisfied that the participant understood the treatment procedure, they 
performed the first treatment during this training session under the guidance of the researcher. At 
the end of the training session participants received a pair of prism goggles in a sealed opaque 
bag, a pointing sheet, written instructions, and a link to a video tutorial (see Video S1, 
https://youtu.be/dcLuyPfFowM) to take home. In addition to the treatment that they underwent 
during training, participants were instructed to perform twice-daily self-guided treatment sessions 
at home for two weeks, resulting in 29 treatment sessions in total. Participants were instructed to 
commence the home-based treatment on the day following RS2, perform one session in the 




2.2.2. Sham treatment 
Participants randomized to the sham treatment carried out exactly the same procedure as described 
above, except they used welding goggles fitted with neutral lenses that did not induce any lateral 
visual shift [11,70]. The neutral lenses distorted the acuity and clarity of vision to a similar extent 
as prism lenses (only without any lateral shift), therefore the two treatment arms were similar 
aside from the sensorimotor adaptation.  
2.3. Randomisation and blinding 
Participant randomization was performed 1-5 days before RS2 by JHB, who was not involved in 
any data collection. Participants were randomly assigned to either PA or sham treatment group 
with equal allocation ratio, using MINIM [69] software to minimize baseline (RS1) group 
differences in current pain intensity, CRPS severity score, primarily affected arm, pre-CRPS 
dominant hand, sex, age, presence of CRPS in other body parts, presence of other non-CRPS pain, 
and CRPS duration. The primary outcome measures (current pain intensity and CRPS severity 
score) were given double weighting compared to the other minimisation characteristics as we 
considered matching the two groups for these factors to be a higher priority. Minimisation ensures 
balance between groups across multiple factors, even in small samples. While the first participant 
is allocated using simple randomisation, the treatment allocated to the subsequent participants 
partly depends on the characteristics of those participants already allocated [1,108]. Note that 
participants excluded between treatment allocation and completion of RS3 (Figure 2) were 
removed from the minimisation procedure so that subsequently recruited participants could be 
allocated independent of these exclusions and according to the current pool of participants 
remaining in each arm. 
The only researchers who were aware of individual treatment allocations were those who 
randomised the participants and/or trained them in carrying out PA or sham treatments and 
provided them with prism or neutral goggles (JHB and/or ADV). These researchers were not 
involved in the assessments of any outcomes at any point in the trial. In RS3, the participants 
returned the goggles in a sealed opaque bag to MH, which she handed unopened to JHB. The 
researcher responsible for enrolment and all data collection (MH) remained blinded to 
participants’ treatment allocation until the last participant completed their RS4. Following RS4, 
there were no further in-person assessments as the long-term follow-up was conducted via postal 
questionnaires and scored by blinded research assistants. The participants were blinded to their 
treatment allocations throughout the entire duration of the trial. They were informed that they 
might receive real or sham treatment, and that both involved reaching out to touch visual targets 
with their affected arm while wearing goggles that distort vision. However, participants were not 




goggles used in the two treatment arms. All documentation and instructions referred to the 
treatment arm as “sensorimotor training”. 
2.4. Measures 
2.4.1. Demographics  
In RS1, participants reported on demographic characteristics, including age, sex, and handedness 
prior to CRPS onset. They were asked to complete two versions of Edinburgh Handedness 
Inventory (EHI) [81]: once rating their recalled hand preference prior to CRPS onset, and once 
rating their current hand preference. Total scores can range from -100 (extreme left-handedness) 
to 100 (extreme right-handedness). To approximate the functional impact of CRPS, we calculated 
an absolute difference between current and recalled EHI scores, that is, change in handedness. 
We also interviewed the participants regarding their clinical history, including the date and type 
of any inciting injury, CRPS duration (time since diagnosis), any co-morbidities, and any ongoing 
treatments for CRPS.  
2.4.2. Primary outcomes 
A change between RS2 and RS3 in current pain intensity and CRPS symptom severity score were 
the primary outcomes. In RS1-RS4 and LTFU1-LTFU2, participants rated their current pain 
intensity in the CRPS-affected limb on a Numerical Rating Scale (NRS) from 0 (no pain) to 10 
(pain as bad as you can imagine). This measure was taken from the Brief Pain Inventory (BPI; 
item 6) [14] and has been recommended as a core outcome for chronic pain trials [17,30]. CRPS 
severity was assessed in RS1-RS4 according to a standardised protocol [36]. Eight self-reported 
symptoms and eight signs evaluated upon clinical examination were scored as 0 (absent) or 1 
(present) based on sensory testing, and visual and manual examination (see section 2.4.3.2. for 
details). The summed CRPS severity score can range from 0 (no CRPS symptoms) to 16 (most 
severe CRPS symptoms). The CRPS severity score has good discrimination abilities, concurrent 
validity, and adequate sensitivity to change [35,36], and was recommended as the core outcome 
measure for CRPS clinical studies [30]. 
2.4.3. Secondary outcomes 
2.4.3.1. Self-report measures 
Self-reported secondary outcomes measured in RS1-RS4 and LTFU1-LTFU2 included 
questionnaires about pain, body representation, and emotional functioning. We measured pain 
intensity and interference, using the BPI (0-10 scale for each subscale; higher scores indicate 
greater intensity/interference [14]), and neuropathic features of experienced pain, using Pain 
Detect Questionnaire (PDQ; -1-38 scale; higher scores indicate greater neuropathic component of 
pain [25]). Body representation was measured using the Bath CRPS Body Perception Disturbance 
Scale (BPDS; 0-57 scale; higher scores indicate greater distortions of body perception [50]). For 
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emotional functioning, we measured pain-related fear of movement and re-injury, using Tampa 
Scale for Kinesiophobia (TSK; 17-68 scale; higher scores indicate more severe kinesiophobia 
[68]) and mood disturbance, using Profile of Mood States (POMS; 17-229 scale; higher scores 
indicate greater mood disturbance [65]). In RS1, participants also rated their levels of optimism 
and pessimism, using Revised Life Orientation Test (LOTR; 0-24 scale; higher scores indicate 
higher optimism level [98]), and their expectations and criteria for success in chronic pain 
treatment, using Patient Centred Outcomes Questionnaire (PCOQ; each item scored on 0-10 
scale; higher scores indicate higher usual, desired, expected, and considered successful (in terms 
of the treatment outcome) levels of pain, fatigue, emotional distress, and interference, and higher 
importance of improvement in each of these areas [92]). In post-treatment RS3-RS4 and LTFU1-
LTFU2, participants rated their impression of how much their activity limitations, symptoms, 
emotions, and overall quality of life related to CRPS changed due to treatment, using the Patient 
Global Impression of Change questionnaire (PGIC; 1-7  scale; 1 indicates no change or worsening 
of symptoms; higher scores indicate greater improvement [39]). We chose the abovementioned 
self-report questionnaires based on recommendations for core outcome measures for chronic pain 
trials [17] and the existing literature on CRPS implicating other relevant measures (e.g. [29]). The 
LOTR and PCOQ were included to assess whether two treatment groups were matched on their 
average optimism and expectations of outcomes, because these factors can affect the success of 
novel treatments [5,52,110]. 
Throughout the first 10 weeks of the trial (RS1-RS4), participants rated their average level (over 
the past 24 hours) of pain intensity, the degree to which their symptoms interfered with their daily 
life, and range of movement in the affected limb, using daily logbooks (0-10 NRS scale; higher 
scores indicate greater pain intensity, symptoms interference, and better range of movement).  
2.4.3.2. Clinical assessments 
We assessed participants’ CRPS signs and symptoms, and sensory, autonomic, and motor 
functions in RS1-RS4. Each assessment started with the unaffected side. Sensory tests were 
performed on the most painful site on the CRPS-affected limb and the corresponding site on the 
unaffected limb, unless specified otherwise. 
2.4.3.2.1. CRPS diagnostic criteria and symptom severity score 
The Budapest research criteria were assessed in RS1 and RS2 to confirm CRPS diagnosis, and in 
RS3 and RS4 to determine whether participants still met the diagnostic criteria post-treatment. 
The same assessments were used to calculate the CRPS severity score in each research session. 
Specifically, participants reported whether they experienced: (1) continuous, disproportionate 
pain in their affected limb; (2) allodynia, hyperpathia, and/or hypoesthesia in their affected limb; 
(3) temperature, (4) colour, and (5) sweating asymmetries between the affected and unaffected 
limbs; (6) oedema, (7) dystrophic changes, and (8) motor abnormalities in their affected limb. 




hyperalgesia, using a single pinprick; (10) allodynia, using a single brush stroke, touch of a 128Hz 
tuning fork, and of a cold metal pen; (11) temperature asymmetry, using an infrared thermometer 
(arithmetic mean of three recordings from each limb; asymmetry was present if absolute 
difference between two limbs was >1°C); (12) colour asymmetry, using visual examination; (13) 
asymmetric oedema, using a figure-of-eight hand size measure [83] (arithmetic mean of three 
measurements of each hand; oedema was present if size of the affected hand was >0.56cm larger 
than size of the unaffected hand [48]); (14) sweating asymmetry, using visual and tactile 
examination; (15) dystrophic changes, using visual examination; and (16) motor abnormalities, 
using an electronic hand dynamometer (arithmetic mean of three maximum force grips with each 
hand; weakness was present if affected/unaffected hand grip force ratio was <0.95 [left-handed 
participants] or <0.85 [right-handed participants] [41,84]), delta finger-to-palm distance [106] 
(∆FTP; decreased range of movement was present if affected/unaffected ratio was <0.9), and 
visual examination (tremor, muscle spasms, dystonia, range of movement).  
The reported symptoms, and the signs of CRPS rated as present upon in-person examination were 
summed to obtain the CRPS severity score. We additionally took photographs of both limbs and 
videos of fist closure and opening, wrist flexion, extension, and radial and ulnar deviation. These 
were double-scored for the presence of colour asymmetry, dystrophic changes, and motor 
abnormalities by a trained research assistant who was blind to treatment allocation, affected limb, 
and time point of assessment. Cohen’s kappa statistics for inter-rater agreement were significantly 
different from zero, indicating fair agreement for colour asymmetry (κ = .21, p = .004) and 
dystrophic changes (κ = .23, p < .001), and borderline slight/fair agreement for motor impairment 
(κ = .20, p < .001). 
2.4.3.2.2. Sensory, autonomic, and motor signs of CRPS 
Secondary outcomes of sensory function of the affected relative to unaffected limb assessed in 
RS1-RS4 included elements of quantitative sensory testing, administered according to the 
standardised protocol [93]. Specifically, we measured Mechanical Detection Thresholds (MDT) 
using von Frey filaments. A positive threshold ratio [(MDTaffected-MDTunaffected)/MDTaffected] 
indicates increased tactile detection threshold (hypoesthesia) on the affected side. We further 
measured Mechanical Pain Thresholds (MPT) using pinprick stimulators. A positive threshold 
ratio [(MPTunaffected-MPTaffected)/MPTunaffected] indicates decreased pain threshold (hyperalgesia) on 
the affected side. A procedure to measure allodynia was adapted from the dynamic mechanical 
allodynia test [93], in which a cotton ball, a Q-tip, and a brush were applied to the skin five times 
each, in a random order. An arithmetic mean of participants’ ratings for each sensation from 0 
(no sharp, pricking, stinging, or burning sensation) to 100 (most intense pain sensation 
imaginable) was used to quantify the severity of allodynia on the affected limb. We also measured 
Two-Point Discrimination thresholds (TPD) using a disk with one and two plastic tips separated 
by 2-15mm distance, which were applied to participants’ index fingertips. Participants reported 
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whether they perceived touch on one point or two points on their finger. Starting from 7mm 
distance, we increased or decreased (down to a single tip) the distance according to a staircase 
procedure (analogous to that used for MDT and MPT), until we obtained five subthreshold 
(perceived touch on one point) and five suprathreshold (perceived touch on two points) values. A 
geometric mean of these 10 values was taken as a TPD threshold for each hand. A positive 
threshold ratio [(TPDaffected-TPDunaffected)/TPDaffected] indicates higher tactile discrimination 
threshold, that is, less precise discrimination ability of the affected hand.  
In addition to contributing to the CRPS severity score, the following measures were used as 
secondary outcomes of autonomic and motor function of the affected relative to unaffected limb: 
temperature difference (affected–unaffected; a negative score indicates that the affected limb was 
colder; absolute values were also analysed); oedema (affected–unaffected; higher scores indicate 
greater swelling of the affected limb); grip strength (affected/unaffected; scores <1 indicate 
weaker strength of the affected hand); and ∆FTP distance (affected/unaffected; scores <1 indicate 
lower range of movement of the affected hand).  
2.4.3.3. Tests of neuropsychological functions 
In RS1-RS4, the participants completed six experimental tests of the following 
neuropsychological functions: visuospatial attention (Temporal Order Judgement, Landmark, and 
Greyscales tasks); mental representation of space (Mental Number Line Bisection task, MNLB); 
spatially-defined motor function; and body representation (Hand Laterality Recognition task). 
Detailed descriptions of the experimental materials and methods can be found in the trial protocol 
[33] (see Chapter 3). Below we summarise the key details of the administered tasks that are 
necessary to interpret the results.  
All experimental tasks were programmed and administered using PsychoPy software [82]. For 
the tasks involving presentation of visual stimuli on a computer screen, a touchscreen (34.5cm x 
19.4cm size, 1920 x 1080 pixels resolution) was positioned at 50cm viewing distance. In all tasks 
(except the MNLB), participant’s head was stabilised by a chinrest and they were instructed to 
focus their gaze on a fixation cross that was aligned with their body midline. When a manual 
response was required, participant used their unaffected hand to press the buttons, which were 
aligned orthogonally to the required response format (i.e. for left/right responses, participant 
pressed colour-coded bottom/top buttons). A short practice session was completed before each 
task to familiarise the participant with the procedures and ensure that they could follow the 
instructions. Data for stimuli/responses in the left and right sides of space for all tasks were 
recoded after collection in terms of affected and unaffected space relative to each participant’s 




2.4.3.3.1. Visuospatial attention 
2.4.3.3.1.1. Temporal Order Judgement task 
The Temporal Order Judgement (TOJ) measures covert spatial attention. On each trial, participant 
saw a pair of brief (10ms), identical, red light flashes, presented with different offsets onto a white 
table surface, one on each side of space (approximately 18° to the left and 18° to the right of a 
fixation point, located approximately 28cm away from their torso). Participant reported which of 
the two lights they perceived first (in one response block) or second (in another response block) 
by saying “left” or “right”. The stimulus locations and responses were expressed relative to each 
participant’s CRPS-affected side (i.e. as affected and unaffected). There were 10 temporal offsets 
between the lights (10, 30, 60, 120 and 240ms; negative values indicate that the light on 
the affected side appeared first). Each temporal offset was presented 15 times in pseudorandom 
order, resulting in 150 trials per response block. The participant’s responses to different temporal 
offsets were fitted with a cumulative Gaussian using a criterion of maximum likelihood to derive 
the Point of Subjective Simultaneity (PSS) for each block of the task. The PSSs from two response 
blocks were then averaged to account for any response bias [22]. The PSS expresses by how many 
milliseconds the light in the affected side of space had to precede (negative PSS) or follow 
(positive PSS) the light in the unaffected side of space for both lights to be perceived as 
simultaneous. Information that receives greater attention is perceived earlier than information that 
receives lesser attention [102]. Thus, a negative PSS value indicates reduced attention to the 
affected side of near space relative to the unaffected side.  
2.4.3.3.1.2. Landmark task 
The Landmark task [58] measures visual representation of relative horizontal distance in near 
space. On each trial, participants saw a fixation cross on constant display in the centre of the 
computer screen. After 500ms, a pair of landmarks (white 1.1° diameter circles) was presented 
simultaneously, one landmark to the left and one landmark to the right of the fixation cross. The 
landmarks were displayed for 300ms and were followed by a 200ms mask. While the distance 
between both landmarks was 15° across all trials, their relative distance from the fixation cross 
varied from 8.1° to 6.9° away from fixation in the horizontal plane by 0.1° increments (negative 
values represent the location of the left landmark, and positive values represent the location of the 
right landmark, relative to central fixation at 0°). Participants pressed a button to indicate whether 
the left or the right landmark appeared closer to (in one response block) or further from (in another 
response block) the fixation cross, which initiated the next trial. The stimulus locations and 
responses were expressed relative to each participant’s CRPS-affected side (i.e. as affected and 
unaffected). Each of the 13 pairs of landmarks (six pairs in which the landmark on the affected 
side was further from fixation, six pairs in which the landmark on the unaffected side was further 
from fixation, and one pair in which both landmarks were equidistant) was presented 15 times in 
pseudorandom order, resulting in 195 trials per block. The participant’s responses to different 
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relative landmark locations were fitted with a cumulative Gaussian using a criterion of maximum 
likelihood to derive the Point of Subjective Equality (PSE) for each block of the task. The PSEs 
from two response blocks were averaged to account for any potential response bias. The PSE 
expresses the relative distance (°) at which the landmark on the affected side of space had to be 
further from (negative PSE) or closer to (positive PSE) the fixation cross in order to perceive the 
two landmarks to be equidistant. A negative PSE value indicates underestimation of the distance 
on the affected relative to the unaffected side, and thus underrepresentation of the affected side 
of near space.  
2.4.3.3.1.3. Greyscales task 
The Greyscales task [80] measures overt spatial attention. On each trial, participants saw a pair 
of horizontal bars (9.95° or 12° x 1.95°) presented in the centre of a computer screen on constant 
display, one above the other. The two bars were filled with greyscales (i.e. a gradient of shading 
with one horizontal end darker than the other) and were mirror images of each other so that one 
bar was darker on the left side and the other bar was darker on the right side (expressed relative 
to each participant’s CRPS-affected side, i.e. as affected and unaffected side). Participants pressed 
a button to indicate whether the top or the bottom bar appeared to be darker overall, which initiated 
a 150ms mask followed by the next trail. There were 40 trials in which the bars were presented 
in different vertical alignments. We calculated an index of spatial bias by subtracting the number 
of “unaffected” responses (choosing a bar darker on the unaffected side, regardless of its vertical 
alignment) from the number of “affected” responses, and dividing the difference by the total 
number of trials. A negative value indicates that a higher proportion of overall darkness 
judgements was made based on the unaffected sides of the stimuli, consistent with reduced 
attention to the affected relative to unaffected side.  
2.4.3.3.2. Mental representation of space 
The Mental Number Line Bisection (MNLB) task [104] measures mental representation of space, 
based on an implicit representation of numbers in a left-to-right linear arrangement [16]. On each 
trial, the experimenter read aloud a pair of numbers (from 2-98 number range) that were separated 
by an interval of 9, 16, 25, 36, 49, or 64 digits. Participants were instructed to verbally report the 
subjective midpoint between the given pair of numbers, without making any calculations. Each 
pair of numbers was presented once in ascending and once in descending order to account for any 
response bias, and each of the six intervals was repeated seven times, resulting in 84 trials 
presented in pseudorandom order. We calculated an index of spatial bias by subtracting 
participant’s subjective midpoint from the objective midpoint number on each trial and averaging 
the scores across all trials. A negative index is consistent with overestimating the subjective 
midpoint towards larger numbers (i.e. a rightward bias). The results were expressed relative to 




affected side of the mental representation of space, or underrepresentation of the affected side of 
mental space. 
2.4.3.3.3. Spatially-defined motor function  
The spatially-defined motor function task [60] measures directional hypokinesia and directional 
bradykinesia, that is slowing of initiation and execution of movements directed towards the 
affected relative to unaffected side. On each trial, participants focused on a fixation cross in the 
centre of a computer screen and held down a button with their index finger. After a 1500ms-
3000ms interval, a black target (1.4° high “X”) appeared 12° to the left or 12° to the right of 
fixation (i.e. in the left or right visual field, hereafter VF), in pseudorandom order, for 2000ms. 
Once the target appeared, participants were required to release the button, touch the screen, and 
return their index finger to the button as soon as possible, which initiated the next trial. There 
were 30 trials per block. We recorded the times elapsed between the target onset and button 
release (movement initiation time), and between the button release and touch on the computer 
screen (movement execution time). There were three hand starting positions, in which the button 
was aligned with the participant’s body midline (central), located 25cm to the left from body 
midline (left), and located 25cm to the right from body midline (right). Hand starting positions 
and target locations (VFs) were expressed relative to each participant’s CRPS-affected side, that 
is, as affected, central, and unaffected starting positions, and affected and unaffected VFs. 
Participants completed the task from each starting position twice, once with their unaffected hand, 
and once with their affected hand, resulting in six blocks in total. The order of the blocks was 
counterbalanced between participants, and they alternated between the affected and unaffected 
hand. 
Participants’ average movement initiation and execution times for each combination of hand 
starting position and VF were used to calculate indices of directional hypokinesia and 
bradykinesia towards the affected side [97], separately for each hand used to complete the task. 
Index A quantifies the speed of initiating movements towards the affected side (from central 
starting position) relative to the unaffected side (from affected starting position). This index was 
calculated as: [central starting position (affected VF – unaffected VF) – affected starting position 
(affected VF – unaffected VF)]. Index A allows to dissociate motor and perceptual neglect (i.e. 
effect of VF), however, it involves movement trajectories of different length. Thus, we also 
derived Index B that directly quantifies the speed of initiating movements of the same physical 
length towards the affected side (from central starting position) relative to the unaffected side 
(from affected starting position). Index B was calculated as: [central starting position (affected 
VF) – affected starting position (affected VF)]. Positive values of indices A and B indicate 
slowing of initiation of movements directed towards the affected relative to unaffected side, 
suggestive of directional hypokinesia towards the affected side. The same indices A and B were 
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calculated for movement execution times. Here, positive values suggest directional bradykinesia 
towards the affected side. 
2.4.3.3.4. Body representation 
The Hand Laterality Recognition task [99] measures body representation. On each trial, 
participants focused on a fixation cross in the centre of a computer screen. After 1000ms, an 
image of a hand (12.9° x 12.9°) appeared for 180ms, 8° to the left or 8° to the right of fixation 
(i.e. in the left or right VF). Participants were required to indicate as fast and as accurately as 
possible whether the image depicted a left or a right hand by pressing a button, which initiated 
the next trial. We measured accuracy and reaction times. There were 25 images of left hands in 
different postures and rotations from upright (0°, 90°, 180°, or 270°). The same images were 
mirror-reversed to create images of right hands in the same postures and rotations. Each image 
was presented once in the left and one in the right VF in pseudorandom order, resulting in 100 
trials. The depicted hand was expressed relative to individual participant’s CRPS-affected side, 
that is, as affected and unaffected hand.  
Participants’ accuracy rates and average reaction times to correctly responded-to trials for each 
task condition were averaged across two VFs, because the visual field effects were not the primary 
interest of this trial and will be reported elsewhere. We calculated the differences in accuracy 
rates and reaction times between depicted hands to obtain two indices of hand laterality 
recognition: accuracy index (unaffected hand – affected hand) and RT index (affected hand – 
unaffected hand). Positive values of each index indicate less accurate and slower recognition of 
depicted hands corresponding to participant’s affected hand, relative to depicted hands 
corresponding to their unaffected hand. Thus, positive accuracy and RT indices suggest distorted 
representation of the CRPS-affected limb. 
2.5. Statistical analyses 
2.5.1. Sample size calculation 
The study was powered to evaluate the effects of PA treatment on a change in the primary 
outcome of pain intensity between RS2 and RS3. We estimated [18] that a sample of 21 
participants with CRPS per treatment group would provide 90% power to detect a minimal 
clinically significant reduction of 2 on the primary outcome of pain intensity (0-10 NRS; [20]), 
with a SD of 1.98 (based on our previous research [12]), and a 2-tailed alpha of 0.05.  
2.5.2. Incomplete outcome data 
Our primary analysis involved the intention-to-treat (ITT) population, that is, participants who 
received their allocated intervention, regardless of their treatment adherence or completion of the 
outcome assessments. Note that three participants who were allocated to PA treatment did not 




and did not receive any treatment (Figure 2), and were not included in the ITT sample. Therefore, 
the total ITT sample consisted of 49 participants. Eight participants dropped out of the study after 
having been trained in their allocated intervention (PA treatment n = 2, sham treatment n = 6), 
and four more participants were lost to long-term follow-up (n = 2 in each treatment group). These 
participants were retained in the ITT sample. To account for any missing data in the primary ITT 
analysis, we carried forward the baseline post-randomisation observation (RS2; the PGIC 
questionnaire data was only collected post-treatment, thus RS3 observation was carried forward). 
We report a supportive per-protocol analysis of those participants who completed their allocated 
treatment (missed no more than six treatment sessions) and provided complete outcome data in 
Text S6, Supplemental Material. The total number of participants with complete data was 41 (out 
of 42 as per sample calculation), because one participant in sham treatment group withdrew after 
we terminated the recruitment, therefore, we did not recruit any additional participant in their 
place.  We chose ITT as primary analysis to address any potential selection bias associated with 
non-random loss of participants, and per-protocol as means of sensitivity analysis to assess the 
robustness of the ITT findings [71,112]. The results of the per-protocol analysis were broadly 
consistent with the ITT analysis.  
Any missing questionnaire items were estimated using the individual participant’s mean for the 
relevant subscale (0.08% of items across all sessions and participants). Any missing data from the 
self-report questionnaires, clinical assessments, and computer-based tasks within each research 
session were replaced by a mean score of the relevant treatment group on the same measure 
(0.08% of data points across all measures and sessions). Note that six participants completed the 
test of spatially-defined motor function only with their unaffected hand (due to exacerbation of 
pain, limited range of movement, or weakness of the affected hand), but their affected hand data 
was not replaced because data for each hand was analysed separately. 
2.5.3. Analyses 
We used IBM SPSS Statistics 25 [40], R 3.5.3 [86], and MATLAB 2018b [59] software to process 
and analyse the data. Data preparation procedures are reported in Text S3, Supplemental Material. 
Throughout, we reported bootstrapped bias-corrected and accelerated 95% confidence intervals 
(BCa 95% CIs) around all mean and median values. We used bootstrapped χ2 tests, bootstrapped 
t-tests (or their non-parametric alternatives in case of violation of parametric assumptions), and 
ANOVAs to compare mean values between treatment groups and between data collection time 
points. ANOVA is robust to moderate violations of normality and homogeneity of variance [6,7], 
and we used Greenhouse-Geisser corrections if the sphericity assumption was violated. However, 
where severe (i.e. more than borderline significant and in multiple conditions) violations of the 
assumptions of normality, homogeneity of variance, and sphericity were found, we used linear 
mixed models analyses with non-parametric bootstrapping procedures (n = 1000). For linear 
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mixed models analyses, a model term made a significant contribution to predicting an outcome 
when the 95% CI around the coefficient estimate (B) did not include zero. For the remaining 
analyses, statistical significance was defined as p < .05. We used one-tailed tests for comparisons 
for which we had directional hypotheses (i.e. RS2 vs. RS3 comparisons, as we predicted greater 
reductions on the outcome measures in PA than sham treatment group), and two-tailed tests for 
the remaining comparisons. We controlled for type I errors in the primary (but not exploratory) 
analyses by using Holm-Bonferroni correction for multiple comparisons within analysis of each 
outcome and reported adjusted p values (padj).  
2.5.3.1. Descriptive characteristics and group matching 
We performed a series of bootstrapped contrasts (t-tests or Mann-Whitney U tests for continuous 
variables, and χ2 tests for categorical variables) to determine whether the two treatment groups 
were successfully equated on the minimisation factors, as well as on the average POMS, LOTR, 
and PCOQ scores, and the extent of exposure (i.e. average number of logged treatment sessions).  
2.5.3.2. Effects of PA treatment on the primary outcomes 
To evaluate the effects of PA treatment on the first primary outcome of pain intensity and the time 
course of any changes, we conducted a 2 (Group: PA treatment, sham treatment) x 6 (Time: RS1, 
RS2, RS3, RS4, LTFU1, LTFU2) ANOVA. We planned sixteen a-priori contrasts to compare 
RS1 vs RS2, RS2 vs RS3, RS3 vs RS4, RS2 vs RS4, RS2 vs LTFU1, RS4 vs LTFU1, LTFU1 vs 
LTFU2, and RS2 vs LTFU2 within each treatment group.  
To evaluate the effects of PA treatment on the second primary outcome of the CRPS severity 
score and the time course of any changes, we conducted a 2 (Group: PA treatment, sham 
treatment) x 4 (Time: RS1, RS2, RS3, RS4) ANOVA. We planned eight a-priori contrasts to 
compare RS1 vs RS2, RS2 vs RS3, RS3 vs RS4, and RS2 vs RS4 within each treatment group.  
2.5.3.3. Effects of PA treatment on the secondary outcomes 
To evaluate the effects of PA treatment on self-reported pain and psychological functioning, 
sensory, motor, and autonomic function, and neuropsychological functions, and the time course 
of any changes, we conducted 2x6 and 2x4 ANOVAs and planned the same contrasts as described 
for the analyses of the primary outcomes.   
2.5.3.4. Predictors of the CRPS progression over time 
To investigate whether any baseline factors could predict CRPS progression over time, 
independent of the treatment, we used the data from the total sample (N = 49) to perform 
exploratory best subsets regression analyses on the overall change in pain intensity and CRPS 
severity score throughout the course of the study. Change on these outcomes was quantified as 
individual regression slopes fitted to each participant’s ratings of current pain intensity across 
RS1-LTFU2 and to each participant’s CRPS severity scores across RS1-RS4. Negative slopes 




explanatory variables included participants’ demographic characteristics, self-reported pain and 
psychological functioning, sensory, motor, and autonomic function, and neuropsychological 
functions, as measured in RS1. We restricted the pool of potential predictors by excluding factors 
that lacked linear relationships with each outcome or were collinear with other predictors (see 
Text S4, Supplemental Material). Best subsets regression is an automated approach that performs 
an exhaustive search for the best subset of factors for predicting the outcome and returns the best 
model of each size (up to a specified number of predictors) [57]. Considering our sample size (N 
= 49), we compared best subsets models that included one up to five predictors of each outcome. 
From the five models, the one with the lowest Akaike Information Criterion (AIC) was preferred 
as best fit. To address a potential issue of overfitting, we also performed a five-fold cross-
validation [49] of each of the five models suggested by best subsets regression analyses. This 
approach randomly splits the data set into five folds (subsets of observations). Each model is 
trained using the 80% of the data (four folds) and then tested on the remaining 20% of the data 
(one fold). This process is repeated until each fold has served as a test subset. The average of five 
recorded errors is a cross-validation (CV) error. The lowest CV error indicates best model 
performance.  
3. Results 
3.1. Participant characteristics 
Table 1 presents baseline characteristics and comparisons between PA and sham treatment 
groups. On average, participants reported moderate pain intensity (6/10), comparable with 
previous studies on prism adaptation (5.8-6/10; [13,105]) and other neurocognitive treatments 
(5.3-7/10; [44,62,75]) for CRPS. Median CRPS severity score in our sample was higher than the 
average severity reported for individuals with stable CRPS in the validation study of this tool (13 
vs. 11.2/16; [36]), possibly because we used stricter inclusion criteria (Budapest research 
diagnostic criteria; [34]). Our participants on average had longer CRPS duration compared to 
other studies of neurocognitive treatments for CRPS (58 vs. 5-24 months; [10,13,44,62,75,105]). 
The proportion of participants with CRPS affecting their right side of the body was consistent 
with a large population study [72], although it was lower than in small-sample studies on prism 
adaptation (41% vs. 71-80%; [13,105]). Both the mean age and proportion of females were 
consistent with those previously reported in CRPS [13,36,72,96,105]. The most common 
comorbidities in our participants were depression (37%), anxiety (22%), migraines (16%), 
fibromyalgia (14%), and asthma (14%). These conditions were found to be prevalent in CRPS in 
previous population studies [53,73]. The most common treatments in the current sample included 
weak or strong opioids (57%), anticonvulsants (47%), paracetamol (45%), antidepressants (45%), 
physio-, hydro-, or occupational therapy (39%), and nonsteroidal anti-inflammatory drugs (35%; 
see Table S1, Supplemental Material). Overall, demographic and clinical characteristics of our 
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sample appear to be representative of general population of people with CRPS [3,36,72,96] and 
comparable to those reported in previous research investigating neurocognitive treatments for 
CRPS [10,13,44,62,75,105], except for the longer average disease duration in our study.  
The randomization procedure successfully equated the two treatment groups on the minimisation 
factors (Table 1). The two groups were also matched on baseline mean levels of optimism, mood 
disturbance, fear of movement, and expectations and criteria for success of the treatment (there 
were no significant differences between PA and sham treatment groups on any of the PCOQ 
items, Us ≥ 212.00, psadj ≥ .27, ds ≤ 0.51).  




treatment (n = 23) 
Sham treatment  
(n = 26) 
Contrast 
Minimisation factors    
Current pain intensity (/10) M 
5.96 [5.02, 6.80] 6.15 [5.26, 7.00] t(47) = -0.33, p = 
.741, d = 0.10 
CRPS severity score (/16) 
Mdn 
13.00 [12.07, 13.93] 12.50 [11.00, 13.00] U = 287.50, p = 
.809, d = 0.07 
Primarily affected arm (% 
right) 
48% 35% χ2(1) = .88, p = 
.348, ϕ = -0.13 
Pre-CRPS dominant hand (% 
right) 
91% 92% χ2(1) = .16, p = 
.898, ϕ = 0.02 
Sex (% female) 
83% 85% χ2(1) = .04, p = 
.850, ϕ = -0.03 
Age (years) M 47.35 [43.20, 51.95] 45.31 [39.85, 50.85] t(47) = 0.53, p = 
.601, d = -0.15 
CRPS in other body parts (% 
present) 
13% 8% χ2(1) = .38, p = 
.537, ϕ = -0.09 
Other non-CRPS pain (% 
present) 
44% 39% χ2(1) = .13, p = 
.721, ϕ = -0.05 
CRPS duration (months since 
diagnosis) M 
61.26 [47.15, 75.12] 52.31 [39.49, 66.35] t(47) = 0.84, p = 
.388, d = -0.24 
Other control measures    
Optimism (LOTR; /24) M 13.00 [10.97, 15.07] 12.31 [11.00, 13.61] t(47) = 0.59, p = 
.560, d = -0.17 
Mood disturbance (POMS; 
/229) M 
94.81 [79.96, 109.93] 84.22 [70.94, 98.08] t(47) = 0.97, p = 
.349, d = -0.28 
Fear of movement (TSK; /68) 
M 
38.79 [35.45, 41.95] 40.38 [37.17, 43.35] t(47) = -0.65, p = 
.502, d = 0.19 
Number of logged treatment 
sessions (/29) Mdn 
29.00 [28.54, 29.46] 29.00 [28.55, 29.45] U = 297.00, p = 
.977, d = 0.01 
LOTR, Revised Life Orientation Test; POMS, Profile of Mood States; TSK, Tampa Scale for 
Kinesiophobia. Bootstrapped bias-corrected and accelerated 95% confidence intervals are reported in 





Eight participants (16%) withdrew from the study after receiving their allocated treatment. They 
were excluded from per-protocol analysis (Text S6, Supplemental Material), but their RS2 data 
was carried forward for the purpose of the primary ITT analysis. We compared their baseline 
(RS1) pain intensity and CRPS severity against confidence intervals around the mean pain 
intensity and CRPS severity score of participants who remained in the trial. Out of those who 
dropped out, five participants had greater pain intensity and four participants had greater CRPS 
severity compared to those who remained. However, the same or lower pain intensity and CRPS 
severity scores were found in another three and four participants who dropped out, respectively.  
3.2. Treatment adherence and participant blinding 
Twenty-one out of 23 participants (91%) in the PA treatment group and 20 out of 26 participants 
(77%) in the sham treatment group missed no more than six treatment sessions according to their 
logbooks (see Table S1, Supplemental Material). Two participants in the PA and six participants 
in the sham treatment group missed more than six treatment sessions and/or did not provide post-
treatment outcome data. The extent of exposure to treatment (i.e. average number of logged 
treatment sessions) was not significantly different between the two treatment groups (Table 1). 
The median recorded durations of the treatment sessions according to the participants’ logbook 
entries were 2min 25s in the PA group and 2min in the sham treatment group. 
At the end of RS4, we asked each participant (N = 41) which treatment they thought they received. 
They could respond “real [PA]”, “sham”, or “no idea”. Similar proportions of participants in each 
group made correct (real: 12.2%; sham: 12.2%) or wrong (real: 12.2%; sham: 7.3%) guesses as 
to their actual treatment allocation, or responded that they had no idea (real: 26.8%; sham: 29.3%), 
χ2(2) = .52, p = .771, Cramer’s V = 0.11. Only 12% of participants in each group correctly guessed 
their treatment allocation, therefore participant blinding was successful. 
3.3. Effects of PA treatment on the primary outcomes 
Despite the PA group showing some reduction in the current pain intensity scores immediately 
after treatment (RS3; Figure 4a), the ANOVA did not reveal any significant main effects of Time, 
F(4.04, 189.81) = 1.82, p = 0.126, ƞ2p = 0.04, or Group, F(1, 47) = 0.26, p = 0.615, ƞ
2
p = 0.01, nor 
did it show any significant interaction between these factors F(4.04, 189.81) = 0.66, p = 0.624, 
ƞ2p = 0.01. This indicates that there were no significant changes in pain intensity over time in 
either treatment group. Thus, contrary to our hypothesis, PA treatment did not reduce pain 
intensity more than sham treatment.  
Analysis of the CRPS severity scores (Figure 4b) showed a large significant main effect of Time, 
F(2.28, 107.08) = 17.57, p < .001, ƞ2p = 0.27, indicating that regardless of treatment, CRPS 
severity decreased over time (Figure 4b). Contrasts revealed a significant reduction in CRPS 
severity immediately after treatment (RS3; Mdn = 11.00, BCa 95% CI [11.00, 11.00]) compared 
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to immediately before treatment (RS2; Mdn = 12.00, BCa 95% CI [12.00, 12.00]), Z = -3.91, padj 
= .002, d = 0.86. This reduction relative to RS2 was maintained four weeks after completing the 
treatment (RS4; Mdn = 11.00, BCa 95% CI [11.00, 11.00]), Z = -3.70, padj = .002, d = 0.81, but 
without further significant change from RS3, Z = -0.81, padj = .433, d = 0.16. CRPS severity did 
not change significantly between the first (RS1; Mdn = 13.00, BCa 95% CI [13.00, 13.00]) and 
the second baseline session, Z = -1.71, padj = .170, d = 0.35. There was no significant interaction 
effect, F(2.28, 107.08) = 0.17, p = .886, ƞ2p < 0.01, nor was there any significant effect of Group, 
F(1, 47) = 0.17, p = .685, ƞ2p < 0.01, on the CRPS severity scores. Thus, contrary to our 
hypothesis, CRPS severity did not decrease more following PA compared to sham treatment, but 
both groups improved over the treatment period. 
 
Figure 4. Primary outcomes (intention-to-treat analysis). Mean [BCa 95% CI] current pain 
intensity (A) and CRPS severity scores (B) in prism adaptation (PA; orange circles) and sham 
treatment (blue diamonds) groups in each time point. RS1, RS2, RS3, and RS4, research sessions 
1, 2, 3, and 4; LTFU1 and LTFU2, long-term follow-up 1 and 2. Grey arrows indicate the 
treatment period. **Significant decrease in CRPS severity between RS2 and RS3, maintained at 
RS4, regardless of treatment, psadj < .01. 
We compared mean changes in pain intensity and CRPS severity over the treatment period (RS3 
– RS2) between PA and sham treatment groups. Effect sizes of these differences might be 
important for planning future studies. For current pain intensity, the effect size was small, d = 
0.37, 95% CI [-0.20, 0.94]. Mean pain reduction in the PA treatment group was -0.78 points on 
0-10 NRS scale, BCa 95% CI [-1.55, -0.15]. In the sham treatment group, mean pain reduction 
was -0.19 points, BCa 95% CI [-0.68, 0.28]. For CRPS severity score, the effect size was 




group was -0.78 points on 0-16 scale, BCa 95% CI [-1.19, -0.38]. In the sham treatment group, 
the mean CRPS severity reduction was -0.96 points, BCa 95% CI [-1.54, -0.38]. Individual pain 
and CRPS severity reduction scores over the treatment period are illustrated in Figure S1, 
Supplemental Material. On an individual level, five participants in the PA group and four in the 
sham group achieved clinically significant reductions in pain (i.e. at least two-point decrease on 
0-10 NRS scale [20]). None of the participants achieved clinically significant reduction in CRPS 
severity (i.e. at least 4.9 points decrease on 0-16 scale, although this threshold is quite 
conservative) [36].  
3.4. Effects of PA treatment on the secondary outcomes 
3.4.1. Self-reported pain, body representation, and emotional functioning 
A series of 2x6 ANOVAs was conducted on the self-report questionnaire scores to test the effects 
of PA on pain-related outcomes, body representation, and emotional functioning (see Table 2 for 




Table 2 Mean or median values [BCa 95% CI] of self-reported secondary outcome measures at each time point (intention-to-treat analysis) 
Measure Treatment 
group 
Time point      
 
 RS1 RS2 RS3 RS4 LTFU1 LTFU2 
Pain  
Pain severity (BPI; /10) M PA 5.91 [5.17, 6.58] 6.02 [5.28, 6.71] 5.41 [4.50, 6.26] 5.43 [4.55, 6.24] 5.62 [4.69, 6.48] 5.59 [4.69, 6.41] 
Sham 5.81 [5.02, 6.50] 5.95 [5.12, 6.78] 5.85 [5.04, 6.65] 5.84 [4.82, 6.74] 6.04 [5.12, 6.80] 5.95 [5.07, 6.73] 
Pain interference (BPI; /10) 
Mdn 
PA 6.71 [6.29, 6.71] 6.43 [5.00, 7.08] 5.29 [3.57, 6.43] 5.57 [4.71, 6.29] 6.00 [5.22, 6.14] 5.86 [4.57, 6.86] 
Sham 5.79 [5.00, 7.14] 5.86 [5.72, 5.86] 5.57 [5.43, 5.57] 5.64 [4.00, 6.14] 5.50 [3.71, 6.57] 5.72 [4.14, 6.57] 
Neuropathic features of pain 
(PDQ; /38) Mdn 
PA 26.00 [26.00, 26.00] 25.00 [20.00, 26.00] 24.00 [21.00, 27.00] 24.00 [20.00, 26.00] 26.00 [25.00, 26.00] 26.00 [21.46, 28.00] 
Sham 23.50 [21.50, 27.00] 24.00 [23.00, 24.00] 23.50 [20.00, 26.00] 22.50 [17.06, 26.00] 23.00 [20.00, 25.00] 22.50 [18.00, 26.00] 
Body representation 
Body perception disturbance 
(BPDS; /57) M 
PA 27.65 [22.83, 32.34] 27.78 [24.00, 31.22] 22.13 [17.88, 26.44] 24.39 [20.48, 28.57] 25.52 [21.78, 29.30] 24.57 [20.91, 28.44] 
Sham 28.96 [23.96, 33.76] 27.73 [21.98, 33.92] 29.00 [23.00, 35.36] 26.81 [20.92, 33.61] 26.77 [21.48, 32.68] 27.65 [22.53, 33.28] 
Emotional functioning 
Fear of movement (TSK; /68) 
M 
PA 38.79 [35.45, 41.95] 38.52 [35.02, 41.73] 37.43 [34.26, 40.50] 37.91 [34.70, 41.17] 38.74 [35.33, 41.95] 40.05 [36.22, 43.71] 
Sham 40.38 [37.17, 43.35] 39.73 [36.43, 42.81] 38.27 [34.90, 41.45] 37.42 [34.00, 40.71] 38.24 [34.97, 41.56] 37.27 [33.45, 40.79] 
Mood disturbance (POMS; 
/229) M 
PA 94.81 [79.96, 109.93] 98.25 [82.66, 113.93] 86.52 [71.16, 100.10] 86.21 [73.85, 99.00] 88.80 [74.42, 103.51] 95.54 [73.56, 117.95] 
Sham 84.22 [70.94, 98.08] 91.27 [76.05, 106.01] 83.21 [68.95, 96.96] 83.35 [68.76, 97.56] 82.42 [68.05, 96.53] 89.13 [70.81, 106.31] 
Perceived improvement due to treatment 
Patient’s global impression of 
change (PGIC; /7) Mdn 
PA - - 2.00 [2.00, 4.00] 3.00 [3.00, 3.00] 2.00 [2.00, 4.00] 3.00 [2.00, 3.00] 
Sham - - 3.00 [1.00, 4.00] 4.00 [3.00, 4.00] 2.00 [2.00, 3.00] 2.00 [1.00, 4.00] 
BPI, Brief Pain Inventory; PDQ, Pain Detect Questionnaire; BPDS, Bath CRPS Body Perception Disturbance Scale; TSK, Tampa Scale for Kinesiophobia; POMS, Profile of Mood 
States; PA, prism adaptation treatment; Sham, sham treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4; LTFU1 and LFTU2, long-term follow-ups 1 and 2.
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Table 3 Analysis of variance results for secondary outcome measures (intention-to-treat analysis) 
Measure Effect df† F p ƞ2p 
Self-report questionnaires 
Pain severity (BPI) Time 4.12, 193.81 1.24 0.295 0.03 
 Group 1, 47 0.19 0.664 < 0.01 
 Time x Group 4.12, 193.81 1.06 0.379 0.02 
Pain interference (BPI) Time* 2.88, 135.32 2.84 0.043 0.06 
 Group 1, 47 0.04 0.838 < 0.01 
 Time x Group 2.88, 135.32 0.74 0.526 0.02 
Neuropathic features of 
pain (PDQ) 
Time* 3.29, 154.50 3.32 0.018 0.07 
 Group 1, 47 0.32 0.574 0.01 
 Time x Group 3.29, 154.50 0.61 0.625 0.01 
Body perception 
disturbance (BPDS) 
Time 3.41, 160.11 2.43 0.059 0.05 
 Group 1, 47 0.57 0.455 0.01 
 Time x Group* 3.41, 160.11 2.60 0.047 0.05 
Fear of movement (TSK) Time 3.86, 181.61 2.41 0.053 0.05 
 Group 1, 47 < 0.01 0.993 < 0.01 
 Time x Group* 3.86, 181.61 2.89 0.025 0.06 
Mood disturbance 
(POMS) 
Time 3.60, 169.21 2.29 0.069 0.05 
 Group 1, 47 0.36 0.554 0.01 
 Time x Group 3.60, 169.21 0.25 0.894 0.01 
Patient’s global 
impression of change 
(PGIC) 
Time 3, 120 0.96 0.414 0.02 
 Group 1, 40 0.02 0.890 < 0.01 
 Time x Group 3, 120 0.56 0.644 0.01 
Clinical assessments 
Allodynia (affected limb) Time 2.23, 104.67 1.03 0.367 0.02 
 Group 1, 47 0.25 0.616 0.01 
 Time x Group 2.23, 104.67 0.35 0.730 0.01 
Absolut temperature 
difference 
Time 3, 141 0.43 0.731 0.01 
 Group 1, 47 0.16 0.695 < 0.01 
 Time x Group 3, 141 0.63 0.595 0.01 
Oedema difference Time 2.41, 113.08 0.99 0.387 0.02 
 Group 1, 47 0.06 0.805 < 0.01 




Measure Effect df† F p ƞ2p 
Experimental tests of neuropsychological functions 
Temporal Order 
Judgement task (PSS) 
Time 1.70, 79.69 1.08 0.335 0.02 
 Group 1, 47 0.16 0.692 < 0.01 
 Time x Group 1.70, 79.69 0.63 0.512 0.01 
Greyscales task Time 2.17, 101.82 0.57 0.581 0.01 
 Group 1, 47 0.02 0.899 < 0.01 
 Time x Group 2.17, 101.82 0.52 0.609 0.01 
Mental Number Line 
Bisection task 
Time 2.39, 112.17 0.48 0.656 0.01 
 Group 1, 47 0.50 0.481 0.01 




Time 3, 141 2.39 0.072 0.05 
 Group 1, 47 1.54 0.221 0.03 




Time 3, 141 1.32 0.269 0.03 
 Group 1, 47 0.05 0.826 < 0.01 
 Time x Group 3, 141 1.48 0.224 0.03 
* Statistically significant effect (p < .05). 
† Greenhouse-Geisser adjusted degrees of freedom are reported where sphericity assumption was violated. 
BPI, Brief Pain Inventory; PDQ, Pain Detect Questionnaire; BPDS, Bath CRPS Body Perception 
Disturbance Scale; TSK, Tampa Scale for Kinesiophobia; POMS, Profile of Mood States. PSS, Point of 
Subjective Simultaneity. 
A significant main effect of Time on pain interference (BPI) indicated that participants reported 
less interference from RS2 (Mdn = 6.00, BCa 95% CI [5.57, 6.71]) to RS4 (Mdn = 5.57, BCa 95% 
CI [4.86, 5.86]), regardless of treatment, Z = -2.56, padj = .040, d = 0.54. There were no significant 
changes in pain interference between other time points, Zs ≤ 1.86, psadj ≥ .273, ds ≤ 0.38. A 
significant main effect of Time for neuropathic features of pain (PDQ) suggested that participants’ 
scores decreased over time, regardless of treatment group. However, follow-up analyses revealed 
no significant differences between any of the time points of interest Zs ≤ 1.76, psadj ≥ .576, ds ≤ 
0.36. An ANOVA on body perception disturbance (BPDS) revealed a significant interaction 
between Time and Group. While there were no changes in the sham treatment group, PA group 
showed reductions in body perception disturbance over time, yet these effects did not withstand 
correction for multiple comparisons, ts ≤ 2.86, psadj ≥ .336, ds ≤ 0.54. An ANOVA on fear of 
movement also revealed a significant interaction between Time and Group. While there were no 
changes in the PA group, the sham treatment group showed reductions in fear of movement over 
time; however, these effects did not withstand correction for multiple comparisons, ts ≤ 2.63, psadj 
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≥ .312, ds ≤ 0.26. There were no other significant main effects or interactions (see Table 3). 
Participants’ global impression of change due to treatment (PGIC) also did not differ between PA 
and sham treatment group at any of the post-treatment time points and indicated that on average 
participants in both groups perceived their symptoms to be either “almost the same”, or “a little 
better” (2-3 out of 7). Overall, contrary to our hypothesis, we found no evidence of significantly 
greater reductions in self-reported pain-related and psychological disturbances following PA 
compared to sham treatment.  
Average daily logbook ratings of pain intensity, symptom interference, and range of movement 
for each group are illustrated in Figure S2, Supplemental Material. The PA and sham treatment 
groups did not differ on any of these measures at any time point [pain intensity: ts(45) ≤ 1.75, ps 
≥ .093, ds ≤ 0.51; symptom interference: ts(45) ≤ 1.24, ps ≥ .240, ds ≤ 0.36; range of movement: 
ts(45) ≤ 1.81, ps ≥ .062, ds ≤ 0.53]. The median number of days from the beginning of treatment 
to reach peak improvement and from peak improvement to return to baseline on each of these 
measures were similar in the PA and sham treatment groups (see Text S5, Supplemental Material). 
3.4.2. Sensory, motor, and autonomic functions 
A series of 2x4 ANOVAs was conducted on the scores from clinical assessments to test the effects 
of PA on sensory, autonomic, and motor functions. We reported group average values for these 
measures across four time points in Table 4. For the allodynia on the affected limb, absolute 
temperature difference, and oedema difference data, the ANOVA results are reported in Table 3. 
The MDT, MPT, and TPD threshold ratios data, as well as grip strength and ∆FTP ratios data 
were analysed using linear mixed models due to severe violations of the assumptions of normality, 
homogeneity of variance, and/or sphericity. The results of these analyses are reported in Table 5. 
A significant main effect of Time on the MPT ratios indicated that participants experienced less 
hyperalgesia on the affected relative to unaffected limb over the treatment period, regardless of 
treatment. However, this effect did not withstand correction for multiple comparisons, and there 
were no significant differences between other time points, Zs ≤ 1.60, psadj ≥ .208, d ≤ 0.33.  We 
also found a significant interaction between Time and Group on the MPT ratios. Despite the PA 
group showing a reduction in hyperalgesia over the treatment period, this effect did not withstand 
correction for multiple comparisons, and there were no other changes on MPT ratios in either 
group, Zs ≤ 1.68, psadj ≥ .440, ds ≤ 0.51.  
Our analyses did not reveal any other significant main effects or interactions (see Tables 3 and 
5). Overall, contrary to our hypothesis, we found no evidence of significantly greater 
improvements in sensory, autonomic, or motor functions following PA compared to sham 
treatment, except for the trend towards predicted reduction in hyperalgesia (MPT ratio) in the PA 





Table 4 Mean or median values [BCa 95% CI] of sensory, autonomic, and motor secondary outcome measures at each time point (intention-to-treat analysis) 
Measure Treatment 
group 
Time point    
  RS1 RS2 RS3 RS4 
Sensory functions      
Mechanical Detection Threshold ratio 
[(affected – unaffected) / affected] Mdn 
PA -0.04 [-0.43, 0.38] -0.35 [-1.12, 0.17] -0.44 [-0.84, -0.06] -0.54 [-1.51, -0.10] 
Sham -0.30 [-1.37, 0.24] -0.05 [-0.25, 0.17] -0.14 [-0.91, 0.30] -0.22 [-0.76, 0.28] 
Mechanical Pain Threshold ratio [(unaffected 
– affected) / unaffected] Mdn 
 
PA 0.62 [0.06, 0.69] 0.50 [0.43, 0.56] 0.07 [-0.32, 0.66] 0.50 [0.06, 0.69] 
Sham 0.57 [0.24, 0.67] 0.56 [0.38, 0.73] 0.50 [0.32, 0.71] 0.43 [0.24, 0.78] 
Allodynia (affected; /100) Mdn PA 14.00 [5.76, 26.67] 18.87 [4.67, 30.89] 16.90 [6.00, 26.17] 10.73 [2.87, 18.26] 
Sham 20.50 [9.00, 33.83] 14.37 [6.47, 25.03] 13.87 [6.47, 46.47] 18.03 [7.33, 33.33] 
Two-Point Discrimination Threshold ratio 
[(affected – unaffected) / affected] Mdn 
PA -0.06 [-0.16, 0.11] 0.00 [-0.08, 0.13] -0.08 [-0.20, 0.00] -0.04 [-0.21, 0.03] 
Sham 0.15 [-0.07, 0.31] -0.13 [-0.25, 0.10] -0.09 [-0.17, 0.00] 0.05 [-0.30, 0.22] 
Autonomic functions      
Absolute temperature difference (affected – 
unaffected; °C) Mdn 
PA 0.47 [0.27, 1.40] 0.30 [0.14, 0.68] 0.35 [0.20, 0.73] 0.50 [0.17, 1.17] 
Sham 0.47 [0.30, 0.78] 0.82 [0.53, 1.07] 0.77 [0.43, 1.05] 0.67 [0.40, 1.00] 
Oedema difference (affected – unaffected; cm) 
M 
PA -0.01 [-0.42, 0.43] -0.04 [-0.36, 0.28] -0.19 [-0.58, 0.21] -0.23 [-0.64, 0.20] 
Sham -0.11 [-0.51, 0.34] -0.02 [-0.40, 0.38] -0.12 [-0.52, 0.30] 0.04 [-0.33, 0.43] 
Motor functions      
Grip strength ratio (affected / unaffected) Mdn PA 0.35 [0.17, 0.39] 0.31 [0.25, 0.44] 0.35 [0.30, 0.46] 0.39 [0.30, 0.46] 
Sham 0.32 [0.20, 0.65] 0.33 [0.18, 0.58] 0.44 [0.26, 0.60] 0.42 [0.23, 0.60] 
Finger-to-palm distance ratio (affected / 
unaffected) Mdn 
PA 0.70 [0.60, 0.88] 0.67 [0.61, 0.87] 0.73 [0.63, 0.84] 0.79 [0.70, 0.82] 
Sham 0.69 [0.55, 0.90] 0.72 [0.53, 0.88] 0.79 [0.53, 0.89] 0.77 [0.60, 0.93] 
PA, prism adaptation treatment; Sham, sham treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4. 
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Table 5 The results of the bootstrapped linear mixed models regressions of scores for the tests of sensory and motor function, and a test of visuospatial attention  
(intention-to-treat analysis) 
* Significant effect (95% CI around the coefficient estimate does not include 0). 
The reference condition for dummy variable coding is indicated within parentheses for each term. 





   















Intercept -1.26 [-2.22, -0.37]* 0.19 [-0.10, 0.46] -0.02 [-0.14, 0.11] 0.38 [0.33, 0.44]* 0.60 [0.51, 0.70]* 0.07 [-0.05, 0.19] 
Time (RS2 = 0)       
RS1 -0.44 [-2.03, 1.01] -0.43 [-0.99, 0.07] -0.02 [-0.20, 0.15] -0.03 [-0.08, 0.01] -0.04 [-0.12, 0.04] 0.08 [-0.18, 0.38] 
RS3 -0.24 [-1.21, 0.65] -0.49 [-0.99, -0.06]* -0.14 [-0.32, 0.03] 0.01 [-0.05, 0.06] -0.02 [-0.11, 0.05] 0.06 [-0.09, 0.21] 
RS4 -0.56 [-1.69, 0.50] -0.14 [-0.52, 0.24] -0.04 [-0.21, 0.13] 0.03 [-0.03, 0.09] 0.03 [-0.04, 0.11] -0.02 [-0.16, 0.14] 
Group (PA = 0)       
Sham 0.93 [-0.64, 2.54] 0.06 [-0.35, 0.45] -0.20 [-0.43, 0.03] 0.04 [-0.06, 0.12] 0.14 [-0.05, 0.30] 0.01 [-0.17, 0.20] 
Time x Group (RS2, PA = 0)       
RS1, Sham -0.01 [-1.63, 1.79] 0.34 [-0.33, 1.03] 0.27 [-0.08, 0.64] 0.01 [-0.05, 0.08] 0.03 [-0.07, 0.13] 0.04 [-0.29, 0.34] 
RS3, Sham -0.77 [-2.52, 0.95] 0.65 [0.08, 1.32]* 0.16 [-0.11, 0.44] 0.05 [-0.03, 0.12] 0.05 [-0.04, 0.16] -0.05 [-0.24, 0.15] 
RS4, Sham 0.45 [-1.08, 1.91] 0.16 [-0.41, 0.72] -0.08 [-0.53, 0.30] 0.01 [-0.09, 0.09] 0.00 [-0.09, 0.10] 0.01 [-0.18, 0.21] 
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3.4.3. Neuropsychological functions 
A series of 2x4 ANOVAs was performed on the scores from experimental neuropsychological 
tasks to test the effects of PA on visuospatial attention, mental representation of space, spatially-
defined motor function, and body representation. Table 6 includes group average scores for 
participants’ performance on these measures across four time points. Negative scores on the tests 
of visuospatial attention and mental representation of space would indicate a bias away from the 
affected side. However, confidence intervals around the baseline scores on these tests include 
zero, suggesting that participants did not show significant spatial biases. Positive values of 
directional hypokinesia and bradykinesia indices would indicate slowing of movements directed 
towards the affected side. Yet participants’ median indices were both positive and negative 
depending on the specific condition, suggesting that there were no systematic spatially-defined 
motor deficits at baseline. Positive accuracy and reaction time indices on the test of body 
representation would suggest less accurate and slower laterality recognition for the images of 
affected hands. However, participants’ scores were mostly negative at baseline. Furthermore, 
most of the confidence intervals included zero, indicating that there were no differences in 
recognition of the affected relative to unaffected hands. The ANOVA results for the TOJ, 
Greyscales, MNLB, and Hand Laterality Recognition tasks are reported in Table 3. Due to severe 
violations of the assumptions of normality, homogeneity of variance, and/or sphericity, the data 
for the Landmark task and spatially-defined motor function were analysed using linear mixed 
models (see Tables 5 and 7, respectively).  
There were no significant main effects or interactions on any of the measures of visuospatial 
attention, mental representation of space, or body representation. Linear mixed model analyses 
revealed a significant main effect of group on Index B of directional bradykinesia when using the 
unaffected hand. This effect indicates that participants in PA group (Mdn = 42.39, BCa 95% CI 
[20.42, 150.32]) showed greater directional bradykinesia on this index (i.e. they were slower to 
execute movements directed towards the affected relative to unaffected side) compared to 
participants in sham treatment group (Mdn = 12.07, BCa 95% CI [-26.41, 40.93]), regardless of 
time point of the study, U = 136.00, p = .022, d = 1.06. No significant effects or interactions were 
found on any other indices of spatially-defined motor function.  
Overall, contrary to our hypothesis, there was no evidence of greater improvements in spatial 




Table 6 Mean or median values [BCa 95% CI] of neuropsychological secondary outcome measures at each time point (intention-to-treat analysis) 
Measure Treatment 
group 
Time point    
  RS1 RS2 RS3 RS4 
Visuospatial attention      
Temporal Order Judgement task (PSS; ms) 
Mdn 
PA 0.16 [-13.82, 9.02] -3.26 [-14.51, 8.35] -1.00 [-8.65, 9.71] 5.18 [-1.74, 10.87] 
Sham -0.05 [-7.40, 7.06] -0.75 [-8.55, 6.65] 1.17 [-6.16, 7.33] -2.12 [-10.48, 6.07] 
Landmark task (PSE; °) Mdn PA 0.04 [-0.20, 0.28] 0.09 [-0.01, 0.19] 0.03 [-0.09, 0.40] -0.02 [-0.13, 0.19] 
Sham 0.06 [-0.07, 0.21] 0.06 [-0.12, 0.17] -0.05 [-0.09, 0.10] 0.05 [-0.04, 0.10] 
Greyscales task M PA 0.17 [-0.07, 0.41] 0.12 [-0.11, 0.34] 0.08 [-0.13, 0.30] 0.11 [-0.12, 0.34] 
Sham 0.09 [-0.08, 0.26] 0.12 [-0.08, 0.32] 0.07 [-0.10, 0.25] 0.14 [-0.06, 0.31] 
Mental representation of space      
Mental Number Line Bisection task M PA -0.06 [-0.76, 0.67] -0.10 [-0.73, 0.54] 0.04 [-0.58, 0.63] -0.06 [-0.55, 0.42] 
Sham 0.12 [-0.51, 0.77] 0.24 [-0.50, 0.99] 0.39 [-0.36, 1.21] 0.31 [-0.34, 0.99] 
Spatially-defined motor function      
Directional hypokinesia, affected hand, Index 
A (MIT; ms) Mdn 
PA -4.88 [-41.02, 29.55] -2.23 [-40.87, 16.76] -15.41 [-58.35, -9.44] -21.93 [-40.85, -9.44] 
Sham -15.65 [-79.21, 26.94] 21.51 [-21.38, 56.06] -24.31 [-61.88, -12.51] -12.26 [-47.44, 16.73] 
Directional hypokinesia, affected hand, Index 
B (MIT; ms) Mdn 
PA -37.53 [-90.19, 16.61] -25.46 [-84.04, 13.63] -48.49 [-80.33, -22.88] 4.10 [-40.19, 10.67] 
Sham -40.43 [-48.52, -21.96] -0.40 [-61.60, 15.61] -8.19 [-48.87, 13.72] 3.32 [-43.06, 20.37] 
Directional hypokinesia, unaffected hand, 
Index A (MIT; ms) Mdn 
PA 0.14 [-15.93, 19.88] 10.28 [1.15, 22.22] -6.76 [-19.29, 13.43] -2.78 [-45.45, 13.43] 
Sham 5.57 [-24.54, 26.03] -7.88 [-20.59, 14.27] 6.88 [-15.63, 18.92] 2.51 [-13.48, 23.38] 
Directional hypokinesia, unaffected hand, 
Index B (MIT; ms) Mdn 
PA 4.84 [-6.43, 11.89] 9.41 [-17.73, 25.19] -3.40 [-21.35, 33.52] 7.43 [-26.43, 38.21] 
Sham -23.63 [-48.34, 12.93] 9.18 [-12.92, 28.54] 11.01 [-10.84, 28.46] 16.47 [-2.91, 26.35] 
Directional bradykinesia, affected hand, Index 
A (MET; ms) Mdn 
PA 97.95 [23.29, 216.69] 64.71 [22.36, 123.85] 46.11 [14.19, 72.77] 52.74 [22.18, 66.01] 
Sham 3.73 [-32.67, 67.35] 50.72 [-5.50, 64.21] 31.79 [3.63, 87.48] 41.09 [11.92, 64.21] 
Directional bradykinesia, affected hand, Index 
B (MET; ms) Mdn 
PA -49.68 [-125.50, -8.16] -180.86 [-235.79, -16.96] -124.70 [-129.09, -122.32] -78.67 [-115.85, -42.31] 





Time point    
  RS1 RS2 RS3 RS4 
Directional bradykinesia, unaffected hand, 
Index A (MET; ms) Mdn 
PA 48.80 [35.53, 64.67] 69.36 [35.74, 103.71] 79.01 [45.24, 99.85] 79.78 [59.27, 116.99] 
Sham 86.46 [54.45, 127.39] 69.84 [24.68, 113.96] 84.79 [76.26, 86.26] 48.80 [35.53, 64.67] 
Directional bradykinesia, unaffected hand, 
Index B (MET; ms) Mdn 
PA 31.39 [-13.35, 64.92] 69.35 [25.05, 98.88] 36.70 [21.07, 63.50] 20.37 [-13.72, 66.72] 
Sham -28.35 [-71.98, 41.21] 3.34 [-39.16, 44.61] 28.60 [6.71, 53.45] 3.38 [-22.98, 12.57] 
Body representation      
Hand laterality recognition Accuracy Index 
(%) M 
PA -1.65 [-5.66, 2.34] -2.26 [-5.68, 1.43] 1.30 [-2.23, 4.37] 1.57 [-2.70, 6.00] 
Sham 2.77 [-1.32, 7.37] -1.77 [-5.83, 2.21] 3.92 [0.19, 7.72] 2.54 [-2.00, 6.83] 
Hand laterality recognition Reaction Time 
Index (ms) M 
PA -97.74 [-268.99, 70.43] -57.20 [-187.91, 70.02] -37.44 [-155.06, 78.98] -130.05 [-240.98, -27.84] 
Sham -236.04 [-448.24, -65.14] -129.37 [-263.61, 21.19] -28.65 [-173.14, 95.70] 19.77 [-112.95, 161.67] 
PSS, Point of Subjective Simultaneity; PSE, Point of Subjective Equality; MIT, movement initiation time; MET, movement execution time; PA, prism adaptation treatment; Sham, 
sham treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4.  
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Table 7 The results of the bootstrapped linear mixed models regressions of indices of directional hypokinesia and bradykinesia for the spatially-defined motor function 
task (intention-to-treat analysis) 
Model term  Coefficient estimate [95% CI] 
 Directional hypokinesia (MIT) Directional bradykinesia (MET) 
 Affected hand Unaffected hand Affected hand Unaffected hand 
 Index A Index B Index A Index B Index A Index B Index A Index B 
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* Significant effect (95% CI around the coefficient estimate does not include 0). 
The reference condition for dummy variable coding is indicated within parentheses for each term.  
PA, prism adaptation treatment; Sham, sham treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4; MIT, movement initiation time; MET, movement execution time. 
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3.5. Exploratory correlational and subgroup analyses 
We explored the possibility that we did not observe any effects of PA treatment on pain or CRPS 
severity because participants did not show attention bias away from the affected side or body 
representation distortion (see Table 6 and [31], Chapter 4), which PA should have normalised, 
according to its hypothesised mechanisms. If baseline “neglect-like” bias and/or body 
representation disturbance are necessary for PA to have therapeutic effects, these should be 
observed for the subgroup of participants who did show reduced attention to their affected side 
and/or distorted body representation. However, exploratory correlational and subgroup analyses 
suggest that this was not the case in our study.  
Correlational analyses are illustrated in Figures 5 and 6. We plotted individual pain intensity and 
CRPS severity reduction scores from immediately before treatment to immediately after treatment 
(RS3 – RS2), against individual RS2 scores on tests of visuospatial attention and mental 
representation of space (Figure 5), and body representation (Figure 6). Visual exploration of 
participant-level data and Pearson’s correlation coefficients for each treatment group indicate that 
there were no apparent relationships between the changes on the primary outcomes of pain 
intensity or CRPS severity and any of the spatial biases or body representation distortion, except 
moderate significant correlation between change in CRPS severity and baseline bias on the 
Greyscales task in the PA group and Hand laterality recognition reaction time index in the Sham 




Figure 5. Scatterplots of changes on the primary outcomes vs. baseline performance on tests of spatial cognition (intention-to-treat analysis). Relationships between 
individual participants’ change in pain intensity (top panel) and CRPS severity (bottom panel) over the treatment period (between RS2, research session 2, and RS3, 
research session 3) and their baseline (RS2) performance on the Temporal Order Judgement (A, E), Landmark (B, F), Greyscales (C, G), and Mental Number Line 
Bisection (MNLB; D, H) tasks are illustrated. Negative scores for pain and CRPS severity indicate reduction of these outcomes (i.e. improvement). Negative scores 
on the tests of spatial cognition indicate reduced attention to and/or representation of the affected relative to unaffected side. Lines of best fit with confidence intervals 
(shaded surfaces) are superimposed for each treatment group. Pearson’s correlation coefficients (R) are reported for the relationships between change in pain (top 
panel) or CRPS severity (bottom panel) and performance on the tests of spatial cognition in PA (orange) and sham treatment (blue) groups. For pain reduction score, 




Figure 6. Scatterplots of changes on the primary outcomes vs. baseline scores on tests of body representation (intention-to-treat analysis). Relationships between 
individual participants’ change in pain intensity (top panel) and CRPS severity (bottom panel) over the treatment period (between RS2, research session 2, and RS3, 
research session 3) and their baseline (RS2) scores on the Bath CRPS Body Perception Disturbance Scale (A, D), accuracy indices (B, E) and reaction time indices (C, 
F) on the Hand laterality recognition task are illustrated. Negative scores for pain and CRPS severity indicate reduction of these outcomes (i.e. improvement). Higher 
scores on Bath CRPS Body Perception Disturbance Scale and more positive indices of the Hand laterality recognition indicate greater disturbance of representation of 
the affected limb. Lines of best fit with confidence intervals (shaded surfaces) are superimposed for each treatment group. Pearson’s correlation coefficients (R) are 
reported for the relationships between pain reduction (top panel) or CRPS severity reduction (bottom panel) and scores on tests of body representation. For pain 




We also repeated the analyses of the primary outcomes including only those participants from 
ITT sample who showed reduced attention to their affected side in RS2. First, we selected 
participants who had negative PSS scores on the TOJ task (PA n = 13, Sham n = 13), because 
people with CRPS consistently showed spatial biases on this task in previous studies 
[12,21,77,78,90]. For this subgroup, a 2 x 6 ANOVA on current pain intensity did not reveal any 
significant interaction effect between Group and Time, F(2.96, 71.02) = 0.42, p = .733, ƞ2p = 0.02, 
or any effect of Group, F(1, 24) = 0.04, p = .841, ƞ2p < 0.01. Main effect of Time indicated that 
regardless of treatment, participants reported less pain from RS1 to RS2 (p = .043) and from RS2 
to RS3 (p = .026), and more pain from RS4 to LTFU1 (p = .025), F(2.96, 71.02) = 4.42, p = .007, 
ƞ2p = 0.16. These effects, however, would not withstand correction for multiple comparisons (psadj 
≥ .202). A 2 x 4 ANOVA on CRPS severity scores also did not reveal any significant interaction 
effect, F(3, 72) = 0.72, p = .541, ƞ2p = 0.03. A significant effect of Group indicated that participants 
who received Sham treatment had more severe CRPS in RS2 (p = .007; padj = .028) and RS3 (p = 
.039; padj = .114) compared to those who received PA treatment, F(1, 24) = 4.73, p = .040, ƞ
2
p = 
0.17. There was also a significant effect of Time, indicating that regardless of treatment, 
participants’ CRPS severity decreased from RS2 to RS3 (p = .001) and this reduction was 
maintained in RS4 (p = .011; psadj ≤ .033), F(3, 72) = 8.42, p < .001, ƞ
2
p = 0.26. 
Next, we also repeated the same analyses on participants who had negative bias scores on the 
Greyscales task (PA n = 11, Sham n = 9), because performance on this task correlated with CRPS 
severity reduction scores (Figure 5). For this subgroup, a 2 x 6 ANOVA on current pain intensity 
did not reveal any significant main effects or interactions: Time, F(5, 90) = 0.97, p = .443, ƞ2p = 
0.05; Group, F(1, 18) = 0.04, p = .842, ƞ2p < 0.01; Time x Group, F(5, 90) = 0.80, p = .554, ƞ
2
p = 
0.04. A 2 x 4 ANOVAs on CRPS severity scores did not reveal any significant effect of Group, 
F(1, 18) = 0.01, p = .906, ƞ2p < 0.01, or interaction, F(2.08, 37.36) = 0.17, p = .854, ƞ
2
p < 0.01. 
However, there was a significant effect of Time, indicating that regardless of treatment, 
participants’ CRPS severity decreased from RS2 to RS3 (p = .001) and this reduction was 
maintained in RS4 (p = .005; psadj ≤ .015), F(2.08, 37.36) = 9.63, p < .001, ƞ
2
p = 0.35.  
Finally, we repeated the analyses of the primary outcomes including only those participants from 
ITT sample who showed impaired laterality recognition of images of hands corresponding to 
participants’ affected limbs in RS2, that is, had positive hand laterality recognition accuracy 
indices (PA = 7, Sham = 8). A 2 x 6 ANOVA on current pain intensity did not reveal any 
significant main effects or interactions: Time, F(2.51, 32.59) = 0.45, p = .688, ƞ2p = 0.03; Group, 
F(1, 13) = 2.54, p = .135, ƞ2p = 0.16; Time x Group, F(2.51, 32.59) = 0.93, p = .423, ƞ
2
p = 0.07. A 
2 x 4 ANOVAs on CRPS severity scores did not reveal any significant effect of Group, F(1, 13) 
= 0.02, p = .881, ƞ2p < 0.01, or interaction, F(3, 39) = 0.32, p = .815, ƞ
2
p = 0.02. There was a 
significant effect of Time, F(3, 39) = 4.02, p = .014, ƞ2p = 0.24, consistent with a decrease in CRPS 
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severity regardless of treatment, however, follow-up contrasts revealed no significant differences 
between any time points (ps ≥ .065).  
Overall, in line with the primary analysis of current pain intensity and CRPS severity, there were 
no interactions between Time and Group, even among participants with reduced attention to the 
affected relative to unaffected side, or those with distorted representation of the affected limb at 
baseline. The results of these exploratory subgroup analyses suggest that PA did not result in 
greater reductions in pain or CRPS severity than Sham treatment for those participants who 
showed baseline “neglect-like” bias or those who showed distorted body representation. 
However, note that the current study for not specifically powered to address these questions. 
3.6. Predictors of CRPS progression over time  
We explored which baseline factors (RS1) could predict overall change in pain intensity (across 
RS1-RS4 and LTFU1-LTFU2) and CRPS severity (across RS1-RS4). The identified best subsets 
regression models with respective values of model selection criteria are summarised in Table S2, 
Supplemental Material. A one-factor model for predicting overall change in pain intensity had the 
lowest AIC and CV criteria, F(1, 46) = 5.46, p = .024, adj. R2 = .09, AIC = -132.24, CV = 0.28. 
In this model, greater reduction in pain intensity was best predicted by smaller change in hand 
preference since CRPS onset (absolute ∆EHI; t = 2.34, p = .024, ß = 0.33). For predicting overall 
change in CRPS severity, a three-factor model had the lowest AIC and CV criteria, F(3, 45) = 
6.23, p = .001, adj. R2 = .25, AIC = -55.52, CV = 0.55. In this model, greater reduction in CRPS 
severity was best predicted by lower pain intensity (t = 3.69, p < .001, ß = 0.52), less swelling of 
the affected limb (t = 2.52, p = .015, ß = 0.37), and more accurate recognition of images of the 
affected hand (i.e. smaller Hand laterality recognition accuracy index; t = 2.43, p = .019, ß = 0.32), 
as measured at baseline (RS1). 
4. Discussion 
The results from this double-blind, randomized, sham-controlled trial of PA for upper-limb 
CRPS-I do not support the hypothesis that the effects of PA and sham treatment differed. First, 
two weeks of twice-daily PA treatment performed with the affected arm did not reduce the 
primary outcomes of current pain intensity or CRPS symptom severity more than sham treatment 
of the same intensity and duration. Second, PA did not affect the secondary outcomes of self-
reported CRPS-related and psychological functioning; sensory, motor, and autonomic signs of 
CRPS; or spatial cognition, motor function, and body representation.  
Our findings contradict the conclusion of previous preliminary studies that PA could relieve pain 
and other symptoms of CRPS. In the first study of PA treatment for CRPS, two weeks of once-
daily training resulted in 50% pain relief, and reduced oedema and skin discoloration in five 




pain, reduced autonomic symptoms, and improved motor function [10]. In the third study, a 
shorter but more intense PA regimen (twice-daily for four days) resulted in 36% reduction of pain 
in seven CRPS patients [13]. In the two latter studies, its effects on pain were maintained for up 
to two weeks after discontinuing the treatment. While addressing the limitations of these previous 
small-sample, uncontrolled, unblinded studies, our robust trial showed no benefits of PA for 
CRPS beyond those of a control treatment. A small reduction in pain intensity immediately 
following PA (13% reduction) was not significantly greater than that observed after sham 
treatment (3% reduction). Similarly, there was an overall reduction in CRPS severity immediately 
after the treatment that persisted for four weeks, but it was present in both PA (7%) and sham 
(8%) treatment groups. Consistent across per-protocol and intention-to-treat analyses, these 
findings suggest that PA does not incur any greater benefit than sham treatment, and thus is not 
effective for treating CRPS. 
The decrease in CRPS severity across both treatment groups could be explained by a placebo 
effect and/or general benefits of moving the affected limb. Meta-analysis of clinical trials found 
that placebo response can correspond to 1.84 point immediate post-treatment reduction in CRPS 
pain [61], or 0.65 reduction in chronic pain more generally (on a 0-10 scale) [38]. This effect 
might also be responsible for the reduction in CRPS severity found in our trial. Increased 
movement of the affected limb is a likely alternative explanation, because all participants 
performed the pointing task with their affected hand, regardless of which treatment they received. 
Physical exercise is one of the core pillars of CRPS management [27], and this additional daily 
activity might have been sufficient to reduce CRPS severity. Although there was no change in 
specific movement-related outcomes (except improved grip strength in the per-protocol analysis), 
movement itself could lead to adaptive engagement with the affected limb. It is unlikely that the 
observed changes were due to natural recovery, which might occur within the first year from 
diagnosis [2], as our participants were on average diagnosed with CRPS for five years (only 14% 
were diagnosed for ≤1 year). Disease duration was also unrelated to change in pain intensity or 
CRPS severity (see Figure S3, Supplemental Material). Regression to the mean cannot fully 
account for the decrease in CRPS severity, as no changes occurred over the baseline period. 
Overall, our findings reinforce the importance of including control treatment arms in pain 
rehabilitation studies, and the role of active movement in managing long-standing CRPS.  
The absence of any effects of PA on clinical outcomes could be driven by the absence of any 
effects on spatial cognition and/or body representation. One hypothesised mechanism of the 
apparent benefits of PA treatment in previous studies of CRPS is that it reduces pain by correcting 
“neglect-like” spatial biases away from the affected side (although why such a lateralised bias 
would lead to or exacerbate pain is unclear). Research on prism adaptation in neurologically 
healthy individuals and in brain injured patients with hemispatial neglect demonstrated that the 
pointing after-effects of PA generalise to higher cognitive functions. Specifically, PA can induce 
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a shift in spatial cognition and motor control consistent with the direction of after-effect, that is 
opposite to the direction of lateral visual displacement [4,15,23,42,54,55,66,67,94,95,103]. A 
potential second mechanism for the apparent benefits of PA treatment for CRPS is restoring 
normal sensorimotor integration [10,105]. This is based on the proposal that distorted body 
representation gives rise to discrepancies between anticipated and actual consequences of 
movement, and these discrepancies cause or exacerbate pain in conditions such as CRPS 
[9,37,62,63]. The visual shift during PA induces transient sensorimotor incongruence that might 
provide an error signal that triggers normalisation of body representation. The two proposed 
mechanisms would predict that reduction in clinical symptoms following PA should be 
accompanied by normalisation of spatial cognition and/or body representation. In the present 
study, PA did not change participants’ performance on experimental measures of spatial cognition 
and motor control, or body representation. This might explain why there were no therapeutic 
effects of PA. 
It is possible that PA did not affect these neuropsychological functions because, in contrast to 
previous findings [12,21,24,26,78,89,90,99,104], our participants with CRPS did not have any 
systematic neuropsychological deficits. Despite relatively larger sample size and better 
methodological control, participants with CRPS in our study showed balanced distributions of 
spatial attention and spatial representations, no systematic slowing of movements directed 
towards the affected side, and unimpaired laterality recognition of images of affected hands at 
baseline (see Table 6 and Chapter 4, [31]). In healthy individuals, cognitive after-effects depend 
on baseline spatial bias [15,28,43]. Therefore, absence of pre-existing spatial bias might account 
for why PA had no effects on spatial cognition or motor control in the present study. Furthermore, 
if altering spatial cognition and/or body representation were integral mechanisms through which 
PA reduces CRPS symptoms, the lack of effect of PA on the primary clinical outcomes could be 
because of the absence of baseline neuropsychological deficits. However, below we discuss three 
reasons that do not support this explanation.  
First, we found no relationships between the extent of baseline spatial and body representation 
deficits and changes in primary outcomes over the treatment period (Figures 4 and 5). 
Furthermore, sub-group analyses revealed no evidence that PA benefitted individuals who did 
present with “neglect-like” symptoms or distorted representation of the affected limb. Second, 
Christophe et al. [13] reported reduced CRPS pain after PA in the absence of any baseline spatial 
deficits, and without any effect on spatial cognition or motor control. Finally, Sumitani et al. [105] 
found a significant reduction in pain post-treatment, and a simultaneous shift in the coding of 
external spatial information relative to the body away from the affected side (i.e. in the direction 
opposite to the expected PA spatial after-effects). Therefore, response to PA treatment appears 
unrelated to “neglect-like” spatial bias or body representation distortion. However, both previous 




other non-specific factors. Nonetheless, we dismiss the explanation that the reason why PA did 
not reduce pain or CRPS severity was because our participants showed no baseline deficits in 
spatial cognition or body representation, and thus PA could not normalise these cognitive 
functions. Rather, our findings suggest that PA is not an effective treatment for CRPS. 
There are several potential limitations of the current study. First, we cannot rule out treatment 
compliance violations. We tested PA as a self-administered, home-based treatment that could 
realistically be integrated into CRPS management. Although participants received in-person 
training, written and video instructions, and both groups logged similar number of treatment 
sessions, we solely relied upon self-reported adherence. Lack of apparent difference between the 
effects of PA and sham treatment could potentially be due to deviations from the instructed 
treatment protocol. However, previous CRPS studies reported symptom improvement following 
less frequent [105], shorter [13], and home-based [10] PA, thus potentially missed treatment 
sessions should not disrupt the therapeutic effects of PA. Another limitation is that we did not 
measure whether the adaptation took place, which could potentially explain the lack of therapeutic 
effects of PA. The processes of realignment of spatial reference frames might be altered in 
individuals with CRPS, for instance due to impaired learning of spatial contingencies [8]. This 
question could be addressed by measuring the after-effect (e.g. through subjective straight-ahead) 
immediately after the initial PA training and upon completion of the treatment (i.e. in another 
supervised PA session immediately before RS3). Unfortunately, it was not feasible to confirm 
adaptation by measuring pointing after-affects in this trial due to scheduling issues, researcher 
availability and blinding, and equipment limitations for mobile use across research centres and 
participants’ homes. Nonetheless, consistent with the prescribed regimen of each training session, 
50 movements were sufficient to induce adaptation in previous studies [95]. A recent lab-based 
study from our research group suggested that although participants with CRPS adapt to lateral 
visual displacement at a slower rate than pain-free controls, the adaptation takes place in less than 
50 rapid pointing movements, and the magnitude of after-effects does not differ between CRPS 
and pain-free participants (unpublished data). Therefore, the assumption that adaptation in the PA 
group did take place is plausible. Another factor that could potentially contribute to lack of 
therapeutic benefits of PA for CRPS is insufficient dosage of and exposure to treatment in the 
current trial. Our participants took less time to complete each treatment session (on average 2-
3min) compared to post-stroke patients (20-30min) [23,100]. Furthermore, it was suggested that 
in people with hemispatial neglect, a minimum of 40 treatment sessions is needed to obtain 
significant, long-lasting functional benefits [45]. Thus, it is possible that 29 short PA sessions 
were not sufficient to induce long-term adaptation and realignment of sensorimotor frames in our 
CRPS participants. Yet it is noteworthy that in other studies, PA protocols similar to ours, using 
sufficiently strong prisms (10-20°) and 10 or more treatment sessions, found generalizable, long-
lasting effects on hemispatial neglect [23,79,100]. Nonetheless, a trial of supervised PA with 
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longer exposure and evidenced adaptation might find a significant benefit for CRPS, in which 
case PA would be best integrated into more intensive in-patient pain management programs.  
The longitudinal nature of this study allowed us to explore potential baseline predictors of CRPS 
progression over 10-30 weeks, regardless of treatment. Smaller change in hand preference since 
CRPS onset was related to greater reduction in pain intensity. Consistent with the learned non-
use hypothesis [85], underutilization of CRPS-affected limb and compensatory use of the 
unaffected extremity might maintain CRPS symptoms and hinder recovery. Overall reduction in 
CRPS severity was predicted by smaller pain intensity and oedema of the affected limb, 
suggesting that people with milder symptoms are likely to improve more. Individuals who were 
better at recognising images of affected relative to unaffected hands also achieved greater 
reduction in CRPS severity. Body perception disturbance was previously linked to longer CRPS 
duration and more severe sensory and motor signs of CRPS [46,51,113]. Our finding that less 
distorted representation and maintained use of the affected limb predict greater symptom 
improvement support multidisciplinary pain management approaches and graded motor imagery, 
which aim to normalise body representation and foster active movement [27,75,76]. These 
interpretations are, however, tentative, as the analyses were exploratory and the abovementioned 
factors explained only 9% and 25% of variance in the overall changes in pain intensity and CRPS 
severity, respectively.   
We conclude that PA does not reduce pain and other symptoms of CRPS more than sham 
treatment. The benefits of PA for CRPS reported in previous studies are likely due to the placebo 
effect, greater movement of the affected limb, regression to the mean, or natural recovery.  
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Chapter 5 – Conclusions 
This chapter addressed one of the main objectives of this thesis through testing whether prism 
adaptation treatment can reduce pain and severity of CRPS symptoms. The results of the first 
randomised controlled trial of prism adaptation reported in this chapter challenge the former 
positive findings by showing that prism adaptation has no therapeutic effects beyond those of 
sham treatment. Therefore, the present findings do not support recommending prism adaptation 
as a standard treatment for CRPS. Participants who underwent real prism adaptation reported an 
average reduction in pain of 0.78 points on a 0-10 scale, which is comparable to the size of placebo 
effect identified in clinical pain trials (Hróbjartsson & Gøtzsche, 2001). Although the direction of 
this change in pain intensity was consistent with pain relief following prism adaptation in previous 
studies, the reduction was not significantly greater than that reported by participants in a control 
group (0.19 points), leading to a conclusion that for pain intensity, there was no significant benefit 
of prism adaptation beyond sham treatment. In contrast to pain, CRPS severity significantly 
decreased over the treatment period; however, this reduction did not differ between the two 
treatment groups. Thus, the overall symptom improvement could either be attributed to increased 
movement of the affected limb, which was used to execute pointing movements in both real and 
sham treatment, or to the placebo effect. It is possible that the benefits of prism adaptation 
previously found in small, uncontrolled studies, occurred due to the same factors. The only control 
measure was implemented by (Sumitani, Rossetti, et al., 2007), who re-assessed one of their 
participants with CRPS after administering interventions equivalent to sham treatment. 
Specifically, this patient underwent two non-blinded periods of prism adaptation, once using 
neutral lenses, and once using lenses inducing lateral visual shift of 5°. Neither of these 
interventions produced any adaptation after-effects, and during both periods, the patient’s average 
pain remained constant. This suggests that sham prism adaptation using neutral lenses is a valid 
control condition, and that prism adaptation reduced pain more than sham treatment for this 
individual patient (although lack of blinding prevents ruling out the placebo effect following 
active treatment). Thus, it is possible that prism adaptation could be beneficial for some 
individuals with CRPS, especially considering high individual variability in spatial biases 
demonstrated in Chapter 4.  
Consistent with the findings presented in Chapter 4, participants with CRPS on average did not 
show any deficits in spatial cognition before treatment. Notably, as the primary clinical 
application of prism adaptation is to normalise spatial attention in hemispatial neglect after brain 
injury, it could be argued that if there were no attention deficits to begin with, changes in spatial 
attention would not lead to any improvement. As discussed in the conclusions of Chapter 4, this 
undermines the rationale for using prism adaptation treatment in CRPS, unless alternative 
mechanisms are involved. Yet similarly, if prism adaptation were to reduce pain through 




representation would not yield therapeutic effects on clinical symptoms. However, based on 
further consideration of the data from this and previous studies, I disregarded the explanation that 
lack of therapeutic effects of prism adaptation in this trial could be due to the absence of baseline 
neuropsychological symptoms. Exploratory analysis did not identify any subgroups of individuals 
who responded to prism adaptation better than to sham treatment. Individual variation in spatial 
and body representation biases illustrated in Figures 5 and 6 closely resembled that presented in 
Chapter 4 (Figure 2), yet it was not related to the response to prism adaptation treatment. These 
findings do not support neither of the two proposed mechanisms of prism adaptation for the 
treatment of CRPS. 
Regardless of treatment type, spatial cognition, motor control, and body representation appeared 
to remain stable over 2.5 months period in the present study, in contrast to the spontaneous 
reversal of spatial attention bias over 10 months in one single case of a patient with CRPS 
(Chapter 2). With high individual variation of cognitive biases in mind, such changes might have 
occurred in some participants. However, the drawbacks of using sensitive measures of multiple 
domains of neuropsychological functioning in this study include increased task difficulty and 
prolonged testing time (up to four hours per session). These factors could increase participants’ 
fatigue, which in combination with potential side effects of pain medication, might have had a 
detrimental effect on cognitive performance (Boksem et al., 2005; Hart et al., 2000). That is, the 
sensitivity of the assessments and ability to detect changes in neuropsychological functioning 
over time and / or due to treatment could be reduced. This limitation should be considered when 
making conclusions about the stability of cognitive performance in CRPS. 
On the other hand, it seems relevant to mention how remarkably well the participants coped with 
demanding assessments, long testing time, and engagement in the trial and the treatment itself, 
notwithstanding their pain and related symptoms. The quality of data was good, for instance, it 
was possible to fit psychometric functions to almost all participants’ responses in the 
psychophysical tasks, and the overall loss of data was <1%. One exception was the spatially 
defined motor function task, in which up to 8% of data had to be removed across different 
analyses, mainly in the conditions completed with the affected limb. In that case, specific task 
demands were likely to be affected by the primary motor deficits. Despite the retention of only 
76% of enrolled participants, pain and symptom severity of those who withdrew from the study 
did not systematically differ from the participants who remained. Out of those who completed the 
treatment and all the research sessions, 44% reported severe pain (≥7/10 points) and 98% 
presented with motor impairments on the affected side at baseline. Although some difficulties 
with carrying out the treatment using the affected limb would be expected due to pain evoked by 
movement and primary motor signs of CRPS, on average, participants completed the training 
considerably faster than it would normally take patients with hemispatial neglect. Overall, 
regardless of severe symptoms and continuous pain, participants seemed to manage the functional 
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impact of their condition relatively well, to the extent that allowed them to almost fully engage 
with the trial.  
The limitations of the design of this trial raise a question as to whether different dosage, 
administration, and / or setting of prism adaptation would yield more favourable results. In order 
to maximise any potential effects of treatment, one could directly monitor participants’ 
compliance with the prescribed treatment regimen, ensure that adaptation takes place by 
measuring immediate after-effect, increase the duration of prism adaptation sessions and the 
number of sessions itself (Kerkhoff & Schenk, 2012) to aid long-lasting realignment of 
sensorimotor frames, and / or use more goal-directed and ecologically valid tasks (Fortis et al., 
2020) to facilitate generalisation of the effects of prism adaptation. Nonetheless, the current state 
of evidence does not support the effectiveness of prism adaptation for CRPS treatment. Further 
research on neurocognitive treatments for chronic pain could still be beneficial, provided that the 
theoretical or empirical basis of their mechanisms of action are demonstrated.  
This chapter addressed another main objective of this thesis through investigating whether 
neuropsychological symptoms contribute to clinical manifestations of CRPS. Here I explored 
which baseline characteristics of participants (regardless of their treatment allocation) predicted 
how much their pain and CRPS severity changed over time. The main findings suggest that 
individual differences in baseline motor function and cognitive representation of the affected limb 
are relevant for long-term CRPS outcomes, even though limb laterality recognition was not 
impaired on a group level. The preliminary conclusions drawn from these results, consistent with 
those proposed in Chapter 4, are that improving motor function and re-establishing normal 
cognitive representation of the affected limb have potential to relieve pain and other symptoms. 
Summarising the findings from both chapters, among the tested neuropsychological functions, 
only body representation seems relevant for clinical features of CRPS. Additionally, primary 
motor impairment and underutilization of the affected limb, and bilateral deficits in motor control 
appear to determine the overall severity of the condition. Notably, both chapters suggest that 
changes in spatial cognition are not related to pain nor CRPS severity, or are, at least, less relevant 
than body representation and motor function. 
Taken together, although this randomised controlled trial did not yield the expected results, the 
present findings bear significant contribution to understanding the role of neuropsychological 
functions in the manifestation and treatment of CRPS. The role of any changes in spatial cognition 
appears to be rather limited, whereas body representation emerges as potentially relevant 
symptom in the exploratory analyses. However, further studies would be needed to directly test 
these preliminary proposals. In the context of central mechanisms of CRPS, the present 
behavioural findings do not support the contribution of cortical reorganisation (particularly 





Pain cannot be explained or quantified solely by the severity of physical injury. 
Neuropsychological changes are thought to play a role in the clinical manifestation of chronic 
pain syndromes such as CRPS and have been regarded as an avenue towards better understanding 
of the central mechanisms of chronic pain and improving pain management. Twenty-five years 
of research has suggested that people with CRPS can present with neuropsychological changes in 
attention to and representation of their body and surrounding space, which to some extent 
resemble hemispatial neglect. In the absence of any observable brain pathologies, these 
neuropsychological symptoms could be consistent with functional cortical reorganisation. It has 
been suggested that cortical changes may be underlying pain conditions that lack obvious causal 
pathology, such as CRPS (Harris, 1999; McCabe & Blake, 2007). Furthermore, neurocognitive 
treatments that target neuropsychological symptoms have been used to reduce clinical symptoms 
of CRPS. This thesis examined (1) how neuropsychological functions are altered in CRPS, (2) 
whether neuropsychological symptoms contribute to the clinical manifestations of CRPS, and (3) 
whether prism adaptation treatment can reduce pain and other CRPS symptoms. This general 
discussion summarises the main findings and conclusions from these investigations, as well as 
their contributions to understanding and re-evaluating the role of neuropsychological changes in 
the manifestation and treatment of chronic pain.  
Chapter 1 offered a novel way of looking into the central mechanisms of pathological pain: 
through changes in higher cognition. It significantly enhances the understanding of 
neuropsychological functions in CRPS based on the available evidence, including their relevance 
to clinical signs of the disorder and their treatment. The original contributions of this in-depth 
literature review are a comprehensive synthesis of the existing research findings regarding 
neuropsychological changes in CRPS, and discussion of their potential mechanisms. Furthermore, 
in this chapter, I highlighted inconsistencies in the available findings across different studies, and 
limitations in how certain cognitive functions have been defined and measured (e.g. the ambiguity 
between body representation distortions versus “neglect-like” symptoms), thus providing a useful 
resource for planning future studies. Notably, I addressed the identified limitations further in the 
thesis by conducting robust, well-controlled studies, and by drawing on broader hemispatial 
neglect literature to clearly dissociate spatial attention biases from body representation distortions.  
Chapter 2 characterised biases in spatial attention in a single patient with CRPS over three 
research sessions. This longitudinal case study integrated methods and theoretical frameworks 
established in hemispatial neglect literature with cognitive experimental approach to 
behaviourally investigate potential functional changes in the brain. The findings provide a proof 
of principle that individuals with CRPS can have reduced attention to their affected relative to 
unaffected side of near space that is separable from attention in far space. The original 
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contribution of this study to the existing literature is demonstrating for the first time that the 
direction of spatial attention bias in CRPS might not be stable over time, and can be independent 
of pain severity and body representation distortion. The results also suggested that attention can 
be biased towards the painful side, which thus far has been reported in only one other case 
(Christophe, Delporte, et al., 2016; Jacquin-Courtois et al., 2017). These conclusions have 
potential implications for tailoring rehabilitation approaches to individual patients. They also 
demonstrate a disruption of cognitive functions typical of patients with brain lesions, but in the 
absence of any observable brain pathologies.  
Chapter 3 presented the protocol for the major study of this thesis: the first trial to evaluate the 
effects of prism adaption versus control treatment on pain and symptom severity in a large sample 
of people with CRPS. In addition to clinical outcomes, this trial also examined the effects of 
treatment on neuropsychological changes to elucidate the working mechanisms of prism 
adaptation for CRPS. The participants’ pain, psychological functioning, sensory, motor, and 
autonomic functions, and neuropsychological functions were tracked for up to 7.5 months to 
assess response to two-weeks of prism adaptation or sham treatment and CRPS progression over 
time.  
Previous research found that people with CRPS can present with “neglect-like” symptoms. 
However, in Chapter 4, I comprehensively tested spatial cognition in a large cohort of people with 
CRPS and found no evidence for symptoms resembling perceptual, representational, or motor 
neglect. These findings do not uphold the analogy between hemispatial neglect and CRPS, but 
rather suggest that previously reported changes in spatial cognition might have been overstated. I 
also found no evidence for any clinical relevance of changes in spatial cognition for clinical signs 
of CRPS, thus challenging the assumed involvement of functional cortical reorganisation in the 
central mechanisms of the disorder. These results have further implications for potential 
neurocognitive treatments for chronic pain that target neuropsychological changes to reduce pain. 
For instance, they suggest that normalising spatial attention might not be the desired mechanism 
to target in order to reduce pain and other symptoms of CRPS. Chapter 5 indeed demonstrated 
that the effects of prism adaptation do not outweigh those of sham treatment. Thus, its major 
contribution is providing evidence base against recommending prism adaptation as a treatment 
for CRPS. The results of this chapter further suggest that even if prism adaptation did affect 
CRPS, it is unlikely that the mechanisms of such an effect would be attentional. Increased 
movement of the affected limb or placebo effect provide alternative explanations of previously 
reported reduction in pain and other symptoms following prism adaptation, and a decrease in 
CRPS severity over the treatment period in our trial regardless of real or sham prism adaptation. 
Indeed, findings from both Chapters 4 and 5 suggest that motor function could be an important 
predictor of clinical outcomes of CRPS. Among the tested neuropsychological functions, body 




The overarching question posed in this thesis concerns the role of neuropsychological changes in 
the manifestation and treatment of chronic pain. The overall conclusions and broader implications 
of the presented theoretical and empirical investigations of CRPS to address this question can be 
integrated according to the three main objectives of this work.  
People with CRPS do not show systematic “neglect-like” symptoms 
Integrating the findings from this thesis with the existing literature, our knowledge of the nature 
and prevalence of neuropsychological changes in CRPS is still limited, yet the present research 
provides some clarification. Here I did not replicate “neglect-like” symptoms that were repeatedly 
reported in previous studies. Having tested a large CRPS cohort, using robust, sensitive methods, 
these null findings suggest that previously reported changes in spatial cognition might have been 
overstated. An important factor to consider is individual variability that in some of the previous, 
small sample studies could have induced a selection bias towards individuals with pronounced 
cognitive symptoms. Heterogeneity of clinical manifestations of CRPS is well established and 
reflected in the diagnostic criteria (Bruehl et al., 2016; Harden et al., 2010; Marinus et al., 2011). 
If it were not for the fact that most participants with CRPS did not show any spatial biases in the 
studies reported in Chapters 4 and 5, it could be argued that similar heterogeneity characterises 
neuropsychological symptoms. For instance, there were some individuals with CRPS who, 
relative to healthy controls, clearly deviated either away from or towards their painful side, similar 
to the single patient described in Chapter 2. However, this observed individual variability in 
neuropsychological changes might have limited utility for explaining clinical symptomatology or 
potential treatment stratification. Based on the presented empirical findings, the extent or 
direction of any deficits in spatial cognition does not seem to be related to the severity of CPRS 
symptoms or response to prism adaptation treatment. 
Challenging the presence of neuropsychological deficits in CRPS has implications for 
understanding its proposed mechanisms. From the perspective of chronic pain as a disease of the 
central nervous system, neuropsychological symptoms can be taken as behavioural indicators of 
functional reorganisation of cortical networks involved in higher cognitive processes. 
Resemblance of the previously reported “neglect-like” symptoms for the CRPS-affected side 
(Förderreuther et al., 2004; Galer & Jensen, 1999; Kolb et al., 2012; Reinersmann et al., 2010, 
2012) to hemispatial neglect suggested that they might be associated with functional changes 
within the posterior parietal and temporal cortical networks that are usually disrupted in neglect 
after a stroke (Chechlacz et al., 2012; Molenberghs et al., 2012; Mort et al., 2003; Vallar, 2001). 
My findings challenge this proposal, as they show no evidence of any systematic deficits across 
multiple sensitive measures of spatial cognition in a large cohort of people with CRPS. Absence 
of consistent behavioural indicators of reorganisation within the cortical networks governing 
spatial cognition suggests that CRPS is probably not associated with altered higher-order cortical 
representations. Neuroimaging evidence of any functional changes in the parietal cortex in people 
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with chronic pain is scarce (see Chapter 1). However, in light of the current null findings and the 
previous conflicting literature, this paucity of evidence does not necessitate further research 
aiming to identify neural correlates of neuropsychological changes in CRPS, unless consistent 
and systematic behavioural evidence of such changes emerges (Krakauer et al., 2017).  
In the context of broader neuroplasticity in CRPS, even seemingly well-established evidence of 
shrinkage of the primary somatosensory representation of the affected hand (Di Pietro et al., 
2013b) has been recently disputed (Mancini et al., 2019), further suggesting unaltered cortical 
representations. In the studies presented in this thesis, participants with CRPS did report distorted 
perceptions of and negative feelings towards their CRPS-affected limb. Unfortunately, lack of 
available validation of the self-report measure of altered body representation (Lewis & McCabe, 
2010) limits our understanding of which exact sensory, cognitive, and / or emotional functions 
the patients’ responses reflect. Furthermore, despite on average higher scores on the Bath CRPS 
Body Perception Disturbance Scale compared to pain-free individuals, these responses of the 
CRPS participants did not correspond to any biases in a more objective experimental measure of 
body representation, that is, hand laterality recognition (see Chapter 5). Although a meta-analysis 
found that people with chronic musculoskeletal pain affecting the limbs or face showed altered 
performance on laterality recognition tasks (Breckenridge et al., 2019), the evidence of deficits 
specific to the cognitive representation and motor imagery of the affected limb in CRPS has been 
highly inconsistent (see Chapter 1). Nonetheless, commonly reported subjective distortions of the 
representation of the CRPS-affected limb cannot be disregarded, thus further research could 
investigate what aspects of body perception are indeed affected in CRPS and develop robust 
methods to quantify them.  
While in this thesis I specifically focused on spatial cognition and body representation, 
investigations of other neuropsychological functions in CRPS received relatively little attention. 
Impaired executive functions, deficits in working memory, psychomotor speed, or attentional 
capacity seem to affect people with chronic pain regardless of its location or diagnosis (Berryman 
et al., 2014; Hart et al., 2000; Landrø et al., 2013). Consistent with these findings, over 40% of 
people with CRPS presented with impaired executive functions, independent of medication use 
or mood disturbance (Libon et al., 2010). Aside from investigating neuropsychological changes 
that are thought to be specific to CRPS and elucidate its cortical mechanisms, further research 
could pursue the functional impact of chronic pain on cognitive processes determining, for 
instance, ability to work in these patients. The potential effects of medication or comorbid 
depression on cognitive functions have rarely been controlled for in CRPS research, and these 
factors could further be addressed via multidisciplinary interventions to achieve functional 




Changes in spatial cognition or spatially-defined motor function do not contribute 
to clinical manifestations of CRPS 
The findings summarised in Chapter 1 suggested that larger spatial biases might be related to 
more severe pain and other CRPS symptoms, yet the evidence was mixed. In this thesis, I 
investigated the potential predictors of pain intensity and CRPS severity and their progression 
over time. My findings suggest that the extent or direction of any spatial biases in visual attention, 
representation of space, or motor function is not related to the severity of clinical symptoms of 
CRPS or its long-term outcomes, and that the direction of spatial attention bias can change 
independently of CRPS pain. However, these insights were gained through exploratory analyses, 
thus, the conclusions are tentative and should be taken as indicating hypotheses that could be 
tested in future studies. Overall, my research indicates that “neglect-like” symptoms do not seem 
to contribute to the clinical manifestations of CRPS, adding to the share of previous studies that 
also found no relationships between these factors. The present negative findings do not exclude 
the possibility that clinical manifestations of CRPS might be partly driven by neuropsychological 
changes other than those related to spatial cognition. Further exploratory analyses revealed 
potential clinical relevance of distorted body representation (although limited by the measurement 
method and inconsistency between different tests of this construct). 
The notion of cortical mechanisms underlying chronic pain greatly relies on previous research 
suggesting that reorganisation of somatosensory and motor cortical maps in CRPS, phantom limb 
pain, fibromyalgia, and nonspecific low back pain was related to pain severity (Flor et al., 1995, 
1997; Henry et al., 2011; Karl et al., 2001; Kim et al., 2015; Maihofner et al., 2003; Pleger et al., 
2006). Conversely, another study suggested that specific pathology, such as deafferentation or 
increased constant somatosensory input, rather than chronic pain itself, might be driving cortical 
plasticity (Gustin et al., 2012). Associations between pain severity and the extent of reorganisation 
of somatosensory cortex have been further debated in more recent studies that used robust 
neuroimaging methods accounting for individual cortical morphology. Specifically, Makin and 
colleagues (2015) found smaller than previously reported (and likely use-dependent) spatial shifts 
near the representation of the amputated hand in people with phantom limb pain. Mancini and 
colleagues (2019) found unaltered representation of the CRPS-affected hand. In both cases, 
individual differences in the size or spatial organisation of these maps were not related to 
participants’ pain intensity. Although distorted cognitive representation of the affected limb 
reported by individuals with CRPS has been related to greater pain intensity and worse long-term 
outcome for symptom severity (Chapters 4 and 5), and previously taken as evidence supporting 
cortical mechanisms of the disorder (Lewis & Schweinhardt, 2012; Moseley, Gallace, & Spence, 
2012), somatosensory information is not the sole component upon which a representation of one’s 
body is built (Head & Holmes, 1912; Tsakiris, 2010). Thus, such distorted cognitive 
representation of the affected limb is plausible in absence of somatosensory cortical changes.  
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With regard to motor cortical reorganisation, a meta-analysis of neuroimaging studies in CRPS 
revealed limited evidence of bilateral disinhibition of the primary motor cortex, but no systematic 
changes in spatial motor representations (Di Pietro et al., 2013a). A meta-analysis of similar 
evidence in various chronic pain populations found that motor cortex disinhibition was most 
prominent in CRPS and neuropathic pain, compared to migraine or musculoskeletal conditions 
such as low back pain or fibromyalgia (Parker et al., 2016). However, this evidence does not allow 
to determine whether cortical disinhibition arises due to chronic pain, or whether it facilitates 
persistent pain. In the context of previous neuroimaging studies, bilateral motor slowing described 
in Chapter 5 could stem from reorganisation within the central motor networks. That is, if we 
assume that cortical reorganisation underlies CRPS pathology. However, movement slowing 
could just as well be related to decreased psychomotor speed found in a variety of chronic pain 
conditions, like diabetic neuropathy with predominately cardiovascular, in contrast to cortical, 
mechanisms (Higgins et al., 2018). In this thesis, the extent of motor deficits and the functional 
change in the use of the affected limb since CRPS onset were associated with greater pain 
intensity and CRPS severity, and worse long-term outcomes in these important clinical indicators. 
Thus, motor function appears to play an important role in the severity and maintenance of CRPS 
symptoms. Although we cannot exclude the contribution of disrupted central motor networks, the 
role of motor function can be partly explained via lower-level motor impairment and learned 
behaviour such as underutilisation of the affected limb.  
Beyond the primary sensory and motor representations, my results contribute behavioural 
evidence to challenging the role of higher-order cortical reorganisation in the manifestation of 
CRPS. That is, individual variability in the performance on the tests of spatial cognition was 
unrelated to the severity of pain and other CRPS symptoms. This contrasts the idea that cortical 
plasticity within parietal and temporal networks might be contributing to CRPS pathology. It is 
worth noting, however, that central mechanisms of chronic pain are not limited to the assumed 
cortical reorganisation but can involve other processes such as central sensitisation on the spinal 
level, or descending pain modulation on supraspinal level, including subcortical structures. 
Nonetheless, the present findings call for reconsideration of the cortical mechanisms underlying 
chronic pain and rationale for treatments designed to normalise distorted cortical representations.  
Prism adaptation is not an effective treatment for CRPS 
One of the most important contributions of this thesis is to show that prism adaptation was not 
more effective in reducing pain and CRPS severity than control treatment in a double-blind 
randomised controlled trial (Chapter 5). Pain reduction after real prism adaptation was smaller 
compared to the preliminary studies (Figure 1). This is not surprising considering that effect sizes 
get smaller with increasing sample size (Button et al., 2013), which was much larger in the present 
trial. However, the facts that this pain reduction was neither significant nor greater than that 




or sham treatment, suggest that previously reported positive effects of prism adaptation occurred 
due to other factors. Likely alternative explanations are increased movement of the affected limb, 
which would be supported by the clinical relevance of motor function discussed above, or the 
placebo effect, which can reflect a significant therapeutic response to non-active treatment 
conditions (Hróbjartsson & Gøtzsche, 2001). Meta-analyses of randomised controlled trials for 
chronic pain reported that, for instance, higher expectations of treatment efficacy, larger number 
of in-person research visits, or relatively larger active treatment group size are associated with 
greater placebo response (Linde et al., 2007; Vase et al., 2015; Zhang et al., 2008). The trial 
reported in Chapter 5 was double-blind, thus participants’ outcome expectations, which were 
similar at baseline, could have remained high regardless of treatment allocation. No signs of 
superiority of prism adaptation over sham intervention highlight the importance of including 
control treatment arms in chronic pain trials. 
 
Figure 1. Pain reduction following prism adaptation treatment. Change in pain intensity after 
prism adaptation (PA) treatment reported in three previous studies and in the current trial are 
summarised. Pain intensity is expressed on an 11-point Numerical Rating Scale: 0 = “no pain at 
all”, 10 = “the worst pain imaginable” used by Sumitani, Rossetti, et al. (2007), Bultitude and 
Rafal (2010), and in the current study; average ratings from a 0-100 Visual Analogue Scale with 
the same anchors used by Christophe, Chabanat, et al. (2016) were scaled for the purpose of 
comparison with the other studies. 
In the present study, prism adaptation also did not affect other clinical signs of CRPS, 
neuropsychological symptoms, or self-reported psychological functioning. Importantly, although 
participants on average did not show “neglect-like” symptoms, prism adaptation also did not 
improve pain or CRPS severity more than sham treatment for those individuals who did present 
with reduced attention to their affected side or distorted body representation at baseline. 
Therefore, the present findings do not support the attentional or body representation mechanisms 
of the effects of prism adaptation on pain, and suggest that prism adaptation does not have greater 
therapeutic benefits for upper-limb CRPS-I than a control treatment. They also provide no 























Sumitani et al., 2007;
N=5; 2 weeks, once daily
Bultitude & Rafal, 2010;
N=1; 3 weeks, once daily
Christophe et al., 2016;
N=7; 4 days, twice daily
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The empirical research presented in this thesis has overall shown that spatial cognition biases do 
not seem to relate to clinical manifestations of CRPS, and targeting them using prims adaptation 
does not reduce pain. These behavioural findings suggesting rather limited role of 
neuropsychological changes or cortical reorganisation in the manifestation and treatment of CRPS 
challenge the utility of neurocognitive rehabilitation for this disorder. In particular, treatments 
that aim to relieve chronic pain via normalising cortical representations do not seem justified 
considering lack of consistent evidence of neuroplastic changes. However, given the preliminary 
evidence for links between clinical symptoms and motor function and body representation 
reported in Chapters 4 and 5, these domains might be more fruitful avenues for therapeutic 
investigations. Two related neurocognitive interventions for CRPS aim to normalise sensory-
motor integration and body representation. In mirror visual feedback therapy (Ramachandran & 
Rogers-Ramachandran, 1996), patients execute synchronous bimanual movements, while 
viewing the movement of the unaffected limb reflected in the mirror creates an illusion that the 
affected extremity placed behind the mirror is executing identical movements despite motor 
impairment. The therapeutic mechanism of mirror therapy is thought to rely on re-establishing 
the congruent relationship between motor intention and sensory feedback. It has been 
hypothesised that discrepancy between these two processes can cause or exacerbate pain in CRPS 
(Brun et al., 2019; McCabe & Blake, 2007), although direct evidence supporting this mechanism 
is lacking. There is limited evidence of the effectiveness of mirror therapy for acute CRPS 
(McCabe, 2002), and in combination with exercise and medication (Kotiuk et al., 2019). Since 
mirror therapy might not be tolerated by some patients due to movement-related pain, Moseley 
(2004a) preceded it with hand laterality recognition training, and then imagined hand movements. 
Based on behavioural findings, these two stages are thought to sequentially activate cortical motor 
networks and reduce pain, thus facilitating commencement of mirror therapy (Moseley, 2005b). 
These mechanisms are, however, debatable, as laterality recognition of the affected relative to 
unaffected limb might be unimpaired in people with CRPS (Chapter 5; Breimhorst et al., 2018; 
Reinersmann et al., 2012). Nonetheless, graded motor imagery consisting of these three stages 
decreased pain and oedema, and improved limb laterality recognition in three randomised trials 
form the same research group (Bowering et al., 2013; Moseley, 2004, 2005b, 2006), yet it failed 
to reduce pain when applied in clinical practice (Johnson et al., 2012). Further research could 
pursue explaining the mechanisms of mirror visual feedback and graded motor imagery and 
refining their clinical applications. Notably, it is conceivable that their effectiveness does not 
necessitate simultaneous cortical reorganisation, and instead might rely on the improvement of 
motor function, which emerged as an important determinant of other clinical outcomes in the 
studies presented in this thesis. 
In light of largely intact neuropsychological functions, rather than targeting areas of dysfunction, 
we could use unaffected cognitive abilities to aid rehabilitation of CRPS. For instance, people 




2013), suggesting intact multisensory integration. The illusion occurs when watching an artificial 
limb being stroked, while one’s own unseen limb is stroked in synchrony. This causes participants 
to have the impression of “feeling” the tactile sensations that are being applied to the artificial 
limb, as if it belonged to their own body (Botvinick & Cohen, 1998). Hence, inducing the rubber 
hand illusion might enable patients to observe the artificial limb being touched with textures or 
objects that would normally induce painful sensations on their affected limb. This could allow 
them to gradually learn to tolerate real touch on the painful limb, and thus reduce allodynia. 
Another potential avenue for treatment that could make use of intact multisensory integration 
involves manipulating auditory feedback anchored to one’s movement, for example, during 
exercise of the affected limb. Tajadura-Jiménez, Cohen, and Bianchi-Berthouze (2017) showed 
that people with CRPS can adapt their walking to altered auditory feedback of their footsteps. 
Therefore, a form of auditory-motor adaptation could be used to improve movement of the 
affected limb.  
Given the preliminary evidence of the contribution of active movement and maintained use of the 
painful limb to reduced severity of CRPS (Chapters 4 and 5), underutilisation of the affected limb 
could be addressed via more conservative treatments. It has been suggested that this behaviour in 
CRPS develops through operant conditioning, similar to underutilisation of the contralesional 
limb after a stroke (Punt et al., 2013; Taub et al., 2006). This learning-based hypothesis of motor 
impairment in CRPS fits within the contemporary fear-avoidance model of chronic pain (Vlaeyen 
& Linton, 2000). According to this model, the pathway to underutilisation of the affected limb 
leads from pain, through pain-related fear, to persistent avoidance behaviours that maintain the 
pain and disability in the long-term. Following from this model, exposure-based treatments that 
aim to extinguish pain-related fear were found to reduce pain and disability in CRPS (Barnhoorn 
et al., 2015; de Jong et al., 2005; den Hollander et al., 2016; Ek et al., 2009). Behavioural exposure 
therapies could potentially reverse learned underutilisation and restore motor function in a 
subgroup of people with CRPS who report high pain-related fear. It is curious that in the present 
studies, pain-related fear of movement was not related to the extent of motor dysfunction or CRPS 
severity. This could indicate that underutilisation of the affected limb is maintained through other 
factors, such as primary motor symptoms of CRPS. In this case, these symptoms might need to 
be alleviated through other therapies (e.g. pharmacotherapy) before commencing exposure 
treatment.  
Another important therapeutic consideration is generalised functional impact of rehabilitation, 
even if substantial pain and symptom relief is not feasible. Prism adaptation investigated in this 
thesis involved monotonous, repetitive pointing movements. While its effects on hemispatial 
neglect were found to carry over to unexposed sensory, motor, and cognitive functions (Jacquin-
Courtois et al., 2013), generalisation of the results of such training to distinct clinical symptoms 
of chronic pain and their functional impact might be limited. For instance, prism adaptation 
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treatment reported in Chapter 5 had no effects on self-reported pain interference, defined as 
detrimental impact of pain on daily life. A recent study assessed a modified ecological home-
based prism adaptation training, in which patients with chronic hemispatial neglect performed 
daily sessions of scheduled activities involving manipulation of simple everyday objects, and free 
activities related to their hobbies and daily tasks, while wearing prism goggles. Two weeks of 
such training had comparable effects on neglect as traditional prism adaptation, and its benefits 
additionally extended to long-lasting improvement in patients’ daily function (Fortis et al., 2020). 
Although prism adaptation does not appear to be an effective treatment for chronic pain, 
ecological approach to physiotherapy that involves everyday activities and aims to achieve 
specific functional goals could facilitate adherence to treatment and generalisation of any 
therapeutic effects to daily functioning. Indeed, individualised goal setting is the key element of 
pain management programmes, such as an exemplary programme described in Chapter 2 in the 
context of potentially reversing spatial attention bias in one CRPS patient. Multidisciplinary 
approach to treatment of CRPS (Goebel et al., 2018) utilizes pharmacotherapy, patient education, 
exercise and psychological interventions aimed at fostering acceptance and decreasing adverse 
feelings towards the affected limb. It further addresses counter-productive patterns of behaviour 
that might perpetuate disability, and aims to restore pre-CRPS level of daily functioning via 
graded activation guided by patients’ goals. Although such programmes appear to be effective in 
clinical experience, further research should be undertaken to identify their specific active 
components and working mechanisms. This could facilitate broader implementation of relevant 
therapeutic techniques beyond the few specialised clinics. Nonetheless, the described principles 
are largely consistent with evidence-based guidelines for management of chronic pain more 
generally (Sanders et al., 2005; The British Pain Society, 2013).  
Considering high heterogeneity of clinical presentations of CRPS, therapeutic decision-making 
could implement stratified approach, that is, target treatments to subgroups of patients based on 
their distinct characteristics, such as risk of persistent disability, hypothesised underlying 
mechanisms, or likely responsiveness to treatment. For instance, pharmacotherapy for 
neuropathic pain can be stratified according to the patients’ sensory profiles (Baron et al., 2012), 
or type of physiotherapy for back pain can be chosen based on the patients’ estimated prognosis 
(Hill et al., 2011). Since subgroup analyses reported in Chapter 5 failed to identify the responders 
to prism adaptation treatment based on patients’ cognitive profiles, this strategy might not 
necessarily apply to neurocognitive interventions. However, people diagnosed with CRPS may 
present with strikingly different combinations of symptoms, for example, predominance of motor 
deficits, autonomic changes, or positive sensory signs. It would seem reasonable to place greater 
emphasis, respectively, on physiotherapy, anti-inflammatory medication, or desensitisation and 
centrally acting analgesics for these groups of patients. To facilitate such stratified approach, 
multiple research centres could combine their efforts in describing and understanding potentially 




Taking into account the existing treatments for CRPS, the prognosis is still poor (Bean et al., 
2016; de Mos et al., 2009). Based on the findings presented in this thesis, neurocognitive 
treatments targeting neuropsychological symptoms or cortical reorganisation might not be the 
best way forward. Instead, future research could focus on improving and evidencing the efficacy 
of the available treatments through high-quality randomised controlled trials and clarifying their 
mechanisms of action. Importantly, not all patients will respond equally to the same interventions, 
likely due to diversity of their symptoms. Thus, stratified approach targeting heterogeneous 
clinical presentations is likely to advance the management of chronic pain. 
Final conclusions 
To summarise, the predominantly null findings of this thesis regarding the hypothesised “neglect-
like” symptoms in CRPS provide important information in the context of increasing interest and 
emerging research on the central mechanisms of CRPS, including cortical reorganisation and 
associated cognitive changes. Considering the methodological strengths of the presented 
empirical studies, the null results demonstrate that lateralised spatial biases are not a substantial 
part of cognitive symptomatology in CRPS. This conclusion endorses a more balanced 
perspective on changes in spatial cognition (or lack of thereof) in CRPS. It is unlikely that cortical 
reorganisation contributes to the manifestation or treatment of this disorder, which prompts 
reconsideration of the cortical-centred explanations of chronic pain more generally. The potential 
clinical relevance of body representation and motor function demonstrated in previous literature 
and the empirical studies of this thesis implies that deficits in these domains could be targeted for 
treatment of CRPS. This could be through exposure therapies, goal-directed physiotherapy, and 
multidisciplinary treatments, with emphasis on stratified pain management. In contrast, present 
research provides robust evidence that prism adaptation hypothesised to reduce pain through 
normalising spatial attention biases does not incur therapeutic benefits on CRPS compared to a 
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Chapter 2 - Supplemental Material 
Attention upturned: Bias toward and away from the affected side of the body and near space in a 
case of Complex Regional Pain Syndrome 
1. Equipment 
We used the following equipment for the experimental and sensory tests that involved 
presentation of visual stimuli on a computer screen. For the presentation of the Greyscales task in 
near and far space in T2, a 109.5 x 62.0cm size, 1920 x 1080 pixels resolution computer screen 
mounted on a wall was used. A desktop computer screen (47.5 x 26.7cm size, 1024 x 768 pixels 
resolution) was used for Freiburg visual acuity test and Global-local tasks in T2, and for the 
Perimetry, Landolt C, Greyscales, and Global-Local tasks in T3. A chin-rest was used for all 
vision tests and experimental tasks except the Greyscales task in T2, and was adjusted so that the 
participant’s eye level was aligned with the central fixation cross.  
2. Somatosensory testing: tactile detection and discrimination 
2.1. Method 
In T3, we assessed Mechanical Detection Thresholds (MDTs) on the participants’ hands (centre 
of dorsal surface) and knees (centre of kneecap), using von Frey filaments of 0.008g to 300g force 
(Bioseb, model Bio-VF-M). The procedure followed a standardised protocol from Quantitative 
Sensory Testing (Rolke et al., 2006).  
We assessed tactile discrimination thresholds on the participants’ index fingers and knees using 
a Two-Point Discrimination disk (TPD; Exacta, North Coast Medical) in T3. The participants 
reported if they perceived the touch on one point or two points on the centre of their index fingertip 
or the centre of their kneecap. The researcher touched the participant’s skin with one or two tips 
of the disk simultaneously, decreasing (down to a single tip) or increasing (up to 20mm) the 
distance between the two tips according to a staircase procedure. We calculated TPD threshold as 
a geometric mean of ten turning points on each hand / knee.  
We derived relative threshold ratios as [(left - right) / left], separately for each measure (MDT 
and TPD) and each testing location (hands and knees). The results represent the difference in 
tactile sensitivity (MDT) / discrimination (TPD) on the left side compared to the right side, as a 
proportion of overall tactile sensitivity / discrimination on the left side. Negative numbers indicate 
lower thresholds (thus higher sensitivity to touch / more precise discrimination) on the left 
(affected) side. 
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3. Temporal Order Judgement task - Just Noticeable Difference 
3.1. Method 
We calculated half the temporal interval between the 25% and 75% points on the psychometric 
function to derive Just Noticeable Difference (JND). JND is a measure that indicates the delay 
between the two stimuli needed for the participants to perceive the correct order of the two stimuli 
at a specified level. JNDs were also averaged across Response conditions and subjected to the 
same analyses as Points of Subjective Simultaneity (PSSs). 
3.2. Results & conclusions 
The patient had significantly larger JNDs than controls in TOJs of visual stimuli presented in her 
body space in T2 (JND = 202.98), t(11) = 4.05, p < .001, zcc = 4.212, 95% CI [2.381, 6.028], and 
in hands working space in T1 (JND = 144.93), t(23) = 2.25, p < .05, zcc = 2.296, 95% CI [1.518, 
3.061], T2 (JND = 268.53), t(11) = 4.56, p < .001, zcc = 4.744, 95% CI [2.704, 6.770], and T3, 
(JND = 103.16), t(11) = 2.53, p < .05, zcc = 2.633, 95% CI [1.398, 3.845]. This suggests that the 
patient was less precise in judging the temporal order of visual stimuli in these conditions, relative 
to healthy control participants. No significant differences in JNDs were found when visual stimuli 
were presented in near space on eye level, or when tactile stimuli were delivered to participants’ 
lower limbs. 
Due to insufficient variability in the patient’s responses across different temporal offsets, we were 
not able to fit the cumulative Gaussian to determine the JNDs in Uncrossed Hands condition in 
T1, and Crossed Hands conditions in T1 and T2. It appears that the patient was not able to make 
reliable perceptual judgements in the conditions which could be associated with increased 
cognitive or emotional difficulty, stemming from conflicting left/right information (incongruence 
between the two sides of the body and external space), and focusing on the information appearing 
on the CRPS-affected part of the body. Achieving a reliable pattern of responses that allowed 
fitting cumulative Gaussian in Uncrossed Hands condition in T2 could be attributed to using 
longer temporal offsets between the stimuli compared to T1. Nevertheless, the procedural 
adjustments were not sufficient to provide reliable data in Crossed Hands condition in T2.  
4. Global-Local Processing task 
To determine if the left inattention that we observed in the CRPS patient in T1 was accompanied 
by cognitive symptoms indicative of broader changes to right hemisphere function, we used 
Global-Local Processing tasks in T2 and T3 to assess whether she showed a local processing bias 
compared to healthy controls. We also aimed to test whether any local processing bias would be 
limited to or stronger in the CRPS-affected side of space (left visual field) or present in both sides 
of space. In general, control participants show a tendency for prioritising global configurations 
relative to local features (Heinze & Münte, 1993; Navon, 1977; Pomerantz, 1983; Proverbio, 
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Minniti, & Zani, 1998). This can be measured in the form of faster and / or more accurate 
performance when identifying global configurations compared to local features (global 
precedence). It can also be seen as less interference from incongruent local level information 
when identifying global configurations (local interference) compared to the interference from the 
global configurations when identifying local features (global interference). We hypothesised that, 
compared to controls, the patient would show significantly lower global precedence, lower global 
interference, higher local interference, and a higher ratio of local to global interference. 
4.1. Method & results (T2) 
The stimuli and procedure were similar to those described in a previous paper (Bultitude, Rafal, 
& List, 2009). We used hierarchical stimuli (Navon letters; Navon, 1977) of small letters (0.40° 
x 0.60°) that formed the shape of the same (congruent) or a different (incongruent) larger letter 
(2.50° x 3.80°). Participants were required to identify either Global (large letters) or Local (small 
letters) level of the stimuli in two separate blocks (Target Level conditions). In each trial, a black 
fixation cross (0.57° x 0.57°) was displayed in the centre of a white screen. After 1000ms it was 
joined by one of the hierarchical stimuli, with its centre located 3.65° to the left or right of the 
fixation cross. The stimulus was presented for 100ms. Participants were instructed to press the 
“up” arrow key if they identified the local / global stimulus as A, and the “down” arrow key if 
they identified an S. Each trial ended with the participant’s response or after a time out period of 
4000ms since the stimulus onset. Both speed and accuracy were emphasised in the instructions. 
Each of the four types of stimuli (two congruent and two incongruent) was presented 16 times in 
the left (LVF) and in the right visual field (RVF), giving 128 trials per condition. Each Target 
Level condition block was preceded by eight training trials. 
We analysed accuracy rates (Figure S1) and mean reaction times (Figure S2) for congruent and 
incongruent stimuli in Global and Local conditions, separately for each visual field. The analysis 
plan to derive global precedence, local interference, global interference, and global-local 
processing bias indices was described in the preregistration record (osf.io/zx8ad). 
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Figure S1. Global-Local Processing task (T2) – accuracy. The patient’s and controls’ mean 
accuracy rates (%) for congruent and incongruent stimuli in left and right visual field (LVF and 
RVF, respectively) in T2. Error bars represent standard deviations of the controls’ means and are 
not presented for the patient’s single accuracy rates. 
 
Figure S2. Global-Local Processing task (T2) – reaction times. The patient’s and controls’ mean 
reaction times (ms) for congruent and incongruent stimuli in left and right visual field (LVF and 
RVF, respectively) in T2. Error bars represent between-subjects standard deviations of the 
controls’ means and within-subject standard deviation for the patient. 
The results from T2 showed that the patient had low accuracy rates for incongruent stimuli in the 
Local condition (< 20% correct; 20 standard deviations below the mean of the controls; see Figure 
S1). Since this is lower than chance-level performance (50%), this suggests that she was mostly 
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responding to global features throughout the Local block. This could be explained by severe 
global processing bias (tendency to process the global form rather than the local level), or by 
perseveration (as the Global block was conducted first). However, we consider these two 
possibilities to be unlikely due to further information: of those Local Congruent trials that were 
correct (6/32 in LVF and 3/32 in RVF), the reaction times were very fast compared to other 
conditions (Figure S2), suggesting that she was not making a true discrimination judgement on 
these trials. This, coupled with the patient’s report of poor peripheral vision, led us to believe that 
the stimuli were too small for the patient to be able to visually process and discriminate the local 
level and do the task as instructed. Thus, conducting the full planned analysis on these data would 
be uninformative. 
4.2. Method (T3) 
To address the suspected difficulties that the patient had in discerning the local level of the stimuli 
in T2, in T3 we first adjusted the size and other parameters of the visual stimuli so that the patient 
was able to discriminate its local features. We used the method of adjustment to establish the size 
of the stimuli. A single Navon stimulus (2.88° x 4.82°) was displayed ±2.18° to one side of the 
central fixation cross and remained on the screen until the patient’s response. We gradually 
increased the size (0.5° increments in each dimension) and the distance from the fixation cross 
(in 0.3° increments) across consecutive blocks until the patient reported that she could easily 
discriminate the small letters and identify them correctly in both visual fields. In the final Global-
Local Processing task, we used stimuli that were 5.13° x 7.10° at the global level (local level 
0.92° x 1.26°) presented at a distance of ±3.38° between the fixation cross and the centre of the 
stimulus.  
4.3. Results (T3) 
In addition to the results reported in the main article, we also examined whether any of the 
differences in global precedence, local interference, and global interference effects were limited 
to processing of visual stimuli that appear in the affected side of space (LVF) or could be observed 
for visual stimuli on both sides of space (LVF and RVF). Visual field comparisons between the 
patient and controls through RSDTs showed that the patient had larger global precedence in 
reaction times in the LVF than the RVF, t(11) = 9.41, p < .001, zcc = 12.026, 95% CI [5.268, 
20.358], compared to controls. We also found larger local interference in the RVF than the LVF 
for accuracy rates, t(11) = 3.32, p = .007, zcc = 3.643, 95% CI [-0.978, 8.998], and larger local 
interference in the LVF than the RVF for reaction times, t(11) = 28.31, p < .001, zcc = 72.960, 
95% CI [28.462, 124.837]. The patient’s global interference effects for reaction times were also 
larger in the LVF than the RVF, t(11) = 19.08, p < .001, zcc = 35.770, 95% CI [-14.903, 90.740]. 
Overall, there was no systematic pattern linking the patient’s global / local processing biases to 
the affected side of space. Although some effects appear to be stronger in the LVF (affected side), 
consistent biases were present in both visual fields. 
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5. Rarebit perimetry (Frisén, 2002) 
5.1. Method 
The test was conducted in a darkened room, one eye at the time. An eye-patch was used to cover 
the eye that was not being tested. The participants were required to follow the fixation cross and 
detect minute stimuli (rare bits) presented at different locations on a black screen, across a visual 
field that extended ±20° vertically and ±30° horizontally. They used one key press to indicate that 
they detected one stimulus and two key presses if they detected two stimuli in each trial. The 
participants completed a demonstration session that was followed by five blocks of trials testing 
inner zone of the visual field at 100cm viewing distance. Then they completed five more blocks 
of trials testing outer zone at 50cm viewing distance. 
6. Landolt C 
6.1. Method 
We developed the Landolt C task to map the participants’ binocular peripheral visual acuity in 
the manner resembling the presentation of other experimental tasks assessing visual spatial 
attention in this study. We used Landolt C optotypes presented as rings with a gap on the top, 
bottom, left, or right side. To establish the size of the stimuli that the patient was able to 
discriminate at 50cm viewing distance, we first presented the optotypes ±3° from the central 0.46° 
x 0.46° fixation cross. The size of the stimuli varied from 0.5° x 0.5° to 3° x 3° in 0.5° increments. 
Stimuli were displayed for 500ms, with 500ms inter-trial intervals. The patient reported the 
orientation of the gap in Landolt C optotypes. After completing 48 trials (each orientation 
presented once on both sides of the screen in six different sizes, 4 x 2 x 6), we chose the size 1° 
larger than the smallest size for which the patient’s accuracy was 100% at ±3º from central vision 
(size 2° x 2°).  
In each trial, the participants focused of a central fixation cross, which after 500ms was joined by 
an optotype in one of the four orientations. The optotypes were presented for 200ms to the left or 
to the right of the fixation cross at one of six distances (± 3°, 5°, 8°, 12°, 17°, 23°) on the horizontal 
plane. The participants indicated the orientation of the gap in Landolt C in each trial by pressing 
“up”, “down”, “left”, or “right” arrow keys on the keyboard with their right hand, without time 
constraint. There were 144 pseudo-randomised trials, i.e., each orientation was presented 3 times 
in each position relative to the fixation cross (4 x 3 x 12). We analysed the percentages of correct 
responses given by the patient vs controls for each position relative to the fixation cross. 
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Table S1 The patient’s and controls’ mean (±SD) PSS values in each Response condition, and PSS values averaged across two Response conditions in 
each Presentation condition of the Temporal Order Judgement tasks 






“Which side occurred first?” “Which side occurred second?” 
Patient Controls Patient Controls Patient Controls 
T1a Crossed Hands 
(visual) 
-b -6.6±33.9 - - -b -6.6±33.9 
Uncrossed Hands 
(visual) 
-83.7±49.65c -4.9±20.1 - - -83.7±49.65c -4.9±20.1 
Board (visual) -42.22±58.66 -2.9±33.4 - - -42.22±58.66 -2.9±33.4 
T2 Crossed Hands 
(visual) 
-207.42±330.85 12.86±29.84 - 19.18±26.94 - 16.02±26.3 
Uncrossed Hands 
(visual) 
-19.89±76.29 12.21±17.64 -84.07±77.27 -3.76±26.58 -51.98±76.78 4.23±18.23 
Board (visual) -82.92±128.5 4.11±28.9 13.08±73.11 12.21±17.64 -34.92±100.81 2.3±18.19 
T3 Board (visual) 16.26±41.25 -3.76±20.9 42.45±42.86 -6.71±13.24 29.36±42.06 -5.23±10.95 
Wall (visual) 44.97±25.24 3.22±18.69 40.15±32.99 1.17±16.92 42.56±29.11 2.2±13.71 
Knees (tactile) 68.94±62.55 -1.77±31.65 98.48±56.38 2.76±15.76 83.71±59.47 0.49±18.11 
Note. T1 = Session 1; T2 = Session 2; T3 = Session3. SDs were calculated within-subject for the patient, and between-subjects for the controls. 
a The TOJ tasks in T1 were conducted only in one Response condition (“which side occurred first”).  b Lack of systematic pattern of the patient’s responses across different 
temporal offsets in Crossed Hands conditions (“which side occurred first” in T1 and “which side occurred second” in T2) prevented fitting the cumulative Gaussian to 
determine PSSs, therefore only controls’ results are presented for these conditions. c Due to 95% “right” response in Uncrossed Hands condition in T1, nearest neighbour 
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Chapter 3 – Additional Files 
Pain Reduction by Inducing Sensory-Motor Adaptation in Complex Regional Pain Syndrome 
(CRPS PRISMA): Protocol for a Double-blind Randomized Controlled Trial 
Additional file 1 - World Health Organization Trial Registration Data Set 
Table S1 WHO Trial Registration Data Set 




International Standard Randomised Controlled Trial Number ISRCTN46828292 
Date of registration 










Reflex Sympathetic Dystrophy Syndrome Association (USA) 




Contact for public 
queries 




Ms Monika Halicka (m.halicka@bath.ac.uk), Dr Janet Bultitude 
(j.bultitude@bath.ac.uk) 
Public title Treatment of complex regional pain syndrome (CRPS) with sensory-motor 
adaptation 
Scientific title Pain Reduction by Inducing Sensory-Motor Adaptation in Complex Regional Pain 








Complex Regional Pain Syndrome 
Intervention(s) Active comparator: Prism Adaptation Treatment (two weeks of twice-daily 
sensory-motor training using 35-diopter Fresnel lenses that induce visual shift 
away from the CRPS-affected side) 
Placebo comparator: Sham Prism Adaptation (Sham Treatment) (the same 
procedure using neutral lenses that do not induce visual shift)  
Key inclusion and 
exclusion criteria 
Inclusion criteria (Participants with CRPS): male/female; age 18-80; CRPS type I 
primarily affecting one upper limb, meeting Budapest diagnostic research criteria , 
for >3 months; current pain intensity min. 2/10 
Exclusion criteria (Participants with CRPS): insufficient English language ability; 
legally blind; CRPS affecting both sides of the body; CRPS II (confirmed nerve 
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Data category Information 
damage); physical limitation preventing execution of Prism Adaptation / sham 
treatment; severe psychiatric comorbidity 
Inclusion criteria (Healthy control participants): male/female; age 18-80; 
neurologically healthy; no current or chronic pain 
Exclusion criteria (Healthy control participants): insufficient English language 
ability; legally blind; physical disability or injury limiting normal mobility; history 
of neurological or severe psychiatric illness 
Study type Interventional 
Allocation: Randomized (with stratification to minimise baseline group 
differences) 
Blinding: Double-blind (Participants with CRPS, outcomes assessor) 
Assignment: Parallel  
Primary purpose: treatment 
Date of first 
enrolment 
19/06/2017 
Target sample size 42 Participants with CRPS, 21 Healthy control participants 
Recruitment status No longer recruiting 
Primary 
outcome(s) 
Current self-reported pain intensity on a 0 (no pain) to 10 (pain as bad as you can 
imagine) Numerical Rating Scale 
CRPS severity score based on 16-points scoring system by Harden et al. (PAIN, 
2017) 
Time points: Immediately before the commencement of treatment (week 4) vs. 
immediately after the end of the treatment period (week 7) 
Key secondary 
outcomes 
Self-report questionnaires about pain, physical and emotional functioning, body 
representation, expectations about treatment, and impressions of treatment 
outcome in weeks 1, 4, 7, 11, 19, and 31 (Brief Pain Inventory – short form, Pain 
Detect Questionnaire, Bath CRPS Body Perception Disturbance Scale, Tampa 
Scale for Kinesiophobia, Profile of Mood States); week 1 (Edinburgh Handedness 
Inventory, Revised Life Orientation Test, Patient-Centred Outcomes 
Questionnaire); and weeks 7, 11, 19, and 31 (Patient Global Impression of Change) 
Self-reported daily ratings of average pain intensity, range of movement, and the 
extent to which the CRPS symptoms interfere with daily life (weeks 1 to 11) 
Clinical assessments of CRPS signs and symptoms and sensory, motor, and 
autonomic function in weeks 1, 4, 7, and 11 (CRPS severity score, limb 
temperature asymmetry, oedema, grip strength, delta finger-to-palm distance, 
mechanical detection threshold, mechanical pain threshold, mechanical allodynia, 
two-point discrimination threshold) 
Computer-based tests of visuospatial attention (Temporal Order Judgement, 
Landmark, and Greyscales tasks), cognitive representation of space (Mental 
Number Line Bisection task), spatially-defined motor function (Directional 
Hypokinesia task), and body representation (Hand Laterality Recognition task) in 
weeks 1, 4, 7, and 11 
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Additional file 2 - Supplementary text describing the procedure and results 
of a pilot study to select the stimulus set for the Hand Laterality 
Recognition task 
To develop a stimulus set for the Hand Laterality Recognition task, we photographed a gender-
neutral right hand in 36 different postures and mirror-reversed the images to create equivalent 
pictures of a left hand. In a pilot study, these images were presented at four different orientations 
(0°, 90°, 180° and 270°), each in left and right visual field (giving a total of 576 trials). In each 
trail, a black 0.1° fixation cross on a white background was on constant display. After 1000ms a 
colour image of a hand (12° x 12°) was randomly presented 8° to the left or to the right of the 
fixation cross (i.e., in the left or the right visual field) for 200ms. The pilot participants (N = 22 
healthy adults; 11 females; mean age = 27.91; SD = 8.43) were required to indicate whether the 
image represented the right or the left hand by pressing “up” or “down” keys, respectively, using 
the index and middle fingers of their dominant hand. The next trial started after 3000ms from the 
stimulus onset or once the response was given, whichever came first. Participants were instructed 
to be as fast and as accurate in their responses as possible. Following a practice session with 
longer stimulus presentation times (2000ms), participants completed the task in three blocks, 
allowing a break after every 196 trials. Fifty images (25 of each hand in the same posture and 
orientation) were selected from the pilot image bank for the current study based on sufficient 
accuracy obtained in the pilot study: at least 72% accuracy averaged across both hemifields and 
less than 15% difference in accuracy between left and right hemifield. These requirements were 
set to ensure that the stimuli properties were such that a healthy participant is able to determine 
the laterality above the chance level. Example stimuli are presented in Figure 6 in the manuscript.  
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Additional file 3 - SPIRIT 2013 Checklist 






Administrative information  
Title 1 Descriptive title identifying the study design, population, 
interventions, and, if applicable, trial acronym 
131 
Trial registration 2a Trial identifier and registry name. If not yet registered, name of 
intended registry 
132 




Protocol version 3 Date and version identifier 132 
Funding 4 Sources and types of financial, material, and other support 139, 168 
Roles and 
responsibilities 
5a Names, affiliations, and roles of protocol contributors 131, 168 
5b Name and contact information for the trial sponsor 167 
 5c Role of study sponsor and funders, if any, in study design; 
collection, management, analysis, and interpretation of data; 
writing of the report; and the decision to submit the report for 
publication, including whether they will have ultimate authority 
over any of these activities 
 
167 
 5d Composition, roles, and responsibilities of the coordinating 
centre, steering committee, endpoint adjudication committee, 
data management team, and other individuals or groups 





Introduction    
Background and 
rationale 
6a Description of research question and justification for 
undertaking the trial, including summary of relevant studies 




 6b Explanation for choice of comparators 134, 141 
Objectives 7 Specific objectives or hypotheses 134-135 
Trial design 8 Description of trial design including type of trial (eg, parallel 
group, crossover, factorial, single group), allocation ratio, and 




Methods: Participants, interventions, and outcomes  
Study setting 9 Description of study settings (eg, community clinic, academic 
hospital) and list of countries where data will be collected. 
Reference to where list of study sites can be obtained 
137 
Eligibility criteria 10 Inclusion and exclusion criteria for participants. If applicable, 
eligibility criteria for study centres and individuals who will 
perform the interventions (eg, surgeons, psychotherapists) 
137-139 







Interventions 11a Interventions for each group with sufficient detail to allow 
replication, including how and when they will be administered 
140-1342 
11b Criteria for discontinuing or modifying allocated interventions 
for a given trial participant (eg, drug dose change in response to 
harms, participant request, or improving/worsening disease) 
136, 142 
11c Strategies to improve adherence to intervention protocols, and 
any procedures for monitoring adherence (eg, drug tablet return, 
laboratory tests) 
141-142 
11d Relevant concomitant care and interventions that are permitted 
or prohibited during the trial 
142 
Outcomes 12 Primary, secondary, and other outcomes, including the specific 
measurement variable (eg, systolic blood pressure), analysis 
metric (eg, change from baseline, final value, time to event), 
method of aggregation (eg, median, proportion), and time point 
for each outcome. Explanation of the clinical relevance of 






13 Time schedule of enrolment, interventions (including any run-
ins and washouts), assessments, and visits for participants. A 
schematic diagram is highly recommended (see Figure) 
135-137, 
Table 1 
Sample size 14 Estimated number of participants needed to achieve study 
objectives and how it was determined, including clinical and 
statistical assumptions supporting any sample size calculations 
160-161 
Recruitment 15 Strategies for achieving adequate participant enrolment to reach 
target sample size 
139 
Methods: Assignment of interventions (for controlled trials)  
Allocation:    
Sequence 
generation 
16a Method of generating the allocation sequence (eg, computer-
generated random numbers), and list of any factors for 
stratification. To reduce predictability of a random sequence, 
details of any planned restriction (eg, blocking) should be 
provided in a separate document that is unavailable to those who 






16b Mechanism of implementing the allocation sequence (eg, central 
telephone; sequentially numbered, opaque, sealed envelopes), 
describing any steps to conceal the sequence until interventions 
are assigned 
140 
Implementation 16c Who will generate the allocation sequence, who will enrol 




17a Who will be blinded after assignment to interventions (eg, trial 




 17b If blinded, circumstances under which unblinding is permissible, 
and procedure for revealing a participant’s allocated intervention 
during the trial 
159 
Methods: Data collection, management, and analysis  










18a Plans for assessment and collection of outcome, baseline, and 
other trial data, including any related processes to promote data 
quality (eg, duplicate measurements, training of assessors) and a 
description of study instruments (eg, questionnaires, laboratory 
tests) along with their reliability and validity, if known. 




 18b Plans to promote participant retention and complete follow-up, 
including list of any outcome data to be collected for participants 
who discontinue or deviate from intervention protocols 
139, 161-
162 
Data management 19 Plans for data entry, coding, security, and storage, including any 
related processes to promote data quality (eg, double data entry; 
range checks for data values). Reference to where details of data 
management procedures can be found, if not in the protocol 
146-159, 
168 
Statistical methods 20a Statistical methods for analysing primary and secondary 
outcomes. Reference to where other details of the statistical 
analysis plan can be found, if not in the protocol 
161-165 
 20b Methods for any additional analyses (eg, subgroup and adjusted 
analyses) 
161-165 
 20c Definition of analysis population relating to protocol non-
adherence (eg, as randomised analysis), and any statistical 
methods to handle missing data (eg, multiple imputation) 
 
161-162 
Methods: Monitoring  
Data monitoring 21a Composition of data monitoring committee (DMC); summary of 
its role and reporting structure; statement of whether it is 
independent from the sponsor and competing interests; and 
reference to where further details about its charter can be found, 
if not in the protocol. Alternatively, an explanation of why a 
DMC is not needed 
NA 
 21b Description of any interim analyses and stopping guidelines, 
including who will have access to these interim results and make 
the final decision to terminate the trial 
161 
Harms 22 Plans for collecting, assessing, reporting, and managing solicited 
and spontaneously reported adverse events and other unintended 
effects of trial interventions or trial conduct 
162 
Auditing 23 Frequency and procedures for auditing trial conduct, if any, and 
whether the process will be independent from investigators and 
the sponsor 
NA 
Ethics and dissemination  
Research ethics 
approval 
24 Plans for seeking research ethics committee/institutional review 




25 Plans for communicating important protocol modifications (eg, 
changes to eligibility criteria, outcomes, analyses) to relevant 
parties (eg, investigators, REC/IRBs, trial participants, trial 
registries, journals, regulators) 
167 
Consent or assent 26a Who will obtain informed consent or assent from potential trial 
participants or authorised surrogates, and how (see Item 32) 
167-168 







 26b Additional consent provisions for collection and use of 
participant data and biological specimens in ancillary studies, if 
applicable 
NA 
Confidentiality 27 How personal information about potential and enrolled 
participants will be collected, shared, and maintained in order to 




28 Financial and other competing interests for principal 
investigators for the overall trial and each study site 
168 
Access to data 29 Statement of who will have access to the final trial dataset, and 





30 Provisions, if any, for ancillary and post-trial care, and for 




31a Plans for investigators and sponsor to communicate trial results 
to participants, healthcare professionals, the public, and other 
relevant groups (eg, via publication, reporting in results 
databases, or other data sharing arrangements), including any 
publication restrictions 
168 
 31b Authorship eligibility guidelines and any intended use of 
professional writers 
NA 
 31c Plans, if any, for granting public access to the full protocol, 
participant-level dataset, and statistical code 
168 
Appendices    
Informed consent 
materials 
32 Model consent form and other related documentation given to 




33 Plans for collection, laboratory evaluation, and storage of 
biological specimens for genetic or molecular analysis in the 
current trial and for future use in ancillary studies, if applicable 
NA 
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Chapter 4 - Supplementary Material 
Disputing space-based biases in unilateral complex regional pain syndrome 
1. Spatially-defined motor function - results 
The results of the linear mixed models analyses on the spatially-defined motor function task data 
are reported in Table S1. In the main text, we reported the main effects of Group on movement 
initiation times with either hand, indicating that participants with Complex Regional Syndrome 
(CRPS) were overall slower compared to controls. There was also a main effect of Starting 
Position on initiation times with the affected limb suggesting that, regardless of Group or Visual 
Field (VF), movement initiation was slower from the affected (Mdn = 477.32, BCa 95% CI 
[455.98, 532.44]) than unaffected side of space (Mdn = 458.88, BCa 95% CI [435.17, 505.13]). 
This pattern is consistent with directional hypokinesia towards the unaffected side (i.e. slowing 
of movements directed toward the unaffected, rather than affected side of space).  
Also reported in the main text is that main effects of Group were also found for movement 
execution times with either hand, with slowing among CRPS patients relative to controls. There 
was also an interaction between Group and hand Starting Position for the unaffected limb, 
suggesting slower execution of movements from the unaffected than affected Starting Position 
among CRPS patients compared to controls. In addition to these results reported in the main text, 
we found the following effects on execution times that did not involve Group.  
A main effect of VF suggested that, independent of Group or Starting Position, execution of 
movements with the affected limb was slower towards the targets in the unaffected (Mdn = 
891.65, BCa 95% CI [795.69, 939.31]) compared to the affected (Mdn = 826.69, BCa 95% CI 
[770.99, 924.28]) side of space. This suggests that movements to the targets in the side of space 
ipsilateral to the affected limb were faster than to the contralateral side of space.  
Main effects of Starting Position also indicated overall slower movement execution from the 
affected (Mdn = 937.65, BCa 95% CI [810.78, 980.04]) than central (Mdn 799.22, BCa 95% CI 
[743.69, 880.67]) position with the affected limb, and from the unaffected (Mdn = 786.88, BCa 
95% CI [739.55, 847.88]) than affected (Mdn = 750.09, BCa 95% CI [707.51, 803.14]) position 
with the unaffected limb, regardless of Group or VF. These suggest that movements from starting 
positions ipsilateral to the hand used were slower than from contralateral or central positions.  
Furthermore, there were interactions between Starting Position and VF on execution times. When 
executing movements with the affected or unaffected hand, participants were slower in reaching 
targets in the unaffected VF (affected hand Mdn = 943.60, BCa 95% CI [847.43, 1047.72]; 
unaffected hand Mdn = 789.42, BCa 95% CI [702.34, 824.93]) than affected VF (affected hand 
Mdn = 887.55, BCa 95% CI [790.22, 926.11]; unaffected hand Mdn = 726.93, BCa 95% CI 
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[681.03, 774.97]) from the affected Starting Position (Figure S1a). Conversely, from the 
unaffected Starting Position, participants were slower in reaching targets in the affected VF 
(affected hand Mdn = 857.01, BCa 95% CI [781.54, 931.30]; unaffected hand Mdn = 821.87, BCa 
95% CI [776.09, 860.07]) than unaffected VF (affected hand Mdn = 814.83, BCa 95% CI [754.59, 
905.28]; unaffected hand Mdn = 759.12, BCa 95% CI [705.55, 802.46]) (Figure S1b). Movement 
execution with the affected hand towards the targets in the unaffected VF was significantly slower 
from the affected than unaffected Starting Position (Figure S1c), whereas when the unaffected 
hand was used, movement execution to the targets in the affected VF was significantly slower 
from the unaffected than affected Starting Position (Figure S1d). These interactions suggest that 
regardless of Group, participants were slower to execute the longer movements that crossed the 
body midline with either hand than to execute the shorter movements that were made within the 
same side of the body midline. Additionally, participants were slower to execute movements from 
the central Starting Position with the unaffected hand towards the affected VF (Mdn = 717.05, 
BCa 95% CI [679.23, 802.12]) than unaffected VF (Mdn = 690.13, BCa 95% CI [637.05, 
754.59]), regardless of Group (Figure S1e). This effect would be consistent with directional 
bradykinesia towards the affected side. Alternatively, it could reflect slowing of movement to the 
side of space contralateral to the limb used. However, execution of the unaffected hand 
movements towards the unaffected VF (that is, side of space ipsilateral to the limb used) was also 
slower from the affected than central Starting Position (Figure S1f). There were no further 
significant main effects or interactions for movement execution times. 
Overall, the results provide some evidence for directional bradykinesia towards the affected side 
when using the unaffected limb, as well as directional hypokinesia and bradykinesia towards the 
unaffected side when using the affected limb. However, these patterns were not specific to CRPS, 
but largely consistent across both groups. Most of the significant effects for movement execution 
time as a function of hand starting position and target location can be explained by the length of 
the required movement pathway and whether it crossed the body midline. In summary, we 
observed little systematic evidence of directional motor deficits consistent with motor neglect in 
participants with CRPS. 




Figure S1. Diagrams illustrate the results of significant post-hoc contrasts following Starting 
Position x Visual Field interactions on movement execution times with the affected (orange) and 
unaffected (black) hand. Arrows indicate the direction of movement. Dashed lines represent 
slower movement execution as compared to solid lines. “X” represents the target, and the grey 
cylinders represent the possible button locations / hand Starting Positions. Regardless of Group, 
participants were slower to execute movements (A) towards the unaffected VF than affected VF 
from the affected Starting Position, with either hand; (B) towards the unaffected VF than affected 
VF from the unaffected Starting Position, with either hand; (C) towards the unaffected VF from 
the affected than unaffected Starting Position, with the affected hand; (D) towards the affected 
VF from the unaffected than affected Starting Position, with the unaffected hand; (E) towards the 
affected VF than unaffected VF from the central Starting Position, with the unaffected hand; (F) 




Table S1 The results of bootstrapped (n = 1000) linear mixed modelling of main effects and interactions on movement initiation / execution times for each hand in the 
test of spatially-defined motor function 
Note. *Significant effect (95% CI around the regression coefficient estimate does not include zero). The levels of each model term are indicated in brackets, with the reference term listed first. Group 
factor had two levels (Con = control participants, CRPS = participants with Complex Regional Pain Syndrome) and Visual Field factor also had two levels (AVF = affected, UVF = unaffected). The hand 
Starting Position factor had three levels (CP = central, AP = affected, UP = unaffected), necessitating the inclusion of two terms in the model for each main effect and interaction involving this Factor.  
 
 
Movement initiation time 
Affected hand 
Movement initiation time 
Unaffected hand 
Movement execution time 
Affected hand 
Movement execution time 
Unaffected hand 
























Intercept 0.433* 0.425 0.440 0.421* 0.413 0.429 0.693* 0.674 0.713 0.672* 0.641 0.702 
Group (Con vs CRPS) 0.191* 0.159 0.222 0.073* 0.049 0.099 0.444* 0.357 0.523 0.112* 0.077 0.147 
Starting Position (AP vs CP) -0.009 -0.021 0.003 0.006 -0.005 0.019 -0.083* -0.112 -0.057 0.006 -0.040 0.054 
Starting Position (AP vs UP) -0.025* -0.036 -0.012 0.006 -0.008 0.020 -0.006 -0.044 0.029 0.066* 0.015 0.118 
Visual Field (AVF vs UVF) -0.005 -0.016 0.007 -0.007 -0.019 0.004 0.050* 0.021 0.078 0.021 -0.021 0.061 
Group (Con vs CRPS) x Starting Position 
(AP vs CP) 
-0.008 -0.049 0.038 -0.020 -0.055 0.008 -0.010 -0.109 0.085 0.007 -0.044 0.061 
Group (Con vs CRPS) x Starting Position 
(AP vs UP) 
0.010 -0.035 0.055 -0.008 -0.043 0.023 0.047 -0.064 0.164 0.063* 0.002 0.120 
Group (Con vs CRPS) x Visual Field 
(AVF vs UVF) 
0.023 -0.021 0.068 -0.010 -0.041 0.018 0.110 -0.003 0.222 0.020 -0.029 0.068 
Starting Position (AP vs CP) x Visual 
Field (AVF vs UVF) 
0.008 -0.010 0.024 0.004 -0.013 0.022 -0.023 -0.057 0.012 -0.066* -0.126 < -
0.001 
Starting Position (AP vs UP) x Visual 
Field (AVF vs UVF) 
0.009 -0.008 0.026 0.006 -0.012 0.025 -0.085* -0.129 -0.040 -0.079* -0.143 -0.014 
Group (Con vs CRPS) x Starting Position 
(AP vs CP) x Visual Field (AVF vs 
UVF) 
-0.005 -0.062 0.052 -0.004 -0.041 0.037 0.060 -0.123 0.284 -0.022 -0.099 0.052 
Group (Con vs CRPS) x Starting Position 
(AP vs UP) x Visual Field (AVF vs 
UVF) 



















































































































































































































0.43 0.90 1.00 
BPI 
interference 
0.53 0.57 0.73 0.90 
Age -0.19 -0.12 -0.17 -0.11 0.80 
Duration -0.12 0.11 0.07 0.08 0.30 0.70 
PDQ 0.43 0.38 0.45 0.50 -0.07 -0.13 0.60 
Tampa 0.22 0.22 0.30 0.37 -0.05 0.09 0.22 0.50 
BPDS 0.34 0.49 0.52 0.46 -0.07 -0.07 0.47 0.39 0.40 
POMS 0.15 0.24 0.34 0.46 -0.16 -0.09 0.44 0.51 0.59 0.30 
EHI (pre-
CRPS) 
0.08 -0.09 -0.08 0.13 0.24 0.06 0.15 0.11 0.19 0.11 0.20 
Abs. ∆EHI 0.46 0.04 0.20 0.24 -0.12 -0.21 0.19 0.21 0.16 0.04 0.08 0.10 
Temp. 
difference 
0.02 0.22 0.24 0.23 0.07 0.29 0.14 0.40 0.20 0.25 0.16 0.05 0.00 
Abs. temp. 
difference 
0.14 -0.14 -0.10 -0.09 -0.02 -0.16 -0.12 -0.39 -0.16 -0.30 -0.17 0.16 -0.84 -0.10 
Oedema 0.09 -0.32 -0.25 -0.02 0.06 -0.22 -0.05 -0.03 -0.04 -0.09 0.22 0.48 0.03 0.05 -0.20 
Grip 
strength 
-0.60 -0.33 -0.44 -0.45 0.08 0.07 -0.24 -0.10 -0.33 -0.19 -0.11 -0.45 -0.03 -0.17 0.17 -0.30 
∆FTP -0.47 -0.14 -0.25 -0.24 -0.09 0.16 -0.20 0.01 -0.21 -0.03 -0.05 -0.41 -0.07 -0.16 0.01 0.68 -0.40 
MDT -0.21 -0.03 -0.08 0.01 0.12 0.13 -0.20 -0.01 -0.13 -0.02 0.09 0.18 0.30 -0.24 0.19 0.10 -0.03 -0.50 
MPT 0.29 0.18 0.19 -0.02 -0.11 0.02 0.22 0.16 0.23 -0.13 -0.06 0.00 -0.10 0.11 0.00 0.00 0.04 -0.27 -0.60 
Allodynia 0.32 0.45 0.51 0.36 -0.09 -0.08 0.52 0.14 0.50 0.32 0.11 0.16 -0.03 0.04 -0.10 -0.38 -0.29 -0.38 0.28 -0.70 
Two-point 
discrim. 
-0.09 -0.02 -0.08 0.07 0.01 0.04 -0.02 0.07 -0.04 0.17 -0.20 -0.08 0.04 -0.11 -0.14 -0.06 0.03 0.05 -0.17 0.09 -0.80 
PSS 0.18 0.07 0.16 0.27 0.01 0.12 0.20 0.30 0.20 0.13 0.06 0.01 0.20 -0.21 -0.02 -0.08 0.04 -0.18 0.20 -0.08 -0.17 -0.90 
PSE 0.07 0.18 0.20 0.29 0.10 0.27 0.08 0.05 0.10 0.08 0.00 -0.22 0.22 0.01 -0.30 -0.13 -0.22 0.15 -0.16 -0.14 0.00 0.10 -1.00 












MNLB -0.07 0.20 0.15 -0.04 0.06 0.06 0.06 -0.10 -0.02 0.00 -0.27 -0.54 -0.07 0.10 -0.49 0.04 0.00 -0.22 0.07 -0.01 -0.15 -0.09 0.38 0.37 
MIT AH 0.31 0.17 0.32 0.28 0.21 0.32 0.41 0.19 0.52 0.33 0.23 0.27 0.23 -0.16 -0.04 -0.44 -0.25 -0.26 0.10 0.45 0.09 0.26 0.12 -0.22 -0.23 
MIT UH 0.21 0.06 0.15 0.12 0.32 0.28 0.32 0.20 0.45 0.14 0.24 0.26 0.20 -0.11 0.21 -0.21 -0.20 -0.07 0.18 0.21 -0.26 0.35 0.12 0.02 -0.24 0.71 
MET AH 0.16 0.02 0.21 0.20 0.14 0.01 0.09 0.12 0.12 0.26 -0.04 0.45 0.13 -0.02 0.02 -0.45 -0.33 -0.01 -0.29 0.15 0.29 0.07 -0.07 -0.26 -0.12 0.54 0.21 
MET UH 0.05 0.17 0.21 -0.02 0.32 0.00 0.25 0.15 0.05 -0.05 0.06 0.33 0.18 -0.15 -0.01 -0.18 -0.39 0.05 -0.07 0.08 0.00 0.00 0.07 -0.11 -0.07 0.42 0.45 0.38 
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Figure S2. Correlation matrix illustrating relationships between participant characteristics; self-reported pain, fear of movement, body perception, and mood; sensory, 
motor, and autonomic function; and experimental measures of visuospatial attention, mental representation of space, and movement speed. The numbers represent the 
Pearson’s correlation coefficient. The strength and direction of the correlations are colour-coded according to the legend on the right-hand side. Numbers in bold 
represent correlations significant at the level of p < .05. CSS = CRPS symptom severity score; BPI = Brief Pain Inventory; PDQ = Pain Detect Questionnaire; Tampa 
= Tampa Scale for Kinesiophobia; BPDS = Bath CRPS Body Perception Disturbance Scale; POMS = Profile of Mood States; EHI = Edinburgh Handedness Inventory; 
Abs. ∆EHI = absolute change in handedness index from before CRPS onset to current handedness; ∆FTP = Finger-To-Palm distance; MDT = Mechanical Detection 
Threshold; MPT = Mechanical Pain Threshold; PSS = Point of Subjective Simultaneity; PSE = Point of Subjective Equality; MNLB = Mental Number Line Bisection; 
MIT AH = movement initiation time with the affected hand; MIT UH = movement initiation time with the unaffected hand; MET AH = movement execution time 
with the affected hand; MET UH = movement execution time with the unaffected hand. 
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Chapter 5 - Supplemental Material 
Supplemental text 
Text S1. Summary of any deviations from the original trial protocol  
Deviations from the protocol [3] (Chapter 3): 
1. Universities of Oxford and Exeter were listed as research sites in the trial protocol, however, 
no participants were tested in these locations. 
2. In the original protocol, we defined intention-to-treat population as all participants allocated 
to treatment, regardless of their adherence or completion of outcome measures. This did not 
account for the possibility that participants could drop out after treatment allocation but before 
they received the treatment, that is, before they were trained in how to carry out their allocated 
intervention. For instance, this was the case when participant was allocated to treatment but 
did not show up for RS2 and did not cancel their appointment beforehand. Therefore, in this 
manuscript we defined the intention-to-treat population as those participants who received 
their allocated treatment (i.e. received in-person training) immediately after RS2. 
3. The treatment protocol stated that the targets will be located at approximately 60cm distance 
from the participant. In the manuscript we reported the actual measured distance, on average 
50cm, which depended on how far participant could extend their arm.  
4. We stated that we will report the total number of treatment sessions per group in which 
deviations other than missed or extra sessions were suspected, however, no such deviations 
were identified. 
5. Although the protocol stated that we will calculate the Number Needed to Treat for the 
primary outcomes, we did not perform these analyses because there was no effect of prism 
adaptation (PA) treatment. Nonetheless, we reported effects sizes for mean between-group 
differences in change on the primary outcomes over the treatment period, which was not 
explicitly included in the protocol. 
6. The protocol mentioned that we would take thermal images of participants’ arms when 
available, however, we only had access to a thermal imaging camera when testing the first 
few participants, thus we did not include the images or performed any formal analyses for 
this manuscript. 
7. It was not specified in the protocol whether we would analyse signed or absolute limb 
temperature difference. For this manuscript, we conducted analyses on the absolute 
temperature difference, to test whether PA treatment can reduce temperature asymmetry, 
regardless of whether the affected limb was colder or warmer than unaffected limb at baseline.  
8. In the protocol we stated that we would conduct exploratory analyses of potential predictors 
of response to PA treatment and/or CRPS progression over time. We only explored the factors 
that could account for the second outcome, because we did not find any effects of PA 
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treatment beyond that of sham treatment. Furthermore, we used pain intensity ratings across 
six rather than four time points (i.e. including the long-term follow-up), to capture change in 
pain over longer period. Moreover, we stated in the protocol that in the first instance we would 
consider those factors on which participants with CRPS significantly differed from pain-free 
participants at baseline, to be potential predictors in the regression models. However, 
participants with CRPS did not present with hypothesised abnormalities on the tests of 
neuropsychological functions compared to controls [2] (Chapter 4). Thus, we included all 
primary and secondary outcomes in best subsets regression analyses to allow unbiased 
selection of the best combination of explanatory variables. These analyses were explicitly 
identified as exploratory both in the original protocol, and in this manuscript. 
9. Exploratory subgroup analyses were not specified in the protocol but were clearly labelled as 
such in the manuscript and supplementary files. These were conducted to aid interpretation 
of our findings that PA did not affect participants’ pain intensity, CRPS severity, or spatial 
cognition, as we initially hypothesised.  
 
Text S2. Instructions for training CRPS participants in therapy for 
PRISMA trial (script) 
“I’m going to read the instructions out to you. This makes sure that I don’t forget anything, and 
also that everyone hears the same instructions. Feel free to ask me any questions if anything is 
unclear”.  
“I am going to train you in how to perform sensorimotor adaptation therapy. You will perform 
the therapy twice a day, and each time it should take no more than a few minutes. The therapy 
involves making some pointing movements while wearing some goggles that distort your vision. 
I am going to explain the entire process to you now, and we will go through the first therapy 
session together. After today, you can refer to these written instructions to help you remember 
how to perform the therapy. We have also included a link to a video that shows the entire therapy”  
Point out the video link in the instructions.  
“We will watch this now together and then I will go through the entire therapy with you.”  
Show participant the training video. Write in pen and in large letters under the link to the video 
which arm they should use for the treatment (it should be their affected arm). If their affected arm 
is their left arm then make a point of saying that they will do everything the same as in the video, 
except that they will use their LEFT arm (not the right, as shown in the video). 
“First we need to put this sheet up on the wall. This needs to be placed so that the red circles are 
at the same level as your eyes, and this black arrow is in line with the centre of your body. You 
should be able to reach both of the circles with your affected arm stretched out almost as far as it 
can go.” 
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If you are meeting them in their own home, fix the sheet in the place where they will do their 
treatment sessions. Have the participant do this themselves if possible, and help them and/or 
correct them if necessary. 
Have the participant position their chair in front of the pointing sheet and reach to touch each of 
the targets. Have them move their chair closer/further away if necessary. They should be able to 
reach the targets with their arm slightly less than fully outstretched. Measure and record the 
distance between their eyes and the centre of the page upon which the targets are printed.  
“You’re going to make pointing movements to each of these dots. You need to start with your 
finger on your chest, then reach out and touch the left target, then bring your hand immediately 
back to your chest, then reach out and touch the right target, and so on”. (perform these movements 
yourself while you talk). “I want you to do this as fast as possible” (demonstrate). 
They should use their index finger to point if possible, otherwise they can use whichever finger is 
most comfortable, but is MUST be a finger of their affected hand. They can also point with a 
knuckle. Make note of any such adjustments.  
“Before we start the treatment, I’ll have you practice the pointing movements.  
Have the participant practice these movements. Correct them if necessary.  
“That was just a practice to make sure you have the hang of the movements that are required 
during treatment. During the treatment, you will put your goggles on and make these movements 
as fast as possible a total of 50 times. That’s 25 times per dot”  
Take the goggles out of the bag. Fiddle with the lenses a little as though you are adjusting them, 
and then look through them as though you are checking that they are correct. 
“These goggles distort your vision in a few different ways. For example, they restrict your field 
of vision, and they also make your vision a bit foggy. They will make it a bit more difficult to 
point to the targets. The treatment that we are testing seems to work by forcing the brain to re-
learn how to combine different sources of information about where your limb is while it moves.” 
“Because the goggles distort your vision, you might be tempted to slow down your pointing 
movements. It is VERY important that you resist the temptation to slow down. Even if you miss 
the targets at first, keep moving and you will find that after a few goes you will probably become 
more accurate again.“ 
“Once you have put the goggles on, it is important that you move your head as little as possible, 
however you should make sure that you can see both of the red dots. You will need to count your 
pointing movements and stop when you reach fifty. Do you have any questions?” 
Answer any questions that the participant has (within reason!). Once they are happy to start the 
treatment, give them the goggles and let them do the treatment. Ask them to count their own 
pointing movements aloud. Let them run the treatment themselves as much as possible, but 
provide advice and feedback if necessary. This could include urging them to move rapidly if you 
see them slowing down in order to hit the target, reminding them to bring their hand all the way 
back to their chest in between pointing movements, or making sure that they stop after 50 pointing 
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movements. If participants find it hard to make high-quality pointing movements for 50 trials in 
a row, have them stop to rest after 25. If this is necessary, then have them close their eyes while 
they are resting, and tell them to use the same procedure for all of their treatment sessions. Make 
a note of this in your own records and also in their instruction sheet or log book. 
Once the participant has finished have them take the goggles off.  
“The treatment that you will do from now on will be exactly the same as what you just did while 
wearing the goggles. You don’t need to do any of the pointing that we did before you put the 
goggles on, just the 50 pointing movements while wearing goggles. You will do this twice a day. 
You should aim to do the two treatment sessions about 12 hours apart from each other, although 
we advise that you just find a way to make it part of your normal morning and evening routine, 
even if this means that the treatments aren’t exactly 12 hours apart. I’d like you to decide now 
when you will do the treatments” 
Ask them to choose 2 times of day that are roughly 12 hours apart, and write these times in their 
log book. Talk the participant through the logbook. The notes section is where they could write 
any information they think is relevant, e.g. anything that might have meant the treatment session 
proceeded differently (e.g. it was completed late due to coming home last), or reasons for missed 
sessions.  
“It’s very important that you do all of the treatment sessions, regardless of whether your 
symptoms improve or stay the same. One thing that we do know about this treatment is that any 
benefits seem only to arise after several days of treatment, and the number of days is likely to 
vary between people. So even if you’re in the real treatment group, it might take a few days for 
you to feel any changes in symptoms. Even if you don’t think your symptoms are changing, please 
complete all of the treatment sessions. It might be that you are in the real treatment group but that 
your symptoms aren’t relieved by the treatment, in which case it would be very important for us 
to know that you have done the full two weeks of treatment.” 
“Similarly, if you find that you have a big reduction in CRPS symptoms, please keep doing the 
treatment twice a day. However, if your symptoms get a lot worse during the course of the 
treatment period, please contact me using the contact details at the top of these instructions, 
because it might be that it would be better for you to stop doing the treatment early.” 
Explain when they should perform the first self-guided treatment session, which will be on the 
morning of the next day. Write this in their log book. Also explain when they should perform the 
last self-guided treatment session, which should be the evening of the day before RS3. Indicate 
the date and time of their last session in their log book. 
“Before we finish, I want to remind you that Monika [MH] should not know what treatment group 
you are in. For this reason, it is very important that you seal the goggles back in this bag before 
you return the goggles to her at the next treatment session so that she won’t see what they look 
like.” 
Check if the person has any more questions. Give them the goggles sealed inside the bag. 
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Text S3. Data preparation 
Participant-level data from the spatially-defined motor function task was processed to remove 
invalid trials. These included trials in which the movement endpoint did not match target location, 
the movement was initiated before target onset, or the screen touch time was not recorded (the 
latter type of invalid trials was only removed for movement execution times). Across all 
participants, both hands used, and all research sessions, 4.60% and 7.85% of all completed trials 
was removed for further processing of movement initiation and execution times, respectively. 
Movement initiation and execution times that were 3 SDs above or below individual participant’s 
mean for each task condition (i.e. each combination of movement time measure, hand used, hand 
starting position, and visual field) were identified as participant-level outliers and replaced with 
the nearest non-outlier value (1.01% and 0.50%, respectively). If the number of invalid trials per 
task condition exceeded 3 SDs of a total group mean of invalid trials for that condition, we 
excluded participant’s data from further analysis of this task. This meant that we could not obtain 
the complete set of the indices of directional hypokinesia or bradykinesia for some participants 
(8% of all possible indices). Any missing logbook ratings of pain, interference, and range of 
movement were interpolated using linear regression, except for two participants who dropped out 
and did not return their logbooks. Participants who withdrew following treatment allocation and 
did not return their treatment logbooks (PA treatment n = 2, Sham treatment n = 1) were assumed 
not to have completed any treatment sessions (thus their number of logged treatment sessions was 
entered as zero). 
Reaction times 3 SDs above or below participant’s mean for each condition of the Hand Laterality 
Recognition task (i.e. each combination of depicted hand and VF) were identified as participant-
level outliers and replaced with the nearest non-outlier value (0.69% of trials across all 
participants and research sessions).  
Participant scores on the self-report questionnaires, clinical assessments, and computer-based 
tasks that were 3 SDs above or below the mean scores of their relevant treatment group were 
identified as group-level outliers and replaced with the nearest non-outlier value (0.98% of data 
points across all measures and sessions). 
 
Text S4. Factors excluded from exploratory best subsets regression 
analyses  
We removed one influential observation from the analysis of change in pain intensity but retained 
all observations for the analysis on change in CRPS severity. The pool of potential predictors was 
limited by excluding factors that were nor linearly related with each outcome. For both change in 
pain intensity and CRPS severity score, we excluded baseline CRPS severity score, MDT ratio, 
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MPT ratio, and PSE (Landmark task). For change in pain intensity, we additionally excluded 
baseline PSS (TOJ task). We further identified predictors that were highly correlated with each 
other (r > 0.70), and excluded one of each pair, keeping the predictor that had higher correlation 
with each outcome. This was the case for the following pairs of predictors: grip strength ratio and 
∆FTP ratio, current pain intensity and BPI pain severity, and BPI pain severity and BPI pain 
interference. We excluded grip strength ratio and BPI pain severity from the analysis of change 
in pain intensity, and ∆FTP ratio and BPI pain severity from the analysis of change in CRPS 
severity. Moreover, as there were two indices of directional hypokinesia and bradykinesia for 
each hand, we excluded one index of each pair which had lower correlation with each outcome. 
Thus, for the analysis of change in pain intensity, we excluded Index A of directional hypokinesia 
for the affected hand, and Index B for the unaffected hand, as well as Index B of directional 
bradykinesia for the affected hand, and Index B for the unaffected hand. For the analysis of change 
in CRPS severity, we excluded Index B of directional hypokinesia with the affected hand, and 
Index A for the unaffected hand, as well as Index B of directional bradykinesia for the affected 
hand, and Index A for the unaffected hand. Following these exclusions, variance inflation factors 
were < 5 for all best subsets fits. 
 
Text S5. Daily logbook analysis: number of days to reach peak 
improvement and return to baseline during the treatment period 
For daily pain intensity, median number of days from the beginning of treatment to reach peak 
improvement was 5 in PA group and 4.5 in sham treatment group. However, six participants in 
PA group and two participants in sham treatment group did not improve throughout the treatment 
period. Median number of days from peak improvement to return to baseline was 2.5 in PA group 
and 3 in sham treatment group. Two participants in each group did not return to their baseline 
average pain intensity throughout the treatment period or four weeks follow-up period. 
For daily ratings of symptoms interference, median number of days to reach peak improvement 
was 4.5 in PA group and 4 in sham treatment group. However, four participants in PA group and 
eight participants in sham treatment group did not improve. Median number of days to return to 
baseline was 2 in PA group and 3.5 in sham treatment group. Five participants in PA group and 
four participants in sham treatment group did not return to their baseline symptoms interference.  
For daily ratings of range of movement, median number of days to reach peak improvement was 
6.5 in PA group, and 5 in sham treatment group. However, eight participants in PA group and 12 
participants in sham group did not improve. Median number of days to return to baseline was 3 
for both treatment groups. Two participants in PA group and three participants in sham group did 
not return to their baseline range of movement. 
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Text S6. Per-protocol analysis 
Per-protocol population consisted of participants who completed their allocated treatment 
according to the trained protocol and missed no more than six retreatment sessions; and completed 
the primary outcome measures in RS1-RS4 (n = 41) and LTFU1 and LTFU2 (n = 37).  
1. Participant characteristics 
Table S3 presents baseline characteristics and comparisons between PA and sham treatment 
groups. The two groups were matched on the minimisation factors. They were also matched on 
baseline mean levels of optimism, mood disturbance, fear of movement, and expectations and 
criteria for success of the treatment (there were no significant differences between PA and sham 
treatment groups on any of the PCOQ items, Us ≥ 140.00, psadj ≥ .107, ds ≤ 0.60). Median number 
of logged treatment sessions did not significantly differ between the PA and sham treatment 
groups, indicating that they had similar extent of exposure to treatment.  
2. Effects of PA treatment on the primary outcomes  
We conducted a 2 (Group: PA, sham treatment) x 6 (Time: RS1-RS4, LTFU1-LTFU2) ANOVA 
on the primary outcome of current pain intensity (see Figure S4a). Significant main effect of 
Time, F(5, 175) = 2.46, p = .035, ƞ2p = 0.07, suggested overall reduction in pain intensity 
(regardless of treatment) from RS2 (Mdn = 5.00, BCa 95% CI [5.00, 6.00]) to RS3 (Mdn = 5.00, 
BCa 95% CI [5.00, 6.00]). However, this effect did not withstand correction for multiple 
comparisons, Zs ≥ -1.77, psadj ≥ .320, ds ≤ 0.40. There were no significant Group, F(1, 35) = 0.02, 
p = .901, ƞ2p < 0.01, or interaction effects, F(5, 175) = 0.68, p = .638, ƞ
2
p = 0.02. Effect size of 
the difference in mean change in pain intensity over the treatment period (RS3-RS2) between the 
PA and sham treatment groups was small, d = 0.38, 95% CI [-0.24, 1.00]. Mean pain reduction in 
the PA treatment group was -0.86 points on 0-10 NRS scale, BCa 95% CI [-1.89, -0.09]. In the 
sham treatment group, mean pain reduction was -0.20 points, BCa 95% CI [-0.89, 0.44]. 
A 2 (Group: PA, sham treatment) x 4 (Time: RS1-RS4) ANOVA on the primary outcome of 
CRPS severity score (see Figure S4b) revealed a significant main effect of Time, F(2.29, 163.45) 
= 19.73, p < .001, ƞ2p = 0.34. Follow-up contrasts indicated overall reduction in CRPS severity 
(regardless of treatment) from RS2 (Mdn = 12.00, BCa 95% CI [12.00, 12.00]) to RS3 (Mdn = 
11.00, BCa 95% CI [10.00, 11.00]), Z = -3.91, padj = .002, d = 0.96, which was maintained in RS4 
(Mdn = 11.00, BCa 95% CI [10.00, 11.00]), Z = -3.70, padj = .002, d = 0.90. There were no 
significant differences between the remaining time points, Zs ≥ -1.85, psadj ≥ .122, ds ≤ 0.42. 
There were no significant Group, F(1, 39) = 0.11, p = .746, ƞ2p < 0.01, or interaction effects, 
F(2.29, 163.45) = 0.35, p = .738, ƞ2p = 0.01. Effect size of the difference in mean change in CRPS 
severity over the treatment period (RS3-RS2) between the PA and sham treatment groups was 
small, d = -0.28, 95% CI [-0.89, 0.34]. Mean CRPS severity reduction in the PA treatment group 
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was -0.86 points on 0-16 scale, BCa 95% CI [-1.27, -0.41]. In the sham treatment group, mean 
CRPS severity reduction was -1.25 points, BCa 95% CI [-2.05, -0.48].  
Individual pain and CRPS severity reduction scores over the treatment period are illustrated in 
Figure S5. Five participants in the PA group and four in the sham group achieved clinically 
significant reductions in pain (i.e. at least two-point decrease on 0-10 NRS scale [1]). None of the 
participants achieved clinically significant reduction in CRPS severity (i.e. at least 4.9 points 
decrease on 0-16 scale) [4]. 
3. Effects of PA treatment on the secondary outcomes 
Group average scores on the self-report questionnaires, clinical assessments, and experimental 
tests of neuropsychological functions across all time points are reported in Table S4.  
3.1. Self-reported pain, body representation, and emotional functioning 
We conducted a series of 2 (Group: PA, sham treatment) x 6 (Time: RS1-RS4, LTFU1-LTFU2) 
ANOVAs on self-reported pain, body representation, and emotional functioning to test the effects 
of PA on these secondary outcomes. Results are reported in Table S5. A significant main effect 
of Time on pain interference (BPI) indicated that regardless of treatment, participants reported 
less interference from RS2 (Mdn = 6.00, BCa 95% CI [5.42, 6.71]) to RS3 (Mdn = 5.29, BCa 95% 
CI [4.57, 5.86]), and to RS4 (Mdn = 5.14, BCa 95% CI [4.00, 6.14]). However, these effects did 
not withstand correction for multiple comparisons, Zs ≥ -2.57, psadj ≥ .080, ds ≤ 0.59. There was 
also a significant main effect of Time for neuropathic features of pain (PDQ). Regardless of 
treatment, participants reported decreased neuropathic component of pain from RS1 (Mdn = 
25.00, BCa 95% CI [22.00, 26.00]) to RS2 (Mdn = 24.00, BCa 95% CI [24.00, 24.00]), and from 
RS3 (Mdn = 23.00, BCa 95% CI [21.00, 26.00]) to RS4 (Mdn = 22.00, BCa 95% CI [19.00, 
25.00]). However, these effects did not withstand correction for multiple comparisons, Zs ≥ -2.08, 
psadj ≥ .288, ds ≤ 0.47. ANOVA on body representation (BPDS) also revealed a significant main 
effect of Time. Despite participants reporting reduction in body perception disturbance from RS2 
(M = 27.95, BCa 95% CI [24.63, 31.28]) to RS3 (M = 25.22, BCa 95% CI [21.22, 29.20]) and to 
RS4 (M = 25.46, BCa 95% CI [21.68, 29.02]), regardless of treatment, these effects were not 
sufficiently large to withstand correction for multiple comparisons, ts ≤ 2.30, psadj ≥ .288, ds ≤ 
0.48. We found a significant main effect of Time on fear of movement (TSK), suggesting that 
regardless of treatment, participants reported less fear of movement from RS2 (M = 38.49, BCa 
95% CI [35.85, 41.48]) to RS3 (M = 37.05, BCa 95% CI [34.39, 39.81]) and to RS4 (M = 36.68, 
BCa 95% CI [34.07, 39.61]). However, these effects did not withstand correction for multiple 
comparisons, ts ≤ 2.56, psadj ≥ .144, ds ≤ 0.35. There was also a significant interaction between 
Time and Group, indicating that sham treatment group reported decrease in fear of movement 
from RS2 to RS3, which was maintained in RS4 and LTFU2 (see Table S4). However, these 
effects also did not withstand correction for multiple comparisons, and there were no other 
Appendix – Chapter 5 
335 
changes in either treatment group, ts ≤ 2.76, psadj ≥ .192, ds ≤ 0.73. Our analyses did not reveal 
any other significant main effects or interactions on self-reported pain, body representation, or 
emotional functioning.  
We also investigated whether PA affected participants’ global impression of change due to 
treatment. A 2 (Group: PA, sham treatment) x 4 (Time: RS3, RS4, LTFU1, LTFU2) ANOVA did 
not reveal any significant main effects or interactions (see Table S5). 
We performed a series of t-tests on the daily logbook ratings. PA and sham treatment groups did 
not differ on average daily ratings of pain intensity (ts(39) ≤ 1.75, ps ≥ .071, ds ≤ 0.58), symptoms 
interference (ts(39) ≤ 1.44, ps ≥ .158, ds ≤ 0.45), or range of movement (ts(39) ≤ 1.19, ps ≥ .242, 
ds ≤ 0.37) at any time point during the first 10 weeks of the trial.  
3.2. Sensory, motor, and autonomic functions 
We performed a series of 2 (Group: PA, sham treatment) x 4 (Time: RS1-RS4) ANOVAs on 
allodynia ratings on the affected limb, two-point discrimination threshold ratios, absolute 
temperature and oedema differences between the two arms, and grip strength ratios. The results 
are reported in Table S5. Upon these clinical assessments, we only found a significant main effect 
of time on grip strength ratios. That is, regardless of treatment, participants’ grip strength in the 
affected relative to unaffected hand improved from RS2 (Mdn = 0.31, BCa 95% CI [0.21, 0.41]) 
to RS3 (Mdn = 0.42, BCa 95% CI [0.33, 0.46]), Z = -2.26, padj = .032, d = 0.52. There were no 
significant differences between the remaining time points, Zs ≥ -1.92, psadj ≥ .159, ds ≤ 0.43. 
The Mechanical Detection Threshold, Mechanical Pain Threshold, and delta finger-to-palm 
distance ratios data were analysed using linear mixed models due to severe violations of 
normality, homogeneity of covariance, and/or sphericity assumptions. The results are reported in 
Table S6. There were no significant main effects or interactions on these outcomes. 
3.3. Neuropsychological functions 
We conducted a series of 2 (Group: PA, sham treatment) x 4 (Time: RS1-RS4) ANOVAs on the 
scores from test of neuropsychological functions, that is, visuospatial attention (Temporal Order 
Judgement and Greyscales tasks), mental representation of space (MNLB task), and body 
representation (Hand Laterality Recognition task). The results are reported in Table S5. We found 
a significant main effect of Time on the Hand Laterality Recognition accuracy index. Regardless 
of treatment, participants’ accuracy in recognising images of unaffected relative to affected hands 
increased from RS2 (M = -2.93, BCa 95% CI [-5.56, -0.59]) to RS3 (M = 2.68, BCa 95% CI [0.15, 
537]), t(40) = -2.55, padj = .036, d = 0.40, and this increase was maintained in RS4 (M = 1.95, 
BCa 95% CI [-1.17,4.98]), t(40) = -2.58, padj = .039, d = 0.46. There were no significant 
differences between the remaining time points, ts ≤ 1.43, psadj ≥ .314, ds ≤ 0.19. This finding 
suggests an overall increased impairment of the representation of the affected hand over the 
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treatment period, as positive indices represent less accurate recognition of the images depicting 
affected hands.  
The Landmark task and spatially-defined motor function task data were analysed using linear 
mixed models due to severe violations of normality, homogeneity of variance, and/or sphericity 
assumptions. The results are reported in Table S6. We found a significant main effect of Time on 
Index A of directional hypokinesia when participants used their affected hand. Regardless of 
treatment, participants became faster to initiate movements directed towards their affected relative 
to unaffected side from RS2 (Mdn = 11.24, BCa 95% CI [-31.99, 20.28]) to RS3 (Mdn = -23.63, 
BCa 95% CI [-46.40, -14.89]), Z = -2.24, padj = .040, d = 0.60. There were no significant 
differences between the remaining time points, Zs ≥ -0.94, psadj ≥ .240, ds ≤ 0.24. This suggests 
an overall reduction in directional hypokinesia over the treatment period. However, this effect 
was not evidenced on any other indices of directional hypokinesia or bradykinesia.  
We found no other significant main effects of interactions on the tests of visuospatial attention, 
mental representation of space, spatially-defined motor function, or body representation.  
4. Per-protocol versus intention-to-treat analysis 
The results of per-protocol (PP) analysis were largely consistent with those of intention-to-treat 
(ITT) analysis in that there were no significant effects of PA on the primary or secondary 
outcomes. That is, we did not find any significant interactions between Time and treatment Group, 
which would yield significant differences following the corrections for multiple comparisons. 
Furthermore, overall (regardless of received treatment) reduction in CRPS severity over the 
treatment period, maintained four weeks later, was consistent between PP and ITT analyses. 
Overall reduction in self-reported pain interference over the treatment period (ITT) did not 
withstand correction for multiple comparisons in PP analysis. PP analysis revealed a significant 
overall improvement in grip strength of the affected relative to unaffected limb over the treatment 
period, which was not found in ITT analysis. Similarly, only PP analysis showed a significant 
overall change in hand laterality recognition accuracy over the treatment period, maintained four 
weeks later. Contrary to our hypothesis, this effect suggested greater impairment in representation 
of the affected limb following treatment period. Index A of directional hypokinesia when using 
the affected hand decreased over the treatment period, suggesting overall reduction of spatially-
defined motor deficit over the treatment period, only in PP analysis. Overall slowing on Index B 
of directional bradykinesia when using the unaffected hand in PA group compared to sham 
treatment group found in ITT analysis, was not present in PP analysis. The above effects occurred 
regardless of PA or sham treatment. 
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Figure S1. Individual pain intensity and CRPS severity reduction scores (intention-to-treat 
analysis). Grey circles represent individual participants’ change on the primary outcomes of pain 
intensity (A) and CRPS severity (B) from immediately before treatment (RS2, research session 
2) to immediately after treatment (RS3, research session 3). Negative scores indicate reduction in 
pain or CPRS severity over the treatment period. Red circles represent mean (95% CI) reduction 
scores in prism adaptation (PA) and sham treatment groups. Green dashed lines represent the 
threshold of clinically significant reduction in pain and CPRS severity and labels represent IDs 
of participants who achieved that reduction (see Table S1). 
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Figure S2. Daily logbook ratings (intention-to-treat analysis). Mean ratings of average daily pain 
intensity (A), symptom interference (B), and range of movement (C) in prism adaptation (PA; 
orange line) and sham treatment (blue line) group throughout the first 10 weeks of the study. 
Higher scores indicate greater pain intensity, greater symptoms interference, and better range of 
movement of the affected limb. Shaded areas around the lines represent BCa 95% CIs. Grey 
shaded rectangles represent the treatment period. 
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Figure S3. Scatterplots of changes on the primary outcomes vs. CRPS duration (intention-to-treat 
analysis). Relationships between individual participants’ change in pain intensity (A) and CRPS 
severity (B) over the treatment period (between RS2, research session 2, and RS3, research 
session 3) and participants’ disease duration (months since diagnosis) at the time of research 
session 1 are illustrated. Negative scores for pain and CRPS severity indicate reduction of these 
outcomes (i.e. improvement). Participants in the PA (prism adaptation) group are represented by 
orange circles, and those in the sham treatment group are represented by blue triangles. Lines of 
best fit with confidence intervals (shaded surfaces) are superimposed for each treatment group. 
R, Pearson’s correlation coefficients for the relationships between pain reduction and disease 
duration (A) and CRPS severity reduction and disease duration (B). For pain reduction score, one 
observation was removed as an outlier (score = -7). 
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Figure S4. Primary outcomes (per-protocol analysis). Mean [BCa 95% CI] current pain intensity 
(A) and CRPS severity scores (B) in prism adaptation (PA; orange circles) and sham treatment 
(blue diamonds) groups in each time point. RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, 
and 4; LTFU1 and LTFU2, long-term follow-up 1 and 2. Grey arrow represents treatment period. 
** padj < .01. 
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Figure S5. Individual pain intensity and CRPS severity reduction scores (per-protocol analysis). 
Grey circles represent individual participants’ change on the primary outcomes of pain intensity 
(A) and CRPS severity (B) from immediately before treatment (RS2, research session 2) to 
immediately after treatment (RS3, research session 3). Negative scores indicate reduction in pain 
or CPRS severity over the treatment period. Red circle represents mean (95% CI) reduction scores 
in prism adaptation (PA) and sham treatment groups. Green dashed lines represent the threshold 





Table S1 Individual participant characteristics at baseline (RS1) and treatment exposure 




Inciting injury Dur. Pain  CSS  Current treatment / medication Other pain Other comorbidities EHI pre-
CRPS / ∆EHI 
Treat.  
P01 60 / M / R L Hand surgery 51 7 9 Aspirin, paracetamol* - Frozen joints, 
hypertension 
100 / 0 29 
P02 50 / F / R L Hand STI, 
shoulder surgery 
45 7 13 Co-codamol, tramadol*, 
duloxetine, amitriptyline (LTFU2)‡ 
Fibromyalgia Depression, IBS 100 / 0 29 
P03† 36 / M / R R Finger & arm 
fracture 
28 8 13 Morphine, pregabalin, baclofen, 
oramorph*, paracetamol*, 
ibuprofen* 
- Depression, anxiety 100 / -150 0 
P04 63 / F / L L Arm fracture 74 4 9 Paracetamol, HT Fibromyalgia - -100 / 0 29 
P05 31 / F / R L Hand surgery 19 8 14 Amitriptyline, fluoxetine, 
gabapentin, codeine, tramadol*, 
paracetamol*, PT 
Fibromyalgia Asthma 80 / 20 29 
P06 50 / F / R R Wrist 
sprain/crush  
83 5 11 Ibuprofen, co-codamol, tramadol, 
amitriptyline (LTFU2) 




Disease, slipped disk 
67 / -167 29 









100 / -50 28 
P08 37 / F / R R Finger STI 48 7 13 Naproxen, tramadol, pregabalin, 
amitriptyline, TENS, PT (stopped 
LTFU1) 
- Anxiety, depression, 
dyspraxia 
100 / -117 27 
P09 71 / F / R R Hand STI & 
surgery  
66 2 11 Paracetamol*, co-codamol* (RS3; 
stopped RS4) 
- - 100 / -111 28 
P10 54 / F / R L Finger fracture, 
wrist STI 
210 10 13 Gabapentin, amitriptyline, 
naproxen*, morphine patch* 
Frozen shoulder 
(L), hip pain (L), 
back pain 
Psoriasis, depression, 
diabetes II, high blood 
pressure, perforated ear 
drum (L) 
56 / 44 29 
P11 52 / F / R L Wrist fracture, 
elbow fracture & 
surgery 
12 6 14 Amitriptyline, paracetamol*, co-
codamol* (stopped LTFU1) 
- - 29 / 38 29 
P12 54 / F / R L Elbow fracture & 
surgery 
63 7 12 PT, HT (stopped LTFU1) - - 60 / 40 29 
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Inciting injury Dur. Pain  CSS  Current treatment / medication Other pain Other comorbidities EHI pre-
CRPS / ∆EHI 
Treat.  
P13 40 / F / R L - 36 3 14 Gabapentin, nortriptyline, 
tramadol*, PT, co-codamol (RS3) 
- Endometriosis, polycystic 
ovaries, tachycardia 
0 / 5 27 
P14 36 / F / R R Wrist fracture 135 5 13 Pregabalin, duloxetine, co-
codamol, PT, HT (stopped RS3) 
- - 62 / -22 28 
P15 48 / F / R R Wrist surgery 64 7 11 Tramadol*, tapentadol*, SCS (off) Migraines Arthritis (back) 100 / -57 31 
P16 58 / F / R R Wrist fracture 3 2 13 Amitriptyline, paracetamol, 
ibuprofen, PT 
Chronic headaches Arthritis (L knee), 
osteoporosis (R hand & L 
foot; RS3) 
89 / -14 29 
P17† 39 / F / R L - 85 7 12 Gabapentin, co-codamol, 




- 100 / 0 0 
P18 49 / F / R R Wrist surgery 97 4 13 Oxycodone, naproxen, 
buprenorphine patch 
- Carpal tunnel syndrome 
(L wrist), depression, 
anxiety, diabetes 
100 / -114 27 
P19 59 / F / R R Wrist fracture 30 5 14 Paracetamol, lidocaine patch, HT Hips pain Asthma, hyperacusis 100 / -176 28 
P20 38 / F / R L Shoulder 
whiplash injury 
31 7 10 Amitriptyline, pregabalin, 
etoricoxib, duloxetine, HT, tai chi 
Face & neck pain Anxiety 100 / 0 29 
P21 48 / F / R L Shoulder 
whiplash & STI 
70 9 12 Duloxetine, ibuprofen, lidocaine 
patch, pregabalin, tramadol, SCS, 
PT 
CRPS (legs) Crohn's disease, 
depression, 
thyroidectomy  
100 / 0 28 
P22 24 / M / L L Finger STI 103 6 13 Nortriptyline CRPS L leg Depression -43 / 116 27 
P23 53 / M / R R Wrist fracture & 
surgery  
93 5 14 Amitriptyline, pregabalin, co-
codamol, tramadol, morphine, SCS, 
PT 
- - 100 / -200 29 
S01 24 / F / R R Wrist sprain  42 8 15 Pregabalin, tramadol, duloxetine Fibromyalgia Depression, anxiety, 
diabetes, polycystic 
ovaries, asthma 
100 / -120 28 
S02† 54 / F / R L Arm fracture & 
surgery 
6 8 13 - - Hypertension 40 / 60 15 
S03 47 / M / R R Wrist fracture and 
surgery  
38 7 13 Lidocaine patch, co-codamol - Prostate cancer 
(remission), depression, 
anxiety 
100 / -200 25 
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Inciting injury Dur. Pain  CSS  Current treatment / medication Other pain Other comorbidities EHI pre-
CRPS / ∆EHI 
Treat.  






-100 / 50 28 
S05 66 / M / R R Arm STI 108 6 11 Pregabalin, nortriptyline - - 100 / -20 29 
S06 51 / F / R L Shoulder surgery 51 8 13 Gabapentin, ibuprofen, 




 Osteopenia (back) 80 / 20 29 
S07 51 / F / R R Hand fracture 23 3 13 Gabapentin (stopped LTFU2), 
amitriptyline, lidocaine patch, 
ibuprofen*, paracetamol*, stellate 
ganglion block, PT (RS3), 
pregabalin (LTFU2) 
- Asthma, IBS 100 / -180 29 




100 / -114 29 
S09 30 / F / R R Elbow fracture, 
wrist sprain & 
surgery 
71 4 9 Gabapentin, meptazinol, 








Carpal tunnel syndrome 
(R wrist; RS2) 
100 / 0 29 
S10† 66 / F / R L Finger fracture 75 2 11 Co-codamol*, PT - - 100 / 0 8 
S11 53 / F / R R Hand fracture 120 6 11 Ibuprofen* - Vertigo (RS4) 100 / -55 29 
S12 36 / F / R L Finger & wrist 
STI 
6 3 11 Gabapentin, PT, etoricoxib (RS2), 
ibuprofen* (LTFU1) 
Fibromyalgia Depression 100 / 0 29 
S13 49 / F / R L Breast surgery 74 6 13 Gabapentin, fentanyl, baclofen, 
rizatriptan* (migraine), PT 
Migraines Depression 100 / 0 29 
S14 73 / F / R L Arm STI 38 9 12 Buprenorphine, amitriptyline, 
aspirin, PT 





100 / 0 29 
S15† 28 / F / R L Elbow STI 35 6 13 None Migraines Depression, anxiety, 
epilepsy 
27 / 73 23 
S16 20 / F / R R Hand STI 11 5 14 Paracetamol (stopped RS4), OT 
(stopped LTFU1), co-codamol 
(RS4), pregabalin (LTFU2) 
- Asthma 80 / -140 29 
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Inciting injury Dur. Pain  CSS  Current treatment / medication Other pain Other comorbidities EHI pre-
CRPS / ∆EHI 
Treat.  
S17 25 / F / R L wrist sprain and 
laceration 
46 6 13 Tramadol* - Depression, PTSD 44 / 45 28 
S18† 72 / M / R L Heart surgery 123 8 12 Lidocaine patch* - Hernia surgery (recent), 
high blood pressure 
100 / 0 8 
S19 44 / F / R R Hand surgery 20 8 14 Gabapentin, amitriptyline - - 100 / -200 29 
S20 67 / F / R L Arm fractures & 
surgery 
139 7 13 Amitriptyline, gabapentin, 
duloxetine (stopped RS4), 
tapentadol 
Peripheral 
neuropathy (L foot) 
PTSD, depression, 
double vision, high blood 
pressure, anaemia, UTI, 
incontinence 
100 / 0 29 
S21† 41 / M / R L Shoulder 
dislocation 
68 6 10 Amitriptyline, pregabalin, 
morphine* 
CRPS (L leg, face) IBS 100 / 0 29 
S22 35 / F / L L Wrist sprain 58 8 11 Amitriptyline, pregabalin, co-
codamol 
- - -100 / 40 29 
S23 37 / F / R L Wrist fracture 79 9 15 Amitriptyline, duloxetine, 
pregabalin, paracetamol, HT, 
tramadol* (RS2) 
CRPS (L leg) Fowler's syndrome 90 / 10 28 
S24 37 / F / R L Shoulder 
dislocation & 
surgery 
33 4 11 Morphine, paracetamol, TENS, PT, 
desensitization 
Migraines Polycystic ovaries 50 / 50 28 
S25 47 / F / R L Wrist fracture 3 4 11 Lidocaine patch, naproxen (stopped 




90 / 10 29 
S26† 44 / F / R L Wrist sprain 28 7 13 Paracetamol* (RS2) - Bipolar disorder -18 / 118 0 
† Participant withdrew from the trial. 
* Medication taken as needed. 
‡ Time point in which a medication was introduced or stopped, or a new comorbidity reported, is specified in brackets where relevant. 
ID, participant code (P, Prism Adaptation; S, Sham treatment); M, Male; F, Female; L, Left; R, Right; STI, soft tissue injury; Dur., CRPS duration in months since diagnosis; CSS, 
CRPS symptom severity score; RS2, RS3, and RS4, research sessions 2, 3, and 4; LTFU1 and LFTU2, long-term follow-ups 1 and 2; HT, hydrotherapy; PT, physiotherapy; TENS, 
transcutaneous electrical nerve stimulator; SCS, spinal cord stimulator; OT, occupational therapy; NOS, CRPS not otherwise specified; IBS, irritable bowel syndrome; PTSD, post-
traumatic stress disorder; UTI, urinary tract infection; EHI pre-CRPS, recalled hand preference prior to CRPS onset (-100, extreme left-handedness; -40 – 40, ambidextrousness; 100, 
extreme right-handedness); ∆EHI, change in hand preference since CRPS onset (current – recalled pre-CRPS EHI); Treat., number of completed treatment sessions (/29). 
Appendix – Chapter 5 
347 
Table S2 Best subsets of factors (as measured in RS1) for predicting overall change in pain 
intensity and CRPS severity throughout the study period (intention-to-treat analysis) 
Best subsets models Adj. R2 AIC CV 
Change in pain intensity†    
Model 1: (+) Absolute change in handedness* 0.09 -132.24 0.28 
Model 2: (+) Absolute change in handedness*, (+) Index A of 
directional bradykinesia for unaffected hand 0.13 -119.08 0.28 
Model 3: (+) Oedema difference**, (-) Index B of directional 
hypokinesia for affected hand**, (-) Finger-to-palm 
distance ratio* 0.25 -105.79 0.30 
Model 4: (+) Oedema difference**, (-) Index B of directional 
hypokinesia for affected hand*, (-) Finger-to-palm 
distance ratio*, (+) Mood disturbance 0.27 -105.68 0.29 
Model 5: (+) Oedema difference**, (-) Index B of directional 
hypokinesia for affected hand**, (+) MNLB score*, 
(+) Absolute change in handedness, (-) Finger-to-palm 
distance ratio 0.32 -107.60 0.33 
Change in CRPS severity†    
Model 1: (+) Current pain intensity** 0.13 -50.21 0.60 
Model 2: (+) Current pain intensity**, (-) Index B of directional 
bradykinesia for unaffected hand* 0.23 -48.39 0.59 
Model 3: (+) Current pain intensity***, (+) Oedema 
difference*, (+) Hand laterality recognition accuracy 
index* 0.25 -55.52 0.55 
Model 4: (+) Allodynia on affected limb*, (-) Index B of 
directional bradykinesia for unaffected hand*, (-) 
Index B of directional hypokinesia for unaffected 
limb*, (+) disease duration 0.21 -45.66 0.58 
Model 5: (-) Index B of directional bradykinesia for unaffected 
hand*, (-) Index B of directional hypokinesia for 
unaffected limb, (+) Allodynia on affected limb, (+) 
Disease duration, (+) Body perception disturbance 
score 0.21 -44.84 0.58 
† Predicted outcomes were quantified as individual regression slopes based on pain intensity ratings 
throughout RS1-RS4 and LTFU1-LTFU2, and CRPS severity scores throughout RS1-RS4. 
Asterisks indicate significant predictors: * p < .05, ** p < .01, *** p < .001; (+), positive predictor; (-), 
negative predictor. 
Adj. R2, adjusted R-squared; AIC, Akaike Information Criterion; CV, cross-validation error; MNLB, 
Mental Number Line Bisection;  
Figures in bold indicate the lowest AIC and CV.  
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Table S3 Baseline (RS1) participant characteristics by treatment group (per-protocol analysis) 
Measure 
Prism adaptation 
treatment (n = 21) 
Sham treatment  
(n = 20) 
Contrast 
Minimisation factors    
Current pain intensity (/10) 
Mdn 
6.00 [5.00, 7.00] 6.00 [5.00, 8.00] U = 189.00, p = 
.580, d = 0.17 
CRPS severity score (/16) 
Mdn 
13.00 [11.00, 14.00] 12.50 [11.00, 13.00] U = 210.00, p = 
1.00, d < 0.01 
Primarily affected arm (% 
right) 
48% 45% χ2(1) = .03, p = 
.876, ϕ = -0.03 
Pre-CRPS dominant hand (% 
right) 
91% 90% χ2(1) < .01, p = 
.959, ϕ = -0.01 
Sex (% female) 86% 90% χ2(1) = .18, p = 
.675, ϕ = -0.07 
Age (years) M 48.29 [43.00, 52.83] 43.65 [37.36, 50.39] t(39) = 1.14, p = 
.276, d = -0.35 
CRPS in other body parts (% 
present) 
14% 5% χ2(1) = 1.00, p = 
.317, ϕ = -0.16 
Other non-CRPS pain (% 
present) 
43% 45% χ2(1) = .02, p = 
.890, ϕ = -0.02 
CRPS duration (months since 
diagnosis) M 
61.71 [48.57, 75.91] 51.25 [34.72, 68.56] t(39) = 0.90, p = 
.397, d = -0.28 
Other control measures    
Optimism (LOTR; /24) M 12.90 [10.89, 14.76] 11.70 [10.07, 13.27] t(39) = 0.94, p = 
.360, d = -0.29 
Mood disturbance (POMS; 
/229) M 
96.12 [80.01, 113.80] 84.80 [69.97, 100.30] t(39) = 0.91, p = 
.388, d = -0.28 
Fear of movement (TSK; /68) 
M 
38.34 [34.18, 42.62] 39.90 [36.36, 43.63] t(39) = -0.55, p = 
.578, d = 0.17 
Number of logged treatment 
sessions (/29) Mdn 
29.00 [28.56, 29.44] 29.00 [28.52, 29.48] U = 184.50, p = 
.418, d = 0.21 
LOTR, Revised Life Orientation Test; POMS, Profile of Mood States; TSK, Tampa Scale for 
Kinesiophobia. 
Bootstrapped bias-corrected and accelerated 95% confidence intervals are reported in square brackets, [BCa 
95% CI].  
There were no significant differences between groups on any measures. 
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Table S4 Mean or median values [BCa 95% CI] of self-reported; sensory, autonomic, and motor; and neuropsychological secondary outcome measures at each time 
point (per-protocol analysis) 
Measure Treatment 
group 
Time point      
RS1 RS2 RS3 RS4 LTFU1 LTFU2 
Self-report questionnaires 
Pain  
Pain severity (BPI; /10) M PA 5.84 [4.88, 6.70] 6.01 [5.04, 6.91] 5.22 [4.15, 6.27] 5.34 [4.30, 6.41] 5.47 [4.38, 6.57] 5.49 [4.43, 6.53] 
Sham 5.72 [4.82, 6.53] 5.63 [4.65, 6.49] 5.49 [4.61, 6.27] 5.49 [4.26, 6.50] 5.75 [4.83, 6.57] 5.58 [4.36, 6.59] 
Pain interference (BPI; /10) 
Mdn 
PA 6.29 [5.71, 7.00] 6.29 [5.00, 7.29] 5.14 [2.57, 6.43] 5.14 [2.71, 6.71] 5.86 [2.50, 6.86] 5.71 [4.57, 6.57] 
Sham 5.79 [5.00, 6.86] 5.79 [3.81, 6.36] 5.36 [4.00, 6.29] 4.64 [3.43, 6.14] 5.14 [3.00, 6.57] 5.50 [3.14, 6.43] 
Neuropathic features of pain 
(PDQ; /38) Mdn 
PA 26.00 [26.00, 26.00] 24.00 [19.00, 26.00] 23.00 [19.00, 27.00] 22.00 [15.50, 27.00] 24.00 [16.00, 28.00] 24.00 [18.00, 28.00] 
Sham 23.50 [20.50, 28.00] 23.50 [19.00, 26.00] 22.50 [19.00, 26.50] 20.50 [14.00, 25.00] 21.00 [20.00, 24.00] 21.00 [17.00, 26.00] 
Body representation 
Body perception disturbance 
(BPDS; /57) M 
PA 27.95 [21.83, 35.18] 27.21 [22.22, 31.85] 20.79 [15.15, 26.95] 23.74 [19.09, 29.00] 24.63 [20.12, 29.81] 23.32 [18.98, 28.62] 
Sham 27.89 [21.83, 34.07] 27.61 [20.82, 34.30] 27.83 [21.56, 34.14] 25.72 [18.59, 32.37] 26.22 [20.50, 31.74] 26.89 [21.31, 32.56] 
Emotional functioning 
Fear of movement (TSK; /68) 
M 
PA 38.43 [33.82, 43.05] 38.11 [33.57, 42.82] 37.11 [33.01, 41.26] 37.79 [32.94, 42.45] 38.32 [33.56, 43.16] 39.95 [34.65, 44.90] 
Sham 39.44 [36.17, 42.72] 38.00 [34.75, 41.29] 35.94 [32.64, 39.31] 34.50 [30.78, 37.90] 35.85 [32.17, 39.41] 34.33 [30.58, 37.85] 
Mood disturbance (POMS; 
/229) Mdn 












Sham 68.00 [58.00, 80.00] 84.00 [64.00, 113.00] 69.50 [60.50, 85.34] 78.00 [51.00, 90.00] 74.50 [49.00, 91.00] 82.64 [48.00, 102.00] 
Perceived improvement due to treatment 
Patient’s global impression of 
change (PGIC; /7) Mdn 
PA - - 2.00 [2.00, 4.00] 3.00 [3.00, 3.00] 2.00 [2.00, 4.00] 3.00 [2.00, 3.00] 
Sham - - 2.00 [1.00, 5.00] 3.00 [1.00, 5.00] 2.00 [1.50, 2.00] 2.00 [1.00, 4.00] 
        





Time point      




Threshold ratio Mdn 
PA -0.04 [-0.67, 0.25] -0.35 [-0.80, -0.13] -0.44 [-0.76, -0.10] -0.54 [-1.89, -0.10] - - 
Sham -0.30 [-1.37, 0.62] 0.00 [-0.35, 0.17] -0.27 [-1.19, 0.31] -0.46 [-1.24, 0.45] - - 
Mechanical Pain Threshold 
ratio Mdn 
PA 0.62 [0.00, 0.69] 0.50 [0.43, 0.53] 0.07 [-0.32, 0.69] 0.50 [0.13, 0.69] - - 
Sham 0.58 [0.24, 0.67] 0.59 [0.44, 0.75] 0.61 [0.34, 0.84] 0.50 [0.26, 0.78] - - 
Allodynia (affected; /100) 
Mdn 
PA 14.00 [8.07, 26.67] 18.87 [4.33, 30.89] 16.90 [7.40, 26.67] 10.73 [2.53, 18.00] - - 
Sham 25.83 [8.36, 41.00] 14.67 [4.33, 32.00] 21.00 [2.27, 65.67] 25.00 [5.23, 52.00] - - 
Two-Point Discrimination 
Threshold ratio M 
PA -0.05 [-0.24, 0.14] -0.04 [-0.20, 0.11] -0.19 [-0.39, 0.00] -0.09 [-0.27, 0.09] - - 
Sham 0.11 [-0.05, 0.26] 0.00 [-0.20, 0.16] 0.03 [-0.14, 0.20] 0.08 [-0.14, 0.29] - - 
Autonomic functions 
Absolut temperature 
difference (°C) Mdn 
PA 0.57 [0.30, 1.43] 0.30 [0.13, 1.00] 0.47 [0.20, 0.73] 0.53 [0.17, 1.33] - - 
Sham 0.60 [0.25, 0.80] 0.72 [0.40, 1.10] 0.65 [0.40, 1.10] 0.43 [0.35, 0.83] - - 
Oedema difference (cm) M PA 0.04 [-0.40, 0.46] -0.05 [-0.40, 0.27] -0.22 [-0.66, 0.22] -0.26 [-0.65, 0.12] - - 
Sham -0.01 [-0.50, 0.57] 0.11 [-0.38, 0.63] -0.01 [-0.52, 0.49] 0.19 [-0.27, 0.66] - - 
Motor functions 
Grip strength ratio Mdn PA 0.35 [0.18, 0.39] 0.31 [0.19, 0.44] 0.35 [0.30, 0.45] 0.39 [0.30, 0.46] - - 
Sham 0.28 [0.18, 0.66] 0.33 [0.14, 0.67] 0.44 [0.15, 0.81] 0.42 [0.16, 0.77] - - 
Delta finger-to-palm distance 
ratio Mdn 
PA 0.70 [0.62, 0.86] 0.67 [0.61, 0.84] 0.73 [0.63, 0.84] 0.79 [0.70, 0.82] - - 
Sham 0.85 [0.63, 0.92] 0.78 [0.42, 0.94] 0.88 [0.61, 0.92] 0.86 [0.64, 0.94] - - 
Experimental tests of neuropsychological functions 
Visuospatial attention 
Temporal Order Judgement 
task (PSS; ms) Mdn 
PA -9.77 [-14.38, 5.52] -3.76 [-14.83, 8.35] -3.26 [-8.75, 11.16] 5.18 [-7.84, 20.27] - - 
Sham -2.42 [-7.40, 7.06] -0.75 [-8.33, 9.15] 1.17 [-5.25, 9.56] -2.12 [-10.48, 11.52] - - 





Time point      
RS1 RS2 RS3 RS4 LTFU1 LTFU2 
Sham 0.06 [-0.09, 0.27] 0.05 [-0.12, 0.15] -0.05 [-0.11, 0.10] 0.02 [-0.04, 0.09] - - 
Greyscales task M PA -0.22 [-0.40, -0.03] -0.15 [-0.38, 0.07] -0.11 [-0.33, 0.09] -0.14 [-0.37, 0.07] - - 
Sham -0.05 [-0.26, 0.17] -0.02 [-0.21, 0.19] 0.05 [-0.13, 0.22] -0.04 [-0.22, 0.16] - - 
Mental representation of space 
Mental Number Line 
Bisection task M 
PA -0.04 [-0.91, 0.75] 0.03 [-0.62, 0.71] -0.11 [-0.69, 0.49] -0.01 [-0.51, 0.50] - - 
Sham 0.35 [-0.21, 0.98] 0.24 [-0.41, 0.89] 0.05 [-0.60, 0.74] 0.15 [-0.32, 0.73] - - 
Spatially-defined motor function 
Directional hypokinesia, 
affected hand, Index A (MIT; 
ms) Mdn 



















affected hand, Index B (MIT; 
ms) Mdn 



















unaffected hand, Index A 
(MIT; ms) Mdn 



















unaffected hand, Index B 
(MIT; ms) Mdn 



















affected hand, Index A 
(MET; ms) Mdn 































Time point      
RS1 RS2 RS3 RS4 LTFU1 LTFU2 
Directional bradykinesia, 
affected hand, Index B 
(MET; ms) Mdn 










unaffected hand, Index A 
(MET; ms) Mdn 



















unaffected hand, Index B 
(MET; ms) Mdn 



















Hand laterality recognition 
Accuracy Index (%) M 


















Hand laterality recognition 
Reaction Time Index (ms) 
Mdn 


















BPI, Brief Pain Inventory; PDQ, Pain Detect Questionnaire; BPDS, Bath CRPS Body Perception Disturbance Scale; TSK, Tampa Scale for Kinesiophobia; POMS, Profile of Mood 
States; PSS, Point of Subjective Simultaneity; PSE, Point of Subjective Equality; MIT, movement initiation time; MET, movement execution time; PA, prism adaptation treatment; 
Sham, sham treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4; LTFU1 and LFTU2, long-term follow-ups 1 and 2. 
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Table S5 Analysis of variance results for secondary outcome measures (per-protocol analysis) 
Measure Effect df† F p ƞ2p 
Self-report questionnaires 
Pain severity (BPI) Time 3.98, 139.33 1.50 0.205 0.04 
Group 1, 35 0.01 0.944 < 0.01 
Time x Group 3.98, 139.33 0.69 0.600 0.02 
Pain interference (BPI) Time* 3.24, 113.39 5.06 0.002 0.13 
Group 1, 35 0.15 0.702 < 0.01 
Time x Group 3.24, 113.39 0.83 0.489 0.02 
Neuropathic features of 
pain (PDQ) 
Time* 3.30, 115.47 4.20 0.006 0.11 
Group 1, 35 0.38 0.542 0.01 
Time x Group 3.30, 115.47 0.79 0.511 0.02 
Body perception 
disturbance (BPDS) 
Time* 3.42, 119.54 2.82 0.035 0.07 
Group 1, 35 0.43 0.515 0.01 
Time x Group 3.42, 119.54 2.15 0.089 0.06 
Fear of movement (TSK) Time* 3.90, 136.61 3.02 0.021 0.08 
Group 1, 35 0.45 0.507 0.01 
Time x Group* 3.90, 136.61 4.08 0.004 0.10 
Mood disturbance 
(POMS) 
Time 3.57, 125.02 2.47 0.055 0.07 
Group 1, 35 1.18 0.284 0.03 
Time x Group 3.57, 125.02 0.27 0.881 0.01 
Patient’s global 
impression of change 
(PGIC) 
Time 3, 105 0.64 0.588 0.02 
Group 1, 35 < 0.01 0.988 < 0.01 
Time x Group 3, 105 0.38 0.765 0.01 
Clinical assessments 
Allodynia (affected limb) Time 2.14, 83.43 1.13 0.332 0.03 
Group 1, 39 0.84 0.366 0.02 




Time 3, 117 1.07 0.364 0.03 
Group 1, 39 1.81 0.186 0.04 
Time x Group 3, 117 0.80 0.499 0.02 
Absolut temperature 
difference 
Time 3, 117 0.66 0.577 0.02 
Group 1, 39 0.01 0.913 < 0.01 
Time x Group 3, 117 0.33 0.802 0.01 
Oedema difference Time 2.54, 99.16 1.12 0.339 0.03 
Group 1, 39 0.40 0.531 0.01 
Time x Group 2.54, 99.16 2.64 0.063 0.06 
Grip strength ratio Time* 2.36, 92.03 4.43 0.010 0.10 
Group 1, 39 0.28 0.599 0.01 
Time x Group 2.36, 92.03 0.78 0.479 0.02 
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Measure Effect df† F p ƞ2p 
Experimental tests of neuropsychological functions 
Temporal Order 
Judgement task (PSS) 
Time 1.74, 67.97 1.75 0.186 0.04 
Group 1, 39 0.35 0.556 0.01 
Time x Group 1.74, 67.97 0.73 0.466 0.02 
Greyscales task Time 3, 117 1.54 0.207 0.04 
Group 1, 39 0.97 0.330 0.02 
Time x Group 3, 117 0.15 0.927 < 0.01 
Mental Number Line 
Bisection task 
Time 2.41, 94.10 0.40 0.712 0.01 
Group 1, 39 0.30 0.586 0.01 




Time* 3, 117 2.71 0.049 0.06 
Group 1, 39 2.00 0.165 0.05 




Time 3, 117 1.58 0.198 0.04 
Group 1, 39 0.87 0.357 0.02 
Time x Group 3, 117 0.47 0.702 0.01 
* Statistically significant effect (p < .05). 
† Greenhouse-Geisser adjusted degrees of freedom are reported where sphericity assumption was violated. 
BPI, Brief Pain Inventory; PDQ, Pain Detect Questionnaire; BPDS, Bath CRPS Body Perception 




Table S6 The results of the bootstrapped linear mixed models regressions of scores on the tests of sensory and motor function, visuospatial attention, and spatially-
defined motor function - directional hypokinesia and bradykinesia (per-protocol analysis) 
Model term Coefficient estimate [95% CI]     
 Sensory functions  Motor function Visuospatial 
attention 










    
Intercept -1.31 [-3.24, 0.31] -0.09 [-0.89, 0.73] 0.70 [0.64, 0.75]* 0.25 [-1.28, 2.67]     
Time (RS2 = 0)     
RS1 -2.81 [-8.37, 1.05] -0.57 [-1.92, 0.46] -0.04 [-0.12, 0.04] 2.72 [-0.23, 8.90]     
RS3 -0.55 [-3.15, 1.66] -0.66 [-1.99, 0.42] -0.02 [-0.12, 0.05] 0.11 [-1.84, 2.16]     
RS4 -1.66 [-5.21, 1.24] 0.17 [-0.68, 1.12] 0.02 [-0.06, 0.10] 0.24 [-1.79, 2.58]     
Group (PA = 0)     
Sham 0.29 [-2.25, 2.80] 0.23 [-0.74, 1.20] -0.01 [-0.09, 0.08] -0.27 [-2.70, 1.23]     
Time x Group (RS2, PA = 0)     
RS1, Sham 2.95 [-1.97, 8.99] 0.32 [-1.13, 1.89] 0.05 [-0.06, 0.17] -2.53 [-8.79, 0.47]     
RS3, Sham -2.04 [-7.86, 2.51] 1.00 [-0.29, 2.47] 0.06 [-0.04, 0.19] -0.09 [-2.13, 1.87]     
RS4, Sham 1.95 [-1.92, 6.40] -0.04 [-1.19, 1.10] 0.02 [-0.08, 0.13] -0.24 [-2.57, 1.76]     
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Model term Coefficient estimate [95% CI]     
 Directional hypokinesia (MIT) Directional bradykinesia (MET) 
 Affected hand  Unaffected hand  Affected hand  Unaffected hand  
 Index A Index B Index A Index B Index A Index B Index A Index B 
















Time (RS2 = 0)     
















































Group (PA = 0)     
















Time x Group (RS2, PA = 0)     
















































* Significant effect (95% CI around the coefficient estimate does not include 0). 
The reference condition for dummy variable coding is indicated within parentheses for each term. 
PA, prism adaptation treatment; Sham, sham treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4; PSE, Point of Subjective Equality; MIT, movement initiation time; 
MET, movement execution time. 
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Table S7 CONSORT 2010 checklist of information to include when reporting a randomised trial 
Section/Topic Item 
No 
Checklist item Reported on 
page No 
Title and abstract 
 1a Identification as a randomised trial in the title 230 




2a Scientific background and explanation of rationale 232-233 
2b Specific objectives or hypotheses 232-233 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 233 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons 233 
Participants 4a Eligibility criteria for participants 234 
4b Settings and locations where the data were collected 233 




Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed 239-246, Figure 
1 
6b Any changes to trial outcomes after the trial commenced, with reasons Text S1 
Sample size 7a How sample size was determined 246 
7b When applicable, explanation of any interim analyses and stopping guidelines 234 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 238 




9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), describing any 
steps taken to conceal the sequence until interventions were assigned 
238 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to interventions 237-238 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those assessing 
outcomes) and how 
237-239 





Checklist item Reported on 
page No 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 247-248 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 247-249 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and were analysed for 
the primary outcome 
246-247, Figure 
2 
13b For each group, losses and exclusions after randomisation, together with reasons 246-247 
Recruitment 14a Dates defining the periods of recruitment and follow-up 233 
14b Why the trial ended or was stopped 246-247 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 249-250, Table 
1 





17a For each primary and secondary outcome, results for each group, and the estimated effect size and its precision (such as 95% 
confidence interval) 
251-263, Figure 
4, Tables 2-7 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended NA 




Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) Figure 2 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 271-272 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 268-272 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 268-272 
Other information  
Registration 23 Registration number and name of trial registry 233 
Protocol 24 Where the full trial protocol can be accessed, if available 233, Chapter 3 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 272 
 
 
 
